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Abstract
The annual EU consumption of energy is approaching 3 Terawatt.hr−1, but the majority
of this is powered by fossil fuel. Burning of fossil fuels has produced a global catastrophe,
climate change, and carbon-free replacement technologies are urgently required to prevent
this from becoming worse in the coming years. The CyanoFactory consortium worked
to optimise the organism Synechocystis sp. PCC6803 (herein Synechocystis) to produce
industrially relevant levels of bio-hydrogen as one such potential solution. This thesis
discusses aspects of this ambitious project, focusing on understanding and optimising the
internal protein network of the organism to engineer a functional and efficient system.
Synechocystis is a model cyanobacteria – and so has a significant body of research asso-
ciated with it compared with other cyanobacteria, but is nowhere near as well studied
as the other major model organisms such as E. coli or S. cerevisiae – particularly in
protein-level studies, although this is changing with time. Whole-proteome studies are
highly advanced in medical applications, however bioengineering using proteomics still
lags behind studies which directly measure individual proteins, metabolic outputs, or nuc-
leic acid studies. A number of proposals emerge from the literature as the most effective
way to move forward, part of which is filling the gaps in the literature for Synechocystis
and production strains in general. The major improvement missing from this field is the
broad-spectrum inclusion of broadly applicable bioengineering techniques, such as syn-
thetic biology, being integrated with whole-proteome studies, rather than just focusing on
individual pathways. This gap is likely to be filled in the near future, with the recent im-
provements to proteomic technologies and the increasing popularity of the methodology
– which has seen a sharp increase since the start of 2015.
The current gap between the medical studies and production strains provides an oppor-
tunity to test a variety of different approaches, that look more at general whole-cell level
responses rather than targeted observations. These gaps in knowledge are assessed herein,
and new methods for analysing Synechocystis specifically are proposed. These proposals
cover both alterations to the practical protocol, including physically lysing cells based
on meta-analysis of the literature with experimental verification, more accurate methods
of determining protein levels – which are generally complicated by coloured compounds
found in cyanobacteria; and computational protocols for improving the quantity, qual-
ity and relevance of the data obtained, including better observation of low-abundance
proteins in a complex background, assessment and recommendations for expanding the
number of different samples that can be measured simultaneously, and simpler tools for
identifying broad-sweeping changes, where metabolic-network derived investigations are
unsuitable.
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Isobaric tags are popular methods for analysing the relative quantity of proteins observed
in a cell-wide sample, however there are different technologies for this method. The two
most popular tag-based quantification technologies – iTRAQ and TMT – are directly
compared, to determine which method is more suitable for analyses in Synechocystis.
The study was focused on Synechocystis, however the observations are also more generally
applicable to other investigations. To perform this study, a modelled assessment of the
‘proteomic background’ of Synechocystis was carried out, providing an impression of the
internal proteome distribution – a valuable set of information for carrying out more
accurate engineering of the internal mechanisms with technologies, such as Synthetic
Biology. The study found that whilst TMT tags generally produced more quantifications,
the iTRAQ tags were more accurate over a greater range – however to take advantage
of this would require a larger number of repeated injections of the iTRAQ samples,
producing a relatively inflated cost for better quality data.
Combining these tools, a direct assessment was carried out of the systemic changes that
occur in Synechocystis under hydrogen-producing conditions, along with an assessment
of a media proposed for optimised H2 production. This experiment first carried out with
the methods used more widely at the start of this analysis, and the second was con-
ducted afterwards, utilising many of the methodological improvements proposed in this
thesis. Ultimately, an increase in data quantity and quality was observed. As hydrogen
production is a response to a change of conditions, the pathway-level assessment of the
proteome changes show a concordant switch between 2 very clear states under the exper-
imental conditions used. This suggests that finding a way to produce hydrogen directly
– under normal growth conditions in light – will be extremely challenging as it funda-
mentally competes with the growth and function of the organism; however an integrated
approach, merging the production of high-value side products during the day, coupled
with hydrogen production at night for generating power to run the bioreactor system,
has a much greater chance of success. A decision on which products should be targeted
to make the system economically viable will dictate further analysis of the data.
The major conclusions of this work show that the suggested improvements are beneficial
to proteomic studies in Synechocystis, producing an improvement to quantity, quality
and accessibility of proteomic data. These observations have been applied to hydrogen
production systems, demonstrating that whilst bio-hydrogen is unlikely to be the white
knight that will save the world from climate change, it can be integrated into large-scale
production systems to improve energy efficiency – where the energy saved can reduce
costs and power-inputs required from carbon-based fuels. The methods suggested here,
whilst ultimately adding little to the assessment of H2 production, have huge potential
when integrated into future project focused on the production of more economically viable
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1.1 Energy, Biofuels and High Value Products
1.1.1 Fossil Fuels
In 2010, European countries consumed over 2.77 Terawatt.hr−1 of energy (Energy Inform-
ation Administration, 2013), with the major provision of this generated from fossil fuel
sources. Fossil fuels are convenient for use: they are high-energy density hydrocarbon mo-
lecules that can be transported great distances and stored stably for long periods of time.
This makes fossil fuels ideal for transportation such as automobiles, where electrically
powered solutions are limited by battery technologies or lack of a constantly availabile
of a power supply. Furthermore, a stockpile of fossil energy resources can be collected
and pooled, enabling the provision of stable outputs of electricity from a powerstation
over long periods of time, generally without dramatic short-term fluctuations in either
price or supply. This means that the energy output can also be tuned to the operational
requirements at the time, and so during winter months when energy demand is generally
higher, the output of the power stations can be altered to provide what is needed.
Beyond this convenience of use and flexibility, the technology has been in widespread
use for over a century and is implemented in every country across the modern world.
As a result, there is huge financial backing of the fossil fuel industry, who have been
investing in carbon capture and efficiency-improving technologies; such as clean-burning
liquefied natural gas plants (Metz et al., 2005). These are a significant improvement
on the classic coal-fired power plants, which produced harmful environmental pollutants
such as sulphur dioxide derived acid rain, and are now largely decommissioned - although
these coal-fired power stations are still notably used widely in developing countries such
as China and India, which together make up over 75% of the currently planned coal-fired
power stations (Yang and Cui, 2012). Ultimately, the strongest support for fossil fuels is
that there is a great deal of infrastructure already in place, along with widespread public
acceptance of pre-existing technology powered by coal, oil and gas.
1.1.2 Limitations of Fossil Fuels
Despite these key advantages, there are several world-altering drawbacks to the wide-
spread use of fossil fuels. Supplies are limited because creation of these fuels takes hun-
dreds of thousands of years and extraction techniques are becoming more expensive as
easily obtained oil is consumed. We are now beyond the era referred to as ’peak oil’,
where the amount of energy required to draw the oil from the ground was significantly
lower than the energy that could be obtained by burning it as fuel (Bardi, 2009). The
ratio was initially 1:100 input to output, but recent estimates place it at a range closer
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Figure 1.1: A graph charting global CO2 concentrations in parts per million over the last
century. (Image created in Wolfram Mathematica.)
to 1:8. Both of these factors drive the price of fossil fuels up, which – given the heavy
requirement for it in modern society – has potentially catastrophic economic and social
consequences.
Burning fossil fuels releases a number of pollutants into the environment that have been
long-dormant. Numerous world-wide investigations have been conducted, and a compiled
report published by the Intergovernmental Panel on Climate Change (IPCC) has shown
that over the past 60 years, human activity is responsible for most of the systematic
warming effect. The report goes on to say: ’Emmissions of CO2 due to fossil fuel burning
are virtually certain to be the dominant influence on the trends in atmospheric CO2
concentration during the 21st century’ (Metz et al., 2005). CO2 is a known greenhouse
gas that has been strongly linked to changes in global climates and levels of CO2 have
been rising at an accellerating rate in recent decades - as seen in figure 1.1 (p. 15).
Europe alone produces over 4 billion metric tonnes of CO2 each year (Energy Information
Administration, 2013).
Furthermore, in 2014 the EU imported 1.4×106 ktoe (kilotonne oil equivalent) of energy,
whilst producing 7.7 × 105 ktoe and exporting 5.3 × 105 ktoe. This resulted in a gross
consumption of 1.6 × 106 ktoe, with more than 80% of that energy being supplied from
outside the EU (Eurostat, 2016). This influx of energy puts the EU energy supply at risk
of disruption due to external political instability, or world-wide events – and the risk is
compounded when the climate effects produced by the burning of fossil fuels trigger that
instability. Two key recent examples of major climate-change driven disruptions, which
have impacted the global energy price and supply, are hurricane Katrina and the drought
that precipitated the Syrian war (Janković and Schultz, 2016; Fröhlich, 2016). The first
led to the closure of a major oil refinery and resulted in a large spike in oil prices, whilst
the second resulted in a rapid decline in oil prices: triggered by the decreased stability in
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the middle east resulting from the war led to in a large influx of oil into the market from
Saudi Arabia, to undermine oil sales funding factions with opposing interests. Both of
these events had world-wide consequences that could have been mitigated if not for the
dependence on fossil fuels.
It is worth noting at this point that large-scale electricity generation methods, such as
hydroelectric and nuclear, are ready-to-go alternatives for producing large-scale electrical
power; however without radical increases in battery power they are insufficient to con-
tinue to power the world the same way as fossil fuels can. There is a great deal of research
currently being carried out in the field of energy storage, which has been greatly boosted
by the rise of cellular powered mobile telephones and personal devices. So whilst energy
storage is an unsolved problem, and batteries and charge-station infrastructure are im-
proving at a rapid rate, they are unable to offer an out-of-the-box replacement to fossil
fuels at this time – although they may in the future.
In terms of issues with these forms of power generation, whilst hydroelectric can be
tuned to match output requirements, and energy can be stored in the form of water held
against gravity; construction of new hydroelectric plants can be highly disruptive to the
environment, as it requires flooding of areas and re-engineering of the landscape. The
major issues in the case of nuclear power is that it is generally distrusted by the public
and seen as a dangerous form of energy. As such, it must undergo a major re-brand
if it is to become more prominent – particularly in the west. There is also an issue of
long-lived, very harmful waste; although new generation reactors, such as propagating
wave reactors, can overcome these limitations.
1.1.3 Renewable Energy and Biofuel
There has been large-scale investment in renewable energy that has been rising year
on year over the last decade; the majority of investment in 2015 was in solar panels
(80% of investment) and wind turbines (10% of investment). In 2015, renewable energy
(excluding large hydro) made up 16.2% of the established power capacity - up from 15.8%
in 2014, but only contributing to 10.3% of the global electricity supply – the difference
between these figures resulting from the part-time energy generation ability of solar and
wind power (McCrone et al., 2016). Whilst these technologies are vital for electricity
generation and provide part of a solution to weaning the world off of fossil fuels, they do
not address the issues like the need for automotive fuel or long term energy storage. This
is where biofuels have potential to contribute to the solution.
Biofuel is any fuel generated from biological processes, although it usually refers to liquid
fuels that are terrestrially generated when referred to in public reports. These are usually
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Figure 1.2: A probable cause for the increasing CO2 concentrations in parts per million
over the last century. (Image by Z. Weinersmith - SMBC (Weinersmith, 2016))
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classified as first and second generation biofuels, where first generation uses food crops
as a feedstock to make fuel, whilst second generation uses non edible, woody or grass-like
plants. These biofuels can either be utilised directly, in cases such as oil seed rape, or else
processed by microbial action to produce organic molecules such as bio-ethanol (Ducat
et al., 2011). Direct photosynthetic creation of biofuel using photosynthetic microbes is
referred to as 3rd generation biofuel. This can produce oils, alkanes or even hydrogen
gas. Like fossil fuels, biofuel has the advantage of being an energy-dense carrier molecule
and is considered to be a viable replacement for fossil fuels (Savage et al., 2008). All
fossil fuels that are used today were originally biologically generated, and so it follows
that biofuels would be a suitable substitute.
Biologically, processes can broadly be divided into two categories, heterotrophic growth –
or those deriving energy from a chemical supply, and photo-autotrophic growth – or those
deriving energy from a solar supply. When considering a solution to the current energy
crisis, it is important not to generate a solution which creates foreseeable problems in
the near future. The majority of biofuel being produced currently is derived from first
generation biofuels, with the bulk of remaining production coming from second generation
biofuels (Doshi et al., 2016). The three most prominent first generation biofuels are
maize (USA), sugarcane (Brazil), and oilseed rape (Europe)(Hill et al., 2006; Escobar
et al., 2009; Ajanovic, 2011; Gasparatos et al., 2013). These biofuels are supported
financially by public bodies to make them competitive with fossil fuels, however this has
artificially raised the prices as a food crop, and has also contributed to a broader food
price increases of between 5 - 15% over the last decade by raising the prices of agricultural
feed (Rosegrant, 2008; Mitchell, 2008; Drabik, 2011). The most prominent example from
these is maize, where around 40% of the recent increases in price are as a direct result
of fluctuations in the biofuels market (Fischer et al., 2009). As both first and second
generation biofuels utilise terrestrial space, they both have issues of competing with
agricultural land needed to produce food. Where crop-bearing land is not used, conversion
of land into cause CO2 release through the clearing of land; and these biofuels take a
long time to produce a return on investment – either financially when discounting the
government subsidies, or even from CO2 reduction given the dependence on fossil fuels for
harvesting or requirements for blending, although this ‘green paradox’ can be mitigated to
a certain extent by simultaneously subsidising bio-ethanol but imposing counter-balancing
taxes on fossil fuel use (Galinato and Yoder, 2010). It has been predicted that reaching
a carbon neutral state with land-clearing can take around 100 years, with a maximal
prediction of 700 years when considering natural carbon sinks like peat rainforest land
(Doshi et al., 2016). Finally, it is not just land use but also water use that generates
issues for crop-based biofuel production. Agricultural processes and energy production
currently utilise around 90% of global fresh water. In addition, treating and recycling
1.1. ENERGY, BIOFUELS AND HIGH VALUE PRODUCTS 19
that water uses about 3% of the annual electricity generated.
1.1.4 Third generation biofuels and high value bio-products
Third generation biofuels, where energy is generated directly from photosynthetic inputs,
have a more promising outlook. It has been estimated that 20 - 30% of global bioproduc-
tion takes place in the sea by photosynthetic algae, microalgae and cyanobacteria (Hall
and Rao, 1999); and it is possible to grow certain these photosynthetic organisms in envir-
onments that would otherwise be unsuitable for crop production, such as locations with
extreme soil pH or high salinity (Ducat et al., 2011). Potable water resource utilisation is
less of an issue as well; as water salinity is a local rather than global phenomenon, and so
microalgae tend to be resistant to ranges of salinity, from fresh water, to brackish water,
to full marine and even hyper-saline environments such as the dead sea for Dunaliella
(Evans and Kates, 1984; Kirst, 1990). Some photosynthetic algae are also particularly
fast-growing, high-producing strains, such as Chlorella can reach productivities of up to
30 g/m2/day with a starch content of 37% (Hirano et al., 1997).
Certain species of photosynthetic microalgae, such as Spirulina, are also considered ‘su-
perfoods’ and as a result, have the potential to add to the global food supply, rather than
detracting from it (Ciferri, 1983). In addition to this, 3rd generation biofuels have the
potential to produce a wide variety of high value products (HVPs) along side the pro-
duction of oils for fuel, such as carotenoids (Wijffels and Barbosa, 2010) or astaxanthin
from Haematococcus (Lorenz and Cysewski, 2000) – which retail from $10 kg and $100
kg respectively (price estimates taken from alibaba.com on 09/2016). These HVPs can
provide a grown-in financial support system, which is usually provided by government
subsidies for previous generations of biofuels (Heidorn et al., 2011; Stephens et al., 2010).
Whilst the prospects for third generation biofuels appear to be quite promising (Duffy
et al., 2009), there are also a large number of limiting factors that need to be considered.
Firstly, cyanobacteria and algae represent a huge variety of diverse species, and whilst
there are a variety of very advantageous features, these are spread across 3 phyla –
cyanobacteria, green algae and red algae. As a result, many of the projections about
their potential productivity have been greatly exaggerated, as to date no single organism
has ever existed containing all the key features often described when considering the
future of the field; Klein-Marcuschamer quite humorously states:
"lignocellulosic ethanol could probably be a widespread product today if one could design
and build a process that used a microbe with the growth rate of Escherichia coli, the
ethanol tolerance of Saccharomyces cerevisiae, the thermophilic nature of Sulfolobus
acidocaldarius, and the cellulolytic activity of Trichoderma reesei."
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(Klein-Marcuschamer et al., 2013)
Whilst photosynthetic growth has been suggested as a good method of carbon capture and
a promising biofuel production facility for the future (Chisti, 2010; Chisti and Yan, 2011),
it is important to be realistic about the capabilities. There is an issue with providing
the required amount of CO2 and other nutrients where algal growth parameters are also
optimal (Pate et al., 2011). It has been estimated that to produce 100 t algal biomass
requires approximately 183 t CO2, at a concentration approximately 100 fold higher than
that found in ambient air (Chisti, 2007). From a practical point of view, this would require
a dedicated industrial source within an area that is conducive to large scale algal growth.
It has been estimated 35 mt of algal oil is the feasible limit at which freely available CO2
resources in suitable locations are able to supply in the US (Pate et al., 2011), utilising
around 10% of the CO2 generated from electrical production (Klein-Marcuschamer et al.,
2013).
The technology is still in its infancy, and whilst there are a number of pilot-scale studies
detailing extensive research and promise (Wijffels and Barbosa, 2010), there are relat-
ively few functioning large-scale algal biotechnology companies worldwide, and fewer still
pursuing biofuels (Schmidt, 2012). The largest risk associated with generating photo-
synthetic output comes from the initial capital expenditure (capex) of the project vs the
rate of return through operation expenditure (opex) (Bosma et al., 2014). The plant
set ups are therefore an important consideration when looking at scale-up. There are
two major designs for large scale algal production, open topped ‘raceway ponds’ – also
known as Oswald ponds after their creator (Oswald, 1988) and enclosed photobioreactor
sysytems (PBRs). PBRs have both higher capex and opex costs than raceway systems,
however, PBRs also have higher productivity (1% vs 3% in vertical column designs) and
the protection against contamination that is observed in raceway systems (Bosma et al.,
2014; Klein-Marcuschamer et al., 2013). In addition, a direct comparison between the
two methods has shown that whilst there is higher initial expense for the set up and
operation of a PBR, the biomass is axenic (only the intended culture is present) and
can grow up to 30 fold higher density, which reduces costs for downstream processing
steps, such as removing the algae from the growth media (Chisti, 2007). More recent
developments in this field have found that separation of biomass from the liquid culture
is less of an issue (Chisti, 2013), at least when considering biomass harvesting for crude
production. Ultimately, when considering a production platform it should be matched
accurately to the production system required. Raceway systems are by far the more
prevalent system for biomass production, however a single, highly profitable system of
tubular bioreactors operates in Israel producing high value (>$100,000/t) H. pluvialis
biomass (Klein-Marcuschamer et al., 2013), demonstrating that when the value of pro-
duction is high enough it can offset the capex and opex costs – although this is a very
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specific case.
It is important at this point to also consider the socio-economic effects of wide-spread
biofuel production. The locations where the environmental conditions are optimal for
algal biofuel production: good solar light availability, high ambient temperatures, nearby
water resources and a built up industry for CO2 influx, are also frequently in the de-
veloping world and could be subjected to political ‘land-grab’ events (Comelli, 2012).
In addition, some of the products that are planned for algal development are currently
produced in the developing world, such as palmitate (palm oil), and so could cause eco-
nomic disruption to communities that rely on the production of such resources. A similar
argument was made when the company Amyris planned to perform microbial produc-
tion of the anti-malarial artemisinin, which is extracted from the plant Artemisia annua
(Thompson, 2012). Amyris initially claimed that their efforts were to reduce the costs of
this important drug, however later this was revisted to increasing stability of the supply.
As of 2011, the synthetic variant of the drug made up approximately 1/3 of annual global
production, and Amyris re-branded and became publicly listed as a biofuels company
(Thompson, 2012).
1.1.5 Hydrogen and biohydrogen
Many of the issues mentioned above relate directly to algal oil production, however there
are other, less prevalent forms of biofuel that have promise. Biohydrogen is a clean-
burning waste product, that can either be produced by a single organism directly or
through fermentative processing of biomass (Vignais and Billoud, 2007; Saifuddin and
Priatharsini, 2016). H2 is light, burns in air to produce H2O, has the highest energy
density of all known chemical molecules by mass, and can be used in fuel cells to directly
produce high-efficiency electricity.
Around 80% H2 generated is produced chemically, through steam reforming of natural
gas (Friedrich et al., 2011); although this requires a fossil fuel input and produces CO2
as a side product. Potentially carbon neutral chemical processes, such as electrolysis,
are well established but generally require high temperatures and pressures to operate
efficiently. As a result, these processes are typically coupled to large-scale centralised
energy production facilities, such as nuclear power stations, where such conditions are
readily available. Other methods, such as direct photovoltaic separation are also possible,
however the costs of such processes are currently an order of magnitude above a financially
viable level (Tributsch, 2008). Through biological action, the initial activation energy
required to conduct this process is greatly reduced, as it is performed at biologically
relevant temperatures, and so biological processes have the potential to produce H2 in an
efficient manner. Hydrogen infrastructure is currently limited, however, it is important
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to note that despite this, H2 driven technologies are developing. The first H2-powered
vehicles already in existence, a device that runs on low temperature hydrogen fuel cells
(Eberle and von Helmolt, 2016) and is powered by compressed H2 gas (von Helmolt and
Eberle, 2014). When comparing the cost of energy storage for a hydrogen car vs an
electric car, the H2-powered car costs around 1/10th of a similar Li-ion battery system
(US$3000 vs US$30,000 - 50,000) (Eberle et al., 2012); making the hydrogen car a cheaper
option.
Fermentation of biomass to produce H2, typically with bacterial organisms such as Clostridium,
has a wide variety of applications and is far more prevalent in the literature; however it
faces many of the same issues as algal oil production in terms of requirements for biomass.
Biohydrogen production within a single organism, such as through direct photolysis of
water, atmospheric nitrogen fixation and light/dark fermentative production within a
photosynthetic system (Karthic and Joseph, 2012; Tamagnini et al., 2002), are a collec-
tion of much more promising options for avoiding some of these issues. The product can
be collected without the need for harvesting the biomass, where the hydrogen is produced
through either photolysis of water or through fermentative processes, which can poten-
tially reduce operational costs significantly for the requirements of nitrate, phosphate,
and carbon; as the biomass doesn’t need to be harvested completely. As the technology
is still largely undeveloped, there are numerous technological impediments to its util-
isation: the costs involved are very high, the yields are very low, the infrastructure for
supporting hydrogen as a fuel sources doesn’t exist in a particularly large scale at the mo-
ment. Whilst pilot scale plants operating at between 0.035m3− 100m3 (Ren et al., 2006;
Morra et al., 2014; Zhi et al., 2010; Vatsala et al., 2008) have demonstrated fermentative
production of H2 (Ren et al., 2006), there are no large-scale tests of a single-organism
biohydrogen production system currently in operation.
There are issues with H2 storage. Due to its small size, H2 has a particularly prevalent
issue with permeation – where a gas or liquid can pass directly through a solid. This is not
an issue when using industrial level aluminium coated storage tanks (Korinko et al., 2001),
but when considering low cost polymer-based tanks as found in many motor vehicles, the
permeation can be as high as 12 orders of magnitude higher than in aluminium tanks
(Stodilka et al., 2000). This poses efficiency and safety issues, as there can be explosion
risks when considering such tanks being placed within an enclosed space, such as when
a car is stored in a garage (Saffers et al., 2011). While the need for this advanced tank
does add to the price of a hydrogen powered vehicle, as stated above the cost is still far
lower than an equivalent rechargeable battery storage device.
The need for specific storage tanks adds to the capex of any biohydrogen production
plant planning on storing hydrogen. In addition, as hydrogen is a gas, storing it will
require a compression step which reduces efficiency that is not present with liquid fuels.
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As an example, a 50m3 pilot-scale hydrogen production plant in China, attached to a
citric acid production plant, showed that whilst chemical waste could be converted into
hydrogen and stored. As an efficiency comparison, the loss associated with hydrogen
storage was compared to directly converting the output into electricity and charging a
vanadium battery, which showed that the stored H2 had both a lower efficiency and higher
associated costs (Zhi et al., 2010) – although the energy outputs between the systems
were small. The efficiency in this case was affected by several factors, the output gas from
fermentative processing also contained CO2, which made up around 60% of the gas. To
purify the H2 to >99.99% purity, it was carbon-scrubbed through an alkaline absorption
tower, which reduced the energy efficiency. Compression was also needed for storage, and
so the efficiency was reduced by a further 30%. In terms of final storage systems, the H2
produced by the process was stored in 11 660 L storage tanks. These additional systems
brought the total cost to around 60% more than the battery system (Zhi et al., 2010).
When considering biohydrogen by direct photolysis or light-fermentation, the issue of CO2
removal from the outputs are removed as fermentative processes are not active within the
cell. Unfortunately, there is the much more significant problem of oxygen inactivation
of the process. O2 is already a limiting factor for microbial photosynthetic production –
when the O2 levels get too high they inhibit photosynthesis and cause oxidative damage
to the cells; which impacts on PBR design, necessitating gas exchangers and limiting PBR
pipe lengths to a maximum of around 80 m (Chisti, 2013; Chisti and Yan, 2011; Wijffels
and Barbosa, 2010; Bosma et al., 2014). Hydrogenases are generally highly O2 sensitive
(discussed in more detail later), and so when producing H2, either the O2 levels need to
be kept at a minimum within the system (a significant challenge during photosynthesis),
or the cell must have a method of excluding O2 around the hydrogenase machinery. This
is not an insurmountable task, although will require technological development. There
are some O2-tolerant hydrogenases, which still function in the presence of O2 although
operate at a lower energy density (Lenz et al., 2010). Beyond this, intracellular oxygen
consuming devices have been created for photosynthetic organisms (Tamagnini et al.,
2002, 2007), and hydrogenases that hijack the photosynthetic process to directly channel
electrons into hydrogen production, preventing O2 production are also under development
(Friedrich et al., 2011).
1.1.6 CyanoFactory
As shown, there are many issues with the production of third generation biofuels, however
a large number of these are technical. For example, a reduction in the cost of PBRs and
improvements in operating efficiency will significantly reduce the related costs whilst
maintaining the benefits. In addition, it is possible to make an operation feasible by
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increasing the value of the outputs of production, such as with the utilisation of HVP
side products as mentioned above.
Ultimately, the creation of a cost-effective photosynthetic microbial production system
spans a number of disciplines, ranging from genetic and molecular, to analytical mod-
elling, to large scale process design and scale-up. As a project of this nature is very
interdisciplinary, it requires a few principles to ensure cohesive flow: firstly a suitable
organism or chassis should be selected and the entire process should engineered specific-
ally around the features of that organism. This avoids problems of incompatible modules
being developed by different individuals. Secondly, it is essential that the different mod-
ules of work feed back into each other through regular communication. This enables a
broad point of view to be taken over the whole project at each step, to ensure that drift
doesn’t occur during progression of the project. Finally, when a terminal product is the
desired output, a clear plan for final integration of the modules should be presented at the
outset and re-evaluated for feasibility at regular intervals. This ensures that the project
has a global final aim, which enables benchmarking of progress and allows contextual
demonstration of issues that arise during the project.
This thesis was written in concordance with such a project – CyanoFactory. CyanoFactory
(CyanoFactory, 2012) was a European consortium of 10 groups in 7 countries working
towards optimising the model cyanobacteria Synechocystis sp. PCC 6803 (herein referred
to as Synechocystis) for the photosynthetic production of H2 as a biofuel. The consortia
was funded over a three year period by the 7th Framework Program as a future emerging
technology (FET) project in energy development under grant agreement number 308518.
CyanoFactory was the second stage of a longer-standing project on hydrogen production
in Synechocystis, where it was built upon the FP6 EU pathfinder project Biomodular
H2. Biomodular H2 was a pioneering study into genetic modification of the cyanobac-
teria Synechocystis and development of Synthetic Biology tools – it was one of 18 such
projects funded by the EU, yet received 8.3% (1/12) of the total funding awarded to
Synthetic Biology projects under the 6th Framework program NEST (Pei et al., 2011).
During this project, the Ni−Fe hydrogenase was investigated in detail, and the functional
subunits of the hydrogenase-active ‘hox’ cluster were identified. This was verified through
the production of a hydrogenase-inactivated mutant, which was found to be sensitive to
reductive stress environments such as those found during anaerobic fermentative produc-
tion. This mutant was one of several resources that were created, with others including
biological models to provide and an understanding of the background genetic interactions,
an oxygen consuming device construct, and the groudwork for developing a number of
molecular tools (Heidorn et al., 2011; Pinto et al., 2009; Ow et al., 2011; Huang et al.,
2010; Camsund et al., 2011; Noirel et al., 2008).
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Where Biomodular H2 looked mainly at the molecular aspects, CyanoFactory aimed to
both further develop a system based on those tools, and then pull them together for the
first time to identify a possible complete system that could be taken forward for further
development. Cyanofactory therefore approached the problem of biofuel production on
many different levels simultaneously, as shown in figure 1.3 (p. 26):
• Four groups focused on working on modifying the organism, where investigations
into improving the H2 output were carried out.
• A Synthetic Biology toolbox was produced, to enable much simpler and stand-
ardized genetic modification of the organism, using synthetic biology techniques
(Huang and Lindblad, 2013; Lindblad et al., 2012).
• Synechocystis was stress-tested for salinity survival and ab investigation was carried
out into how the organism was affected by the typical extremes of temperatures
experienced within a PBR system during annual operation - with temperatures
ranging from 4 - 40 ◦C.
• The genome of the organism was assessed for genetically neutral sites (Pinto et al.,
2015) is also being optimised for genetic transformation and production of H2.
• A light harvesting mutant referred to as ‘olive’, with better permittivity of light
through the culture, was analysed to determine how it could improve the efficiency
of the system (Kwon et al., 2013).
• There was also work performed on a biological safety mechanism, as a fail-safe in
the event that the organism escapes into the environment; which was coupled with
an investigation on the growth of the lab strain in local waters.
• Two industrial partners designed and produced flat-panel PBR systems. This PBR
design has been shown to be the most efficient PBR designs for maximising cell
dispersal and light harvesting; whilst minimising extreme temperature and light
conditions and reducing costs for harvesting (Bosma et al., 2014).
• Two different flat-panel PBR systems were designed, each at different scales. The
first was a lab-scale 5 L system, whilst the second was 2000 L outdoor reactor. The
outdoor system was tested and investigations into predation management systems
and daily operational effects were investigated (Touloupakis et al., 2016).
Information collected within the consortium was fed back to the other members through a
central electronic storage facility known as the ’Data Warehouse’. Information in the Data
Warehouse was presented as a central interactive biological model, which was annotated
and maintained by a consortium partner (Wünschiers, 2016).
Throughout this project, the Sheffield partners were responsible for assessing how modi-
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Figure 1.3: Within CyanoFactory, work conducted at Sheffield made up work package 7.
This work package integrated a variety of different ‘omics approaches for understanding
the systems-level changes occurring within the organism. The three deliverable reports
– highlighted as green ovals labelled D7.1, D7.2 and D7.3 – made up the core returns
throughout the project and are available as an appendix to this thesis.
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fications to the genetics and reactor environment affect the molecular state of the cells.
This was done through a combination of different ’omics techniques, initially proteomics,
followed by transcriptomics and metabolomics. Data generated in this manner was passed
on to other partners as direct feedback, but also included in biological models for under-
standing the features of the system. In addition to this, the Sheffield partners worked on
a number of developments to improve the quality of the data being fed back to the group.
As a final action, a general summary of all compiled data was prepared to highlight issues
arising from the metabolic level and to understand the remaining targets for converting
the complete body of work into a series of practical goals. The experimental work in
the thesis is driven by CyanoFactory investigations, with the final chapter containing the
summary of key recommendations for the progression of this technology.
All the different ‘omics approaches described here were conducted at Sheffield during Cy-
anoFactory, combining transcriptomics and transient C13 labelled metabolic flux into the
investigations. As these investigations were spread across a number of different applica-
tions – investigating the effects of salinity on the organism, and how the internal meta-
bolic fluxes were affected in a mutant with altered light-harvesting capabilities – combining
all these together made the thesis too broad-reaching. The proteomic improvements were
chosen as the main focus, however the other investigations are alluded to within the thesis.
If the reader is interested, the project deliverable reports are included as an appendix to
this report, giving a summary of the overall assessments that were conducted throughout
the CyanoFactory project.
1.2 Scale-up and large scale processing
In the previous section, there was a large amount of discussion regarding the features
of photosynthetic microbes and how they were suitable for biofuel production, but there
were very few examples of taking that photosynthetic output and scaling it to a larger
size (Bosma et al., 2014). Taking any process and making it large scale is non-trivial,
however it is important to explain some key terms here that are referred to later; and also
to explicitly state some of the major pitfalls associated with the scaling up of biological
processes. The following sections use ethanol as an example, since it provides a clearer
example for describing a biological process being described in a chemical engineering
manner. The pitfalls for scaling bio-hydrogen production have been discussed previously
in section 1.1.5.
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1.2.1 Biotechnology markets and scale
Biology has played a major role in human industry for centuries. The majority of the
industrialised biological processes are fermentative, where sugar is converted to acids,
alcohols and other organic components in the absence of air. These fermentative processes
were the earliest examples of biotechnology, and were mainly used in the production of
foods and beverages, like cheese, yoghurt and wine. The same processes are still used
today, albeit on a much larger scale (Liese et al., 2006). Fermentation is still the most
widely used biotechnological production method for anything that needs to be produced in
a substantial quantity, ranging from antibiotics (Strohl, 1997), to vitamins (Leeper, 2000),
to speciality chemicals that are difficult to synthesise chemically, such as isoprenoids
(Schreiber, 2000). Isoprenoids are a family of high-value molecules synthesised from
isoprene, and are the basis for a wide variety of aromatic and flavour enhancing molecules,
as well as a number of human drugs, such as the anti-cancer agent lupeol.
To give an idea of the scale of production: in 2005, fermentative processes produced
26,000,000 tons of ethanol, 1,000,000 tons of both MSG and citric acid, 80,000 tons of
vitamin C and 35,000 tons of antibiotics (Gavrilescu and Chisti, 2005). The antibiotics
market alone exceeded US$30 billion, with the total pharmaceutical market being well
in excess of US$400 billion, and all of these processes rely on micro-organism production
(Gavrilescu and Chisti, 2005). Over the past 40 years the biotech market has grown dra-
matically, with concerns about limitations on products previously derived from fossil fuels
pushing biological replacements back into the production chain. This is especially true
for speciality and life science chemicals, where harmful chemical processes can be made
cheaper and more efficient by introducing a biological agent into the process (Gavrilescu
and Chisti, 2005).
1.2.2 Basic principles of chemical engineering from a biological
perspective
In many of the cases listed above, it is convenient to think of a biological organism as a
type of catalyst – a substance added to a reaction to reduce the energy input needed to
carry out a chemical reaction, with a specific outcome. This broad-stroke overview of a
biological organism is a useful analogy when considering a process at scale, despite the
actual organism being far more complicated in reality than providing a simple catalytic
function. This enables the underlying chemical process taking place to be evaluated
simply, for example, Saccharomyces cerevisiae, or brewers yeast is well known for the
ability to convert sugar into ethanol and carbon dioxide, resulting in a widely appreciated
carbonated beverage. This process can be summarised as:
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glucose Saccharomyces−−−−−−−−→ ethanol + carbon dioxide
or
(1) C6H12O6
Saccharomyces−−−−−−−−→ 2CH3CH2OH + 2CO2
This balanced chemical observation shown here is referred to as stoichiometry, where all
the inputs or reactants are balanced on a molar level to all the outputs or products. This
technique is useful for calculating the concentration of the final products, so in the above
example each mole of glucose would produce 2 moles of ethanol and 2 moles of carbon
dioxide. This gives an overview of a system, without delving into the specifics.
Whilst fermentative processes, like equation (1) are widely used in industrial production,
aerobic or respirative (in the presence of oxygen) processes have application for cases
where biomass accumulation is the major aim. One such case is in sewage treatment,
where the principle aim is removal of nitrate, phosphate and organic molecules from a
wastewater supply, to protect downstream waterways from eutrophication. Eutrophica-
tion is a process that occurs when high levels of nutrients, such as nitrate or phosphate,
are deposited into a waterway, resulting an a ‘bloom’ of algae. When the nutrient spike
is exhausted, the algae usually die back, providing conditions for rapid growth of bac-
teria. This rapid growth removes the dissolved oxygen, which results in death of other
aquatic life in the waterway (Schindler, 2006). Within wastewater treatment, the sewage
is aerated to encourage bacterial growth in a controlled environment; this depletes the
nutrients and provides biomass, which can then be harvested and converted into useful
products or energy for the system. The amount of oxygen consumed during this process
is referred to as biological oxygen demand (BOD), which is a common feature used to
assess sewage. When describing this system, the mass of the organism, or the ‘biomass’,
can be considered as a product rather than a catalyst
wastewater + O2
bacteria−−−−→ biomass + treated wastewater
As no matter has been created or destroyed during either the fermentative or water
treatment process (ie. neither involved the use of a nuclear reaction), all the mass that
is put into the process must either be retained within the system or released from the
system – in accordance with the first law of thermodynamics (conservation of energy).
This can be described by the simple equation:
reactants - products = mass change in the system
This forms the basis of a chemical engineering principle referred to as (unsteady state)
mass balance, or material balance (Himmelblau and Riggs, 2012). This can be either
positive, where the system is gaining mass; negative, where the system is losing mass;
or 0, where the mass of the system doesn’t change. From a bioreactor point of view, a
positive value indicates growth of the biomass, whilst a negative value indicates ‘wash out’
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and 0 indicates a state of continuous culture. The wastewater example listed above could
be re-written from an operational view-point, where the reaction it monitors is a large
holding tank for growing biomass with an aeration nozzle, an in-flow for waste water and
an out-flow for treated water. In this case, the inputs are air (or oxygen) and wastewater,
and the outputs are treated/depleted wastewater. Assuming the biomass remains within
the holding tank, the mass of the reactants will be more than the products, and so the
system gains mass during operation. As the system has a finite volume, this process is
unsustainable unless a biomass ’harvesting’ step is added into the reaction.
1.3 Key biological principles
1.3.1 A simple model of a cell
Previously, we considered the cell to be both a catalyst for producing an output, and an
output itself in the form of biomass. To resolve this dichotomy, we need a new model for
understanding a biological cell. Instead of considering it as a catalyst for a single reaction,
it is more accurate to consider a cell as a partially-permeable living ‘bag’ containing a
large number of individual catalysts and intermediates. Selected reactants can freely
pass into the bag, and selected products can pass out, although this is controlled to
prevent the bag from either over-filling and bursting, or draining completely and losing
all contents. One final additional point is needed for the bag model, not only does it
have a wide array of catalysts and intermediates contained within it, but the number
and properties of these catalysts changes dynamically in response to the environment as
well. This generally gives a hint of the complexity involved in predictably engineering a
biological organism.
At this point, before becoming overwhelmed by the complexity of the model, it is worth
tearing the bag open and re-examining our previous fermentation reaction in the light of
this discovery. In reaction (1), there are actually a number of different steps taking place.
Expansion of this process is important for understanding the concepts of ‘intermediates’
and ‘side reactions’. The actual process goes through 3 individual catalytic ‘stages’:
glycolysis, which converts glucose into pyruvate; pyruvate decarboxylase, which converts
pyruvate into acetaldehyde and carbon dioxide; and finally alcohol dehydrogenase, which
converts acetaldehyde into ethanol (Berg et al., 2006). Glycoloysis is one of the most
ancient and highly conserved pathways observed in nature (Romano and Conway, 1996),
and is thought to have occurred originally in oceans in archean times (Keller et al., 2014).
glucose glycolysis−−−−−→ pyruvate
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can be considered as two separate reactions:
(2) C6H12O6 + 2NAD+
glycolysis−−−−−→ 2CH3COCOO– + 4H+ + 2NADH
and
(3) 2ADP + 2Pi
glycolysis−−−−−→ 2ATP + 2H2O
This reaction is slightly more complicated when considered chemically. The reason for
this is that whilst glycolysis has been summarised into a single step here, it is actually
made up of 10 separate catalysed reactions, each with intermediates. It is important to
note here that this reaction contains a ‘side reaction’, denoted as (3). The energy made
available from the exothermic (energy liberating) reaction of splitting the glucose molecule
in reaction (2) is used to power the synthesis of adenosine triphosphate (ATP) from
adenosine diphosphate (ADP) and inorganic phosphate (Pi) – this reaction is referred
to as a condensation reaction, as it results in the production of a water molecule; such
reactions are usually stable and do not usually spontaneously reverse. ATP is used in a
wide range of biological reactions and will be discussed in more detail later.
In addition, the conversion of glucose to pyruvate is an oxidation reaction – it liberates
electrons. For this reaction to move forward, another agent needs to be present to drive
this – in this case the electrophile nicotinamide adenine dinucleotide (NAD+) acts as an
oxidising agent. During this process, NAD+ consumes 2 electrons (2 e–) and 1 proton
(H+) from the reaction and is converted to its reduced form (NADH). This reaction is
reversible, and so when NADH is converted to NAD+ the electrons are liberated again.
NAD+, and its phosphorylated cousin NADP, play an important role as electron carriers
for oxidation and reduction reactions within the cell, and are extremely important in
hydrogen synthesis. In this reaction there are also 4 protons (H+) produced which were
not present in reaction (1). These are intermediates, products that are created in one
stage of a process but then consumed in another before the entire reaction is complete.
Intermediates are ubiquitous in biology, and while they can often be bundled into a process
and ignored to keep the general system simple, they frequently contribute in additional
side reactions of their own and should be considered when the system performs in an
unexpected manner.
pyruvate pyruvate−decarboxylase−−−−−−−−−−−−−−→ acetaldehyde + carbon dioxide
(4) 2CH3COCOO– + 2H+
pyruvate−decarboxylase−−−−−−−−−−−−−−→ 2CH3CHO + CO2
For clarity, the reactants and products from (3) have been excluded, as have any products
from (2) that do not participate at this stage. Two of the protons (H+) generated as a
product in (2) have been used as a reactant in (4), and so have been stoichiometrically
‘neutralised’. This balance between reactants and products results in no net change in
the global reaction, and is the reason they were not visible in (1).
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acetaldehyde alcohol−dehydrogenase−−−−−−−−−−−−−→ ethanol
(5) 2CH3CHO + 2NADH + 2H+
alcohol−dehydrogenase−−−−−−−−−−−−−→ 2CH3CH2OH + 2NAD+
Finally, in (5) the NADH and NAD+ occur on the opposide sides of the reaction compared
with (2). As with the protons in the previous stage, there is no net global change in the
reaction and so they are also intermediates, which can be excluded in (1).
So to summarise, the intermediates from the catalytic bag cell model are the outputs
of individual reactions, driven by the different catalysts present within the bag. Due to
the close proximity of all the bag contents, it is a good general rule of thumb to assume
that any intermediate produced within the bag will be immediately exposed to all other
catalysts present, which can result in side reactions. A side reaction is displayed in
reaction (3), in this case the production of ATP from ADP and Pi. In this case, energy
is taken from the reaction and stored by the cell, but material products from a reaction
can become participants in side reactions as well. Side reactions can cause branching-
chain effects, and as a result, can make producing a desired product, or understanding
a reaction pathway, challenging within the complexity of a cell background, especially
when the catalytic properties can change in response to the environment!
1.3.2 Proteins
In the semi-permeable catalytic bag cell model, the most important aspect is clearly the
catalysts, since they drive all the reactions taking place within the bag. Within a real cell
system, these catalysts are called proteins. Proteins play a wide role of functions within
a cell, ranging from structural roles, to catalytic functions, to storage and controlling the
flow of materials into, around and out of the cell.
At its most basic level, a protein is a polymer of individual building blocks called amino
acids. Amino acids are a class of chemical molecules, which vary greatly in their indi-
vidual chemical properties, but are all composed of an amino (−NH2) and carboxylic
acid (−COOH) functional group – hence the name. The general chemical structure of
an amino acid is H2N−CHR’−COOH, where the R′ group can be one of 21 commonly
occurring side chains. The carbon that the R′ group falls on is referred to as the α
carbon, and this is also a chiral centre. In living organisms, all amino acids are L-form
enantiomers; this is an important feature for the structural properties of proteins. There
are other, rarer side chains, however these will not be discussed here. A complete table
of the most commonly used amino acids is given in figure 1.4 (p. 33). These amino acids
all have a single letter code, as shown in figure 1.4, which is used as short-hand when
describing the sequence of amino acids in a protein.
During protein synthesis, the the amino acid units (monomers) are built into a chain
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Figure 1.4: A graphical representation of the 21 most frequently occurring amino acids,
grouped by their general features. All amino acids presented here are shown with charge
states based on pKa values at physiological pH (7.4). This figure was produced by
(Cojocari, 2016), and is freely available for reuse under the creative commons licence, via
Wikimedia Commons
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(polymer) sequentially through a series of amide (or peptide) bonds; this is where the
carboxylic acid group reacts with the amino group in a condensation reaction, to form
a covalent linkage between the two monomers. As the polymer grows, the protein has a
regular repeating chain referred to as the protein ‘backbone’, with the R groups spanning
out from it. Due to physical space requirements (also referred to as steric hindrance),
these groups usually arrange themselves on alternating sides of the backbone in the
absence of external forces.
Chirality is a description of the ordering of the atoms or groups within the molecule
around a central point in 3 dimensions, which is typically a carbon atom as it readily
forms 4 bonds with tetrahedral conformation. What this means is that around each of
these ‘chiral carbon’ centres, there are 2 distinct conformations the surrounding atoms
can take – and in one arrangement there is no amount of rotation that can be performed
to reach the other arrangement. In order for a carbon to be chiral, it must be surrounded
by 4 different atoms or groups of atoms. These two forms are called enantiometers, and
are referred to as l and d – signifying the left- or right- handedness of the direction
rotational of atomic ordering ordering.
All amino acids have uniform l-chirality, with the exception of glycine, which lacks a
chiral carbon as the R′ group is H. As a result, the order in which the subunits are joined
has an effect on the structural properties of the protein. When joining 2 amino acids,
A+H 6= H +A; as a result, a protein sequence is always read beginning from the amino
side and ending at the acid side by convention. It should be noted that it is possible to
form palendromic sequences that ignore this directionality (the peptide ‘RACECAR’, for
example), and whilst these are generally rare, they can cause problems with proteomic
data processing in some cases (discussed later). Polymers of amino acid residues are
referred to as peptides when they are ‘short’ and proteins when they are longer, although
the cut-off boundary for this is fairly arbitrary. In this thesis, a peptide will refer to either
any polypeptide molecule that is less than 4000 da (generally <36 amino acids long on
average), or any protein that has had its backbone severed.
Shapes and structures are vitally important in biology, and are the driving force for
specificity of reactions and the catalytic activity of the proteins. Protein structure is
controlled at 4 levels to produce the final functional structural conformations. These are
referred to primary, secondary, tertiary and quaternary structure. The precise ordering
and type of amino acid residues that makes up the peptide backbone is referred to as
the ‘primary structure’. This primary structure is fundamentally important for structural
properties of the protein, as it controls the order of the different R′ groups and is generally
fixed at the point when the protein is created. A major exception to this is the cysteine.
When 2 of these sulphur-containing amino acid residues are spatially close together, a
spontaneous oxidation reaction occurs, resulting in a covalent bond forming between the
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two. This reaction can either happen between 2 cysteine residues in the same protein,
forming a loop in the primary protein structure, or between 2 separate protein molecules,
forming a quaternary covalent bridge between different proteins. It is also worth noting
that the amino acid proline has a significant effect on the structure of proteins and
peptides. Proline is the only one of the 21 common amino acids that contains a secondary
amine instead of a primary amine – this occurs due to the R′ group reacting with the
amine, and so the regular repeating structure of the peptide backbone is kinked at an
unusual angle due to steric hindrance. This kink is also pronounced in short peptides
that would normally otherwise be linear.
‘Secondary’ protein structure consists of local structures called α-helices and β-sheets.
These regular repeating structures are stabilised by hydrogen bonding from the peptide
bonds in the backbone, and are observed repeatedly across all proteins. Glycine and
proline residues are referred to as ‘helix breaking’, and can disrupt these structures;
as proline has a secondary amine it is uncharged and therefore doesn’t contribute to the
hydrogen bonding motif, whilst in the case of glycine as the R′ group is simply a hydrogen
atom, the residue is non-chiral and therefore too unconstrained to contribute to a regular
repeating pattern. ‘Tertiary’ protein structure refers to the global packing of the whole
protein. This structure is stabilised by a range of different forces:
• Hydrophobic interactions – a form of packing that takes place where water is present
in the environment. This is partially secured by van der waals forces, although is
largely an expression of hydrogen bonding effects of water excluding hydrophobic
residues. These forces are supported by hydrophobic amino acids such as trypto-
phan.
• Hydrogen bonding – an induced dipole effect that is responsible for the interactions
between water and other charged species. Hydrogen bonds are responsible for
stabilising the majority of biological interactions and can form on any amino acid
residue that is not hydrophobic.
• Salt bridges – a permanent dipole effect. A salt bridge forms between 2 residues
with opposite charge signs, such as lysine and aspartic acid. They are affected by
the surrounding pH, as raising or lowering the pH beyond a pKa value can determine
if an R′ group is charged or not.
• Disulphide bonds – as described above, a covalent bond that forms spontaneously
in oxidising conditions. These bonds can be reversed through exposure to a redu-
cing environment, however unless the cysteine residues responsible are chemically
blocked – typically through alkalation – then the bonds will spontaneously reform
when exposed to an oxidising environment again.
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• Steric hindrance – The forces associated with stopping two atoms occupying the
same physical space. Also referred to as Pauli exclusion, this occurs when the neg-
atively charged electron clouds of two atoms attempt to occupy the same physical
space.
These features are a direct result of the different amino acid residues that make up the
protein and how they pack together. Whilst this process is currently too complex to
accurately predict a protein structure from its primary sequence alone, two proteins with
the same primary sequence will fold to produce exactly the same terminal structure, and
so controlling the primary sequence of the protein gives control over the final 3 dimensional
structure. Finally, ‘quaternary’ structure is stabilised by all the same features as tertiary
structure, however it refers to interactions between 2 or more distinct proteins. These
proteins can be identical subunits, or two distinct proteins – the important part of this
interaction is that two separate primary protein chains are interacting together to produce
a functional final product.
Proteins can also be modified after their creation, in a process called post translational
modification (PTM). The most common PTM is the addition of a phosphate (Pi, or a
mix of HPO42– + H2PO41–) onto an alcohol containing residue, such as serine, threonine
or tyrosine. This addition is performed by proteins known as kinases, and is reversed
by proteins known as phosphorylases. This can have a number of effects on a protein,
firstly by adding a large charged molecule to the residue it becomes charged, enabling
it to participate in hydrogen bonding and salt bridge formation. Adding phosphate can
disrupt entire hydrophobic sections of a protein and result in dramatic re-shuﬄing of
the protein structure. As a result, phosphorylation is the most frequently method for
feedback and cascade control in living organisms, and so phosphorus levels are typically
a limiting factor for biological growth. Beyond the charge aspect, the modification is
relatively large, particularly for a residue like serine, and so addition of phosphate can
physically change the shape of a protein by generating a steric hindrance effect. Both of
these features can occur in differing amounts, but can enabling participation, or exclusion,
of the modified protein in quaternary interactions by attaining a different shape. Dozens
of other known PTMs exist, include glycosylation, namely the addition of sugars onto
proteins; ubiquitination, which can attach smaller proteins to a protein to signal for
its destruction; and alkylation, where hydrophobic hydrocarbons are added to charged
residues, blocking their activity (such as cysteine forming disulphide bridges) or burying
them within the hydrophobic core of the protein.
The same way that the structures of proteins are stabilised by these different forces,
the arrangement of charges and flexibility of protein molecules are also what provide
their catalytic properties. For example, some proteins have ‘pockets’ that certain shaped
molecules fit into but others are excluded from, and buried within these protein pockets
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are arrangements of charges that, due to close proximity to the molecules held within the
pockets, can have strong catalytic activity. A good example of a protein like this is the
protease trypsin. Trypsin has pockets that only long-chain, positively charged residues
can fit into; but when one binds to the pocket it triggers a catalytic reaction that results
in cleavage of a peptide bond. The resulting effect is that trypsin will selectively cleave
proteins at regions where arginine and lysine are present, but not elsewhere. This is
referred to in proteomics as site-specific cleavage. Cleavage is a very important topic in
proteomics, and will be discussed at length in a later section in this chapter.
Whilst there is a fairly good understanding of how different properties contribute to
the structure; even if the structures of all proteins were known it is still impossible to
know exactly what function a protein will have from either its sequence or structure
alone. The most effective method for measuring what a protein does involves measuring
that protein directly – referred to here as a de novo investigation. This can be done
through purification of the protein and direct analysis; although while some proteins can
be removed from the cellular environment and still retain their function (in vitro analysis
- in glass), in other cases proteins produce different functions when removed from a living
environment (in vivo analysis - in life).
In practice, beyond de novo investigation into the function of the protein, the accumulated
knowledge of pre-existing proteins of a similar sequence is used to infer what newly dis-
covered proteins do. Whilst this practice is not perfect, as similar protein sequences does
not necessarily mean similar protein function, it provides a lot more utility to proteomic
data generated in organisms that haven’t been studied as extensively.
1.3.3 Nucleic acids
In the previous section, the importance of the primary sequence of proteins, and how it
affects their catalytic activity – for the sake of the semi-permeable catalytic bag model
– has been described. What hasn’t been described so far is how that primary sequence
is determined. To understand this requires an investigation of the main features of the
‘genetic material’ or ‘nucleic acids’. It is worth briefly noting that the term ‘nucleic acid’
refers to 2 different acidic polymers found within a cell – deoxyribonucleic acid (DNA)
and ribonucleic acid (RNA). These are fundamental to the variability of the catalytic
properties of the cell, and will be explained in more detail in this section. The polymers
are referred to as ‘nucleic acids’ as they were originally extracted from a central cell
structure called the nucleus; however whilst not all cells have a nucleus, all living things
and even viruses contain nucleic acids.
In a living organism, the genetic material or DNA carries all the information for a cell
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to produce proteins, which in turn facilitate life. DNA is a double-stranded, α-helical
polymer made up of four unique base molecules – adenine (A), cytosine (C), guanine
(G) and thymine (T) that are joined in a specific sequence. Like protein, DNA has a
regular repeating backbone structure, where the bases are joined by negatively charged
phospho-diester bonds, and the bases themselves are planar hydrophobic disks that stack
on top of each other. The double-helix is an anti-parallel dimer, where one strand is the
inverse of the other – in this case, where an A is present on the first strand, it will be
hydrogen-bonded to a T on the other and vice-versa. The same is also true for C and G.
The structure was first identified famously by Watson and Crick in 1953, work that lead
to them being awarded the Nobel Prize in Physiology or Medicine along with Maurice
Wilkins in 1962 (Watson and Crick, 1953). The sequence of all the DNA in a cell is
referred to as the genome sequence. Within the genome sequence, the specific sequence
– as with proteins – is vitally important.
From a conceptual point of view, DNA can be considered as the blueprints for the catalytic
bag. The instructions for forming the complete list of every protein that can possibly
be produced, under any condition, is found within the genome. The blueprints for an
individual protein are referred to as a ‘gene’, and the collection of all protein-coding
sequences within an organism is referred to as the ‘genome’. As mentioned above, however,
the exact numbers and even the specific presence of any of the catalytic components is
variable. Not all of the potential catalysts that the genome has blueprints for will be
produced in the same quantities, in fact not even all the potential catalysts that can be
produced will be under all conditions. This can be considered using a facile analogy of a
factory producing cars – there will be a blueprint for a wheel, an axle, a door; however
a standard car will require 4 wheels, 2 axles, between 3 and 5 doors, etc. depending on
the model. In a cell, whilst the genome exists as a central repository for all the proteins
that can be produced, a second nucleic acid, RNA, is responsible for actually converting
those blueprints into reality.
Before protein is produced, selected parts of the DNA sequence must be ’transcribed’ into
a substance called mRNA (mesenger RNA) by a protein called RNA polymerase. mRNA
is a subset of RNA (ribonucleic acid) exclusively used for the transfer of information from
DNA into protein (Brenner et al., 1961). RNA is a single-stranded polymer molecule with
a highly variant structure depending on the sequence. Whilst RNA also has a wide variety
of functions, including structural features and regulatory controls, these are diverse and
fall outwith the scope of this review. The DNA bases are transcribed into equivalently
named RNA bases – A, C and G; with the exception of thymine, which transcribes to
uracil (U), carrying the sequence information from the DNA forward. This sequence
of bases are read by a molecule called a ribosome, which translates the sequence into
a protein. As described above, proteins act together to produce functions within a cell
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based on the genome sequence, and so the movement of information flows from DNA to
RNA to protein. This is referred to as the central dogma of molecular biology (Crick,
1970).
This direct link between the genome and the catalytic capabilities of a cell has important
consequences for engineering. Conceptually, by removing a gene from the genome, the
capability for a cell to produce the protein it coded for has been removed as well. The
inverse is also true, it is possible to add a gene or collection of genes to a genome and
add functionality. This forms the fundamental principles of genetic engineering. This
first methods for targeted genetic modification of an organism were developed by Cohen
and Boyer in 1973 (Cohen et al., 1973), and 2 years later in 1975 the historic Asilomar
conference on recombinant DNA molecules was called due to concerns arising over the
engineering of life (Berg et al., 1975). Whilst finding a gene that relates to a specific
protein can be done relatively easily, the principles behind rationally engineering a system
are more complicated.
Production of mRNA is controlled by a complex series of feedback reactions, which enable
the production of proteins in response to the specific requirements at the time. One of
the major difficulties in understanding this is that a snap-shot of cellular response is
heavily influenced by the previous state the cell was in, which can make understanding
and engineering cells difficult. A modern cell cannot function without a comprehensive
collection of all of the materials mentioned above in a prior state, which has been provided
in the form of an unbroken chain of living organisms since the first origins of life around
4 billion years ago (Haldane, 1929).
When physically ‘translating’ mRNA into a protein sequence, there is a clear issue of
disparity between the number of nucleic acid bases (4) and the number of commonly
used amino acids (21). To get around this issue the bases of mRNA are read in groups
of 3 bases at a time, these triplets of bases are also known as ’codons’. There are unique
codons for each amino acid, as well as specific codons indicating the beginning and end of
a protein coding sequence (start and stop codons, respectively). As there are 64 possible
codons (3 bases with 4 possible states per base, 43 = 64) and only 23 codon ‘states’;
with 21 amino acids plus start and stop codons, the genetic code is degenerate (Crick,
1968). This degeneracy means that different codons code for the same amino acid. By
measuring the occurence of codons within the translated genome a ‘codon usage table’
can be produced. This shows the rate of occurence of individual codons within specific
organisms, which have been found to be biased towards certain codons in certain species;
however comprehensive studies of this phenomenon only became possible in the post-
genomic era (Duret, 2002).
The presence of an ‘annotated genome’ for an organism is vital for modern proteomics-
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level investigations. This simply refers to genome sequence being known, and also being
run through computational tools to identify putative genes and proteins.
1.3.4 Metabolites and membranes
The previous section described how the nucleic acids can be used to both monitor, and
ultimately to control or engineer the catalyst content of the semi-permeable catalytic
bag model. The conceptual origins for the information that makes up the catalysts
(or proteins) has been given, but no clear path to their creation has been laid out. To
understand the origins of proteins, we return to the glycolysis example from the beginning
of this section. Pyruvate, which was an intermediate in the ethanol production pathway,
is one of the building blocks for creating the amino acid alanine. The chemical molecules
within the cell which are used to produce all other parts, are referred to as ‘metabolites’.
Metabolite is a catch-all term that is given to cellular contents which are smaller than
around 500 Da. This includes a variety of molecules with wide-ranging properties, and
since the term is driven by size, rather than a function or process of creation as pro-
teins and nucleic acids were, it is much more difficult to succinctly describe the role of
metabolites within the cell. All intermediates are metabolites, all things crossing the
outer cell membrane into the cell are metabolites, and all parts of the cell are built from
metabolites during the cell cycle.
Clearly with such a diverse range of chemical molecules; maintaining a functioning cell
requires either spacial separation of parts, or a series of strong kinetic chemical drivers,
to ensure reactions go in the optimal route for life. In practice, both methods are used.
Amphipathic metabolites called phospholipids, which have a charged phosphate group
attached to a hydrophobic hydrocarbon chain, spontaneously self-assemble into mem-
branes in aqueous environments – with the hydrophobic ‘tails’ aggregating together and
the hydrophilic charged groups interacting with the water in the environment. Bio-
logical membranes are vital to life, and are interspersed with proteins that perform a
range of functions, from structural roles, where they stabilise and strengthen the barri-
ers, to creating gates and molecule-specific channels through them, to physically moving
membrane-bound ‘containers’ around the cell.
Membranes are essential for life, and are used to drive a number of reactions that would
otherwise be impossible. The ubiquitous example of this was mentioned above – the
generation of ATP. ATP is a nucleotide-containing molecule that is fundamental to the
creation of DNA within the cell (it makes up the A, of ACTG), but is also the fundamental
energy carrier molecule used across all species. The molecule has 3 phosphate groups
joined in tandem on one side, but in precisely controlled reactions, these phosphate
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groups can be removed or transferred to other molecules (such as proteins, as mentioned
above), releasing energy in the process.
Creation of ATP from ADP and Pi is a highly conserved and ubiquitous system of life,
and is a good example for how cells utilise membrane separation to perform a func-
tion. The reaction is endothermic, meaning that it requires external energy to take place
spontaneously under standard conditions. This energy in the cell is driven by a ‘pro-
ton gradient’. A proton gradient requires a highly acidic reservoir, which spontaneously
diffuses into a less acidic environment due to positive charge interactions between the
atoms – this process is analogous to water being stored behind a dam against the force
of gravity. A number of reactions within the cell release protons into the environment –
one of these is glycolysis, which was mentioned previously. By spatially controlling where
these reactions take place within the cell, energy can be expended to pump these output
protons into a membrane against the electrical gradient. A small collection of specialised
proteins are found sitting across these membranes called ATP-synthases. Collectively
they form a carousel-like device, which works in a similar manner to a water wheel, and
converts energy from the flow of protons in a controlled manner to generate rotational
energy. The ATP-synthase has binding sites for both ADP and Pi, and as the molecule
rotates it pushes the reactants together and excludes H2O, shifting the reaction equilib-
rium to favour ATP production. ATP is then released from the protein and the reaction
continues.
Membranes are also used to exclude molecules that might otherwise be damaging to the
cellular constituents, and are used for a range of other reactions within the cell.
1.3.5 Integrating the system
Throughout the cell, there are a number of proteins which – when working in a concordant
manner – take the fundamental molecules of life and convert them into self-replicating
states. These states are commonly referred to as metabolic ‘pathways’ – or chemical
routes by which a specific set of reactants can be converted into the products needed
to facilitate life. One method to interpret this series of catalysed reactions is to order
them into a matrix of stoichiometric equations, where relative amounts of reactants and
intermediates are considered, rather the actual amounts.
These equations can then be assembled and simultaneously solved for a single, hypothet-
ical equation of all the inputs required by a cell to undergo a single cellular division, or
for a culture to produce a single mole of biomass (Saha et al., 2012). This method of
analysis is called flux balance analysis (FBA) modelling. There are online repositories of
these equations, such as the Kyoto Encyclopedia of Genes and Genomes (KEGG), which
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have been arranged into a general metabolic network. ‘Omic level data can be overlaid
on this to gain a general understanding of changing systems in terms of chemical outputs
of a cell (an example of this is given is chapter 5).
As mentioned above, proteins are often assembled into ‘pathways’. These often give
the impression of linear flows or pipelines of materials around a cell, indeed this is a
convenient model for understanding biological life, however it is not strictly true. Instead,
the apparent flow of material around a cell is a naturally occurring phenomenon that is
a combination of the following features:
• Close proximity of all catalysts and intermediates
• High reaction rates of catalytic conversions by proteins
• Better specificity for certain types of intermediates than others
This can be exemplified in the case of the proteolytic enzyme trypsin. It cleaves peptides
with incredible accuracy at targeted locations in the primary chain, however if left in
a reaction long after its preferred target is exhausted it begins to exhibit non-specific
cleavage action. This effect is small to the point of being negligible whilst the substrate is
present, however, generating a practical specific effect – especially within the time-frame
of the presence of intermediates within a cell.
It may seem overly specific to consider this differentiation, since it doesn’t appear to make
much difference on a practical level, however this wide-reaching availability of interme-
diates to all catalysts and the presence of non-specific effects can be the causes of major
impediments to rational genetic design of a construct. Likewise, they can be responsible
for a leak of metabolites from one pathway into another in an unexpected manner. There
are also literally billions of protein permutations, and slight modifications to the sequence
or environment can entirely change their function.
Despite these limitations, there are a number of tools that can be used to predict the
function of new proteins, based on their evolutionary relatedness to pre-existing measured
proteins. The most commonly used tool for this purpose is the basic local alignment search
tool (BLAST) (Altschul et al., 1997). This works by taking the ‘target sequence’, either
from DNA or protein, and breaking it up into smaller sequences. The smaller sequences
are then searched against a database of known protein or DNA sequences and aligned to
specific points in the sequence. Initially matching sequences are then searched against
again, with gradually extending lengths of the target sequence; this continues until only
a series of sequences with strong similarity remain. This search method is robust to both
individual base changes, as well as deletions and insertions into the sequence. There are
more advanced algorithms that perform the search more rapidly, however there can be
trade-offs in sensitivity for more distantly related sequences (Edgar, 2010).
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When a new genome is sequenced, sections of DNA that appear to be gene-like – meaning
they match a series of rules, such as beginning with a start codon and being a suitable
length before encountering a stop codon – are identified in the genome. These are then
searched using the BLAST-like tool to generate an informatic profile of the genes, where
proteins that appear similar to pre-existing proteins are labelled as such and linked to-
gether. If information is known about the related protein, it can be used for the protein
about which nothing is known – although sites are generally careful to label purely in-
formatic information as such. It is important to note that with a new organism without
an evolutionarily similar biological model organism, these techniques are of limited value
– leaving large sections of the database labelled as ‘putative’ or ‘hypothetical’ proteins.
These profiles are stored in online databases, such as UniProt (www.uniprot.org), and
will gradually be updated over time as novel informatic tools and proteomic informa-
tion become available. The large databases regularly exchange and update information
between themselves, which helps maintain a good general standard of knowledge world-
wide; however some industrially relevant or proprietory organisms – such as Chinese
Hamster Ovary cells, have information held in databases that are not publicly available.
On method of assessing protein functions are Gene Ontology terms (GO terms) (Ash-
burner et al., 2000). GO terms are a notation system that describes a series of key
functions the protein has been found to be related to. GO terms refer specifically to
functions, rather than a specific species or protein, and so whilst there would be a term
for oxidoreductase activity, there is not for a protein that triggers it, such as cytochrome
C. GO terms are grouped into three major categories:
• cellular component, which dictates structural properties or localisation within the
cell – this can include details such as ‘membrane protein’
• molecular function, indicating how the protein physically operates – for example an
Fe binding protein
• biological process, which describes any metabolic pathways the protein is associated
with – such as glycolysis
As a result of this, a single protein can have multiple GO terms, and a single GO term
can be attributed to many proteins within an organism. The documentation on the
gene ontology website is useful for getting a better understanding of the full scope of
the system (http://www.geneontology.org/page/documentation). It is important to note
that like all current informatic conventions, GO terms are not currently a perfect system.
The terms are fallible, as there is no way to differentiate researcher inputed terms from
automatically assigned terms. In addition, not all functions have been identified, and
so some terms may be missing from proteins where the association has not yet been
made. Over time this will improve, as more information enters the system, however it is
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important to be aware of potential errors or bias in function analysis on the ‘omic level.
1.3.6 Investigating the biological system
Informatic in silico and in vitro techniques for assessing individual proteins in isolation
have been described, but these are not as effective as a direct investigation into the effect
of the protein (or gene) directly inside the living organism. These studies are referred
to as in vivo. A common practice in genetics is to remove the genes that code for a
protein from the cell, a technique referred to as creating a ‘knock out’ (KO or δ) mutant,
and make observations on how its functionality changes. If the cell is no longer viable
– ie. if it dies, then the gene is considered to be ‘essential’ for basic cellular survival.
If the cell no longer produces a particular function then the gene can be linked to that
function – for example removal of the alcohol dehydrogenase gene from yeast removes
the capacity for yeast to make alcohol, then we could infer that the protein is related to
ethanol production from glucose.
The typical final test for determining the function of a protein is to add either the removed
gene back into the mutant, or to replace it with a well-understood gene from a different
organism expected to perform the same function to the organism, and see if original
functionality is restored. If function is restored then the gene is classified as performing
the same function. If this does not restore the original state of the cell (or phenotype)
then the genetic modification either caused off-target effects elsewhere in the genome, the
attempted restoration failed, or the alternative gene for a different organism either did
not perform all of the same functions as the gene that was removed, or produces other
off-target effects.
The inverse can also be done, a gene that has been found to perform a specific function
in an external organism can be added to the genome of a target organism to see how the
outputs are affected. This is generally expected to produce a novel function – and is the
fundamental principal in genetic modification of organisms used in biotechnology. This
technique is used when an organism has properties that are valuable, but it grows poorly
in an industrial setting; and so the functional parts of the organism are translated to an
organism that is easier to grow on scale. An example of this was mentioned previously,
where Amyris transferred the genes from the artemisinin pathway from Artemisia annua
into a microbial host. Again, if the gene has been shown to responsible a specific phen-
otype and fails to do so after being moved to the new organism, it can fail for the same
reasons mentioned above.
A genome can be altered by putting a piece of DNA into the cell, and then utilising
the pre-existing mechanisms for repairing DNA damage or re-ordering DNA. Through
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careful design, this can be used to either remove sections from the genome or add in
external genes. The initial limiting factor to integrating DNA into the genome of an
organism is physically bypassing the outer membranes. Some cells will naturally take up
DNA from their environment – these are referred to as naturally competent cells. Other
methods of penetrating the outer cell membrane include temporarily making them porous
chemically, introducing breaks in them with sonic energy, physically forcing DNA through
the membrane with kinetic energy, altering the membrane polarity with a technique called
electroporation.
During the CyanoFactory, a number of knock-out and gene insertion studies were per-
formed to understand the most effective way to produce H2 in Synechocystis. The next
section will focus on more specific details of cyanobacteria, hydrogenases, and specifically
the organism Synechocystis.
1.4 Synechocystis and Hydrogen Production
1.4.1 Summary of the organism
Cyanobacteria, also referred to as ‘blue-green algae’, are a large group of widely diverse
unicellular micro-organisms. They are believed to have been the first group to develop
oxygenic photosynthesis more than 2 billion years ago, and are responsible for the aerobic
conditions in the atmosphere on earth that support life as we know it (Olson, 2006).
Species are found in both salt water and freshwater, with a number of species being
halotolerant. Cyanobacteria tend to be intolerant to high light intensities, and some have
been reported to change their buoyancy in response to different light regimes – notably
through the use of structures called gas vacuoles (Walsby, 1972). Cyanobacteria are most
well-known for their roles for over-taking algal growth during algal blooms of eutrified
water, where the cells take advantage of reduced light levels to thrive (Mur et al., 1977).
Several of the well-known species, such as microcystis and trichodesmium are more widely
known because of their roles in harmful algal blooms, where they produce an array of
toxins, which can have a detrimental economic effect on domesticated wildlife, such as
cattle (Beasley et al., 1989). There area also a number of beneficial products that can be
engineered (Ducat et al., 2011)
Synechocystis became a model for cyanobacterial species through serendipity to a certain
extent. It is naturally transformable, although the transformation process can be accel-
erated through electroporation or sonication transformation methods(Tran et al., 2009);
and it was the first cyanobacterial species to be sequenced - the third fully sequenced
organism in history(Kaneko et al., 1996). It bears a striking resemblance to the chloro-
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Figure 1.5: Left: A simplified diagram showing the internal membrane structure within
Synechocystis, where moving in from the outside, the outer yellow circle is the outer mem-
brane, the white circle is the periplasm, and the shaded region is the thylakoid membrane
system. An arrow indicates the passage of light through the organism, image adapted
from (Schuergers et al., 2016). Right: an electron micrograph of a Synechocystis cell.
The thylakoid membrane structures can be clearly seen, image adapted from (Nickelsen
et al., 2011).
plast and was believed to be an ancestral precursor to the structures found in many
economically important C4 higher plants.
Synechocystis is a unicellular photosynthetic cyanobacteria that can live both autotroph-
ically, generating energy from light by photosynthesis to survive, and heterotrophically
by digesting glucose. Division occurs approximately once every 20 hours, although this
can vary depending on conditions. Growth is slightly accelerated under heterotrophic
conditions, to around 14 hours per division, and doesn’t occur at all during dark phase in
autotrophic conditions. The cells are spherical, approximately 3-4 um long and contain no
gas vacuoles – a feature which enables them to be differentiated from physically similar,
but bloom-forming species such as microcystis (Walsby, 1981). The general structure of
the cells can be seen in figure 1.5 (p. 46) The cells consist of approximately 70 - 110 mg/g
DW fatty acids, with over 70% of those fatty acids being palmitic acid (Tran et al., 2009).
By mass, the largest cellular component is protein, which makes up approximately 700
mg/g DW (Touloupakis et al., 2016). The species contains a series of layered membranes,
called thylakoids, which are embedded with photosynthetic machinery that generate en-
ergy enabling the cell to live solely on light energy – a state known as photoautotrophic
growth (Heidorn et al., 2011).
It is the model organism for cyanobacterial research as a result of its fully sequenced
and annotated genome, which was first completed in 1996 (Kaneko et al., 1996). The
genome consists of a single large chromosome containing 3317 genes, and seven additional
plasmids with a total of 408 additional genes, resulting in a total of 3725 genes and a
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Figure 1.6: A word-cloud showing the gene names, with size related to the frequency
within the gene list. Unknown function genes, or genes that are not closely related to
any currently categorised proteins, are excluded (Kazusa, 2016))
total genome size of 3.95 mbps (mega-base pairs) (Kazusa, 2016), although of these genes
only 1060 have been confidently identified, with the majority of the remaining genes
coding for transposable elements, or being of unknown function. This is exemplified in
the word-cloud in figure 1.6 (p. 47).
The organism is polyploid, meaning it has multiple copies of its single chromosome.
Initially, up to 12 copies of the genomic chromosome were identified under normal growth
conditions within Synechocystis (Labarre et al., 1989), although the separation of these
chromosomes has been found to vary irregularly, as a result of uneven segregation of the
genetic material during cell division (Schneider et al., 2007). Further study identified that
this was an underestimation, with some strains containing over 200 copies of their genome
– a value higher than that seen in the radiation-resistant organism radiodurans, although
this value was seen to vary between 40 and 218 copies depending on strain and growth
stage (Griese et al., 2011). A follow-up investigation also looked at stress effects, and
found that phosphate levels were a key factor, when phosphate levels are abundant the cell
accumulates multiple copies of its genome; however under prolonged phosphate starvation
this copy number can drop until the cells ultimately became monoploid (only a single
genome copy per cell) (Zerulla et al., 2016). Traditionally this polyploidy poses significant
difficulties when performing genetic knockouts, as the high copy number can result in
partial uptake of the genetic construct, resulting in ’heterozygous’ cells containing the
uptake biomarker. As a result of this and the slow rate of growth, creation of knock-out
(∆) mutants can take several months; and in cases where the mutant is significantly less
viable than non-transformed variants it may be impossible (Heidorn et al., 2011). On a
personal reflection, the recent research identified by Zerulla et al. (Zerulla et al., 2016)
suggests that it might be possible to radically accelerate the rate of mutant generation in
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Synechocystis by running mutations under phosphate-limited conditions; although this
would have to be weighed against the reduction in growth rate caused by such conditions.
Synechocystis has a highly complex system of membranes, composed of outer, plasma
and thylakoid membranes. On the outer-most layer is the mucilaginous sheath, a layer
of polysacharides and glycolipids; beneath this rests the largely unknown surface layer
(or S-layer). Underneath the surface lie the the outer and plasma membrane, which
surround the peptidoglycan cell wall, and the thylakoid membranes are found within
the cell (Heidorn et al., 2011). The majority of the protein content, around 60% by
concentration, is made up of 4 phycobilisome pigment proteins, which are localised to the
light harvesting machinery of the organism, known as the antenna (Colyer et al., 2005).
1.4.2 Hydrogen production in Synechocystis
In cyanobacteria, hydrogen can be produced by two enzymes, either directly by hydro-
genases or indirectly by nitrogenases. Within the hydrogen-evolving species, H2 is used
as an electron sink. Hydrogen producing enzymes are typically activated when the en-
vironment is highly reducing, as this triggers the production of radicals that can cause
oxidative stress, which is harmful to a cells continued existence through the destruction
of structural and genetic components. Oxygen is by far the favoured terminal electron
acceptor, as it is much more electronegative (3.41) than hydrogen (2.20). This means
it will absorb electrons more readily than hydrogen, and can therefore be used to drive
a much more efficient set of energy production and storage reactions in the cell. In the
absence of O2, or when the environment is excessively reducing, other mechanisms are
required to prevent oxidative stress build-up.
Hydrogenases and nitrogenases are typically inactivated by the presence of O2, due to the
nature of how hydrogen is generated. The enzymes channel electrons into a fixed area
containing protons in a controlled manner, which drives the reaction 2H+ + 2 e– −−⇀↽− H2
to the right hand side. If O2 enters the active site of the hydrogenase enzyme, it is
immediately converted into a free radical that begins to cause oxidative damage to the
surrounding environment, which results in destruction of the enzyme. Oxygen tolerant
hydrogenases exist, which exclude oxygen from the active site, however given the evolu-
tionarily favourable (more efficient) reactions present in the cell for dealing with reductive
stress using oxygen, they are much rarer. Hydrogenases are metalloenzymes that catalyse
the combination of protons and electrons into hydrogen gas (2H+ + 2 e– −−⇀↽− H2). Ni-
trogenases are the enzymes that fix atmospheric nitrogen in the form of ammonia, where
hydrogen gas is produced as a side-product as seen below (Tamagnini et al., 2002).
N2 + 8H+ + 8 e– + 16ATP −−→ 2NH3 + H2 + 16ADP + 16Pi
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Figure 1.7: A figure indicating the general mechanism of hydrogen production within
Synechocystis. On the left the general equation for H2 production is given, along with
the combustion reaction for H2. Moving to the right, the antenna structures harvest
light energy (hv) and in doing so drive an electron gradient across the membrane. These
electrons are used to convert NADP to NADPH, which interacts with the hydrogenase
to drive the equilibrium of the bidirectional hydrogen production equation to the right.
This process is inhibited by the presence of O2.
Within the active site of the bi-directional hydrogenase, there is a square-planar arrange-
ment of moieties and coordinated metal ions. These act simultaneously as an electron
sink and a reaction surface, where two protons are held in close proximity to the metal
ions and preferentially draw electrons to form a single molecule of H2. The electron sup-
ply to the hydrogenase in Synechocystis is provided by NADPH, and an overview of the
system is shown in figure 1.7 (pg. 49).
Synechocystis contains a native bidirectional [NiFe]-hydrogenase, which is encoded by a
cluster of genes known collectively as the hox cluster. It is believed that the primary
function of this enzyme is to operate as an e– valve during photosynthesis, allowing the
organism to respond rapidly to changing levels of light in the environment without slowing
e– transport (Appel et al., 2000). Hydrogen is produced in Synechocysitis as a terminal
electron acceptor in highly reducing environments, achievable as it pushes the reversible
reaction towards the right due to an excess of e– (McIntosh et al., 2011).
The the multi-subunit hydrogenase is formed from 5 proteins and contains two functional
moieties, the hydrogenase moiety, responsible for the formation and degradation of hy-
drogen, and the diaphorase moiety, responsible for collecting and transferring e– during
the reaction (Eckert et al., 2012). The assembly of the hox cluster proteins is localised
to the cell membrane where it can be effectively coupled to the photosystem proteins
embedded within the membrane (Schultze et al., 2009). It is important to note that the
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link is not as clear as implied here, based on the reported observations of a variety of
mutant phenotypes in recent work (Eckert et al., 2012).
The functional portion of the hydrogenase is composed of the HoxYH subunits. This has
been demonstrated with overexpression experiments that show increased activity, as well
as with KO experiments that show a loss of function (Germer et al., 2009; Pinto et al.,
2012a). Transcription of the hox genes is controlled by a number of factors, including
light level, inhibition of the calvin cycle and anoxia (Kiss et al., 2009). This is thought
to be coordinated by the transcriptional regulators AbrB-like protein, Sll0359 and LexA;
although these are not exclusive coordinators of expression as they fail to account for
oxygen and redox related response (Gutekunst et al., 2005; Oliveira and Lindblad, 2008;
Kiss et al., 2009).
Measuring the internal systems that drive effects like hydrogen production, requires a
number of focused techniques. In the remaining sections of this chapter, the core tech-
niques used to analyse ‘omic data are described and discussed.
1.5 DNA and RNA analysis
There are a number of different methods for determining the sequence of DNA, however
the original method, dideoxy Sanger sequencing, was devised by Sanger et al and remained
in popular use for almost 30 years (Sanger et al., 1977). This sequencing method involves
the use of DNA polymerase to replicate a strand of DNA, but in addition to the normal
mix of nucleotides, the sample is doped with a small amount ( 1%) dideoxynucleotides
for one of the bases. When a dideoxynucleotide is incorporated into an elongating strand
of DNA, it is blocked from further expansion. This occurs by random chance, as both
the normal base and the dideoxy variant are present, resulting in a series of differently
sized pieces of DNA that exactly correspond to a position of the base. Four separate
reactions are run in tandem, with one dideoxy base variant included in each pot. These
four reaction mixes are then run together on a gel and the bands can be read in sequence
to give the sequence of the DNA. A variant of this technique exists where each of the
dideoxy nucleotides are functionalised with different coloured tags. The reaction proceeds
as above, however the tags can be added into a single pot and run on a capillary gel with a
detector at the end. The detected colour sequence corresponds to the DNA sequence. The
DNA sequencing for human genome project was conducted using this technique (Venter
et al., 2001; Lander et al., 2001), however since then, there has been a rapid advancement
in new sequencing technologies. There are a large number of ‘next generation’ DNA
sequencing technologies - which have been recently comprehensively reviewed by Goodwin
et al. (Goodwin et al., 2016).
1.5. DNA AND RNA ANALYSIS 51
Transcriptomics is the measurement of all the messenger RNA (mRNA) within the cell.
When analysing RNA, there are a few key factors that need to be addressed. Beyond
its role as a transitional step between DNA and protein, RNA plays a variety of non-
messenger roles within the cell related to protein synthesis. These include providing
structure for the ribosome – the construct that facilitates protein synthesis (rRNA) –
and transferring amino acids to the ribosome for protein elongation (tRNA). Overall,
mRNA makes up around 5% of the total RNA within the cell (Warner, 1999), although
this can vary slightly with species (Kopf et al., 2014).
RNA is a single-stranded molecule that is generally considered to be unstable, and so
when analysing the transcriptome it is typically converted back into DNA using enzymes
called reverse transcriptases, producing cDNA (coding DNA) for analysis. Traditionally
the measurement of cDNA was used to infer the amount of protein within a cell, as RNA
was thought to translated into protein fairly directly. This was found to not always be
the case, due to different rates of translation and different levels of turnover of mRNA
and protein (Washburn et al., 2003), and so a more accurate model for the presence of
RNA within a cell must also take into account the rates of protein production, RNA and
protein turn-over, and the absolute levels in a given time.
The first full-genome scale combined proteomic/transcriptomic study was carried out by
Schwanhausser et al. on mouse fibroblasts (Schwanhausser et al., 2011). Previous studies
had shown a disconnect between the levels of mRNA and proteins; however this was
suggested by Schwanhausser and colleagues to be caused by experimental differences,
such as studies carried out in differing labs at different times or effects of reagents that
were used during the experiment. They showed that the difference between protein and
transcript levels measured in tandem were not as great as previously thought – there
are clear correlations between protein copies and RNA copies per cell; this correlation
is improved drastically by also considering the rate at which protein is translated from
the RNA, which was found to be the major influencing factor for cellular protein levels
(Schwanhausser et al., 2011). It was later found that additional levels of control may in
fact play a larger role in protein translation than previously thought, due to a systems
feedback effect called coupling (Dahan et al., 2011). This study was then repeated in
Mycoplasma pneumoniae, this time also measuring the rate of protein turnover within
the cell (Maier et al., 2011). They showed that gene expression is largely decoupled
from protein levels and that translation efficiency is more prominent when considering
actual protein levels. This same effect was also observed in Sulfolobus species, granting
additional credence to the concept of codon usage being a key controlling point for cellular
protein levels (Zou et al., 2012; Gingold et al., 2012). To date, a study of this nature has
not been conducted for Synechocystis.
RNA-Seq is a method of sequencing the complete transcriptome of an organism at a
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relatively low cost using next generation sequencing techniques (Wang et al., 2009). It
does require the initial production of a cDNA library, however, and this can take a great
deal of time and effort. As a result the method can be described as highly efficient, but
with a high initial cost and low costs thereafter.
RNA-seq was first performed in Synechocystis for an ethanol production study by a group
in China (Wang et al., 2012a). Considering the comprehensive quantitative information
obtained from the transcriptome, it is easily the most time and energy efficient method
of periodically observing the entire transcriptome under a variety of different conditions.
This method has also already been employed to observe hydrogen production in the green
algae, Chlamdymonas reinhartii (Toepel et al., 2013).
1.6 Proteomics
Proteomics is a discipline that analyses a collection of proteins — polypeptides which
perform functions in vivo — extracted from a biological sample. Unlike other ’omics
methods, such as genomics and transcriptomics, proteomics is complicated by additional
factors. These include alternate splicing of the RNA before translation, which changes
part of the primary sequence of the protein, or the addition of post translational modi-
fications (PTMs) such as the addition of phosphate. These changes can radically change
identifiable features of the protein such as function, weight or iso-electric point. Beyond
simply identifying the presence of a protein within a specific proteome, this discipline can
be expanded to identify a change in concentration of specific proteins within a sample;
or to isolate specific PTMs which may alter functionality.
Whilst phenotypic variations can be measured based on how the organism interacts with
its environment relatively simply, such as increased hydrogen production, the causes and
limitations to these changes — and therefore the useful biological leads — are dictated
by a plethora of small alterations at the metabolic level. The central dogma of molecular
biology shows that steps taken by the organism to cope with its metabolic environmental
conditions, at both a genetic and post-transcriptional level, will be reflected in the con-
stitution of the proteome (Crick, 1970). As a result, by identifying and quantifying
protein within an organism under specific conditions, a framework for a metabolic model
to measure phenotypic response or adaptation can be formed.
Traditionally, proteins were identified using Edman degradation (Niall, 1973). This
method sequenced a protein one amino acid at a time by cleaving the terminal amino
acid and then identifying it; however it was prone to errors, can only sequence a single
protein at a time, took hours or days to complete each run and required that the protein
being sequenced was not blocked on the amino-terminus to Edman reagents. In the 1990s,
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tandem mass spectrometry became the standard method of protein identification, as it
bypassed these problems (Wilm et al., 1996). Technology has advanced over the past
two decades and now it is possible to process a large number of proteins simultaneously,
giving tandem mass spectrometry proteomics a much higher throughput rate than other
methods (Steen and Mann, 2004).
1.6.1 The Proteomics Pipeline
The proteomics pipeline is the process that a sample goes through from experimental
method, ending with a list of proteins and how they reflect the metabolic state within a
cell. A summary of this process is available in Figure 1.8 (p. 54).
The first step is the extraction of the proteins. There are multiple methods of performing
this task, which are discussed in detail in Chapter 3. The extracted sample is denatured
then digested with a protease. Undigested protein detection, or top-down proteomics,
can be performed with mass spectrometry but will not be discussed here. During the
denaturation step, cystine disulphide bridges need to be reduced and then alkylated to
prevent reformation. This improves the rate of proteolytic cleavage and also degrades
tertiary structure based connections, which cannot be determined from genomic inform-
ation alone. The digestion is commonly performed using trypsin, due to its high fidelity
to specific cleavage sites, after either a lysine (K) or arginine (R) residue (Olsen et al.,
2004).
As there are a great number of variables between different runs on a mass spectrometer,
the simplest way of getting quantitative information of a difference between two samples
is to label them separately and then combine the samples into a single work-flow. It
is important to note that due to the limited nature of mass spectrometry proteomics,
the technique cannot be used to prove the absence of a protein from a sample. This
is because due to the nature of tandem mass spectrometry only a small subset of the
sample is actually measured in a way which transforms it into useful information. This
is further limited by features such as the dynamic range of a sample — the difference in
concentration between the most abundant and least abundant peptides being measured.
The spectrometer runs a large number of scans to attempt to capture the scope of the
information, however relatively low abundance peptides will still fail to be detected.
These peptides may be seen as a single m/z on the survey scan, but without further
fragmentation data they cannot be identified.
As the sample is highly complex at this point, it is fractionated with liquid chromato-
graphy. This helps to reduce the dynamic range by separating out the peptides into
multiple fractions, each containing a smaller number of peptides. This is done with a
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Figure 1.8: Proteomics Pipeline: Cells from different samples are collected, the proteins
are extracted and cleaved before labelling. The labelled peptides from all the different
samples are combined and then fractionated with liquid chromatography to reduce com-
plexity. Fractions are then analysed with mass spectrometry and the data is analysed
to produce results. For more details, please refer to the text. Taken from (Couto et al.,
2013; Evans et al., 2013)
1.6. PROTEOMICS 55
Figure 1.9: The ideal cleavage patterns of a peptide following collision. Rn are the
functional groups on the amino acids and dotted lines indicate fragmentation - for example
fragmentation between R4 and R5 would produce fragments b4 (amino fragment) and y4
(acid fragment). Observation of these fragments within a spectrum enables identification
of the sequence of the amino acids within a peptide. Taken from (Steen and Mann, 2004)
method such as HILIC, where peptides are separated based on hydrophobicity. If the
sample is not fractionated then peptides from high-abundance proteins will mask the
presence of peptides from low-abundance proteins. Ideally during this stage peptides are
grouped together within the fractions giving better intensity readings whilst hopefully
reducing the dynamic range.
Tandem mass spectrometry (please see Section 2.4.4 for more details on Mass Spectro-
metry) was first proposed in 1978 (Yost and Enke, 1978). The actual detection method
works by running two simultaneous mass scans on a sample, the first scan monitors the
mass to charge ratios (m/z) of all material (including peptides) moving through the ma-
chine and hitting the detector. This is known as the MS or MS1 scan. An on-board
computer algorithm then identifies m/z values of interest from this scan.
Objects of the selected ‘mass of interest’ are filtered from the sample and draw through
into a collision chamber, where they are fragmented. This level of fragmentation is
fine-tuned to produce single cleavages within peptides, occurring at more or less specific
points in the peptide bonds between the amino acids (Biemann, 1992). The output of
this collision is fed to a second detector, where it produces an MSMS or MS2 scan. In
an ideal situation, due to a large number of molecules passing onto the detector, high-
intensity peaks are seen for m/z values with a difference corresponding to the weight of
each amino-acid in the peptide sequence, facilitating identification. See figure 1.9 (p. 55).
As the proteolytic cleavage (with trypsin, for example) occurs at specific sites, a theor-
etical digest can simultaneously be performed on a digital proteome, deduced from the
genome of an organism. This provides a list of possible ‘hits’ for detected peptides to
be validated against. The expected m/z values from the sample can be simulated, pro-
56 CHAPTER 1. INTRODUCTION
ducing a database of expected values. This can be used to identify peptides of interest
within the data produced from the mass spectrometer. The observed and expected values
are compared to assign possible identifications, with numerical methods being employed
to attempt to counteract background noise and missing information. Alternatively, a
method known as de novo sequencing can be used, where peaks within the spectrum are
used to determine the amino acid sequence — as well as any modifications to those amino
acids. These peptide sequences are then searched against the existing database of known
proteins, leading to protein identification. When an MS2 scan is confidently assigned to
a peptide unique to a particular protein, the protein can be considered present within
a sample. If the peptide is not unique to a particular protein, it is considered ’shared’,
shared peptides are often ignored as they cannot accurately be assigned to an individual
protein.
There are several complicating factors to the database-search method of identification.
Firstly, PTMs can’t be detected from genomic sequence alone and therefore peptides
with modifications will cause discrepancies between expected and observed m/z values.
It is important to note that this issue can be avoided when using de novo sequencing if a
comprehensive list of modifications is available — however this may exponentially increase
the search time. Fortunately, not every peptide in a modified protein will be modified,
and as a result a protein can still be identified in spite of PTMs. Additionally, there
is the issue of isotopic variation of elements within a sample, for example the presence
of 13C will alter the mass of the peptide and therefore must be accounted for in the
identification stage. The occurrence rate of this effect is known, and as the peptides are
relatively small (around 6 - 20 amino acids long each) it can be accounted relatively easily
using a method known as Isotopic Distribution Deconvolution. There is also a benefit to
this effect - by identifying the distance between isotopic distribution peaks, it is possible
to identify the overall charge (z) of the molecule being measured. These will occur at a
rate of 1 in a singly charged molecule, 0.5 in a doubly charged molecule, 0.33 in a triply
charged molecule and so on.
Mass spectrometry also suffers when identifying fragments of very similar mass, for ex-
ample leucine and isoleucine have identical masses, making them indistinguishable on
this basis. Finally, since not every peptide within the spectrometer can be measured high
abundance proteins can completely mask the presence of low abundance proteins. The
difference in abundance between the lowest and highest copy proteins is referred to as
the dynamic range, and having a large dynamic range can result in reduced identification
efficiency. Such as the case of phycobiliproteins in Synechocystis.
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1.6.2 Mass Spectrometry
Mass spectrometry is essentially a highly accurate molecular weighing scales. Samples
are loaded into the machine, ionised and then separated by their mass to charge ratio
(m/z) before hitting a detector. There are multiple methods of ionising and separating
molecules, resulting in a variety of different spectrometers — although they all follow
the same basic principle described above. Preparation, and also the method of ‘simpli-
fication’ of the samples varies, depending on the type of ionisation method employed by
the spectrometer. Two major methods of ionisation are the most common within proteo-
mics: Electro-Spray ionisation (ESI) and Matrix Assisted Laser Desorption/Ionisation
(MALDI). These are both ‘soft’ ionisation techniques, which cause very little to no frag-
mentation to the molecule being charged. Minimal fragmentation is essential for the
survey scan in tandem mass spectrometry.
In ESI, the protein sample is digested (as described above) before fractionation. This is
done gel-free, using High Performance Liquid Chromatography (HPLC). The sample is
fractionated with a mass spectrometer competent buffer such as acetonitrile (CH3−C−−N),
which does not interfere with the operation of the spectrometer. The solution is run down
a charged needle, situated next to the mass analyser collector. There is an electric current
applied between the needle and the collector, which pushes charged ions down to the tip
of the needle. On reaching the tip, the sample is repulsed into a Taylor cone with droplets
escaping from the end of the cone and flying towards to spectrometer. These gradually
reduce in size as the buffer dissociates, increasing the charge density of each droplet and
spraying out ions as the droplet shrinks. On complete evaporation, typically only a single
charged molecule remains. This is then processed through the mass analyser.
In MALDI, the sample is first separated using 2D gel electrophoresis. This is done
by firstly running the protein sample on a column gel that is gradiated by pH, which
separates proteins out by iso-electric point. The column gel is then loaded into another
gel and standard gel electrophoresis is used to separate the proteins out by size. Different
phenotypes are run on different gels, which produce a similar output as the sample is
mostly identical. Relative abundances are measured by spot-size on the gel and proteins
believed to be differentially expressed by a significant amount are picked from the gel and
digested (as described above). This assessment is made by graphical analysis software,
as the task is daunting for a researcher when attempting to measure a full cell proteome.
Selected samples are then loaded onto plates within a MALDI matrix material. The
machine ionises the sample by firing a wavelength of ultra-violet light at the matrix,
causing its degradation. This simultaneously ionises the sample, whilst releasing it into
the gas phase and launching it into the mass analyser.
There are four types of mass analyser: Time of Flight (ToF), Quadrupole, Quadrupole
58 CHAPTER 1. INTRODUCTION
Ion Trap (QIT) and Orbitrap.
The simplest form of mass spectrometer is the ToF separation technique. In this method,
all the ions are accelerated to the same kinetic energy (Ek) and passed through a flight
tube to a detector. As Ek = 12mv
2, where m is mass and v is velocity, molecules with
a smaller mass move more quickly and therefore hit the detector first (Mirsaleh-Kohan
et al., 2008).
In the quadrupole, the sample is passed between 4 parallel rods before hitting the detector.
These rods generate a tunable electrical and radio-frequency field that alters the flight
path of ions moving through it, causing ions with a non-permissible m/z to collide with
the rods and never reach the detector. The frequencies can be run through a range of
steps that allow a spectrum of m/z values to be detected (Wolfgang and Steinwedel,
1956).
QIT works similarly to quadrupole, with the exception that it operates an exclusion
detection method instead of a permissive detection method. Ions pass into the field and
are then trapped by a dynamic alternating current. These collected ions are only ejected
when the quadrupole is tuned to let those with a specific m/z pass through. Ejected ions
then hit the detector and the m/z is determined by the frequencies of the field (Schwartz
et al., 2002).
Finally, the orbitrap mass analyser works by trapping ions within an electrostatic field,
without the application of radio frequency. The ions orbit around an axial electrode and
harmonically oscillate with a frequency proportional to (m/z) − 12 . These oscillations
produce an effect on the central electrode, which are detected and can be converted back
into (m/z) values for high-accuracy mass detection (Makarov, 2000).
1.6.3 Quantification
So far, only the detection of the presence of a protein has been described. Whilst this
is useful for confirming that predicted proteins exist or for identifying the presence of a
particular organism or gene within a sample, it doesn’t provide any useful information
about the phenotype being investigated or provide an insight into the molecular function
of the phenotype. The absence of a protein for a phenotype is non-informative as well,
since as previously mentioned peptides can be missing from the data even if they are
present within the sample. As a result, when comparing phenotypes some degree of
quantification of protein is required.
There are numerous approaches for quantifying proteins within a proteome. These include
measuring relative abundances on a gel prior to running through the spectrometer, making
1.6. PROTEOMICS 59
an estimation of abundance based on a known standard, or by labelling samples prior
to running them. There are two forms of quantification, absolute and ratio-based. In
absolute quantification, the concentration of a protein is estimated based on the values
measured, whereas in ratio-based quantification the amounts of protein in a sample are
measured relative to another sample - such as an alternative phenotype or an experimental
control.
In gel-based quantification, a gel is run as described above in either one or two dimensions.
It is then labelled with a protein-specific stain, allowing two samples to be compared
using image analysis techniques. For quantification in LC-MSMS there are a number
of different techniques available, three common methods include label-free, metabolic
labelling techniques — such as Stable Isotope Labelling in Amino acid Cell culture,
(SILAC) — and isobaric tagging.
Briefly, label-free can be done by measuring intensities protein spiking involves inserting
a known concentration of a purified protein into a sample during a run on the machine.
Since the protein and its quantity are known, it can be used as a baseline for quantifying
other proteins, however there are limitations with this method. In an ideal situation,
all peptides from a protein will be passed from the sample to the detector, however
peptides can be lost at different stages in the detection process. Some peptides don’t
ionise particularly efficiently, this can be due to the sequence of amino acids and the
chemistry of the resulting molecule. There can also be an uneven separation of peptides
into different fractions from the HILIC, which can reduce the signal intensity. As a result
of both of these effects, a measured peptide spectra can be of a lower intensity than is
expected. This leads to an under or over estimation of the amount of protein in a sample,
depending on whether the lost peptides are from the sample or the spiked protein.
In SILAC quantification, one phenotype is fed/grown on media containing amino acids
isotopically labelled with 13C or 15N. These non-radioactive ‘heavy’ labels are typically
arginine or lysine, although this depends on the protease being used during analysis. They
are stably incorporated into the proteins within the cells and over time become present
within the entire proteome. When the peptides from these organisms are extracted, they
can be pooled for detection in the mass spectrometer. As the peptides run through the
MS1 scan, the separate phenotypes can be observed due to a mass difference of 1 (or
more, depending on the number of heavy amino acids present in the sample) (Ong et al.,
2002).
An isobaric tag is a molecule that is made up of three parts, the binding group, the
reporter group and the balancer group. The binding group specifically binds covalently
to primary amines. In the case of peptide tagging, this ensures that the N-terminus of
every peptide can be labelled (lysine residues will also bind the tag). The reporter groups
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Figure 1.10: A summary of isobaric tags. A: The isobaric tag is made up of an amine
specific peptide reactive group enables the tag to bind to the peptide, and a reporter
and balancer group that weigh equal amounts cumulatively. B: This image shows the
tag covalently bound to a peptide. In this example, the isobaric tag is an iTRAQ 4-plex.
There are 4 tags with m/z values differing by 1, and each phenotype is labelled with a
different tag. At this point the weight of all phenotypes has been increased by an equal
amount, due to the balancer group. C: When the peptides move into the spectrometer,
they remain isobaric within the survey scan, but during the collision phase they fragment.
The reporters from the tags are then measured by spectrum intensity, which can be used
to determine quantifications. Taken from (Ross et al., 2004b)
have the same chemical sequence, but contain 13C and 15N isotopes so that each label
differs in molecular weight by approximately one. Finally, the balancer group is also made
up with 13C and 15N isotopes complementary to those in the reporter group, causing the
overall mass of all the tags to be equal when they first pass into the mass spectrometer.
See Figure 1.10 (p. 60).
Each tag is covalently bound to a different replicate or phenotype within the experiment
and after this step the samples are all pooled together for detection. At this point
it is impossible to distinguish between different samples based on weight or molecular
properties, resulting in no bias for particular tagged peptides moving through the LC
or the survey scan. When the tagged peptide is picked for an MS2 scan and undergoes
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fragmentation, the reporter from the tag separates and can be measured by the detector.
The weight of the reporter falls within a relatively clear part of the spectrum and as
a result, relative intensities of the different reporters (and therefore peptides) can be
measured from a single injection. There are two commercially available isobaric tags,
Isobaric Tags for Relative and Absolute Quantification (iTRAQ) by Sciex, (Ross et al.,
2004b) and Tandem Mass Tags (TMT) by Thermo Fisher (Thompson et al., 2003).
In principle these two methods work in the same way, differing only in the compositions
and masses of the reporter tags. iTRAQ is currently available in 8-plex, allowing 8
different samples to be combined in a single run of the mass spectrometer, whilst TMT
has recently released a 10-plex tag system, although this can only be resolved on very
high accuracy machines such as an orbitrap spectrometer (Werner et al., 2012; McAlister
et al., 2012). Once quantitative data has been collected from the mass spectrometer, it
needs to be processed prior to enable understanding of what the results mean biologically.
1.7 In-silico models
1.7.1 What’s in a model?
"All models are wrong, but some models are useful" (Box, 1976).
A model, in simplest terms, is a line drawn between the points on a scatter plot suggesting
a trend. In doing this, we predict that the values that fall between measurements will
follow this line – we make a guess about what the underlying causes of data would do
in the spaces we do not measure. By relating this to some form of algebraic expression,
we can take some controllable value and use it as a ‘predictor’ for an observable one.
Consider the case in figure 1.11 (p. 62). The dotted grey line in this figure is a linear
model with the equation y = 0.1×x, which in real terms tells us that for every 10 ‘units’
we raise x by, we can expect y to raise by one ‘unit’, within a certain degree of error.
In the the first graph, the model appears to fit the data well, but as more data is gathered
in the unmeasured space between points, additional effects are observed and could in turn
be better described by a more accurate model. The important point to realise here is that
whilst the first model did not capture the entire complexity of the underlying system,
it enabled an observation of a trend. The ‘noise’ or error remaining between the data
and the model shows us that there are features within the system that have not yet been
captured, but the observation of y = 0.1×x is still useful for predicting trends generated
by this system – if the researcher can accept that their predictions will contain a margin
of error.
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Figure 1.11: Two plots populated with data generated from the same formula, y =
0.1× x + sin(x). In the first case the linear model appears to fit well (left), but further
observations may reveal this to be an incomplete picture of the underlying trend (right).
Metabolic models of cells operate in a similar manner, they take recorded experimental
values and attempt to describe what observable effects will take place within the cell.
Metabolic models can be used for a variety of predictions for production. These range
from relatively simple models, which consider enzyme kinetics to predict the amount of
a product produced by a given protein (Johnson and Goody, 2011), to more complicated
systems that predict entire pathways of enzymes and metabolite pools inside and outside
the cell to produce a predicted production rate (Montagud et al., 2015).
More detailed models do not always produce better results, and it is worth noting that
highly complex models run the risk of ‘over-fitting’ – or trying to predict the cause of noise
in a system when the experimental data doesn’t capture these observations. Consider
figure 1.11 (p. 62) again; whilst it is possible to predict the sin(x) from this data (as the
underlying function is simple), if multiple underlying effects were present it is possible
that a combination of unmeasured effects could appear to have a pattern that did not
truly exist. The best example available of this is the line of best fit automatically applied
in Microsoft excel graphs – the trend line is generated from few data points that have
been highly interpolated. This generates a line that travels through every point, even if
the system contains noise that cannot be explained by the independent variable.
The risk with over-interpreted models is that they suggest a relationship between the de-
pendent and independent variables that does not exist, which can mislead the researcher.
Models are, after all, only aids to help a researcher make associations between variables
that are difficult to compute; they play a role in iterative research, enabling generation
of new, testable hypotheses and appropriately designed experiments (Box, 1976). It is
also important to point out that a model describes a relationship or correlation, not ne-
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cessarily a causation; determining causation requires a reductive analysis – for example,
consider the following observation: in a closed system, A is increased, and B also increases
(A and B are correlated); however when B is increased and A does not increase, B is not
causative to A.
1.7.2 The Monod model and FBA
Jacques Monod pioneered the metabolic model of cell division in E. coli (Monod, 1949).
In his experiment, he equated maximum cell growth to the availability of nutrients in
the media; making the first link between a stoichiometric equation and the terminal
point of cell growth – halving the available carbon source resulted in half the maximum
cell density, similarly; doubling the rate of production of a toxic metabolite or the rate
of reaching a critical ion imbalance such as pH also halve the maximum cell density.
Interestingly, in the same work he also mapped the various stages of bacterial cell growth
as they are widely known in biology today: lag phase, acceleration of growth, exponential
phase, retardation of growth, stationary phase, and cell death (although as he points out,
in some cases one or more of these phases are so rapid that they are not observed).
Building on the work of Monod, Flux Balance Analysis (FBA) is one method of attempt-
ing to approximate the various metabolite pools within the cell. It works on the principal
that by using stoichiometric principals described earlier in this chapter, a balanced equa-
tion can be calculated for the entire cell (Orth et al., 2010). To overcome the issue of
the system being under-determined; where missing information leads to several possible
‘correct’ outcomes, or some/all of the equations could be set to 0 to ensure they balance,
the model has a ‘biomass equation’ that it tries to solve the simultaneous equations for.
This creates a bounded solution space – a set of absolute limits required to be satisfied
when balancing the equations. The model then solves for the highest possible amount
of biomass production in a given time – the same ‘objective function’ that holds true
in evolution-driven systems (in most cases, the fastest growing organism dominates an
environment).
In other cases, where adequate literature on the organism being studied is not available,
missing values can be borrowed from similar organisms or ‘fudged’ with fake place-holder
reactions. This is required in some cases, such as where a pathway has no bridging
reactions and so the biomass equation cannot be solved, or when a series of known
reactions form an island that does not participate in the biomass equation. Although
an FBA model may not predict the same outcome for the same model every time, the
solutions it generates are generally not wildly different from each other and they can be
run through multiple iterations to generate a statistically favoured state or probabilities
for various states.
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As it is run on a series of metabolic reactions, which are mapped to enzymes and meta-
bolite pools, an FBA model can be particularly useful for predicting how an organism will
be affected by a genetic modification, or limiting/removing a substrate from the growth
media. In these cases, a series of cheap in silico experiments can be run to determine that
the cell will still be viable (able to grow) – potentially avoiding costly experimentation
that would not work. It is important to note that scepticism of in silico observations is
still high in the scientific community – for good reason.
Many existing models still require extensive testing under experimental conditions to
identify their limitations; which arise from the model being drawn together from disparate
literature sources, generated from different labs, under different experimental conditions,
with different genetic backgrounds, and in the case of models of ‘non-model species’ – from
different organisms entirely. The future is bright, however; as computational analysis of
data improves, and more frequent, higher quality ‘omics-level analyses are performed; our
capacity to test and verify these models is improving.
1.7.3 Reconstruction of the Synechocystis model
Synechocystis has recently been the subject of computational modelling to analyse the
organism for potential biofuel production by Montagud et al (Montagud et al., 2013). This
reconstruction – iSyn811 – contained 956 reactions relating to 811 genes; representing over
75% of the confidently identified proteins known in the organism, and an improvement
over the previous model iSyn669 (Montagud et al., 2010). The model was designed to
investigate the metabolic potential of the organism to produce two key biofuels: ethanol
and hydrogen; and utilised transcriptomic data to improve on the previous model.
In addition to testing stoichiometric balances with FBA against experimental values,
the model also tested for ‘coupling’ or directionality and flux limits to the reactions
(Burgard et al., 2004). This makes the model more accurate, by controlling not only
which reactions are reversible, which are irreversible, and what direction matter flows in
through the directional reactions; but also the rate limiting steps within these clustered
groups, providing maximal and minimal flux limits. During the CyanoFactory project, the
proteomic data generated at Sheffield was forwarded to the research group that generated
these models, to put observations of system-level changes into context.
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1.8 Thesis summary
1.8.1 Chapter 1
In this thesis, systematic improvements to the collection and understanding of proteomics
data were generated, using analytical and experimental methods. This introduction has
(hopefully!) served as a primer to the field of industrial biotechnology, biofuel and H2
production, proteomics, and the cyanobacteria Synechocystis.
1.8.2 Chapter 2
The main body of the thesis begins with Chapter 2, which is made up of 2 separate
literature reviews that were prepared originally as separate manuscripts. The first is an
assessment of the historic development of the field of proteomics in Synechocystis, and the
second an investigation of emerging proteomic technologies and how they will influence
the development of production strain analysis in the future. The second was published
in current opinions in biotechnology, however a publication covering a similar topic to
the first was published by another group removing the niche in the literature that the
study was intended to fill. Despite this, the work carried out in this chapter provided
important ground work for a number of the investigations conducted in chapter 4 for
improving proteomic methods in Synechocystis.
1.8.3 Chapter 3
Chapter 3 details the proteomic investigation of altered media hydrogen production,
which were carried out as part of the CyanoFactory project. This chapter covers the
lab-based practical aspects of the PhD, and the conclusions highlight key changes relat-
ing to the organism when grown under environmental conditions that enable hydrogen
production. Two studies make up this chapter, one was carried out at the end of the first
year of PhD study, whilst the second was a related analysis carried out at the end of the
study utilising the improvements that had been designed over the course of the thesis.
1.8.4 Chapter 4
Chapter 4 covers investigations into optimal experimental proteomic methods is carried
out. This is coupled with data analytical assessments of both the chassis, based on
experimental data collected by both Sheffield and other partners during the CyanoFactory
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project, and key analytical techniques for summarising the data to create a simple output
for a biological specialist to interact with. Two of the studies presented in this chapter
have also already been involved in publications, with a third being included as part of an
industrial study of E. coli in a bioreactor.
1.8.5 Chapter 5
Chapter 5 details a comparative study between two popularly used proteomic tagging
systems in the context of the target chassis – iTRAQ and TMT. This study highlights
confounding effects of the Synechocystis background and details the accuracy, and there-
fore the practical working ranges, of these technologies. It also covers an informatics
investigation into the proteomic background of Synechocystis. Work in this chapter is
currently being prepared for submission as a publication.
1.8.6 Chapter 6
The thesis closes with chapter 6, which draws together the various conclusions from
throughout the thesis and cohesively lists the work that is included in the body of the
thesis. It then highlights the areas that have been developed over the course of this study,
as well as summarising areas where further investigation is needed. The final section of
the conclusions lists the core contributions to science that have taken place over the
course of this PhD.
1.8.7 Methods and appendices
At the end of the thesis, a list of computational methods used in the thesis are included
in a digital repository. The sections included in this chapter are discrete data bundles,
containing the code, data and relevant figures; each bundle is referenced by a DOI. A
description of each of the bundles is given in the computational methods chapter. The
appendices contain each of the deliverable reports from the now complete CyanoFactory
project, which cover a broader base of topics than those contained within the main body
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2.1 Introduction
This chapter is made up of two separate literature investigations, the first related to
Synechocystis, looking specifically at the limits under which the organism has been in-
vestigated, the areas relating to potential biotechnological applications, and the inferred
responsiveness of the organism to a variety of environmental changes. These investiga-
tions are vital for predicting and understanding the proteomic changes that occur under
different growth conditions. In addition, within this section, the literature is assessed for
its progression over time in a bibliometric analysis, suggesting future trends that may
be applicable to other organisms being developed for biotechnological applications. This
study was intended to be submitted for publication, however due to a similar study by
another group it is no longer applicable at this time; and has been retained as in-house
knowledge of the field.
The second section of this chapter is verbatim a paper that was submitted to opinions in
Biotechnology. This section covers in detail the latest trends in proteomics for production
strains – or strains that have biotechnological application for production. Synechocystis
made up a case study in this paper, but the general focus was on the improvements that
need to be made to industrial applications for proteomics compared with where the field
currently is with applications for medical studies. There is a lot of scope for improvement
in this field, and it is likely that looking at pioneering cases, such as Synechocystis – which
has a relatively advanced collection of proteomic research associated with it compared to
other microalgae – can inform and accelerate quality improvements in other strains.
2.2 Proteomics in Synechocystis
Authors: Andrew Landels, Jenifer Parker, Narciso Couto and Phillip C Wright.
2.2.1 Abstract
Cyanobacteria are photosynthetic micro-organisms that hold huge industrial potential
for the biotechnology sector. Predictable engineering is required to realise this potential,
however this is completely dependent on comprehensive systems-level information that in
many cases has not yet been completed. Here we present a summary of recent mass spec-
trometry based gel free proteomic work, one of the key fields required for understanding
and engineering a biological system. We focus on Synechocystis sp. PCC 6803, the first
cyanobacteria to be sequenced and as a result backed by the largest body of supporting
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proteomic literature, to highlight general research trends and the current limits of the
literature.
2.2.2 Introduction
Cyanobacteria are a highly diverse group of photosynthetic microorganisms responsible
for the fixation of 25% of all carbon dioxide on earth, making them the largest global
source of carbon fixation. They accomplish this by also being the largest harvesters of
sunlight energy. They are differentiated from micro-algae by being prokaryotic organisms
which lack internal cellular compartments such as a nucleus. In this review we will focus
on a single species of cyanobacteria, Synechocystis sp PCC 6803 (herein referred to as
Synechocystis). Synechocystis is a small, naturally transformable cyanobacterium with
a relatively small genome that has been colloquially dubbed ‘The Green E. coli’ in the
literature (Branco dos Santos et al., 2014). Synechocystis was the first cyanobacteria to
be fully sequenced, with a genome size of 3947 kilobase pairs, which encodes a predicted
3575 proteins (Kaneko et al., 1996). The photosynthetic machinery is located in the
thylakoid membrane, hosting highly effective light-harvesting complexes.
Synechocystis has been used as a model for photosynthetic systems in eukaryotic organ-
isms numerous times, which can be seen with a brief search of the literature producing
hundreds of matches. It is also industrially relevant, with a rapidly increasing number
of publications investigating Synechocystis as a bio-producer for a variety of fuels and
specialist molecules (Table 2.1, pg. 70). To put this into context, prior to December 2009
there were no publications linking Synechocystis to biofuel production – there are now
more than 80. These bio-molecules range from organic fuel molecules like ethanol (Song
et al., 2014; Dienst et al., 2014; Qiao et al., 2012a)), to gaseous products like hydrogen
(Pinto et al., 2012a) and even synthetic production precursors like isoprenoids and lactic
acid (Kudoh et al., 2014).
Modern technologies, such as online tandem mass spectrometry and next generation se-
quencing, have revolutionised fields like proteomics and genetics by creating the ‘big data’
approach to biology. Despite the challenge, comprehensive proteomics is critical to bioen-
gineering. The proteome is a highly dynamic system that responds on both the transla-
tional (presence/amount of each protein) and post-translational (activity/functionality)
level. Addressing the challenges involved in generating high-quality data from this field
is essential for realising the industrial bioengineering potential. For an introduction to
shotgun proteomics in cyanobacteria, please refer to the review by Ow and Wright 2009
(Ow and Wright, 2009).
Here we focus on a number of key topics related to gel free proteomics in Synechocystis,
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Table 2.1: A table of the different biotechnology products that have been investigated
for production in Synechocystis.
Biomolecule Publication
Isoprenoids (Lindberg et al., 2010), (Bentley et al., 2014),
(Kudoh et al., 2014), (Englund et al., 2014)
Feed-stock for fish (Anemaet et al., 2010)
High-value organic molecules (Reinsvold et al., 2011)
Lactic Acid (Angermayr et al., 2014), (Varman et al., 2013)
Glycerol (Savakis and Hellingwerf, 2015)
Hydrogen (Pinto et al., 2012a), (Rögner, 2013), (Montagud et al., 2013)
Fatty Acids and Lipids (Liu et al., 2010), (Gao et al., 2012), (Cai et al., 2013),
(Chen et al., 2014a)
Hydrocarbons (Kämäräinen et al., 2012), (Wang et al., 2013)
Ethanol (Qiao et al., 2012a), (Wang et al., 2012b), (Dienst et al., 2014)
(Sengupta et al., 2013), (Song et al., 2014)
Hexane (Liu et al., 2012)
Butanol (Tian et al., 2013a), (Varman et al., 2013),
(Zhu et al., 2013), (Anfelt et al., 2013)
Sucrose (Du et al., 2013)
In addition to identifying key Synechocystis proteomics papers we will discuss the cur-
rent research limits in the field, standard procedures for generating proteomic data, a
discussion on effective quantification methods in current use, and future directions for
the field.
2.2.3 Standard procedures in use and protein identification chal-
lenges
There is currently no community-standard method for generating proteomic data from
Synechocystis, however there are a number of techniques in the cell-pellet processing
pipeline that follow broadly the same patterns. Cell disruption is the process of lysing the
cells. There are two techniques that appear in the majority of publications reporting high
protein identifications: sonication and bead-beating. These have become popular because
they are automated, effective and highly reproducible. Other traditional techniques, such
as liquid nitrogen grinding, have a great variation between different users and the methods
are difficult to report accurately and reproduce. High-pressure methods, such as the
French press or Yeda press, have been shown to be thoroughly ineffective at disrupting
Synechocystis cells, as certain strains are pressure resistant. More accurate comparisons
between extraction methods is impossible as no study has directly compared extraction
methods whilst maintaining the same conditions downstream.
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Cell debris processing is where the majority of divergence in publications occurs. This
refers to the process of taking the disrupted cellular material and processing it into
peptides for mass spectrometry analysis. Broadly there are two methods of doing this,
separating the whole proteins out on a gel and using in-gel digestion to produce peptides
or digesting individual samples in solution and fractionating the peptides out by their
individual features. The method chosen is heavily dependent on the down-stream pro-
cessing and the focus of the experiment being carried out – if the user is conducting an
exploratory investigation that does not require merged quantification methods then the
protein-level separation has been shown to have significant advantages over peptide-level
separation. A more in-depth comparison between these methods is made later in this
review.
Peptide post-processing is an optional step, included in studies where the user is inter-
ested in identifying post-translational modifications or applying a peptide-specific tag.
Post-translational modification purification is a rapidly growing topic which requires a
specialised approach for each different modification being concentrated. For further de-
tails on current trends in PTM research methods, please see this review by (Huang et al.,
2014). With over 20% of all Synechocystis proteomics papers citing their use, the most
commonly used peptide-specific tags are iTRAQ (isobaric tags for relative and absolute
quantification). Alternative quantification tags have only rarely been used in Synecho-
cystis with a single study reporting the use of TMT (tandem mass tags). To date no
clear comparison between iTRAQ and TMT tags has been made.
Quantification of proteins in proteomics is generally done in one of two ways, either
through a gel-based method using 2D gel electrophoresis stain intensity analysis, or else
through a spectral intensity counting method on the mass spectrometer. The quanti-
fication method used is dependent on the mass spectrometer available; gel methods are
commonly associated with MALDI spectrometers whilst spectral counts are used with
the LC-MSMS setup. Almost all studies to date have processed spectra for identifica-
tion with the software Mascot (www.matrixscience.com). Alternative programs have been
used previously, but a flat comparison between different software has not been completed.
Proteomic techniques in Synechocystis have been rapidly evolving over the last 5 years.
This can be seen broadly from the number of protein identifications that have been
reported per publication (Fig 2.1 p. 72). A severe limitation on protein identification
in Synechocystis is the presence of small, high-abundance phycobili-proteins (Gan et al.,
2005). These proteins are integral to the light harvesting antennae, which account for
around 40% of all proteins in the cell or 20% by weight due to their relatively small size –
which can be observed on a standard protein poly acrylamide gel electrophoresis (PAGE)
analysis as shown in figure 2.2 (p. 72). The focus of these studies has also been changing
with time, ranging from initial investigations into the membrane eventually leading to
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Figure 2.1: The number of proteins identified in each proteomic study of Synechocystis
per year. All studies that confidently identified more that 1000 proteins are highlighted
in yellow, all the green points were conducted by the same lab over the last 4 years, and
the point in red was the first study that focused primarily on increasing the number of
protein identifications.
Figure 2.2: A slice of a gel image, showing a size ladder in the top row and Synechocystis
proteins in the bottom row. The four strongest bands on the gel are the phycobiliproteins,
which dominate the protein sample. The blue colour on the proteins here is as a result
of dyeing with the Bradford reagent, however the phycobiliproteins also showed as a blue
shift on the band whilst the gel was running.
much broader-reaching studies investigating technical improvements to techniques and
systematic development of the organism for biofuel production (figure 2.3 p. 73). There
have been several limits that have been explored in proteomic investigations, as detailed
in table 2.2 (pg. 74).
2.2.4 Synechocystis proteomic studies
To date, only around 65% of the proteome of Synechocystis has been successfully identified
through mass spectrometry, although this is higher than the number of annotated genes
in the genome.
By focusing on publications that have reported the highest numbers of identifications,
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Figure 2.3: The topics being published in Synechocystis over time. Each publication was
given a tag based on the topic, which are as follows: mut – Mutant study; rev – Review;
starv – Stress, Starvation; tol – Stress, Tolerence; tech – Technical improvement study;
exp – Exploritory Studies. In cases where a publication addresses multiple topics, it was
assigned multiple tags, to reflect current knowledge and direction of interest in the field.
No single publication was given multiple counts of the same tag, regardless of the size of
the study.
Figure 2.4: The overall number of publications per month since January 2012. The levels
remained largely steady until a large spike in publications at the beginning of 2015 – the
dip at the end of the graph results from an incomplete set of data, as this was collected
over the first 16 days of March, 2015; suggesting a continuation in the publication trend.
This figure is taken from the supplementary materials of (Landels et al., 2015).
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Table 2.2: A table listing the current limits that have been investigated with a proteomic
study in Synechocystis. Whilst these data cover a broad base of topics – many of which
are discussed in more detail in the following sections of this section – as can be seen from
figure 2.1 (pg. 72), a number of these studies conducted before 2010 may be of limited
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we highlight techniques and features of proteome investigation that yielded the highest
degree of success. The single point in red is the first investigation into improving protein
identification in Synechocystis, performed by (Gan et al., 2005). The authors highlighted
the importance of separating out the membrane and soluble fractions of the proteome
prior to digestion, to enable solubilisation and digestion of the membrane fraction before
recombining the two fractions together. Here a total of 776 proteins were positively
identified with isoelectric focusing for protein and peptide fractionation prior to reverse
phase giving the best overall number of positive proteins identifications (Gan et al., 2005).
The technique is now a standard in this field.
In Figure 2.1 (p. 72), the points highlighted in green all reference the same protein
extraction protocol from the Zhang group (Qiao et al., 2012a), and are produced in the
same lab using the AB SCIEX Triple ToF 5600 spectrometer. These publications provide
both qualitative and quantitative data through the use of the isobaric tagging agent
iTRAQ. The most notable difference between these studies and others in the field with
far fewer positive protein identifications appears to be the use of the high quality mass
spectrometer. Whilst this is clearly an effective solution to the problem, it is unhelpful
to labs that lack the resources required to purchase more expensive, powerful machines.
The orange points are all other published studies that have produced more than 900
unique protein identifications. The earliest Synechocystis publication to exceed this
threshold was a bioinformatic-based protein identification investigation (Ishino et al
2007). This study was notable as instead of using oﬄine LC separation, proteins were size
selected using electrophoretic mobility and in-gel digestion before analysis with reverse-
phase LC-MSMS. This qualitative method is affordable and highly effective – reporting
1442 unique proteins with good confidence but has yet to be used successfully with quan-
tification methods, such as isobaric tagging.
In 2010 Wegener et al identified almost 2000 proteins ((Wegener et al., 2010). This study
combines the output of 12 different conditions, each double-injected into the mass spec-
trometer. This dramatically increases the number of total identified proteins, suggesting
that this comprehensive method of obtaining data from samples isolated from a variety of
conditions is sufficient to increase the level of proteome coverage at the expense of time.
The three remaining highlighted studies that exceed the selection criteria utilise depletion
methods; one at the cell-pellet extraction level where phycobili-proteins are washed out
of the membrane fraction (Zhang et al., 2013a) and the other two through post-digestion
peptide purification – in this case a side-effect of preferentially selecting cys-containing
peptides (Guo et al., 2014) or phospho-peptides (Talamantes et al., 2014).
There is evidence to suggest that the reduced protein identification is a stochastic feature.
The study byWegener et al doubled the number of unique protein IDs that had been made
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at that time whilst identifying the majority of already identified proteins (Wegener et al.,
2010). Notably, their work combined data from a number of different stress conditions
with data from standard conditions. Low-abundance proteins in Synechocystis can be
considered to fall below a ‘stochastic selection threshold’. Whilst it is feasibly possible to
identify a unique peptide from one of these proteins, it is highly unlikely that the second
unique peptide required for confident identification would be found. In the Wegener study,
stress proteins that would normally be of low abundance became much more prevalent,
therefore enabling identification. By running multiple comparisons and producing much
more data, they lowered the ‘stochastic selection threshold’ for the peptides generating
large numbers of identifications.
2.2.5 Post-translational modification proteomics studies
Advancements in proteomics technology and high accuracy mass spectrometry can now
lead to the identification of thousands of phosphorylation sites in a single experiment from
a eukaryotic organism (Collins et al., 2007). The significance of Ser/Thr/tyr phosphoryla-
tion of bacterial proteins has been an advancing research area in recent years (Jers et al.,
2008; Soufi et al., 2008) and bacterial phosphoproteomics is picking up momentum with
global studies in a vast number of bacterial species. In the last 2 years 3 separate studies
have been published centred on the phosphoproteome of Synechocystis 6803 (Spät et al.,
2015; Lee et al., 2015; Mikkat et al., 2014a). Two of the studies were conducted on WT
Synechocystis grown in standard conditions, and whilst whole-proteome analysis identi-
fied as much as 5% of the proteome containing putative phosphorylation sites, determined
by both data analytics on the protein sequences and staining within a 2 dimensional gel
experiment, less than 1% of the proteome was found to actually be phosphorylated under
standard growth conditions (Lee et al., 2015; Mikkat et al., 2014a). The third study
investigated how phosphorylation changed under nitrogen starvation and found a signi-
ficant increase in the number of detected phosphoproteins – up to the complete 5% of
predicted phosphorylation sites over the course of the investigation (Spät et al., 2015).
Phosphorylation events were found to be much more frequent under nitrogen starvation,
with the number and frequency of phosphorylation events increasing after 24 hours.
Phosphorylation is a much more rapid and efficient response method than protein turn-
over, a fact that is particularly prominent when nitrogen – a key building block of protein
– is limited. As mentioned earlier, within Synechocystis, the antennae proteins represent
the largest single usage of nitrogen within the cell: they have a fast rate of turnover
due to reductive damage caused by photobleaching and the generation of reactive oxygen
species, and they make up a huge proportion of not only the protein mass but the total
mass of the cell ( 15% of each cell by mass). It is therefore unsurprising that the most sig-
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nificant phosphorylation control event in Synechocystis under nitrogen starvation occurs
on the photosystem II control protein(Spät et al., 2015). In addition, this same effect
has also been observed in other another related cyanobacteria, Synechococcus sp. PCC
7942 (Schwarz and Forchhammer, 2005). Nitrogen limitation has been shown to increase
glycogen formation (Joseph et al., 2014b), although this effect is also observed when the
antennae structures are truncated genetically and nitrogen is not limited (Joseph et al.,
2014a).
In addition to phosphorylation, both acetylation and glutathionylation have been iden-
tified as post translational modification systems operating in Synechocystis (Mo et al.,
2015; Chardonnet et al., 2014).
2.2.6 Proteomics stress studies
A number of proteomics studies have been performed using Synechocystis cultures that
are submitted to stress conditions (summarised in Table 1). Almost all of these use
2D-gel protein separation with specific image analysis software to identify changes in
protein levels. Once excised protein spots are analysed by mass spectrometry analysis
for protein identifications. Here were summarise the key studies centred on proteomics
of Synechocystis under a number of different stress conditions.
Understanding the different cellular responses is integral to correctly interpreting pro-
teomic data. A large number of studies conducted in omics tend to be ‘exploratory’, in
the sense that the dataset is considered to be a measurement of responses in the same
way that phenotype is used in genetic studies. Unfortunately, this approach is flawed,
because where the phenotype is considering the cell as a complete unit performing a ter-
minal function – as the fermentation example given in the introduction; the proteomic
response is dynamic due to the internal cellular environment, where an over-abundance
of something will drive forward a different reaction. If it were possible to measure the
complete dataset, such as is the case with nucleic acids, it would be possible to interpret
at least the complete change to the system; however even in this case the analysis is still
limited because the functions of many of the proteins are either incompletely understood
or completely absent. In other words, looking at one or two proteins with related func-
tions being found to be less abundant and stating ‘the cell is changed in this way’ is
incorrect, without making some other empirical observation.
That is not to say that proteomic observations of stress responses are without merit.
Whilst they cannot be used to make direct statements about cellular function, they
can be accumulated to give a comprehensive understanding of how the cell is physically
functioning at a given point in time. In addition, they are the only omic measurement
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form that directly investigates the functional aspects of the system; other methods make
inferrences that are either prediction-based (transcriptomics) or response-based (meta-
bolomics).
2.2.7 Temperature and light
As mentioned above, the photosynthetic machinery of Synechocystis is the largest protein
constituent by a considerable margin, and as a result of photobleaching – where high
intensity light regimes result reductive damage to this machinery and the generation
of reactive oxygen species (ROS) – the turnover of these proteins is also high. The
photosystems, particularly photosystem II, are particularly vulnerable to thermal and
light stresses. Synechocystis has been shown to grow at 34 ◦C, albeit at a reduced rate,
and to survive heat shock treatment of up to 44 ◦C.
In 2006, Slabas et al performed analysis on the soluble proteome of wild-type and a
thermal tolerance mutant (δhik34) of Synechocystis PCC 6803 (Slabas et al., 2006). Al-
though the study only identified 66 altered proteins, they found that the mutant demon-
strated improved protein degradation and re-folding effects, both of which are import-
ant under thermal stress conditions that can cause errors in protein synthesis. Whilst
proteomic technology in Synechocystis at the time of this study was limited, follow-up
microarray studies verified these findings at the transcriptional level (Suzuki et al., 2006;
Rowland et al., 2010). It found that the mutant was transcriptionally in a similar state
to the heat-treated wild type, an effect that was amplified when exposing the organism
to high temperatures for 60 minutes.
An additional response relating to cellular energy supply has also been found (Fu and Xu,
2006), where the upregulated proteins are also involved in making glycogen available as
glucose to the cell for respiration. This switch is important in photosynthetic organisms,
as a disruption to the availability of cellular energy can have consequences for survival
and growth. It is important to note that this fundamental switch between energy supply
methods is typically the most prominent effect observed in Synechocystis studies where
the photosystem has been affected in any way, which is typically all stress studies.
In the absence of a heat shock, sustained higher temperatures have also been investigated
in the context of thermo-tolerant mutants and WT under high light intensity in a study
that measured over 1200 proteins in 2D gel electrophoresis analysis, and found approx-
imately 30 significantly changed proteins (Miranda et al., 2013). This study highlighted
another category of proteins, small chlorophyll A / B - binding proteins, played a role in
thermal response when coupled with high light intensities (1000 photon.µmol.m−2.s−1).
These proteins demonstrated a number of responses focused around the membrane pro-
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teome. In addition, the metabolic response was also assessed, and interestingly whilst
the previous study showed that stress triggered genes that led an increased availability
of glucose, and verified this with an enzymatic assay, during high light-stress at high
temperatures the entire cellular metabolism was found to be depressed.
Exposure to high intensity ultra violet B (UV-B) radiation over the short to long term (8 -
96 hrs) has also been measured with proteomic methods (Gao et al., 2009). Understanding
prolonged UV-B response in Synechocystis is useful for outdoor applications, such as
large scale PBRs. As this was a purely proteomic investigation, it generated a number of
different leads for further investigation, but could only make broad statements about the
general functions of those proteins. Interestingly, different proteomic expression profiles
were identified for the short term and long term exposure regimes. Broadly, long term
exposure suggested a depression of the photosystems and metabolism, and an increase in
cellular defence and repair mechanisms.
2.2.8 pH
During photosynthesis, the media surrounding Synechocystis has been found to transi-
ently raise in pH to levels as high as pH 10. This pH change is often attributed to the
uptake of CO2 from the media, however this belief is likely held because adding additional
CO2 will acidify the media and bring it back down to physiological levels. Conceptually,
simply removing dissolved CO2 from water alone should not be capable of bringing the
pH to a level higher than that of distilled water, which is over 100 fold lower than the
levels observed during photosynthesis. Instead, this pH rise is more likely to be attrib-
uted to the photosynthetic activity directly. During photosynthesis, protons are actively
pumped into the plasma membrane until the point where the pH gradient is too high
for the reaction to continue. At night, or in darkness, when this process stops, the pH
drops back down to levels closer to pH 7. This natural variation in pH that the organism
experiences gives it a good tolerance to a relatively wide-range of pH values, ranging from
pH 7 to 10, although the growth rate is diminished with increasing pH due to a reduction
in photosynthetic efficiency and significant cell damage is observed at pHs higher than
this range (Touloupakis et al., 2016). A proteomic study has been conducted on the outer
plasma membrane under pH 11, comparing it to pH 7 (Zhang et al., 2009). It found a
significant upregulation in the amount of ATP-binding cassette transporters, which in
a transcriptomic study would suggest replacement and repair, but in a proteomic study
suggests reduced transport efficiency or reduced protein turnover. Distinctions like this
are important when combining different levels of ‘omic data and should be considered in
any multi-omic study.
Low pHs are generally rare in the natural growth regime for Synechocystis, and so the
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organism shows reduced growth rates below pH 7, and death of the culture within 120
hrs at pH6, and 24 hrs at pH 5.5 and below (Kurian et al., 2006). A study investigating
non-transient proteome changes under pH6 found that whilst the periplasm experienced
significant changes, internal stress responses to reduced pH were not detected within the
cytoplasm. This suggests that the periplasm is robust enough to tolerate acid pH above
5.5, at least on a temporary basis. Significant changes were observed in the periplasm,
however. Upregulation was found in proteins related to managing the byproducts of
photosynthesis, such as carbonic anhydrase which converts CO2 to carbonate. It appears
from these studies that cell death in this range was due to a general lack of available
energy, due to inhibited photosynthetic activity (Kurian et al., 2006).
2.2.9 Biofuel tolerance
As mentioned in the introduction, evaluating the capabilities of a specific organism is
very important when attempting to produce a system as a production system. When
considering Synechocystis as a suitable producer of biofuel, it is important to test whether
the presence of the fuel will cause damage to the cells before engineering a mutant that
is capable of producing them.
A number of studies into the proteomic responses of Synechocystis to the presence of
biofuels have been conducted recently by the Zhang group, specifically growth in the
presence of hexane (Liu et al., 2012), butanol (Zhu et al., 2013; Chen et al., 2014b) and
ethanol (Qiao et al., 2012a; Wang et al., 2012b). All these studies used high quality
iTRAQ LC-MS/MS technology to investigate proteomic changes along with a modern
advanced mass spectrometer, focusing on the changes in the regulatory mechanisms.
These datasets are therefore very high quality, and in some cases have been further
verified with other ‘omics datasets. The Zhang group has therefore provided an excellent
resource for an informatics-based approach into the possible use of Synechocystis as a
liquid biofuel production platform and systemic stress responses.
A major issue with using Synechocystis as a conventional biofuel producer is that the
organism demonstrates remarkably low tolerence to organic biofuels. Raising the extra-
cellular concentrations to as little as 1.5% ethanol, 0.8% hexane and 0.25% butanol have
impeded cellular growth, which places serious doubts on how useful Synechocystis would
be as a production chassis for their production. In addition to this, the cellular response
in all cases has been found to be complex and multi-faceted; which blocks a simple ‘single
mutant solution’. This is likely as a result of there being no pre-existing metabolic path-
way in place to either degrade or compartmentalise these small organic molecules. As
Synechocystis lacks internal compartments, the most effective engineering solution would
need to examine how to eject the biofuel into the media from within the cell, and how to
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block it from re-entering.
When considering biofuel production, this evidence strongly supports the augmented
production of naturally occuring fuel molecules in Synechocystis, such as palm oil or
biohydrogen. Whilst additional engineered solutions may be possible, the complexity
involved in such a solution would likely require too much initial investment and have too
many potential points of failure to be economically viable.
2.2.10 Starvation studies
The effect of carbon dioxide limitation was evaluated interrogating Synechocystis pro-
teome at 6, 24 and 72 hours using isobaric tags for relative and absolute quantification
(iTRAQ) (Battchikova et al., 2010). 19% of Synechocystis proteome was identified but
only 76 proteins were observed to be up-and down-regulated when cells were shifted
from 3% carbon dioxide to air levels of carbon dioxide at the time points above men-
tioned. Under limiting carbon dioxide environment, major changes in inorganic carbon
uptake, carbon dioxide fixation, nitrogen transport and assimilation and protection of
photosynthetic machinery from excess of light were observed. Conversely, acclimation
to low carbon dioxide down-regulated chaperones biosynthesis indicating that oxidative
stress is not induced under this limiting condition. Small changes were observed for pro-
teins belonging to phycobilisomes, photosynthesis complexes and translation machinery
(Battchikova et al., 2010).
Label free proteomics was employed to investigate the metabolic response of Synecho-
cystis to short and long term exposure to 33 different environmental conditions (Wegener
et al., 2010). In total 1955 protein (53% of the predicted proteome) and 1198 proteins
were identified and quantified respectively. From the quantified proteins, 306 proteins
were found regulated upon carbon dioxide depletion, 548 were found regulated upon ni-
trogen depletion,349 proteins were found regulated upon phosphorous depletion, 390 for
sulfur and 392 with iron depletion. Although different conditions were investigated, a
general trend in protein expression was observed and particularly affected were proteins
involved in amino acid biosynthesis, glucose metabolism, TCA cycle and cytochrome
b6f complex which were found highly up-regulation. Moreover, in all conditions tested,
cells adopt similar metabolic behaviour and a common stress response was the activa-
tion of atypical pathways for acquisition of carbon and nitrogen from urea and arginine.
A comparison between transcript (RNA level) from an independent study and protein
expression from this study revealed in general, poor agreement between transcript and
protein metabolism. From all comparisons, this correlation was lower for sulfur deple-
tion and highest for nitrogen depletion. Nevertheless, stress specific genes showed similar
expression patterns in both transcriptomics and proteomics. Overall these results shows
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that different perturbations generate a common response; nitrate uptake is reduced and
arginine metabolic enzymes are 1.5-3-fold regulated compared with controls suggesting
an active arginine deiminase pathway in cyanobacteria. In this study, key enzymes for
amino acids biosynthesis were overall strongly up-regulated suggestion they cells try to
maintain a metabolically active eventually to activate alternative nutrients for growth.
Levels of proteins involved in photosynthesis were not significantly affected; only the ef-
ficiency of photosynthetic light reactions resulting in lower ATP production was reduced
(Wegener et al, 2010).
2.2.11 Salt stress
The dynamics of the proteome during salt acclimation (NaCl concentration 684 mM) was
investigated by two dimensional gels followed by protein identification by peptide mass
fingerprinting (Fulda et al., 2006). From in-gel digestion, 500 proteins were identified and
55 were induced under salt shock and after long term salt acclimation. While protein
synthesis was nearly blocked, photosynthesis was reduced by 60% of the value in the
control cells. However, salt acclimation activates ABC-type of transporter for compatible
solutes and the photosynthetic and respiration systems are tune by exchange electron
transport activity through photosystem I and the cytochrome oxidase activity. Moreover,
salt stress also activates heat shock proteins to protect and repair proteins under stress,
DNA-binding stress protein and RNA-binding proteins and proteins involved in defence
against reactive oxygen species which are known to be inducible at mRNA level in high
light-stressed cells. In total, 45 proteins showed a greater staining intensity, on 2D-gels,
and accumulate more than 2-fold; these proteins belong to the salt specific stress proteins
i.e. proteins involved in the synthesis of compatible solutes, general stress, enzymes of
the basic carbohydrate metabolism and hypothetical proteins (Fulda et al., 2006).
Li et al 2012 relate acclimation mechanisms regulation to histidine kinases as a sensor
involved in the salt perception by using genetic mutations and DNA arrays. Hik33 is
one of salt sensors its mutation revealed 26 and 28 differentially regulated proteins under
normal and stress conditions. Regulated proteins were found to be related with plasma
membrane rearrangements due to the Hik33 lost (Li et al., 2011).
2.2.12 Integrated ‘omics studies in Synechocystis
As described in the introduction, the next generation of ‘omics analysis will require the
integration of multiple ‘omics datasets to generate a fuller set of data relating to all the
internal cellular functions. Experiments where ‘omics measurements are made independ-
ently of each other have been demonstrated to be of limited to no use for understanding
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interactions within a system (Schwanhausser et al., 2011); and so only experiments that
combine multi-omic analysis in a single experiment will be detailed in this section – a
summary of achievements in different systems-level ‘omic assessments of Synechocystis
has been recently reviewed by hernandez et al (Hernández-Prieto et al., 2014). Notably,
a high-profile meta-analysis analysis of all transcriptomic work that has been performed
in Synechocystis to date was also recently published, demonstrating that the majority
of regulatory effects within the wild-type organism were strongly associated with photo-
synthetic responses and showed distinct patterns in response to (Hernández-Prieto et al.,
2016). This is an new area of study, and so there are relatively few studies that integrate
proteomics with other ‘omics analysis.
A number of integrated proteomic and transcriptomic studies have been performed to
date; all of which were conducted in the Zhang lab (Zhu et al., 2013; Song et al., 2014;
Qiao et al., 2012a; Gao et al., 2015; Pei et al., 2017). Within these studies, the tran-
scriptomic aspect of the analysis was performed using RNA-seq. The studies range from
identifying general proteomic or small-RNA responses to biofuel production stress (Song
et al., 2014; Pei et al., 2017), to an investigation of nitrogen stress (Huang et al., 2013)
and even a network-level method for categorising hypothetical proteins (Gao et al., 2015).
Despite these numerous studies, there is still a requirement within the field for a study
to investigate the relative rates of protein synthesis and RNA stability (Schwanhausser
et al., 2011) – until this is completed, creating an accurate link between protein and
transcript data will remain a challenge for the field.
One of the key metabolic flux experiments first performed in Synechocystis was the tran-
sient 13C metabolic flux analysis; where Shastri spiked in 13C labelled bicarbonate as an
auxotrophic carbon source and monitored the uptake in a number of monitored metabol-
ites (Shastri and Morgan, 2007). This was then analysed by Young et al., who identified
a short-circuit in the central carbon metabolism pathway that fundamentally changed fu-
ture metabolic models of Synechocystis (Young et al., 2011). The earliest metabolomics-
integrating proteomic study was performed by Miranda et al in 2013 – described above
in the heat and light stress section of this chapter (Miranda et al., 2013). Whilst they did
not directly integrate the metabolite and protein data, they did use gene cluster networks
– determined from prior microarray experiments – to map their proteins into a network.
A more comprehensive combination of multi-omics data was performed by Ren et al
in 2014 in the Zhang lab, where a comprehensive proteomic assessment was performed,
backed by targeted metabolomic and transcriptomic analyses under acid stress (Ren et al.,
2014). This was particularly effective, because the mutant being analysed showed only
a small number of significant protein changes; and so targeted transcript measurements
by RT-qPCR were feasible. The transcript measurements generally showed consistent
magnitude and direction of change to the protein measurements; however not in every
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case. This is not surprising, given the findings of Schwanhauser et al., that there is
better correlation between cases when the protein expression rates are considered as well
(Schwanhausser et al., 2011). Ultimately, the researchers successfully mapped a small
network of responses to acid stress and improved understanding of how the cells react to
reducing the pH.
Finally, the most recent metabolite integrating study was also performed in the Zhang
lab, this time looking at 3 hydroxypropanoic acid (3-HP) – a key metabolite in the
synthesis of a number of different high value products (Wang et al., 2016). The process
of this study followed closely the previous study from the same lab, monitoring the levels
a number of ‘key’ metabolites in a targeted metabolic analysis; then tracking the gene
expression profiles of genes of interest with RT-qPCR. They highlighted a number of
targets for future bioengineering, such as requiring a higher overall energy profile within
the cell and highlighting stress responses that were activated in response to increased
3-HP production.
Including metabolite data in this manner, be it targeted or more broad-spectrum, will
be key when attempting to engage industrial practitioners in proteomic analysis of Syne-
chocystis – or indeed in production strains in general (Landels et al., 2015). This need is
covered in the next section of this chapter, and so will not be discussed further here, but
generating repeatable practical observations that are useful on an industrial level remains
a challenge.
2.2.13 Concluding remarks
The work in this section demonstrates the broad range of investigations being made into
the Synechocystis proteome. These range from stress responses, to physiological shifts
between normal environmental conditions, to key studies related to industrial biotech-
nology. This background research is key to predicting the changes that should happen
under different environmental cases; an essential step in understanding the true effects of
a given change in the context of proteomics.
The number of papers described here show that whilst there is a substantial body of
research related to proteomic studies within Synechocystis, the rapid rate of advancement
in the field – particularly with regard to the number of proteins being identified in each
study, suggests that there is scope for the repetition of classic proteomic studies that have
already been conducted in Synechocystis: particularly in experiments where a whole-cell
response to a stress or tolerance factor has been described, as was done by Wegener et
al in 2010. The potential to increase both the quantity and quality of established data
alone justifies the additional costs of the repetition. In addition, the majority of ‘omic
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level studies currently combine between two and three replicates on observations – which
whilst conventional for scientific research, is realistically insufficient when working with
such large datasets that are prone to non-independent variation that confounds classical
statistical analysis.
If accurate bioinformatic models are to be completed in the future, the community will
require repeated experimental verification of results at independent institutions. In ad-
dition, experimental designs including overlaps between existing data, for which there is
a large amount of information, and new data, which need to be interpreted. Comparing
everything to the Wild Type is insufficient when the normal operational features of the
Wild Type are still elusive.
2.3 Advances in proteomics for production strain ana-
lysis
Authors: Andrew Landels, Caroline Evans, Josselin Noirel and Phillip C Wright.
Highlights
• Proteomics is widely used in production strain analysis
• The value of specific strategies is discussed with reference to case studies
• Methodologies often based on prior application to eukaryotic systems
• New developments target quantitative accuracy and proteome coverage
2.3.1 Abstract
Proteomics is the large-scale study and analysis of proteins, directed to analysing protein
function in a cellular context. Since the vast majority of the processes occurring in a
living cell rely on protein activity, proteomics offer a unique vantage point from which re-
searchers can dissect, characterise, understand and manipulate biological systems. When
developing a production strain, proteomics offers a versatile toolkit of analytical tech-
niques. In this commentary, we highlight a number of recent developments in this field
using three industrially relevant case studies: targeted proteomic analysis of heterologous
pathways in Escherichia coli, biofuel production in Synechocystis PCC6803 and proteomic
investigations of lignocellulose degradation. We conclude by discussing future develop-
ments in proteomics that will impact upon metabolic engineering and process monitoring
of bio-producer strains.
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2.3.2 Introduction
Chemical biotechnology is a field directed to harnessing living organisms as cellular factor-
ies, for bio-based production of small molecules and polymers (Fischer and Schaffer, 2014;
Becker and Wittmann, 2015). These biological production systems are less well under-
stood than traditional chemical engineering processes due to their inherent complexity.
As a result, advanced molecular techniques like proteomics are required to engineer more
efficient processes and develop new applications.
First defined in 1995 as a portmanteau of ‘protein’ and ‘genomics’, proteomics is the
large-scale study of proteins within a cell, tissue or organism (Wasinger et al., 1995). It
is a rapidly evolving field focused on identification and characterisation of these proteins
and their proteoforms (isoforms and post translational modification (PTM) variants).
Quantitative methods in proteomics have enabled comparative analysis of protein ex-
pression profiles, typically providing ‘snapshots’ of cells and proteins in different stages of
bio-production. Recent studies have also measured protein turnover by determining rates
of protein synthesis and degradation. These techniques offer a means to gain information
on mechanisms of bio-production for purposes of optimisation and process monitoring.
To date proteomics has found application to well characterised strains such as E. coli
(Wisniewski and Rakus, 2014), emergent bio-producer strains like the cyanobacteria Syn-
echocystis PCC6803 (herein referred to as Synechocystis) (Chen et al., 2014b); as well as
metaproteomic analysis of mixed microbial communities (Abraham et al., 2014).
Bibliometric analysis (see supplementary material) of recent proteomics publications has
highlighted a couple of key trends in producer strain studies: Proteomics in producer
strain analysis tends to focus much more on understanding mechanisms and responses,
or suggesting molecular pathways, indicating that in general production analysis is lagging
behind the general trend toward targeted proteomics (fig. 2.5, p. 87). We cover the topic
of targeted proteomics in more detail below and highlight a small number of cutting edge
studies in our first case study.
In this commentary, we present a typical approach for conducting a proteomics experi-
ment, highlighting key terms and concepts. We then outline novel proteomics approaches
using post-2012 examples, focusing on three industrially relevant case studies: a method-
specific approach, a strain-specific approach and a process-specific approach, concluding
with a discussion of the impact of recent developments in the field.
2.3. ADVANCES IN PROTEOMICS FOR PRODUCTION STRAIN ANALYSIS 87
Figure 2.5: A selection from a rank-plot of
the 200 most frequently used words in ab-
stracts of production-strain proteomics pub-
lications, ranked by frequency. Words in blue
are higher-ranked in production-strain pro-
teomics than in proteomics in general; words
in red are lower ranked, words in black have
not changed relative position. Faded words
have changed rank by 5 places or fewer and
words in bold-face are only present in the
production-strain list. The solid line indic-
ates the change in rank. This figure presents
a snapshot of the full list, which is available
in the supplementary material.
2.3.3 Proteomic analysis pipeline
High-throughput proteomic methods commonly used in biotechnology approaches utilise
the ‘shotgun’ or bottom-up technique (Yates, 2013), where the proteome is digested into
peptides that are typically 5 – 14 amino acids long. Whole proteins or larger polypeptides
can also be analysed (top-down, middle down respectively), but this strategy has sev-
eral technical issues detailed elsewhere (Zhang et al., 2013b). A digested proteome is
complex, containing thousands of peptides with varying abundances. The mix requires
fractionation, typically using oﬄine high performance liquid chromatography (HPLC)
or in solution isoelectric focusing, which splits the single sample into lower complexity
fractions. Doing this collects together peptides with similar features – such as hydro-
phobicity, charge state or isoelectric point – and significantly improves the quality of the
final data. Samples are then subject to nano-flow reverse phase HPLC, coupled directly
to mass spectrometer. This process is referred to as MS-MS or MS2.
The mass spectrometer (MS) initially scans the masses and intensities of all eluting
peptides from the HPLC, on a scale of seconds to milliseconds, this is an MS ‘survey
scan’. Eluting peptides are then selected for fragmentation from the survey scan, either
in a data dependent (DDA) or data independent (DIA) acquisition mode. DDA targets a
specific peak from the survey scan for further analysis, whilst DIA fragments all ions from
the survey scan simultaneously. The data is then analysed computationally to identify and
characterise the proteome. Two detailed reviews provide further information, Altelaar et
al (Altelaar et al., 2013a)9 provide an overview, whilst Zhang et al (Zhang et al., 2013b)
cover the topic more comprehensively.
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2.3.4 Approaches in proteomics
Proteomic approaches can be subdivided into discovery and targeted modes, for charac-
terisation of the proteome and analysis of an identified subset of proteins respectively.
Their application and relevance are outlined in the case studies. Examples of workflows,
gel and non-gel based, together with their major benefits and drawbacks and examples
of their application to bio-producer strains are outlined (Table 2.3, p. 89). Classical pro-
teomics employs two-dimensional electrophoresis (2DE) for analysis of expression profile,
where protein identification requires MS as a second step. Gel free quantification meth-
ods achieve protein identification and relative quantification using MS with significant
advantages over 2DE (Gygi et al., 2000). Protein and peptide labeling methods, meta-
bolic (eg SILAC) or chemical labels (eg iTRAQ) have been widely employed in proteomics
but ‘label-free’ methods are increasingly gaining in popularity (Evans et al., 2012; Chris-
toforou and Lilley, 2012). To date, no direct comparison of all these techniques has been
reported (Table 2.3, p. 89). Technique selection is dependent on the biological context,
number of samples to be processed and compared.
Targeted proteomic approaches are directed to the detection and the precise quantifica-
tion of specific subset of proteins of interest. This complements discovery proteomics and
applications include verification of candidate proteins and process monitoring (George
et al., 2015). Quantification is based on detection and measurement of proteotypic pep-
tides that represent the protein, based on unique amino acid sequence. Specificity and
sensitivity are both conferred via ‘reaction monitoring’ for the presence of (co-eluting)
fragment ions, linking precursor and product transition information. Application of high-
resolution mass measurement and acquisition of full fragment ion spectra have enabled
developments, including higher throughput and specificity conferred by parallel reaction
monitoring (PRM) as recently reviewed (Lesur et al., 2015).
Inclusion of stable isotope forms of reference proteotypic peptides, at known concentra-
tions, enables absolute quantification. QconCATs (concatenated proteotypic peptide se-
quences), are custom designed recombinant proteins, which can be metabolically labelled,
purified and tryptically digested, to provide a set of standards for absolute quantification
of multiple proteins in parallel (Batth et al., 2014). Label free approaches are popular due
to limited sample pre-processing requirements prior to analysis compared to label based
methodologies. Examples include Intensity-Based Absolute Quantification (iBAQ) and
Absolute Protein Expression (APEX), which have been compared for different sample
types and MS platforms (Arike et al., 2012; Ahrne et al., 2013; Krey et al., 2014).
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Technique Mode Example Brief 
description




Discovery 2DE, DIGE Gel based separation 













Mikkat et al. 2014 [19] Analysis of the 
Synechocystis phosphoproteome based on 
visualization of phosphoproteins with a 
phosphoprotein-specific dye
Li et al. 2014 [64] Analysis of lipid-associated 
pathways in chlorella using DIGE
Metabolic 
labeling
Discovery SILAC, 15N In vivo protein 
labeling. Use of heavy
variants allows 
discrimination from 
















be required to 
ensure stable 
isotope is sole 
source of specific 
nutrient eg amino 
acid, ammonium 
salt
Ciesielska et al. 2013 [20] Identification of 
Starmerella bombicola proteins associated 
with production and regulation of sophorolipid
production (biosurfactant precursor)
Chemical label Discovery iTRAQ, TMT In vitro Labeling at 
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of fold change Tang et al. 2013 [21] Metabolic engineering 
by gene knock out or overexpression of 
specific enzymes that lead to enhanced 
biofuel precursor production in 
Saccharomyces cerevisiae. Identification of 
targets for further optimization.
Chen et al., 2014 [5•] Case study – identified 
Slr1037 as a regulon to provide novel target 














based on peak 













Yap et al. 2014 [22] Analyzing protein 
alterations associated with physiological 
changes occurring during different growth 
phases of Lactococcus lactis.
Table 2.3: Proteomic workflows - Application, Benefits and Drawbacks Com-
monly used Discovery and Targeted proteomic methods are outlined with reference to
specific applications.
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2.3.5 Case Study: Targeted proteomics for process optimisation
A key area of proteomic application is assessment and modelling of heterologous path-
ways. Whilst assessing how an inserted pathway is affecting the proteomic background
provides useful information on how the organism is responding; for pathway engineering
purposes it is often more informative to assess either the pathway proteins directly, or a
specific subset of the proteome known to interact with it. Targeted proteomic methods
like selective reaction monitoring mass spectrometry (SRM-MS) are useful for collect-
ing highly repeatable, high-accuracy, quantitative data. These techniques are gaining
popularity in bio-production pathway modelling and optimisation, as well as providing a
means of assessment of standard parts and devices in synthetic biology. Proof of concept
of this approach has been demonstrated for heterologous pathway expression in E coli as
model/paradigm for optimization of heterologous pathways.
SRM-MS has been validated against analysis of red fluorescent protein expression levels
in an expression plasmid and output of the tyrosine production pathway, controlled with
a variety of different strength constitutive promoters (Singh et al., 2012). These methods
can also be coupled with quantification methods that incorporate a standard, such as
QconCAT, to generate absolute protein quantification levels (Batth et al., 2014). A
major advantage of this is that absolute protein values can be incorporated into kinetic
metabolic models alongside metabolite data; whilst relative quantification values – which
are more commonly associated with global proteome assessment – cannot (Weaver et al.,
2015). In practical production terms, it has also been used to optimise production of
biofuels such as isopentanol (George et al., 2014) and biosynthesis precursors like terpenes
(Redding-Johanson et al., 2011).
2.3.6 Case study: Synechocystis PCC6803
Cyanobacteria are a phylum of photosynthetic bacteria that offer promise in solar-powered
bio-production. Synechocystis is a fully-sequenced, naturally transformable strain of cy-
anobacterium that is gaining popularity as a model production chassis (Machado and
Atsumi, 2012). It is currently being investigated for a variety of different products in-
cluding precursors such as isoprenoids and lactic acid from CO2 (Englund et al., 2014;
Angermayr et al., 2014), as well as biofuels like ethanol, butanol and hydrogen (Chen
et al., 2014b; Qiao et al., 2012b; Pinto et al., 2012b).
When engineering a strain for production, proteomic methods integrated with transcrip-
tome data are used in about 20% of studies. These studies are frequently used to as-
sess cellular response to production stresses (supplementary bibliometric analysis). Pro-
teins and pathways found to be regulated in response to stresses are good candidates for
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forward-engineering strategies; either through the more traditional method of managing
metabolic flux in the organism, or by understanding and controlling responses. An initial
proteomics analysis of butanol stress in Synechocystis highlighted multiple simultaneous
pathways activating in response to the stress (Tian et al., 2013b), was followed up by a
transcriptome study (Zhu et al., 2013). Joint analysis of these data identified slr1037 as
part of a butanol-specific paired signal transduction system (Chen et al., 2014b). This
was verified with a knock-out, which was more robust to butanol stress whilst maintaining
wild-type growth rate under standard conditions.
PTMs are a highly conserved method of regulation in biological systems. Despite the
enrichment strategies required for identifying these low abundance features, it is possible
to assess PTMs on a systems level (Altelaar et al., 2013a). Three pioneering studies
have been conducted in the last two years, cataloguing system-wide PTM responses in
Synechocystis and demonstrating their role in regulation of photosynthesis and central
metabolic pathways (Mikkat et al., 2014b; Chardonnet et al., 2014; Mo et al., 2015).
Despite the advantages of proteomics, it requires tuning to the organism being studied. In
Synechocystis, photosynthetic antennae proteins make up 20% of the proteome by mass
(Gan et al., 2005). This results in a large dynamic range relative to other producer-strain
bacteria, such as E. coli, and so the advantage conferred by light harvesting capacity
comes with the negative limit to proteomic coverage. This problem exists in any case
where a small number of proteins are present at a very high abundance, relative to the
rest of the sample such as the case with RuBisCO in plants (Gupta et al., 2015). Work has
been carried out to reduce the abundance of these antenna proteins for better production
and improved proteomic coverage (Kwon et al., 2013). The dynamic range problem can
be alleviated to an extent through depletion strategies and use of high resolution, high
throughput MS.
2.3.7 Case study: lignocellulose degradation
Lignocellulose is a complex polysaccharide constituent of plant cell wall. It is a promising
substrate for production of molecules like ethanol and lactic acid; however, lignin inhibits
the action of many common enzymes by sequestering the cellulose and xylose. This
creates a bottleneck in efficient bio-production from this material [34]. Proteomics is
at the forefront of deciphering solutions to this problem, either through fully integrated
systems analysis or assessment of solutions utilising multiple organisms simultaneously.
Integration of metabolite, transcript and protein data, termed systems analysis, can be
used to generate comprehensive models for how a cell is responding. The protein data
offers an impression of the current state of the cell, whilst the transcript analysis iden-
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tifies responses at high-coverage coverage and the metabolite data give an impression of
flux (Huang et al., 2014; Kasavi et al., 2014). Proteomics data from several lignocellu-
lose degradation investigations, including Clostridium and a variety of filamentous fungi,
have been integrated with transcript and metabolite data to understand how activated
pathways affect cellular dynamics (Schellenberg et al., 2014; Klaubauf et al., 2014). This
approach has also been used to assess how xylose as a carbon source affects metabolism
in yeast, to design better production strategies (Latimer et al., 2014).
The xylose catabolism study utilises pre-existing models for assembled pathways, and
is typical of a proteomic work-flow for pathway analysis where identified and quantified
proteins are overlaid on a metabolic model. Models are assembled using pathways found
with literature analysis and new models are typically constructed by modifying an existing
model from a similar organism. A detailed commentary of advancements in this process
is provided by King et al in this issue (King et al., 2015). Where a pre-existing model
is lacking, other general exploratory assessments, like principal component analysis, can
be used instead to look for general trends in protein expression data (Alonso-Gutierrez
et al., 2015). This technique can highlight proteins, or entire conditions, that cluster
together depending on the focus of the study; with suitable experimental design this can
provide information in lieu of a completed metabolic model. Due to the complexity of
even seemingly simple strains, data interpretation still is a limiting factor in systems level
analyses. This has led to the use of cutting-edge informatics, such as machine learning,
being employed in analysis of the data (Kelchtermans et al., 2014).
Whilst individual organisms have shown effectiveness in degrading lignocellulose, natural
systems utilise a combination organisms performing distinct roles to achieve the effect
more efficiently (Boaro et al., 2014). The study of these communities through the analysis
of the proteins is referred to as ‘metaproteomics’, where the community is profiled instead
of focusing on specific organisms, or specific pathways (Vanwonterghem et al., 2014).
A growing number of studies are being carried out using metaproteomics towards the
ultimate aim of engineering these systems through ‘Synthetic Ecology’ (Pandhal and
Noirel, 2014). This emerging field will likely be of importance to the bio-production
community in the future.
2.3.8 Addressing the challenges and perspectives
Proteomics is a very dynamic area: the proteomic toolkit is constantly expanding with
both the development of both novel technologies alongside new uses of existing techno-
logies. In the latter category, development of quantitative proteomic technologies with
higher multiplexing capability, neutron encoded TMT and SILAC reagents, improves the
multiplexing capability of TMT (Werner et al., 2014; Merrill et al., 2014). This enables
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both higher throughput and the additional benefits conferred by increased sample replic-
ation. Metabolic labels such as SILAC can be directed not only to expression profiling,
but also to protein dynamics (Trotschel et al., 2012). The Super-SILAC approach, in-
volves mixing samples from different conditions to generate an internal standard for cross
sample comparison, and can be combined with iBAQ to give absolute copy-number level
protein quantitation (Soufi et al., 2015a).
Improved sample preparation strategies improve protein identification rates and coverage.
In general, reagents that are very effective at solubilising proteins are incompatible with
MS. The technique of Filter Aided Sample Preparation (FASP), allows removal of deter-
gents such as SDS and other contaminants. The FASP technique, first described in 2009
(Wisniewski et al., 2009) has been adapted for improved proteolytic digestion (eFASP)
(Nel et al., 2015) and for compatibility with chemical labelling strategies for analysis of
proteins (iFASP)(McDowell et al., 2013) or affinity purified protein complexes (abFASP)
(Huber et al., 2014). Protein-protein interactions (PPI) is a growth area in proteomic
analysis, particularly since proteins typically function in complexes which are tempor-
ally and spatially dynamic within the cell (Wright et al., 2013) and analysis of PPI has
value in system based network modelling (Kasavi et al., 2014). Novel strategies include
enhanced capability of protein-protein interaction analysis by use of affinity enrichment
MS, as an alternative to classical ‘pull down’ approaches (Keilhauer et al., 2015).
In terms of MS instrumentation, performance is continually improving in terms of speed,
sensitivity and resolution, such that complete proteome coverage is achievable (Mann
et al., 2013). Unlike DDA, DIA methods are inherently not applicable to use of metabolic
or chemical labels. This limitation is being overcome with approaches such as NeuCoDIA
for multiplex analysis (Minogue et al., 2015). In general, whilst MS instrumentation was
directed to operating in discovery or targeted modes, next generation instruments offer
both capabilities. For example, DIA methods are enabling discovery and targeted modes
of data analysis to be integrated, by retrospective ‘MRM like’ mining of discovery data for
specific peptides. With MS developments there is a need for corresponding capabilities
in processing software to fully mine the increasingly complex proteomic datasets.
2.3.9 Conclusions
In this commentary, we have highlighted using bibliometric analysis of the field and
specific case studies that proteomics is widely used in production strain analysis. Due
to the dynamic nature of the field, there are a number of cutting-edge developments
that have improved quantitative proteomics over the review period and are continuing
to emerge. These have generated step-changes in technical and conceptual approaches to
process optimisation, in both single species as well as microbial communities (Abraham
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et al., 2014; Pan and Banfield, 2014).
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2.3.11 Recommended reading
Papers of particular interest, published within the period of review, have been highlighted
as either of special interest, or of outstanding interest:
• Of special interest
– Chen et al, 2014: This study provides a clear example of a follow-up investig-
ation to a proteomics-led discovery, following identification of targets using a
combination of proteomics and transcriptomics under butanol stress.
– Yates et al, 2013: This review provides a background on the progression of
shotgun proteomics. This is an interesting account of the historical progression
of the field and nicely frames the subject.
– Batth et al, 2014: This study highlights the creation of a tool for high-speed,
high-accuracy quantification of proteins in E. coli. It demonstrates how syn-
thetic biology approaches to proteomics are championing high-accuracy quan-
tification data at the expense of producing a large number of identifications.
– Latimer et al, 2014: This study uses proteomics and metabolomics to determ-
ine how engineered S. cerevisiae catabolises xylose – a sugar created in the
breakdown of lignocellulose. It neatly frames how proteomics can be used to
determine changes in pathway flux to determine the fate of metabolites in an
engineered system.
• Of outstanding interest
– Zhang Y et al, 2013: This comprehensive and detailed review covers a wide
range of proteomics-related topics and discusses depths beyond the scope of
this commentary. We highly recommend this review to readers who would like
to learn more about a variety of topics in proteomics.
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– Altelaar et al, 2013: This review provides an excellent introduction to the
topic. We highly recommend it as background reading for readers who are
interested by proteomics but are unfamiliar with the subject matter being
discussed in this commentary.
– Soufi B et al, 2015: This demonstrates the use of super-SILAC, a cutting edge
quantitative proteomics strategy in E. coli under ethanol biofuel production
stress.
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Chapter 3
Proteomics of hydrogen production
97
98 CHAPTER 3. PROTEOMICS OF HYDROGEN PRODUCTION
3.1 Chapter Background
This chapter follows a series of experiments performed to interpret the internal proteome-
driven effects of a media change on Synechocystis under H2 producing conditions. Growth
rates and practical experimental features are given here, as these provide key background
information for the proteomic investigation, followed by the proteomic data. The proteo-
mic investigation described here was performed before the improvements listed in earlier
chapters were carried out, and was the driving force for the method development work
carried out. The same experiment has also been repeated, with the proteomic samples
being used as the background for the isobaric tag comparison conducted in chapter 5.
A comparison between the before and after states would have been a neat close to this
thesis, however as there are so many changes it is not a fair comparison for anything other
than recognising that the full body of changes collectively provides a huge improvement,
with 345 confident protein identifications with quantification data increased to over 1000
when all changes are implemented.
Where other chapters mainly investigate method development, the work in this chapter
represents an example case of the output-driven work conducted throughout the Cy-
anoFactory project. There were more investigations conducted, covering the features
described in Chapter 1 of this document; however due to the broad-reaching and varied
nature of the different studies, it was necessary to exclude the majority of analyses to
generate a defined scope for this thesis. The deliverable reports for the CyanoFactory
project are included at the end of Chapter 6 as appendices, to give an overall summary
of all the areas that were investigated.
Narciso Couto provided general tuition and assistance with the protein extraction, HPLC
and mass spectrometry lab work carried out in this chapter.
3.2 Abstract
Synechocystis is naturally capable of producing H2 under a defined subset of conditions –
notably the absence of O2, which causes destruction of the active site of the hydrogenase.
The levels of H2 production can be affected by a number of environmental factors, in-
cluding available nitrogen, sulphur and intracellular oxygen. The Burrows media is a
media that was designed through factorial design and optimised for H2 production in
Synechocystis by Elizabeth Burrows, a researcher in the US. In this study we investig-
ate the effects of this optimised media on the growth rate and internal rearrangement
of metabolic pathways within Synechocystis. The major findings show an increase in all




The organisms in the Cyanophyta phylum are considered to be some of the most ancient,
and have been attributed to triggering the oxygenation of the atmosphere – enabling the
development of modern life as we know it. Like all photosynthetic organisms, they have
the capacity to survive both anaerobic and aerobic conditions – despite the fundamentally
different energetic basis needed survival in these very different conditions. In many ways,
it can be more convenient to think of the organisms within this phylum as not a single,
variable organism, but two distinct organisms rolled into a single cell.
Here we attempt to describe changes that take place under isolated conditions, such as
light and dark, aerobic vs anaerobic; but in the natural world many of these changes are
not independent – darkness stops photosynthesis and so the production of O2, generating
an anaerobic environment – and attempting to isolate individual features when performing
a systems-level analysis makes the investigation significantly more challenging. In this
case, the question should not be – "how does factor x affect the internal system", but rather
"what is the natural state of the system, and how does it respond to factor x". These two
approaches may seem similar, but the fundamental difference is that the natural state is
not necessarily the lab-grown state; but rather the state in which the organism evolved
in and therefore optimised itself to.
3.3.1 Hydrogen production in Synechocystis
As described in chapter 1, under environmental growth conditions outside the laboratory
environment, Synechocystis is believed to use H2 as an electron sink under highly reducing
conditions. In these cases, expression of the Hox cluster genes is increased, leading to the
production of the Synechocystis native bi-directional Fe−Ni hydrogenase(Rögner, 2013).
As the hydrogenase is bidirectional, it can convert excess electrons into H2 as a relatively
inert temporary storage. In addition, it can also run in reverse to degrade H2 into electrons
for use within the cell. As a result, H2 measurements will reach an equilibrium after a
certain concentration of H2 is present in the headspace – previous studies have indicated
that this state is reached between 6 and 24 hours (Pinto et al., 2012a). This experiment
was focused on the initial changes that take place, rather than under equilibrium, as in
an industrial production situation the excess H2 would be need to be siphoned away from
the system to ensure the harvest efficiency is as high as possible.
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3.3.2 Burrows Media – background
Synechocystis alters metabolic state under a number of environmental factors, as shown
in chapter 2. The key factors that affect H2 production were investigated in a factorial
experimental design (Burrows et al., 2008), which demonstrated that when nitrogen and
sulphur were limited in the media the rate of hydrogen production was accelerated. In
addition, carbon limitation under photoautotrophic growth was found to limit the rate of
hydrogen production when the cells were switched to a fermentative state, and so carbon
was added in excess.
The nitrogen levels in the media were optimised in a follow-up study (Burrows et al.,
2009), as limiting nitrogen under photoautotrophic growth resulted in a reduced growth
rate and therefore a reduction in overall nitrogen abundance. Interestingly, whilst the
nitrogen levels were optimised in this experiment, they are likely responsive to the growth
regime of the organism. Ultimately, there should be an amount of nitrogen present within
the media to match the amount of desired biomass accumulation during the growth, so
that the limitation effects are experienced by the cell just before they are exposed to
H2 producing conditions. In addition, previous investigation indicated that nitrate can
increase the internal levels of cellular oxygen (Baebprasert et al., 2011, 2010), and so
ammonium chloride was used as the nitrogen source in the media.
The Burrows media used in this experiment was tuned to this level, based on the exper-
imental growth rates that had been observed in BG-11 media in our growth conditions.
This was done by using the biomass equation from the flux balance analysis (FBA) model
– generated by our collaborators in Valencia (Montagud et al., 2015) – to find the number
of moles of ammonium needed to generate a mole of biomass. The molecular weight of
the biomass equation was then used to calculate the number of moles of biomass present
in the dry weight of 50 ml culture grown to OD 0.8, and the required concentration of
ammonium per litre of media was calculated accordingly.
This media mix has also previously been tested under an enhanced reducing external
state, where cyanide was added to the media to drive the production state by excluding
oxygen from the cell (Burrows et al., 2009). These conditions were going to be replic-
ated in this study, however due to hazards associated with working with cyanide, along
with incompatible safety regulations within the department for the disposal of cyanide-
contaminated media, these alterations were not included.
3.4. METHODS 101
3.3.3 Summary of expectations
Due to the limited nitrogen availability in the Burrows media, the specific growth rate of
the cells may hit a plateau if the cells undergo enough divisions to deplete the nitrogen
levels in the media. Additionally, there are likely to be effects within the cell driven by
detection of the limited levels of nitrogen and sulphur in the environment that will limit
photosynthetic repair. There may be a higher rate of nitrogen turnover within the cell,
as components need to be recycled into essential proteins for the cell to function; which
may be visible as in increase in the overall levels of ribosomal and degradation proteins
present. This may also trigger the production of cyanophycin as a storage response to
longer-term nitrogen limitation, as is seen in phosphate depletion.
Nitrate assimilation is also a major route of increased oxygen levels within the cell; in
the Burrows media the nitrate has been replaced with ammonia, and so it is expected
that the ensuing reduced intracellular oxygen levels may lead to a more rapid rate of
oxygen depletion and therefore hydrogen evolution (Baebprasert et al., 2011, 2010). If
the overall energy levels in the cell are low, it is possible that carbon stores will either
be more rapidly degraded compared with the BG11 media; however depending on the
temporal state of growth the cell is in and starvation triggers, the metabolic pathways




BG11 media (Stanier et al., 1971) was made up from 9 standard stock solutions. All
solutions were made up to volume using de-ionised water unless otherwise stated. Solution
1 was sterilised by autoclaving, however to avoid alterations to the chemical composition
of the media all other solutions were filter-sterilised. The stocks were prepared as follows:
1. 15.00 g NaNO3 in 1000ml.
2. 2.00 g K2HPO4 in 500ml.
3. 3.75 g MgSO4 · 7H2O 500ml.
4. 1.80 g CaCl2 · 2H2O in 500ml.
5. 0.30 g Citric acid in 500ml.
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6. 0.30 g Ammonium ferric citrate green in 500ml.
7. 0.05 g EDTA Na2 dihydrate in 500ml.
8. 1.00 g Na2CO3 in 500ml.
9. Trace metal solution (per litre):
• 2.86 g HBO3
• 1.81 g MnCl2 · 4H2O
• 0.22 g ZnSO4 · 7H2O
• 0.39 g Na2MoO4 · 2H2O
• 0.08 g CuSO5 · 5H2O
• 0.05 g Co(NO3)2 · 6H2O
The final media composition per litre:
• 100.0ml stock solution 1
• 10.0ml stock solutions 2 - 8
• 1.0ml stock solution 9
• 889.0ml autoclave-sterilised, deionised H2O
For BG110 media, solution 1 was excluded and sterile water was used instead.
Burrows media
The recipe for Burrows media was derived from a combination of several recommendations
by a series of publications authoured by Elizabeth Burrows (Burrows et al., 2008, 2011,
2009). These publications detail a number of changes determined by factorial design that
lead to increased observable H2 production in Synechocystis. All stock solutions were
filter sterilised - please note that autoclaving the final solution will cause it to become
cloudy and filled with particulates, which causes problems for further analysis. The stocks
were prepared as follows:
1. 19.32 g NaHCO3 in 500ml
2. 2.00 g K2HPO4 in 500ml
3. 3.10 g MgCl2 in 500ml
4. 0.30 g Na2SO4 in 500ml
5. 1.80 g CaCl2 · 2H2O in 500ml
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6. 0.30 g Citric acid in 500ml
7. 0.30 g Ammonium ferric citrate green in 500ml
8. 1.00 g NH4Cl in 1000ml
9. 0.05 g EDTA Na2 dihydrate in 500ml
10. Trace metal solution (As above)
The final media composition per litre:
• 100ml solution 1
• 10ml solutions 2 – 8
• 1ml solutions 9 – 10
3.4.2 Synechocystis growth
Cells were grown in 250 ml shaking flasks each containing a maximum of 50 ml culture
to ensure a good exchange at the air-liquid interface. The flasks were stoppered with
cellulose bungs and rotated at 150 RPM in an illuminated shaking incubator at 25 degrees
Celsius. The light was measured at 40 ±10 µmol.m−2s−1 photons (≈ 3000 ±750 Lux)
during operation.
For analysis of changes taking place after acclimation to a specific media, the cells were
grown in the following regime. Initially, the cells were grown in BG11 for a growth cycle
(approximately 2 weeks), to ensure they were in mid-log phase during transfer. The cells
were then grown in the target media again until mid-log phase, to avoid transient accli-
mation changes on moving between media. This also facilitated degradation of nutrient
stores within the cells in the case of being transferred to Burrows media. At mid-log, the
cells were subcultured again into the target media; then grown to mid-log before harvest
and analysis.
Cell growth was monitored daily by measuring 1 ml culture on spectrophotometer in
polystyrene cuvettes at A730. These measurements were done in triplicate, and diluted
so the optical density (OD) was always between 0.05 and 0.5.
The cells were visually inspected under the microscope at for signs of stress or physical
morphology alterations. Cell counts were conducted on OD7301.0 cultures. These counts
were performed using a haemocytometer, where 10 µl of culture was added to the haemo-
cytometer, and left for 2 minutes to settle. The cells were counted by 0.05 mm2 squares,
until at least 200 individual counts had been observed. Synechocystis cells tended not to
separate clearly after division, as can be seen in figure 3.1 (p. 104) and so circular cells
104 CHAPTER 3. PROTEOMICS OF HYDROGEN PRODUCTION
Figure 3.1: Synechocystis cells being visualised under a microscope. When counting with
a haemocytometer, cells that appeared as type A were considered to be a single count,
whilst cells of type B, where a septum had begun to form for cell division, were counted
twice. This was done to provide some degree of consistency between cells counted near
the start of the measurement, and those counted towards the end or on a recount. These
images were taken with a light microscope under a 100-fold magnification, where the bars
are approximately 2 microns across.
were counted as one cell, whilst cells that were either a pair or showed the initial signs
of septum formation were counted as two. The count was then divided by the number of
whole squares that had been counted, and multiplied by 4×106 to determine the number
of cells per ml. All counts for these measurements were conducted by averaging technical
triplicates and reporting experimental quadruplicates.
Dry mass was determined by taking ≈ 50 ml culture at A730 OD ≈ 1 – taking note of
the exact volume and optical density for calculations later. The cells were collected by
centrifugation and washed in lysis buffer – as described in Chapter 4 – and transferred to
a pre-weighed 2 ml eppendorf tube. This was then centrifuged in a bench-top centrifuge
for 20 minutes at 17000 RPM (at 4 degrees Celsius) and remaining supernatant was
removed by pipetting. The pellet was then flash-frozen in liquid nitrogen and lyophilised
in the freeze-drier under vacuum overnight to remove remaining liquid. The eppendorf
was re-weighed and the difference between the prior and post states determined the mass
of the cells.
Rough whole-cell protein values were measured by taking whole-cell lysate before protein
concentration (see methods in Chapter 4) through use of the Bradford assay, although
these were found to vary with repeated measurements. Values for % protein were also
taken from the literature and other CyanoFactory collaborators – averaging 60%. This
was conducted before the investigation into optimal protein quantification methods de-
scribed in Chapter 4 – no accurate whole-cell protein measurement was determined in
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this study, as the methods described were conducted on purified proteins rather than
lysate.
3.4.3 Hydrogen production and measurements
For growth in anaerobic conditions, 100 ml serum vials were autoclaved, and filled with
95 ml buffer. These were then heated to 90 degrees Celsius and then cooled to room
temperature, whilst being sparged with either Ar or air. The process was carried out using
a bespoke set-up designed by Vi Nguyen at Sheffield University and took approximately
15 minutes. On completion of the heat-cool sparge cycle, each of the vials were rapidly
covered with a rubber septum to prevent air contamination, and then capped and sealed
using a crimping device.
Once the OD730 of the lowest concentration flask of cells reaches 1, the OD of each flask
was recorded. The volume was evenly split between 2× 50 ml falcon tubes for direct
replicate comparison.The culture was spun down (5000 RPM, room temperature, ramp
up and ramp down set to 7), the supernatant removed by pipetting (20 ml stripette),
and the pellet gently re-suspended in 5 ml degassed dd-H2O. This concentrated culture
was then transferred to a 5 ml syringe and leur-lock needle.
The concentrated culture was injected into the vials using the following technique, to
maintain an anaerobic environment and to prevent back-pressure. A second, empty leur-
lock syringe and needle was inserted into the vial above the liquid level; the syringe
containing the culture was then inserted below the liquid level and the contents were
injected. The empty syringe passively filled with the head-space gas during this injection.
The syringe that contained the culture was brought above the liquid level but not out of
the vial. The plunger on the syringe was kept depressed, and the passive syringe filled
with head-space gas was depressed to pressurise the head-space slightly. Whilst this
pressure was applied, the empty syringe was removed – preventing an influx of gas. The
passive syringe was then depressed as fully as manually possible and rapidly drawn out
of the vial to create a positive back-pressure to prevent passive air influx. Parafilm was
wrapped over the top of the serum vials to further limit gas exchange. Timings of the
hydrogen production experiment were started at the point of cellular injection. Figure
3.2 (p. 106) shows the serum bottles prior to hydrogen collection.
The head-spaces were sampled hourly for H2 production using a passive collection method.
The parafilm was peeled back and a balancer syringe, containing 1 ml carrier gas (Ar)
was inserted. This was allowed to passively retract to relieve the head-space pressure.
This was depressed slightly to maintain pressure and a collection syringe (a gas-tight
GC injection syringe) was then inserted into the top of the sample – the plunger was
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Figure 3.2: Samples prior to H2 sampling. Each serum bottle has been capped with a
rubber septum and sealed over with parafilm.
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fully depressed to avoid a drop in pressure. Once the collection syringe was inserted,
the pressure on both of the syringe plungers was relaxed. The balancer syringe was then
depressed to enable passive collection of 1 ml head-space gas in the collection syringe,
which was then sealed. The back-pressure was re-applied using the balancer syringe
and the collection syringe was removed. The balancer syringe was depressed as fully as
possible to replace the back-pressure and was removed as before. The parafilm was then
re-applied to prevent gas exchange.
The samples were measured on a gas chromatography system using manual injection as
described in (Maeda et al., 2007). H2 was detected using a thermal conductivity detector
maintained at 200 degrees. Ar was used as a carrier gas at a flow rate of 20 ml.min−1,
with the column temperature at 70 degrees, injector temperature at 100 degrees. Hy-
drogen retention was approximately 0.46 minutes. The method was used qualitatively,
rather than quantitatively. This was done because the focus of the experiment was in-
vestigating the cells under a shift to a H2 production state, rather than an assessment of
volumes under different conditions. Notably, very low volumes of H2 were produced by
this method. Peaks associated with N2 and O2 were also observed in this method – indic-
ating cases where gas leakage had occurred. Although time-consuming, the experiment
was restarted in cases where external oxygen contamination was observed.
Once H2 was clearly detected in all target samples, the experiment was stopped (this
typically took between 2 – 4 hours). The samples were de-capped, decanted into pre-
chilled 50 ml falcon tubes and rapidly centrifuged at 4 degrees Celsius for 10 minutes.
The pellets were then treated as described in the protein extraction method in Chapter 4.
The cold temperatures were intended to prevent the general proteome response within the
cell from changing too far. This method failed to detect the hydrogenase; as it was likely
destroyed upon contact with oxygen. Direct observation of the hydrogenase proteins
would likely require that the experiment was conducted in an anaerobic chamber, the
cells collected by rapid filtration to shorten processing time, before being flash-frozen
in liquid nitrogen. This experiment was planned, but not carried out due to time and
resource constraints.
3.4.4 Experimental design
To ensure statistical robustness in the experiment, all experiments were conducted in
quadruplicate – this offers the largest single statistical improvement possible to the clas-
sic triplicate method, it is also the most cost-effective statistical improvement possible.
The experimental set-up was designed as outlined in figure 3.3 (p. 109). This set-up
ensured a close relationship between all samples and potentially clearer proteomic out-
comes, although the design was susceptible to failure as the downstream measurements
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were dependant on the robustness of the upstream growth and preparation.
As shown, the replicates were then paired up and pooled together. This was expected
to improve the quality of observations, as purely stochastic variations between replicates
would likely dampen or cancel each other out completely, whilst systematic variations
would re-enforce their respective signals, producing a clearer overall set of data for stat-
istical analysis. A side effect of this approach is that the stochastic variation can, in
certain circumstances, be attributed to alternative organisation within the cell, and so
this method would go further to mask the true state of the cell – however since a cellular
population is being studied, rather than an isolated single cell, this issue persists within
the populations regardless.
3.4.5 HPLC and Mass Spectrometry
The proteins were purified as described in Chapter 4. All pooling of samples was done
at the cellular level before extraction, to ensure homogeneity of sample treatment. The
proteins were reduced and alkylated with MMTS, to break and block cysteine disulphide
bridges, before being digested with reagent grade trypsin. The peptides were labelled
with iTRAQ reagents as per the manufacturers instructions, in the pattern shown in
figure 3.3 (p. 109).
The samples were separated by high performance liquid chromatography using a Hyper-
Carb column over a 60 minute gradient. The fractions were then pooled as described and
separated by reverse phase on either the QStar, maXis or QExactive mass spectrometer;
as described in Chapter 5.
3.5 Results
3.5.1 Synechocystis growth
The growth rate for Synechocystis was monitored in both BG11 and Burrows media over
a period of 6 days, which was found to be approximately the amount of time needed for
a 10-fold increase in biomass. A growth curve was prepared, suggesting a doubling time
of 44.7 hours in BG11 media; however this was calculated when the cells were grown on
a 12/12 light-dark cycle, and as Synechocystis do not divide without the presence of light
(Heidorn et al., 2011) this rate can effectively be considered as a growth rate of 22.3 hours
per division; or a rate of 1.032 cell divisions per hour. In the second growth cycle, 2 of
the cultures were evenly split into both BG11 media and Burrows media at OD730 0.066.
BG11 showed a specific growth rate of 21.4 hours per division; whilst Burrows showed
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Figure 3.3: A flow-chart outlining the experimental design used in the BG11 vs Bur-
rows proteomic experiment. The entire experiment starts from 4 separate flasks which
produced paired replicates through the experiment; which are subsequently exposed to
differing media and environmental conditions. This was done to keep the proteomic
background as similar as possible between the replicates.
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Figure 3.4: Cell culture was grown in BG11, transferred to either BG11 (left) or auto-
claved Burrows media (right) and 100 µl was left overnight within a cuvette, which was
topped with parafilm to prevent evaporation. Some settling was observed in BG11 me-
dia, but a much more substantial separation event was observed in the Burrows media.
As a result, for all further experimentation the constituents of the Burrows media were
prepared sterile and combined under sterile conditions to autoclaved dd-H2O, which did
not show the same settling effects (data not shown).
a rate of 22.9 hours per division. This suggests a slight reduction in growth rate under
Burrows media, however not by an amount that fell outside the initial range, which was
caused by uneven light distribution within the incubator.
When the Burrows media was autoclaved, it produced sediments that caused the cells
within the media to flocculate together and drop out of solution over a single night. This
was found to be a repeatable phenomenon, as demonstrated in figure 3.4 (p. 110), and
so Burrows media was prepared using filter-sterilised constituents.
The cells were transferred to shaken serum bottles overnight, to detect potential changes
occurring within samples as a result of being transferred to a sealed environment – as
shown in figure 3.5 (p. 111). None of the conditions appeared to generate a qualitative
change in the cells that would affect the larger-scale experiment, although the vibrant
green colour seen suggested that the cells had not reached a point of extreme nitrogen
depletion.
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Figure 3.5: Cells were transferred at OD 1 into serum bottles under different growth
conditions overnight, to determine if any clear physiological changes would take place,
such as the settling observed in the autoclaved media. Transferring the cells to serum
bottles did not appear to make a clear difference over a 24 hour period under either media
condition when bubbled with either air or nitrogen.
3.5.2 Hydrogen production
The experiment was run until qualitative hydrogen measurements were made for all of
the test cases that were grown in anaerobic conditions. Three of the four anaerobic
Burrows media samples had begun to produce observable H2 by the second hour of the
experiment, whilst only one of the anaerobic BG11 samples produced observable H2 in
this same period. All anaerobic samples were found to produce H2 within 4 hours of
starting the experiment (Table 3.1, pg. 111).
Table 3.1: Each of the samples was checked for H2 presence in the head-space each hour
after the culture was transferred to the serum bottles. In this table, a positive detection
of H2 is denoted as a o, whilst a sample where H2 was not detected was denoted as x.
The samples are listed in sequence by replicate number, from left to right. Whilst both
aerobic and anaerobic samples were measured for H2 production, no H2 was detected in
the head-spaces of the aerobic serum bottles over the measurement time.
Time (hrs)
Media condition 1 2 3 4
Burrows, Aerobic xxxx xxxx xxxx xxxx
Burrows, Anaerobic xxoo oxoo oooo oooo
BG11, Aerobic xxxx xxxx xxxx xxxx
BG11, Anaerobic xxxx xxox oxox oooo
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Figure 3.6: Within the KEGG structure, metabolites are nodes and proteins are edges.
Proteins that are found to be statistically ‘up-regulated’ or ‘down-regulated’ in a condition
will result in the colouring of any node that they point to. Conflicts aren’t resolved in this
with kinetics, and so the last colour over-laid onto the figure will dictate the apparent fold
change; as a result these figures are guidelines rather than definitive informative graphics.
3.5.3 Proteomics – BG11 vs Burrows
The full detailed list of key protein changes identified here are available in a multi-sheet
excel spreadsheet the digital appendix, DOI: 10.15131/shef.data.5327476.
The initial study of the proteomics data focused on looking at the pathway-level responses.
This was done by mapping the statistically significant changes within the proteome to a
metabolic pathway map – produced by KEGG. This was done using the KEGG-maper
tool, where the observed proteins are overlaid onto the general KEGG metabolic pathway
in black, and statistically significant changes are coloured in either red (lower protein
abundance) or green (higher protein abundance). It is important to note that the KEGG
map is a graph, where the nodes (circles) refer to metabolites and the edges (connecting
lines) refer to proteins that inter-convert between different metabolites – as shown in
figure 3.6 (p. 112).
Figure 3.7 (p. 113) acts as a primer for understanding the other KEGG maps in this
chapter, where the general pathways have been highlighted to aid understanding for the
reader at a glance – without requiring the more in-depth interactive visual tools available
on the KEGG mapper web tool.
From the proteomic analysis, 345 proteins were confidently identified at a 1% false discov-
ery rate (FDR) with at least 2 unique peptide matches. Of these, 335 proteins contained
2 or more unique iTRAQ labelled peptides for quantification, with over 206 unique pro-
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Figure 3.7: A coloured KEGG metabolic pathway map, the nodes are metabolites and
the edges are proteins. The proteins that were identified in the study are highlighted
in black – it is important to note that only the proteins were identified, and so the
nodes are inferred by the identification of an edge. The different pathways have been
approximately grouped and highlighted in a colour, to aid understanding of the major
effects in the different comparisons in this chapter.
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teins being quantified as significantly different over the entire study. These values were
obtained with a single injection from 30 fractions.
In anaerobic dark conditions, 76 proteins were found to be differentially expressed. There
are reductions in the pentose phosphate and carbon fixation pathways, with an increase
in some parts of the TCA cycle. There is also a strong reduction in the phycobiliproteins,
but an increase in the enzymes relating to NADP and NADPH to compensate for electron
transport associated with hydrogen production (fig. 3.8, pg. 115).
The ‘Burrows’ condition media was compared to BG11, the standard media used by
the consortium. Under standard conditions, 137 proteins were found in concentrations
significantly different to BG11 when compared across all biological replicates (fig. 3.9 pg.
116).
Reduced protein quantification was observed across amino-acid biosynthesis pathways
and nitrate-related pathways. This is concordant with the absence of nitrate in the
media and general nitrogen starvation. A reduction of abundance in proteins involved
in metal chelation or with metal ligand properties was also observed, along with other
sulphur-rich proteins. This was an expected observation, as sulphur is a limiting factor
in the ‘Burrows’ condition.
An increase was observed in phycobiliproteins and enzymes relating to electron transport.
These are perhaps responsible for the increase hydrogen production observed in the Bur-
rows media conditions. Large sequences of pathways in the central carbon metabolism,
including carbon fixation and the pentose phosphate pathway were found in lower quant-
ities, however individual proteins between these points in carbon metabolism were also
significantly increased. Ribosomal proteins (non-network) were made up 39% (18/46) of
the identified proteins with significantly increased levels with a fold-change greater than
1.5, indicating a high level of protein turnover.
In anaerobic dark conditions shown to produce hydrogen, 141 quantified proteins were
observed to be differentially expressed between BG11 and ‘Burrows’ conditions. Large
portions of differentially quantified proteome remain similar to the aerobic investigation.
Of particular interest is the further increase in ‘Burrows’ conditions of phycobili-proteins
during anaerobic-dark conditions, as the opposite effect is observed in BG11. There is
also a further reduction in proteins in the central carbon metabolism pathways.
Directly comparing ‘Burrows’ in aerobic and anaerobic-dark conditions produced 53 dif-
ferentially quantified proteins. The differences between these two conditions were less
pronounced, although a further increase in phycobili-proteins and enzymes relating to
NADP and NADPH, further validating the observed increase in antenna proteins for
electron transport. There was also a further reduction in carbon fixation and the pentose
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Figure 3.8: KEGG pathway maps highlighting the changes between aerobic and anaerobic
states in BG11 (top) and Burrows media (bottom). In both cases there is a relative reduc-
tion in carbon fixation, however BG11 shows a large reduction in the pentose phosphate
pathway, whilst Burrows shows a systematic switch off in the GTP synthesis pathway.
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Figure 3.9: KEGG pathway maps highlighting the changes between BG11 and Burrows
media under anaerobic (top) and aerobic (bottom) conditions. Across both states, the
effects of the media change are uniform and highlight the dominant effects the media
produce on the cells, suggesting a completely independent effect to oxygen availability.
In both cases, proteins that heavily consum nitrogen – in this case the photosynthetic
machinery – are less abundant in Burrows, whilst machinery that recycles nitrogen, such
as amino acid biosynthesis, is much more active. In Burrows ATP and GTP production
are both up, along with lipid metabolism, indicating a higher turnover of cellular energy
and membrane breakdown.
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phosphate pathways, similar to BG11 in the same conditions.
3.6 Discussion and Conclusions
The observations seen for altered carbon metabolism under the Burrows media conditions
can largely be explained through the principal of nitrogen starvation – which was found
to be the major contributing factor to increased H2 production under the factorial de-
signed analysis performed previously (Burrows et al., 2009). Under nitrogen starvation,
previous study has demonstrated that the thylakoids and intracellular membranes are
degraded and cellular inclusions of glycogen are increased (Allen, 1984). These effects
have been visualised by electron microscopy, demonstrating glycogen accumulation in
WT Synechocystis (Singh and Sherman, 2005).
Methods proposed by Lefteris (Touloupakis et al., 2016), a collaborator based in Firenze
working on large-scale H2 production within a bioreactor, demonstrated that simply
letting the culture divide over time without replenishing the media resulted in a depletion
of available nitrogen; and under this state placing the culture into darkness optimised
H2 production rates. On completion of H2 production phase, the culture is then spiked
with nitrogen or normal growth media, returned to light, where it returns to a state of
oxygenic photoautotrophic growth, rather than the fermentative state required for H2
production.
Research suggests that reduction in the prior levels of phosphate could accelerate the
switching into this state, as phosphate depletion triggers the production of cyanophycin
– a nitrogen and energy storage compound (Allen, 1984), which could present the cells
with a faster rise out of lag phase when restoring the cells to a state of normal growth. This
would require experimental and modelling design, to determine if the levels of phosphate
could be controlled to deplete before the nitrogen levels without negatively impacting
upon the cell growth.
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4.1 Chapter background
Proteomic data is an important but under-utilised tool for systems-level engineering of
biological systems, particularly in biotech production strain field. In this chapter a num-
ber of core methods are developed for improving the quality of data generated by proteo-
mic analysis, with a focus to improving the quality of data generated from Synechocystis.
Whilst the methods are ultimately focused on Synechocystis applications, not all invest-
igations were carried out on data generated from Synechocystis experiments.
The techniques presented here cover three main areas: Firstly, investigating laborat-
ory techniques that can improve proteomic methods for Synechocystis, such as better
extraction methodologies and looking at alternative protein quantification methods for
determining the prior protein concentration. Secondly, investigating data-driven tech-
niques for expanding or controlling effects arising from tag-based proteomic investigations,
through balancing the effect of missing labels, understanding the lower-limit cut-off in
low-abundance protein samples and merging of multiple investigation datasets together.
Finally, investigating data-driven techniques that are more generally applicable to proteo-
mic studies, such as improving the false discovery rate, automated identification of post
translational modification frequencies, and cluster-based methods of interpreting proteo-
mic data where a prior hypothesis is not determined through the use of Gene Ontology
terms (GO terms).
These techniques were then applied in proteomic experiments utilised during the Cyan-
oFactory project. The work carried out in this chapter has contributed to two public-
ations, (Pinto et al., 2015) and (Chiverton et al., 2016); with other parts of this work
currently in the process of being included in other publications.
4.2 Introduction
Given the multi-faceted collection of work carried out in the Sheffield University Chemical
and Biological Engineering department, whilst the general research was performed with a
view to generating tools that improve Synechocystis data quality, not all analyses within
this chapter are carried out on the organism. Other focal organisms for the investigations
in this chapter include Chinese Hamster Ovary (CHO) cells, and Escherichia coli (E.
coli). Briefly, these organisms are extremely valuable for different biotechnology applic-
ations. CHO cells are the vehicle for the most high-profit pharmaceuticals currently in
production, and are used for the creation of monoclonal antibody (MAb) proteins as they
produce human-compatible glycosylation post-translational modifications on the protein
chains, whilst E. coli is an fast-dividing and extremely well-characterised organism that
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is widely used for developing and testing novel molecular biological systems; and was the
first organism used for Synthetic Biology.
A number of small investigations were carried out to optimise the proteomics pipeline for
Synechocystis – namely producing tools that would interact at points between the moment
the experimental biomass was collected or received up to the point that the final data
output from the investigation was completed. The first set of these was investigations
into the experimental techniques used for protein harvesting, sample characterisation
and preparation steps for processing on the mass spectrometer. These are referred to as
‘experimental’ improvements here, as they are physical modifications to, or measurements
made of the sample to improve the downstream quality of the final data produced. All
other investigations are data-driven and occur after the samples have been run on the
mass spectrometer.
The second set of investigations looked at developing the data processing techniques
during proteomic data analysis. These techniques included the following:
• detection of the presence/absence of proteins in a whole-proteome sample
• increasing the multi-plexing capabilities of tag-based quantifications
• utilising gene ontology terms to drive a cluster-based analysis of a protein system
There were a number of other investigations and automated scripts produced over the
course of the study, including the inter-conversion between different proteomic data types,
quantification of post translational modifications (PTMs) and assessment of the optimal
approach for determining a false discovery rate (FDR) in proteomics. Whilst these are
useful tools for the lab, they do not constitute novel research or a contribution to scientific
knowledge, or in the case of FDR are hard-coded into analysis pipeline in most popular
analysis software and are therefore not readily applicable to other studies; and so the
code for this has been included as an appendix, but will not be discussed further.
As a curiosity, a comparison between different analytical software was conducted, however
the major finding was largely one of personal preference driven by flexibility and conveni-
ence rather that production of an obvious scientific benefit. On analysis, MaxQuant
produced the largest amount of individual files for conducting a variety of investigations.
It also produced data in the most amenable format for down-stream data processing
with both R and Mathematica, and so upon discovery the program was used for all fur-
ther proteomic analysis, rather than being compared against other software available for
accuracy or effectiveness of the identification algorithm.
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4.3 Protein Extraction
The work in this section was carried out in collaboration with Narciso Couto, who assisted
with lab work and ran the HPLC analysis.
4.3.1 Abstract
In proteomic analysis, the first step when analysing an organism is to lyse the cells
and effectively extract the proteins. This can be challenging in hardy organisms like
Synechocystis, where the cells have a tough periplasm and a complex internal system
of membranes. In this section, methods were extracted from the pre-existing body of
literature; and the most effective methods were combined together in an attempt to pro-
duce a more effective extraction technique. The technique combines a series of rounds of
bead-beating with sonication, and when compared with another mechanical disruption
protocol it was found to result in more protein identifications, as well as a more replic-
able extraction protocol. The technique did not appear to cause a biased reduction in
observable proteins across a specific size range, and was also found to be effective for
downstream metabolite extraction.
4.3.2 Introduction
When measuring proteins within a cell, they need to be separated from other cellular
materials, such as lipids and DNA, for analysis. There are currently a variety of ways
to extract protein from cellular samples, which all follow the basic pattern of lysing the
cell and then separating non-desirable cell debris from the proteins whilst maintaining a
good yield of protein content. The second step is usually done with a number of rounds
of centrifugation, using buffer conditions that filter for proteins by solubility.
When considering cell lysis, there are large differences between all organisms. Some are
particularly resistant to extraction techniques, and can be challenging to physically break
apart for analysis; whilst others are much more fragile, and more robust techniques can
lead to disruption of the protein sample due to shearing or rapid release of proteases.
For every organism there exists a set of boundaries within which the optimal extraction
of proteins, metabolites and nucleic acids can be performed, without causing significant
damage to the extracted material. Synechocystis is a relatively hardy organism, due to
the complex membrane structures, coupled with a periplasm which provides a range of
resistances to damage from external sources, such as pressure and pH as described in
Chapters 1 and 2 (Heidorn et al., 2011). From the global analysis of proteomic investig-
ations in Synechocystis, it is evident that there are cases reported where limited protein
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extraction took place. This is inferrable through the low level of reported proteins, where
another reported for this low value – such as a low resolution mass spectrometer – was
not given.
Limitations at the protein extraction level can have significant consequences for down-
stream processing. For example, if a subset of proteins, such as membrane-associated
proteins, are not solublised during the extraction then a subset of the entire dataset
will be missing from the analysis. There is no amount of correction or normalisation
that can substitute for missing data, and so determining a reproducible technique that is
broad-reaching enough to collect a representative sample from the proteome is essential
for robust proteomic analysis in the organism.
There are a number of core extraction techniques that are widely used in Synechocystis
proteomics. These are:
• Sonication
In this method, the cells are subjected to ultrasonic energy at low temperatures.
The energy causes pin-points of stress in the membranes and breaks up aggregations,
causing the membrane to break down leading to lysis of the cellular components.
Sonication as a method for lysing Synechosystis is relatively new, with all of the
studies being conducted in the last 3 years. The recent emergence of this method
is concordant with a recent improvement in the number of identifications in each
study, and the method uses a defined set of parameters that enable repeatable
investigations across different labs.
• Bead beating
In this method, small glass beads are inserted in the sample. It is then vortexed
resulting in the beads colliding with either each other or the walls of the tube,
trapping the cells between two hard surfaces and crushing them open and resulting
in mechanical lysis. First proposed by Norling et al. for analysing membrane
fractions, this is the most established and popular cell lysis method observed in the
literature – with 27 papers citing its use. There are potential issues with proteins
and other materials adhering to the beads during processing, causing issues related
to both recycling of the beats and reduced extraction efficiencies.
• Nitrogen cracking
In this method, the cellular sample is frozen with liquid nitrogen and ground with
a mortar and pestle. This is repeated several times until the researcher is satisfied
that the cells have been lysed. Usually the number of rounds of grinding will be
indicated within the methods, however due to the inherently human nature of the
protocol, this is typically a judgement call based on experience (Axmann et al.,
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2005). Similarly to bead beating, the cells are exposed to mechanical crushing
forces – amplified by the use of very low temperatures that make the membranes
brittle and more susceptible to shearing.
• Freeze-thaw cycling
In this method, the cells are exposed to a series of freezing and thawing cycles. This
causes the cells to rupture due to both osmotic stresses and physical ice-crystal
disruption of the cell membranes. This method has the advantage of being passive,
however it takes longer to complete than the active methods described above.
• High pressure cell disrupter and French Press
These methods are grouped together as the both utilise high pressure to trigger cell
lysis. The cells are run through machines that apply high pressures to the cells.
Whilst widely applied successfully in other organisms, such as E. coli, Synechocystis
has been shown to be extremely resistant to pressure changes (Heidorn et al., 2011),
and as a result such methods are limited in application. This resistance is observed
further observed in the meta-analysis, with a reduced number of proteins observed
in studies that apply such techniques.
• Solubilisation with SDS and FASP
Sodium dodecyl sulfate (SDS) is commonly used to extract proteins from a sample.
SDS is a amphipathic molecule, meaning that it contains both hydrophilic and hy-
drophobic regions, which results in its detergent properties. SDS denatures proteins
and covers them in uniform charge, making it ideal for gel-based electrophoretic sep-
aration, however it causes downstream problems with processing for proteomics and
has therefore not been used in whole-proteome LC-MSMS studies. During liquid
chromatography separation, SDS contaminates the column and is difficult to fully
remove, resulting in destruction of the processing equipment. Additionally, within
the mass spectrometer the detergents ionize well and are at a large excess relative
to the proteins. This reduces the number of spectra collected on peptides, reducing
the overall data quality.
Filter Aided Sample Preparation (FASP) is an improvement on SDS extraction,
enabling the removal of the SDS and avoiding downstream processing issues with
LC-MSMS (Wiśniewski et al., 2009). This preparation removes the SDS from a
sample, enabling it to be used as an extraction method in identification. The first
step is to breakdown the entire cell through a combination of sonication and boil-
ing in SDS; the proteins are then affixed to a membrane by filtration and further
processing is done to the proteins in-situ on the membrane. This method has the
advantage of retaining all the soluble and insoluble proteins for analysis, without
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having to use 2D-gel extraction techniques. The proteins are then reduced and
alkylated, the SDS is removed from the sample by buffer exchange with urea. Fol-
lowing this step, the urea is acidified and the sample is then desalted. At the time
this study was conducted, the method had not been used previously in Synecho-
cystis (based on a literature search – 2014), however the method has since been
used in Synechocystis in 2015, resulting in the confident identification of over 2100
proteins for a phospho-proteomic study (Spät et al., 2015).
The FASP method was proposed as a general protein extraction method for Syne-
chocystis during CyanoFactory in April 2014, however due to strong opposition by
other members of the consortium, it was eschewed for a combination of other tried
and tested methods from previous studies.
4.3.3 Methods
A comprehensive list of papers studying the proteomic response of Synechocystis were
identified using the PubMed search engine (https://www.ncbi.nlm.nih.gov/pubmed/).
The search terms used were "(Synechocystis) AND Proteom*", the search was performed
in June 2013. The full list of papers was downloaded and processed manually, with key
information relating to the topic of the paper, the method of protein extraction and
the number of obtained proteins identified being collected. This data was then used
to generate a meta-analysis to link the number of identified proteins to the extraction
technique.
A new method combining sonication and bead-beating was tested. This involved first
balancing the cells by OD730, diluting all samples to that of the lowest concentration
sample. To ensure enough material was collected for the analysis, 4 replicates were grown,
paired and pooled together to ensure more balanced cell numbers – this meant that the
slowest growing and fastest growing replicates were combined. As these are experimental
replicates, these rates are largely determined by the initial cell concentration which varied
slightly. To mitigate any effects of early stationary changes, all cells were harvested at
mid-log phase – which equated to OD730 of between 0.6 – 0.9.
The pooled cells were centrifuged in 50 ml volumes for 10 minutes at 4 degrees Celsius
at 10,000 RPM. The ramp-up rate on the centrifuge was kept at 9 (maximum), but the
ramp-down rate was reduced to 7 to avoid disrupting the cell pellet. The supernatant was
removed gently, taking particular care as the air-liquid interface passed over the pellet
to avoid disrupting it – during supernatant removal, all supernatant was emptied into a
beaker, to preserve the sample in case of pellet disruption. Once the liquid was removed,
the tubes were inverted and stood on blue roll, being left for 2 minutes to let any residual
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media fall from the tube and to let the pellet air-dry briefly. The cells were re-suspended
in 1 ml of 4 degrees Celsius lysis buffer (recipe described in chapter 5) and transferred
to a 2 ml protein lo-bind eppendorf tube. This also acted as a wash step for the cells.
The tubes were centrifuged at 17000 RPM for 60 seconds and the lysis buffer removed by
pipetting. If the proteins were not being extracted immediately, pellets were snap-frozen
in liquid nitrogen and stored at -80 degrees Celsius.
At this point, the cell lysis-extraction methods diverged. In the nitrogen-grinding ex-
traction, the cell pellet was re-suspended in 500 µl of lysis buffer and transferred to
a mortar and pestle that had been pre-chilled with liquid nitrogen. The solution was
pipetted into the mortar and a small volume of liquid nitrogen was added to freeze the
sample. Manual grinding was performed for approximately 10 minutes per sample, with
additional liquid nitrogen added as the sample thawed. When additional liquid nitrogen
was added, care must be taken to ensure that the sample is not thrown out of the mortar
due to rapid evaporation – this can be avoided with slow, careful addition of nitrogen.
After this, the sample was scraped from the mortar and pestle whilst still frozen and
transferred into a protein lo-bind tube for further processing. The mortal and pestle are
then thoroughly cleaned with distilled water and ethanol between each sample, to avoid
cross-contamination.
In the sonicating and bead beating method, the pellets were re-suspended in 500 µl of
lysis buffer, and an equal volume of glass beads was added to the sample. The glass
beads showed strong electrostatic interactions with the plastic weigh boat, causing issues
for adding accurate, reproducible amounts of beads per sample. To avoid this, a 200
µl pipette tip was found to hold approximately the correct volume of beads when filled
to the top and flattened off, and due to the altered geometry didn’t demonstrate the
same problematic electrostatic interactions, improving the accuracy of this part of the
technique. At all points during protein extraction, the samples were kept on ice to limit
protease activity and changes in cellular state.
Two main cycles were used in combination – a bead beating cycle and a sonicating water
bath cycle. In the bead beating cycle, the samples were put into the bead beater on a
60 second cycle, followed by a 60 second rest period on ice. For the sonication cycle, the
samples were placing into a chilled sonicating water bath, which was further cooled by
the addition of ice, for 60 seconds, followed by a 60 second rest period on ice. Two bead
beating cycles were run, followed by a sonicating cycle, followed by two bead beating
cycles, followed by a sonicating cycle. After these 6 cycles were complete, the samples
were transferred to a 4 degrees Celsius centrifuge and spun at 17000 rpm for 15 minutes.
200 µl of supernatant was transferred to a clean protein lo-bind tube stored on ice, and
an additional 200 µl lysis buffer was added to each of the samples. These were then run
through 2 further bead beating cycles and one sonication cycle before being centrifuged
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again as described above. The supernatant was transferred to the same lo-bind tube as
the first batch of supernatant, which was then centrifuged for 15 minutes at 17000 rpm
at 4 degrees Celsius, to remove any particulates that had been transferred during protein
extraction. The sample was then passed forward for further processing.
The processing methods re-align at this point. In both cases, the supernatant was trans-
ferred to a clean lo-bind tube, which had 5 volumes of ethanol added to precipitate the
proteins. The samples were then transferred to a 4 degrees Celsius refrigerator overnight
to facilitate protein precipitation. The samples were centrifuged for 15 minutes at 17000
rmp and the supernatant was removed. The pellets were then re-suspended in 200 µl stor-
age buffer, completing the protein extraction. These extracts were either used for further
processing straight away – digestion, alkylation, labelling, mass spectrometry analysis –
or stored at -80.
4.3.4 Results
As can be seen from the data (Table 4.1 p. 128), studies that utilise bead beating and
sonication appear to generate the highest number of identifications. It is important to
note that, as can be seen from figure 2.1 (p. 72) in chapter 2, that the majority of
the high-abundance protein extractions have taken place in the last 5 years in line with
improved proteomic methods. This has the potential to skew the results in favour of such
an analysis, and so chosen techniques in a full investigation of this new technique should
have more of a meritorious basis for inclusion beyond being included in previous studies.
The protein gel in figure 4.1 (p. 129) shows that the extraction technique does not appear
to limit the proteins identified by size, although to determine that there are no sections of
the proteome being excluded by this method, both a side-by-side comparison on a single
gel, as well as an informatic analysis on the identified proteins and their localisations
within the cell to ensure unobserved biases were not taking place.
Cells disrupted using this same technique have been utilised in metabolomic studies
during the CyanoFactory (extract shown in fig 4.2 p. 129, data shown in appendix).
4.3.5 Conclusions and Discussion
Overall, when comparing these two techniques there are 3 main features that should be
considered: time, reliability, and proteome coverage. The nitrogen grinding technique
is clearly much faster for a single sample, taking approximately 12 minutes per sample
opposed to the 90 minutes for measuring up to 16 samples simultaneously required for the
sonication-bead beating method. The bead-beating time scales linearly, as the operator
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Table 4.1: Details from a bibliometric analysis of the effectiveness of different studies
utilising a range of extraction techniques. Based on the overall extraction technique and
focus of the study, papers were categorised into papers measuring just the soluble protein
extract (Soluble), just the membrane protein extract (Membrane), and those combining
both fractions together (Full).
Number of Protein Identifications
Membrane Soluble Full
Sonication
Median 123 n/a 1472
Mean 123 n/a 1315
Max 123 n/a 1509
Min 123 n/a 807
Papers 1 0 4
Bead Beating
Median 57 n/a 1200
Mean 224 n/a 1039
Max 1350 n/a 1955
Min 36 n/a 67
Papers 13 0 7
Mechanical Grinding
Median n/a 340 776
Mean n/a 326.285714 776
Max n/a 646 776
Min n/a 120 776
Papers 0 7 1
Freeze-Thaw cycling
Median n/a 15 n/a
Mean n/a 15 n/a
Max n/a 15 n/a
Min n/a 15 n/a
Papers 0 1 0
Pressure based lysis methods
Median 155 102.5 n/a
Mean 155 102.5 n/a
Max 155 105 n/a
Min 155 100 n/a
Papers 1 2 0
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Figure 4.1: A protein gel showing a full set of samples extracted with the improved
method, demonstrating a broad extraction range across the proteome. This extraction
technique does not produce a bias against proteins based on size.
Figure 4.2: Whilst these metabolite samples were not analysed, this clearly shows that
the same extraction technique is suitable for lysing cells for metabolomic analysis.
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can only grind one sample at a time, and so when more than 6 samples are being processed
simultaneously the grinding technique becomes slower. As a result, for an 8-plex iTRAQ
experiment, the sonication-bead beating technique is faster and therefore more efficient
on operator time.
In terms of reliability, the sonication–bead-beating method is a clear winner. The nitrogen
grinding technique is heavily dependant on operator technique, and so the efficacy of
extraction varies between different investigators. This same feature also makes it difficult
to define the energy used to rupture the cells, and so determining if a different method
is directly equivalent is also difficult. During initial attempts with the bead beating
method, there was a large variation in the amount of glass beads added to each tube,
which introduced an unreliable element to the extraction; however with the addition of
the pipette tip method this was rectified.
In terms of proteome coverage, it is difficult to generate an accurate comparison. Further
testing would need to be carried out comparing the same experimental replicate with the
different methods; followed by testing on a mass spectrometer under identical conditions.
Unfortunately, in this investigation the comparison was performed on different samples,
taken at different times, measured with different mass spectrometers; so the best estimate
that can be given for this is that on analysis of the dataset there did not appear to be
a significant under-representation of proteins from a specific subset of the data. This
finding needs to be experimentally verified, however.
No comparison between extraction methods for proteomics in Synechocystis has been
done to date. As a result, there is the potential to generate a publication by building on
the work conducted here, directly investigating a comparison of the methods identified
here, whilst controlling upstream and downstream aspects of the work-flow to produce a
fair comparison.
Whilst the novel technique generated a suitable range of proteins for investigation and
appeared to produce a stable subset of proteins, further experimentation is required to as-
sess whether the technique could be improved at any stage. This could be done by keeping
the biomass from each round of extraction, solublising it and using gel-based techniques
to determine the relative rates of protein loss at each stage. This technique could also to
highlight any set-specific losses, such as fractions rich in membrane-associated parts of
the proteome. Ultimately, due to the time-saving and increased reliability features of the
novel method it was adopted for all further analyses carried out during the CyanoFactory
project.
Beyond the tried and tested extraction techniques, there are also other avenues that could
be investigated, such as the use of microwave radiation or supercritical fluids for aiding
protein and metabolite extraction (Raynie, 2006). In addition, following on from the
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Figure 4.3: A comparison was run between Synechocystis peptides separated on both
a HILIC column (top) and a Hypercarb column (bottom), using the same buffers and
buffer ramp profile. The Hypercarb column showed a much more even distribution of
peaks across the chromatography profile, suggesting a more even separation of peptides
within the sample.
ground-breaking work by Gan et al (Gan et al., 2005), initial investigations suggest that
there are further improvements that could be garnered from investigating other steps
downstream in the proteome processing pipeline – as can be seen in the preliminary data
shown in figure 4.3 (p. 131).
4.4 Protein Quantification
4.4.1 Abstract
Protein quantification is important when analysing samples by mass spectrometry. Dif-
ferent methods of protein quantification are typically subjected to errors. In this section,
an analysis was performed to determine the most accurate method of protein quantifica-
tion in Synechocystis. The Bradford assay – a protein dye colour-change assay, and Kalb
assay – a direct UV spectrometry assay were compared using a BSA standard. The Kalb
assay was found to produce lower quantifications than the Bradford assay, although they
were more consistent with a densitometry analysis than the Bradford quantifications,
which showed condition-specific effects. As a result, the Kalb assay was determined to
be more effective for Synechocystis proteomic quantification.
132 CHAPTER 4. IMPROVING PROTEOMIC METHODS
4.4.2 Introduction
In proteomic analysis, it is important that the amount of protein being analysed by the
mass spectrometer is equal between samples that are being compared. This is incredibly
important for ensuring that the results observed from the analysis are meaningful and
robust for a number of reasons.
As discussed in chapter 1, protein observations from a sample are genearlly considered to
be incomplete when the sample is above a given level of complexity – as in the case in all
full-proteome studies, meaning that not all proteins within a given sample will actually be
observed during a study. This effect is stochastic and driven by the overall abundance of
a given protein in a sample, running the same complex sample on two separate occasions
will not produce the same set of proteins, but the variation will be emphasised more in
the low-abundance proteins than in the high abundance proteins. Additionally, there is
a general requirement for 2 or more unique peptides to be observed for a protein to be
confidently considered to be present in a sample, as a check against a single contaminant
resulting in erroneous identification of a protein, which further emphasises the bias against
low abundance proteins within a sample. As with all things, proteins need to actually be
measured to be compared. If proteins are unevenly weighted, then one sample will have
a much greater range of observations that will not be present in the other, negating the
benfit achieved by increasing the sample range.
Tag-based proteomic quantifications appear mitigate this problem by merging all peptides
together, resulting in an even baseline set of proteins for observation. The resulting
quantification measurements can then be normalised, either by balancing the sum of all
the extracted ion counts for each tag through scalar normalisation, or by using median
correction to balance the central range of observations. On face value these techniques
appear to negate the need for careful balancing of initial protein concentrations, however
in fact they only mask the problem. As discussed in chapter 4, a number of factors
including ratio compression and peptide co-isolation, mean that the observed values do
not represent the true proportions of a protein within a sample – particularly in low
abundance spectra. This means that correction based on these data will compound bias
effects and can ultimately result in either type I (false positive) or type II (false negative)
errors from the analysis of tag-based data, where the observations would simply be missed
in an un-multiplexed sample.
Having highlighted the importance of prior protein quantification for proteomic analysis,
an investigation into methods that might introduce bias into this result is therefore neces-
sary. The standard method widely employed for quantification of protein is the Bradford
Assay (Bradford, 1976). This assay uses a dye called Coomassie Blue to determine protein
quantification accurately within the 0.2 – 20 µg range, and is measured by a colour shift
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Table 4.2: The colourometric protein quantification reagents and their respective absorb-
ance wavelengths for calculating protein concentration.
Figure 4.4: A wave-scan of whole-cell Synechocystis
under increasing light intensity (solid, to dashed, to
dotted lines respectively), adapted from (Kopečná
et al., 2012). Three verticle lines have been added
to the plot, highlighting the different absorbances
for the bicinchonic acid assay, Bradford assay, and
Folin’s phenol assay (running from left to right). The
peaks for phycocyanin and chlorophyll are indicated
with the maximal absorbance values (620 and 682
respectively).
generated through interactions between the dye and basic amino acid residues (Compton
and Jones, 1985). Whilst the test is robust and has a wide applicability to a number
of different samples, different proteins do present minor variations in detection accuracy
based on amino acid composition (Stoscheck, 1990). The Bradford Assay is an example
of a colourometric protein detection assay, where the presence of protein causes a shift in
absorbance of either a dye or a chemical complex. Other examples of this type of assay
include the Lowry protein assay, which measures a shift in Folin phenol reagent under a
reduction of Cu2+ to Cu+ (Lowry et al., 1951) and the bicinchonic acid assay – which
also makes a measurement based on copper reduction, but uses bicinchonic acid, instead
of Folin phenol, at the capture agent (Smith et al., 1985). These three methods generate
absorbance measurements in the wavelengths given in table 4.2 (p. 133).
Synechocystis has 2 major regions of absorbance interference in a spectrophotometer, one
at 620 nm – corresponding to phycocyanin, and the other at 680 nm – corresponding to
chlorophyll (Kopečná et al., 2012). As can be seen in figure 4.4 (p. 133), which shows
measurements made of cells at an equal density under different lighting regimes, these
absorbances can change for Synechocystis where the concentrations and proportions of
light-harvesting proteins are altered. Since this error is variable between samples, and
since there is a clear overlap with the measurement of phycocyanin and the Bradford
reagent, this demonstrates that the Bradford assay is unsuitable for measuring protein
samples with high amounts of phycocyanin present.
Whilst bicinchonic acid and lowry assays may be more suitable for conducting these meas-
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urements, as they measure in regions outside this interference, there is a more general
issue for using colourimetric analyses for quantification in cyanobacteria: the abundance
of brightly coloured compounds that absorb light in the visible spectrum. Synecho-
cystis depends on dynamic control of a variety of light-harvesting compounds during a
given light-dark cycle, and so measurements made within the visible spectrum are always
susceptible to wider variations due to contamination with a range of metabolites that
are either co-extracted with proteins or covalantly bonded, and as such persist through
clean-up stages. These can be observed during the extraction process, as supernatants
and pellets at each stage of extraction are brightly coloured, ranging from blues to yellows
to reds. The relative abundance of these light-absorbing compounds varies depending on
environmental conditions, and so analysis methods focused on the ultra-violet (UV) re-
gion of the light spectrum (100 – 400 nm) was considered to potentially produce more
reproducable results. UV methods have the added advantage of being technically simpler
to achieve, as they don’t require the adition of reagents or incubation times. Analysis
in the UV region of the spectrum requires the use of a quartz cuvette, since polystyrene
and glass cuvettes have interferring absorbances at wavelengths below 340 and 320 nm,
respectively (Stoscheck, 1990).
There are 2 UV absorbance regions in protein molecules, the first is the energy cor-
responding to the peptide bond, which absorbs at 205 nm, and the second is energy
stabilised by aromatic residues, which absorbs at 280 nm (Warburg and Christian, 1941;
Stoscheck, 1990). Whilst the 205 nm region is much more sensitive to changes in protein
concentration, a large number of other molecules also absorb in this region, especially mo-
lecules containing c−c bonds(Stoscheck, 1990), which are present in all coloured organic
compounds; and so measurements of Synechocystis proteome samples in this region were
excluded for the same reason as measurements in the visible spectrum were excluded. On
the other hand, measurements in the 280 nm region are less accurate between samples
with varying protein levels, due to the changes in the relative number of aromatic residues
in the proteins which could again introduce sampling bias. DNA and RNA both generate
interference in the UV region of the spectrum, and so these must be corrected for to give
an accurate protein quantification. This is typically done in the 260 nm region, where pro-
teins do not produce a strong absorbance signal, but nucleic acids do (Stoscheck, 1990).
An alternative method to measuring the 280 or 205 nm regions directly is to measure
the 210 nm absorbance off-target at 230 nm (Kalb and Bernlohr, 1977). This technique,
which produces similar accuracy to levels attained by the Lowry assay, has the advantage
of not being strongly affected by varying proteins in the background. Whilst combining
the best aspects of all quantification techniques, the actual mathod itself is relatively un-
heard of, with the paper only stating 591 citations over the last 40 years, compared with
over 18,000 for the bicinchoninic acid method, 196,000 for the Lowry method, 230,000 for
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the Bradford assay. The formula for calculating protein concentration from this method
is as follows:
µg/ml.protein = 183A230 − 75.8A260
Where A230 and A260 are absorbances at 230 nm, and 260 nm respectively (Kalb and
Bernlohr, 1977). In this study we compare the quantifications produced by the Bradford
assay with those produced by the Kalb UV calculation.
4.4.3 Methods
The spectrophotometer assays were performed as described by Stoscheck (Stoscheck,
1990) and Kalb (Kalb and Bernlohr, 1977). For the Bradford assay, a standard curve
for BSA was created by diluting a 1 mg ml−1 protein solution. Protein concentration
for Synechocystis samples was estimated initially by eye on a protein gel, then informed
estimations by trial-and-error were performed by dilution, until the concentration was
in the correct magnitude – in this case an initial 1 in 50 dilution of the protein samples
was made to bring the absorbance readings to around 1 – then a series of 2-fold dilutions
was made to determine the absorbtion coefficients. Quantification was performed on
the 1 in 100 dilutions of the samples as these absorbance values were determinable on
the BSA curve. The same 1 in 50 initial dilution was used for all samples, resulting
in variations between protein concentrations in different samples. The protein gel was
analysed with densitometry to determine approximate relative protein concentrations in
a numerical fashion other than by eye, where the coomassie-stained gel was photographed
and analysed optically by ImageJ in the UV-plate reader. All data was analysed in the
software R and graphs were made with the ggplot2 package (Wickham, 2009).
4.4.4 Results
Initially the protein concentration levels were checked with SDS-PAGE and densitometry
(fig 4.5 p. 136) to determine the relative quantifications. Prior to extraction, samples had
been pooled and analysed with a spectrophotometer to determine relative concentrations.
The different pooled samples were then diluted to produce samples with approximately
equal numbers of cells.
The protein samples were then analysed with both the Bradford assay and the Kalb
UV spectrometer assay, the quantifications were found to be the values in table 4.3
(p. 136). The Bradford assay gives consistently higher quantifications than the Kalb
assay, although it also gives higher values for cells grown in BG 11 media than Burrows.
The samples generally appear to change in the same way seen in the densitometry analysis.




















































Figure 4.5: A SDS-PAGE gel stained with Coomassie blue and a densitometry analysis
of the image. This shows the relative quantifications of protein between the samples.
Condition Densitometry (Relative) Bradford (mg.ml−1) Kalb (mg.ml−1)
BG Ar 0.74 88 39
BG Ar 0.79 84 41
BG Air 0.81 94 42
BG Air 0.58 60 33
Bu Ar 0.86 66 38
Bu Ar 0.70 52 33
Bu Air 0.73 72 36
Bu Air 1 81 46
Table 4.3: A table showing the different quantifications obtained from the protein samples
for each of the different measurement methods. The Bradford assay has consistently
higher quantifications than the Kalb assay, and also shows higher quantifications for all
the proteins from samples grown in the BG 11 media.


































































































 Bradford assay on dilution series
Figure 4.6: A comparison between serial dilutions of a known BSA standard and Syn-
echocystis proteins from a proteomics experiment on H2 production. Whilst the two
curves are not supposed to match, the ratio of the coefficients in the general linear model
should be consistant between the two. The Synechocystis proteins show a realtively higher
contribution from high-order polynomial terms, suggesting non-linear interferrence.
Bradford analysis was performed on serial dilutions of BSA and Synechocystis samples
to determine protein concentrations, shown in fig 4.6 (p. 137). The dilution series com-
parison shows a higher-order polynomial fit when comparing BSA to the whole proteome
sample, suggesting an unsuitability for the the standard curve as a quantification tool in
this case. Interestingly, there appeared to be a systematic difference between the concen-
trations observed for cells grown in BG-11 media as opposed to those grown in Burrows
media. The dataset was split by media condition and investigated in more detail. A
comparative dilution model was generated for each of the different conditions (fig 4.7
p. 138).
4.4.5 Conclusions and Discussion
The further analysis on the different conditions suggested that a Bradford assay could be
affected by differing environmental conditions more than the UV Kalb assay. This was
based on the better consistency observed between all measurements in the Kalb assay
when compared with the Bradford. Ultimately, the findings of this chapter are interesting
but are badly in need of further repetition of the experiment, under a variety of different
protein-measurement conditions, to verify if the findings are actually legitimate or just a
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 Bradford assay on dilution series
Figure 4.7: A comparison between serial dilutions of BG11 and Burrows media. The ratio
of the coefficients in the general linear model should be consistant between the two; but as
in figure 4.6, this is not the case. The dilution series are coloured by replicate. Cells grown
in Burrows media appear to show the heteroscedastisity expected in a hierarchically-linked
dilution series, whilst this is not as evident in BG11.
one-off effect.
From a practical point of view, the Kalb assay is simpler to perform than the Bradford.
The Bradford assay requires more complicated reagents and a more involved investigation
technique, with the proteins being reacted with a reagent and left for 5 minutes; whilst
the Kalb method is a direct measurement in the UV spectrum. The Kalb assay requires
the use of a quartz cuvette, as other commonly used materials like polystyrene or glass
will absorb radiation in the UV spectrum – this adds expense to the technique. It is a
one off cost, opposed to the reagents needed for the Bradford, and is quicker; so the over
time the Kalb method would be more cost effective.
There was a disparity between the two measurements suggesting that either the Bradford
method was over-estimating protein concentration or the Kalb method was underestim-
ating protein concentration. Due to the research discussed in the introduction, and
evidence of other cases where the Bradford assay over-estimated protein concentration
in the presence of contaminating substances, it seems more likely that the Bradford is
over-estimating, but is still possible that the Kalb is under-estimating protein concentra-
tion. Designing an experiment to verify one or the other being accurate is challenging,
as all experiments for protein quantification discussed here have bias when measuring a
4.4. PROTEIN QUANTIFICATION 139
complex protein mixture.
A possible experiment to investigate this effect would be to run quantifications with both
techniques at various stages of clean-up. This would highlight if a particular step resulted
in a significant loss of signal, which could then be further investigated to determine
whether a large amount of protein was being lost at that stage or if a major contaminant
was being removed. It would also be interesting to comparatively quantify proteins that
had been size-separated, to see if particular bias existed in a detectable size fraction
of the proteome. This may enable the detection of a representative, unchanging part
of the proteome to determine the overall protein quantification – much the same way
such comparisons are performed with ribosomal RNA or caretaker genes in nucleic acid
studies. Determining a simple, replicatable technique for such a process would likely be
challenging.
This experiment was limited because all samples were measured during a single proteo-
mics experiment, and as a result are susceptible to systematic contamination. To verify
these results, additional repeats on different conditions would need to be carried out to
ensure robust analysis. In addition, only the Bradford assay was assessed with a dilu-
tion study, and so the Kalb technique may also display the same level of non-linearity of
absorbance. The Kalb method has the advantage of not being compared to a standard,
however some observations suggested minor variations between different protein stand-
ards being studied. As a result, it would be beneficial to confirm this effect by performing
a comprehensive, systematic study into the effect.
Finally, the curve-fitting model used here that looked at a cubic model was suggested by
the Bradford test supplier to better fit the observed data, but a cubic model is math-
ematically a worse model to fit the data than a linear one in many ways – notably as if
continued there could be up to 3 separate measurements that would result in any given
concentration (polynomial functions with a cubic component typically cross the x axis 3
times). It is likely that that this model is suggested because a more accurate logarithmic
function is more challenging for most operators to calculate. This limitation may also
contribute to the limitations of the Bradford assay, where the calculation for the Kalb
assay is linear.
As another possible improvement to proteome detection – if the phycobiliproteins are
responsible for the visual spectrum contamination, it may be possible to remove the
effect directly. The chromophore in biliproteins is covalently attached during protein
formation to a cysteine through the formation of a disulphide bridge (Scheer and Zhao,
2008). Reducing and alkylating the protein mixture prior to measurement may remove
the chromophores. When not covalently bonded to the biliprotins, the chromophores are
much less stable and energy is given out as heat rather than absorbed in a specific area
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of the visual spectrum (Scheer and Zhao, 2008). Testing this would be relatively simple,
and would require the same steps normally taken during protein sample preparation
– reducing the disulphide bridges with dithiothreitol (DTT) and alkylating them with
MMTS to prevent reformation. The additional secondary and tertiary structural damage
done to the proteins as a side effect of breaking these connections may also further
contribute to the break down of colour in the sample.
4.5 Studies in a low abundance proteomic background
The work in this section has been included as part of a publication, however this descrip-
tion covers a more detailed explanation on the values and cut-off used, as well as the
background challenges from a study of this kind and the parallels that can be drawn with
other studies (Chiverton et al., 2016). The dataset used in this section was generated by
Lesley Chiverton and Caroline Evans. Joselin Noirel provided key insights into the data
analysis.
4.5.1 Abstract
Presence-absence studies are of great biological relevance; although because proteomic
datasets are sparse (not all proteins are measured) and subject to type I errors (false
positives), determining such states is increasingly challenging. In this study, presence-
absence is determined through the use of an α cut-off technique. A cut-off is determined
by modelling background noise within the sample, then all values that fell below this are
set to an α value – in this case equivalent to the lowest possible measurement. This was
conducted by designing an iTRAQ study with 2 missing labels, to determine the overall
level of interferrence of other factors during the study (co-isolation, isotopic contamina-
tion). The experiment shows that whilst determining a cut-off and α level is possible in
a given experiment, creating a general model for this is challenging, however the data do
suggest that a general model should be based on the Poisson distribution.
4.5.2 Introduction
In Synechocystis, a major issue for proteomic analysis is the high-abundance subset of
antenna proteins causing an expansion of the dynamic range(Gan et al., 2005). High
abundance proteins within a sample is a significant challenge for a range of biological
samples, as exemplified with the case of human blood plasma. Blood plasma is a key
target for identifying disease markers (Anderson et al., 2004), since it interacts with all
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cells in the body and can be readily extracted for analysis; however as much as 90%
of the protein present in human serum is albumin (Chan et al., 2004). To facilitate
analysis of these protein samples, numerous techniques have been used to remove these
high abundance but unwanted proteins from the sample – as reviewed by Bellei et al
(Bellei et al., 2011).
Whilst in the case mentioned above – where the high abundance proteins responsible for
expanding the dynamic range beyond measurable levels – selective depletion is an option
as the ‘contaminating’ proteins are not of interest to the investigators, this case is not
true for Synechocystis, where the high abundance proteins are also of interest to the re-
searcher. Unfortunately, as they make up such a significant part of the proteome, changes
in the overall levels of the light-harvesting machinery can have profound consequences
for relative quantification of the other proteins in the sample – where a 50% reduction in
the antennae structures can result in a 10% reduction in the total protein content of the
cell.
Analysing samples which are contaminated with a dominant protein, where simultan-
eously observing the levels of the contaminating protein and the proteomic background are
important, is a real challenge. Statistically speaking, observing relatively low-abundance
proteins within a sample becomes an exponentially challenging endeavour as the difference
between the high-abundance proteins and the background stretches further apart. This
is problem is discussed in fine detail in Chapter 4 of this thesis. The difference between
the highest-abundance protein and lowest-abundance protein in a sample is called the
‘dynamic range’.
In this section, we discuss an analysis that was performed on an industrially relevant clean-
up step of a biosimilar, produced in CHO cells. The product in question was a monoclonal
antibody. The two chains of this protein were parsed as ‘X00001’ and ‘X00002’ during
analysis, due to the industrially sensitive nature of their precise sequences. CHO cells
are favourable to work with for the production of drugs, as they have human-compatible
glycosylation patterning and they will naturally secrete target proteins into the media.
This ideally results in a constant production cycle of the protein, which can be purified
from the media through the use of a protein-A column. During collection, some of the
host cells lyse and release cellular constituents into the media. This investigation looked
at persistence and possible co-concentration of certain proteins within the media, which
could ultimately result in catastrophic outcomes for the patient. The researchers were
interested in both the overall levels of the target drug throughout the study to detect
cases of major product loss through the process, and also the relative levels of background
contamination in the process.
In this work, firstly an observation was made on the intensities of missing labels on an
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iTRAQ 8-plex study, to determine the background level of channel contamination for any
given iTRAQ label. These observations were than used to differentiate between very low-
abundance proteins, and proteins that are completely absent within a multiplex sample.
A minimum threshold – referred to here as the cut-off level – was modelled from the
labels that were unused in the dataset. Values that fall below this cut-off level are then
replaced with the α value, a non-zero value that falls at the minimum observable level
for a dataset. Determining presence-absence in a ratio analysis should not technically be
possible (n0 =∞), but can be conducted with this technique.
The paper describing these techniques was recently published (Chiverton et al., 2016).
This study was directly investigating the efficacy of a depletion methodology, so whilst in
a typical high-abundance background study, such as the ones described at the beginning
of this section, would employ a depletion technique – such as protein-A purification to
increase their sensitivity; it could be argued that such a methodology may generate
artificial results in this study, or mask proteins that co-purify with the host protein and
would, as a result, have been depleted in any such downstream analysis. As a result,
even though our analysis required a number of informatic stretches of the data, it was
experimentally the optimal choice available at the time.
4.5.3 Methods
For the proteomic experiment, 3 states of purification in the same sample were being
compared: the extracellular media that had been protein-concentrated – referred to here
as the culture harvest (CH), the flow-through material collected from a protein-A column
purification (FT), and the eluate from the protein-A column purification (EL). Two rep-
licates of each state were taken during this experiment, resulting in 6 samples, which were
labelled with iTRAQ 8-plex tags. The full experimental methodology of this experiment
is available as supplementary material in the publication (Chiverton et al., 2016).
iTRAQ labels 113 and 121 were intentionally left blank – these two labels should both
have the lowest susceptibility to noise contamination. 113 because there are no lower
mass labels that are susceptible to isotopic contamination through C13 distribution, and
121 as there is no 120 mass label – as a result the isotopic contamination on this label
should also be minimal. Whilst this feature is useful for determining high stringency
noise models, it does mean that the modelled cut-off used will err on the side of presence,
rather than absence, as it comes from a cleaner background than would be expected from
other labels. The median of these background samples was used to determine high-level
differences between the two cases. The cut-off value was calculated by taking the non-zero
values in the dataset, finding the mean value, and adding four standard deviations to it.
This was done to ensure that around 1 in 15,000 cases of noise fell above this cut-off,
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which was chosen as the dataset consisted of 12,879 peptide observations in total. All
values that fell below this level were converted to α, which was set at 0.1 – the minimum
observable value in the dataset after the cut-off was applied. The α value was chosen
to avoid skewing the quantifications away from the other measured values. During this
study, the minimum observed value was also noted to calculate the full dynamic range
observable in the mass spectrometer – where the highest-intensity values result in detector
saturation.
An alternative data-processing technique was used during analysis of this dataset. iTRAQ-
labelled peptides with missing labels were included in the analysis, out of necessity, as all
values in the dataset that fell below the cut-off threshold were raised to it. Within the
experiment, as a result of the ratio-derived quantification in the dataset, the values for α
were not all equal. This was an important feature, but meant that the differences between
presence and absence in different proteins were of different significances. In example, a
high intensity peptide signal will generate a much greater ratio difference between the
observed values and α, although peptides quantified at α should be considered 0 for all
practical intents and purposes and so the ratio based on these values is largely mean-
ingless. Using such quantifications, relative to an arbitrary level, could result in biases
for low-intensity peptides to appear either retained or enriched incorrectly. If the initial
value was very low, with some missing intensities in the prior conditions, then the range
between α and observations will be small as well. As a result of this limited pool of
available data, a non-statistical methodology was instead used to determine if a signal
was changed in a meaningful way from a previous sample – this was described as follows:
0.9× (max.A) < (min.B) = A.Depleted
0.9× (min.A) > (max.B) = A.Enriched
Where max.A is the highest intensity reading for a protein, and min.A the lowest. An
increase in relative concentration relates to a co-enrichment of the protein during the
process, whilst a reduction suggests a depletion – with a 10% boundary to provide addi-
tional stringency on the technique. The advantage of this method is that it is harder to
breach the enriched threshold, which in terms of the aims of the experiment was the best
possible outcome to avoid false positives as far as possible.
4.5.4 Results
The protein quantification data showed a few interesting features that had implications for
industrial preparation of biosimilar drugs, which are discussed at length in the publication
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and will not be repeated here (Chiverton et al., 2016). Of interest in this chapter is looking
at the findings for each of the analytical techniques that were trialled, and determining
whether they were effective or suitable for the task they were trying to achieve.
The full potentially detectable dynamic range of the mass spectrometer was determined
as 8.2× 105, although practical limitations within the peptide dataset reduce this during
experimental observations, due to factors like isotopic contamination.
In the noise models, the data show a Poisson distribution (fig. 4.8 p. 145). This is
expected as a result of how the mass spectrometer works – it makes physical count
events, and so whilst the numbers in the scale appear to be continuous when the counts
become very large, when working at the very low intensity level it is clear that they
are actually discrete. The mean intensity values observed for each of the excluded labels
were 0.064 for tag 113, and 0.045 for tag 121, although the highest intensity measurement
observed for 121 (138.6) was much higher than the highest value observed for 113 (17.98).
These data show that peptide-specific effects may be contributing to the observed high-
intensity peptides in 121, as highlighted previously (Ow et al., 2009); however 113 appears
to generally experience a higher level of isotopic contamination at a persistent low level.
Within a Poisson distribution µ = σ2, so the intensities were converted to discrete values
µ
min
where min = 0.0047, µ113 = 0.064, µ121 = 0.045 and µmodel = 0.55
µmodel
min
= 0.0550.0047 = 11.6
and
σ2 = 11.6, σ = 3.4
(µmodel + 4σ)×min = cut-off intensity ≈ 0.1
4.5.5 Conclusions and Discussion
A simple mean-value Poisson model was used to determine the background contamina-
tion level. It may have been possible to create a more detailed model derived from the
other signals in the data, such as the peptide sequence. This could account for changes
more specifically, however such an approach seemed overly complex based on limited
requirements for this particular study.
For developing a higher-accuracy model of the background noise in future, it would make
more sense to repeat the experiment with blank labels placed differently within the data.
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Figure 4.8: A Poisson distribution (left) and the histogram of the label intensities meas-
ured in the empty iTRAQ channels (right). Due to the discrete nature of the mass
spectrometer measurements at low intensities, the data observed approximates a Poisson
distribution, which was therefore used for the background noise model.
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In this particular experiment, the ideal candidates for determining background contri-
butions should be in tags 117 and 119, with EL samples in 118 and 121. This way, the
samples act as a buffer between each of the samples – ensuring the maximum sensitiv-
ity for detecting low-abundance signal. They also give a direct read-out of the isotopic
contamination coming from other proteomic labels.
Whilst this design was proposed, there were concerns that such an experimental design
would prove too stringent to achieve the aims of the researchers – to detect very low
abundance protein signals – and so the labels with less interference were chosen instead.
Ultimately, the experiment would have been improved if both experimental designs had
been implemented, as it would have enabled a much more accurate model for the data
and would enable comparison between labels considered to be ‘noisier’ – such as 117, with
labels considered to be ‘cleaner’ – like 121; however due to associated costs and limited
value of return such an experiment is not currently economically viable.
The α cut-off technique is, in and of itself, an interesting method of tackling the ‘missed-
label’ ratio quantification problem – which is usually approached with exclusion. An
advantage of this is that there are potentially many more data points available to an
investigator, which is always valuable when analysing data. The two major weaknesses of
this technique are driven by how the model is calculated and the data-specific effects. If
the model is too stringent, it can cloak the observations of low-abundance proteins, which
could collectively be assigned to non-existence when they are truly present; however if
it is too lenient peptides that are actually in the noise level would appear to be present
when they are truly absent, but given more prominence. Besides this, the current model
is highly susceptible to peptide-specific effects that could spoof the cut-off threshold.
Ultimately, if the researcher can accept that there is a practical limit to detection, and
is willing to sacrifice a potentially meaningful ratio for one that is certainly artificial,
then this methodology would enable clean and balanced observations of datasets where
there are significant numbers of missing labels. Whilst a non-statistical approach was
utilised in this analysis, which was required with this dataset due to the dominant MAb
proteins in the sample, it does not preclude statistical analysis of such datasets in a more
normal situation. Arguably, applying an α cut-off to more datasets could improve the
statistical significance of iTRAQ or TMT quantifications in a variety of cases – such as
presence-absence studies within the proteome.
4.6 Merging tag-based experiments
Joselin Noirel provided key insights into the tag-merging techniques and conceived of the
proteomic data analysis method described in this section. The datasets used in this section
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were generated by Filipe Pinto (IBMC, Portugal) and Narciso Couto (Sheffield, UK); and
Bagmi Patternak and Pia Lindberg (Uppsala, Sweden).
4.6.1 Abstract
Within tag-based quantitative proteomics, the experimenter is typically chained to the
number of samples they are able to compare within a single experiment. With some
experimental design consideration, it is possible to chain multiple experiments together
in a manner where the results being compared are not only meaningful on a qualitative
level – proteins that are in higher or lower abundance – but also on a quantitative level
– the levels of fold-change also being proportional between experimental studies. In
this section, a number of these methods are explored and compared, utilising median
correction and mean-ratio scaling. Experimental datasets exemplifying each different
case are shown, demonstrating the improvements gained by each step of processing.
4.6.2 Introduction
There is currently something of a progressive arms race taking place between the com-
panies that produce isobaric tag reagents. Originally, tandem mass tags (TMT) enabled
simultaneous investigation of two samples within a single experiment, and then improved
upon these reagents to enable the analysis of 6 samples simultaneously (Thompson et al.,
2003). Shortly after this tagging technology was released, the rival label producers iTRAQ
generated a 4-plex set of reagents which came coupled with a bioinformatic processing
tool from Applied Biosciences (now ABSciex) (Ross et al., 2004a). This led to the iTRAQ
reagents becoming far more popular that the TMT reagents, despite coming later to the
market.
On the back of its relative success, iTRAQ released the 8-plex tag. In the mean-time,
TMT has been buoyed by becoming the platform-standard isobaric tag for Thermo in-
struments, and have recently announced that they have reagents capable of up to 10-
plex analysis. Whilst this ever-increasing sample multiplexing may be something that
the research-consumer is interested in, there are significant limitations with this ever-
expanding multi-plex capacity, as pooling more samples comes at a cost of direct signal
identifications – for a more in-depth discussion of this phenomenon, please see chapter 4.
Beyond physically creating new chemistry for generating these isobaric tags, it is mathem-
atically feasible to increase the multiplexing ability of these tags through the combination
of multiple experiments into a single analysis. Although technically simple to perform,
such a combination can be challenging, as it depends on experimental design with this
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combination in mind before starting the experiment. In some cases, experimental data-
sets can be tied together from separate experiments, however to produce meaningful
results, these datasets should be generated from the same mass spectrometer with the
same protein extraction procedures and the same experimental conditions during growth.
Failure to adhere to these requirements – whilst philosophically feasible, since cells should
respond to the same conditions in the same manner – is practically very challenging.
The difficulty in this type of analysis is that it makes finding a cohesive set of changes
within the proteome challenging, particularly at the finer level of protein regulation where
the interesting findings are observed. The major issue is that there are multiple ‘ground
states’ that a cell can exist in, which are controlled by kinetic features rather than fixed
‘pathways’. This means that whilst broad-spectrum changes – such as the up-regulation of
carbon uptake machinery or down-regulation of antennae proteins in Synechocystis – are
conserved across different analyses as they are kinetically the most favourable inputs to
the system; smaller-scale changes such as responses in metal-binding proteins might not be
observed systematically. This is not to say that the finer-scale changes are not informative
for a researcher – indeed they give valuable insights into the control processes present
within the organism being studied; however it can be more challenging to observe identical
responses when looking at the system coming with minor variations in starting conditions.
These features are usually grouped together into a pseudo-random variable referred to
as ‘biological variation’, unexplained changes that occur in a systematic manner at a
level that can’t be reliably observed. Such issues can lead some researchers to state that
‘biology can’t be modelled, as biological systems are unpredictable’ – a statement that is
clearly incorrect or else scientific endeavours into biology would be consistently fruitless!
When merging different methods together, assuming that the data is consistently pro-
duced and analysed in the same experiment, there are a number of approaches that can
be taken. Regardless of the method used to merge multiple experiments, there are still
a number of weaknesses with such an approach compared with an increased multiplex
capacity that is chemically generated.
Firstly, and most prominently, is the shared protein requirement for analysis. ‘You can’t
compare what isn’t there’ is a strong mantra in proteomics, and whilst techniques can
be attempted to account for missing labels in multiplex experiments (discussed in the
previous section of this chapter), if the protein to be compared is not present in both
analyses then that usually signifies the end of the analysis. This also presents a chain-
weakness in the analysis, where if one dataset presents with far lower quality data – ie.
fewer protein identifications – than the others, then it limits the maximum quality of the
overall data. Arguably, this effect is a suitable compromise to enable comparisons that
could otherwise not normally be made; and it can be mitigated by the increased rate of
observation that takes place in lower multiplex observations – notably the difference in
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identified peptides between iTRAQ 4-plex and iTRAQ 8-plex can be as high as a 50%
reduction in the 8-plex observations.
Secondly, whilst proteins might show the same direction of change, the magnitude of such
a change is not always consistent. For example, a protein in two independent analyses
shows a statistically significant up-regulation in 2 different experimental conditions, how-
ever in one the fold-change is 2, whilst in the second it is 10. This can be caused by a
number of features that are not actually derived from the proteomic state of the organ-
isms being investigated, including fewer peptide identifications in one dataset compared
to another, additional noise contamination, or stronger ratio compression effects. The
effects of this can have a number of consequences for the data, since the fold-change is
inherently linked to the statistical significance.
Finally, since shared samples are needed across experiments in a number of designs, the
full range of the multiplex comparison is not additive. For two 4-plex iTRAQ experi-
ments, a and b, a completely independent pair of experiments would be {a1, a2, a3, a4}
and {b1, b2, b3, b4}, where a and b refer to the iTRAQ experiments and the subscript
refers to the sample number. The same experiments with a shared control would be
{a1, a2, a3, a4} and {a1, b1, b2, b3}, where a1 is the shared control and a total of 7 unique
samples are compared. This is further reduced if an additional control is shared between
the samples. Adding additional multiplex experiments into the design continues this
trend, due to the consistent requirement for the shared sample, and so the number of
experimental comparisons available in a given number of experiments would be:
(lab− con)exp+ con
Where lab is the number of labels in the multiplex, con is the number of controls shared
between the experiments, and exp is the number of separate multiplex experiments being
merged.
In this section, three methods for merging labels are described – all with 8-plex iTRAQ
analyses. The first utilises two shared samples quantified against a single label to determ-
ine ratios, the second uses a similar comparison but instead of being quantified against
a single label the samples are quantified against the mean quantification from both of
the controls. The final method takes the second method even further, removing identical
controls entirely through a direct repetition of the experiment and normalising the exper-
iments using the mean value of all the labels in the experiment. This method essentially
sacrifices the maximum number of conditions to be compared for a greater increase in
the number of experimental replicates. To close this section, an experimental design is
proposed where 12 conditions, each with 2 replicates, are compared over 3 iTRAQs with
an external reference comparison being conducted in a TMT 6-plex.
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4.6.3 Methods
The simplest method to attain this type of comparison is to perform two independent






Where an refers to the set of all labels in the first iTRAQ, bn refers to the set of all labels
in the second iTRAQ, and ac is the control sample which is identical in both iTRAQ
experiments. The protein lists are then filtered to only contain aprot ∩ bprot, or proteins
that appear in both iTRAQ a and b.
Protein Quantification
The datasets are then analysed in a standard manner for consistent statistically up and
down regulated proteins between the experimental conditions from both analyses. This
is the method used to detect significantly changing proteins and is used in other studies
within this thesis in chapter 5 and the appendix. Initially, all intensities are converted to
ratios through division by a control sample. This is done to convert the values obtained
for each peptide to a relative change, rather than an absolute quantification – since the
intensity of a peptide signal in the MS2 scan is not necessarily proportional to the amount
of protein present and can be affected by peptide-specific effects that distort the values.
The standard method for quantifying proteins is to generate a relative ratio to a single
control sample. The major issue with this in a typical ratio-derived investigation, is that
the noise or variance in a single label is completely collapsed. This method masks cases
where protein measurements in the control sample are erroneous or missing. Alternative
methods to this are described below.
These ratios are then log-transformed. Without this transformation, half of the observed
values lie in the range of 0 – 1, whilst the other half lie between 1 –∞; whereas afterwards
the data is split evenly around 0.
For example, take the values 1 and 100. If 1 is the control sample then the ratio between
the two is 100, whereas if 100 is the control sample then the ratio is 0.01; demonstrating




Making the data much easier to work with, although it does require an exponential
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transformation to obtain the original ratios again.
Identifying statistically significant changes
To determine an up-regulated protein, aup ⊂ aprot, for a given protein prot, under exper-







Where σ is standard deviation, n is the number of quantifications, test is the statist-






The order of protx and proty is reversed to identify a statistically significant reduction in
protein level between two samples.
In the majority of cases in proteomics there are multiple replicates included within the
same experiment. There are two methods for resolving the multiple comparisons gen-
erated in this case, the first is to merge the peptide quantifications from the replicates
together when performing the statistical test, although this isn’t recommended due to
collapsing the hierarchical error associated with both the physical experiment and the
extraction protocol.
An alternative method is to consider each replicate independently, running multiple com-
parisons – for example with 2 replicates this generates 4 separate T-test P-values. De-
pending on how much stringency is wanted in the down-stream analysis, either the highest
P-value can be taken of the four (highest stringency), or the median of the 4 values for
a more relaxed stringency. If the latter method is being used, then P-values should be
converted into Z-scores before being combined, to remove sample-specific bias (Pascovici
et al., 2015).
A z-score is simply a P-value measured by how many standard deviations (σ) it falls away
from the mean of the data. This conversion ensures that the averaging is performed on
a linear scale, and avoids further bias from being introduced to the data. The z-score is
calculated as
z = xi − protx
σx
Where for a given protein x, xi is the label intensity, protx is the mean intensity of the
protein and σ is the standard deviation.
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Merging by statistically significant proteins
Using one of the methods mentioned above, a complete list of proteins that are found
to by significantly ‘up’ or ‘down’ between a test case and some control sample – usually
the WT – are compiled for each iTRAQ. The control sample between the two iTRAQs
are considered to be identical – indeed these samples are often the same samples in both
studies, although they do not necessarily have to be. As a result, samples from different
iTRAQs can be compared not directly to each other, but to their statistical differences
to the control sample, as exemplified in (Mota et al., 2015).
Scaling by control samples for quantification
Cases where the protein changes move in the same direction for each of the samples
(aup ∧ bup) are considered to be unchanging, however where the signs are different and
the proteins are present in both can be considered different. Cases where no significant
change was observed are more difficult to assign, as they lack conclusive evidence either
way.
A more advanced version of this method was published as part of (Pinto et al., 2015),
where two control samples were added to each of iTRAQs being combined, as per the
standard method. Briefly, the paper was investigating the effects of stable integration
of protein production constructs into 5 putatively neutral sites within the Synechocystis
proteome. The aim of this study was to ensure that there were no significant background
effects occurring as a result of this integration across all of the sites, but since replication
was required there were more test cases than iTRAQ labels available within an 8-plex.
The full investigation report that was produced for this work is available as an appendix
to this thesis.
To maintain the variation present within every label, instead of being divided by one of
the control samples, each label was divided by the mean of the two control values:
msxi
µ(msxc1 +msxc2)
Where in a given MS2 scan x, msxi is the vector of the label intensities and µ(msxc1 +
msxc2) is the mean of the control intensities.
Between the two iTRAQ experiments, the values were normalised against each other to
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Where for each protein x, iTRAQb is the full set of labels for each protein in the second
iTRAQ experiment, µ(iTRAQa.Control) is the mean of peptide quantifications for each
protein in the ‘control sample’ labels in the first iTRAQ, and µ(iTRAQb.Control) is the
mean of the peptide quantifications for each protein in the ‘control sample’ labels in the
second iTRAQ.
This simple scaling vector, when applied to the second iTRAQ, is sufficient to cluster the
proteins – a full break-down of this process in code form can be found in the appendices.
Scaling by mean protein intensity
Initially, iTRAQ datasets were sub-setted to only contain proteins present in both exper-
iments. The data within each of the labels was then median-corrected as follows:
iTRAQy,i − ˜iTRAQy
iTRAQy.0.6 − iTRAQy.0.4
Where iTRAQyi is the vector of relative protein quantifications for label y in a given
iTRAQ, ˜iTRAQy is the median value in that vector, and iTRAQy.0.6 and iTRAQy.0.4 are
the 60% and 40% quantiles, respectively.
As described above, the protein data is ratio converted prior to log-transformation; how-
ever instead of using a single control sample or the mean of control samples, the data is
divided by the mean of the entire set of labels measured in the iTRAQ for each peptide,
pepti × µ(pepti), where pepti is the list of label ratios for a given peptide and µ is the
mean. The two iTRAQ experiments were then scaled against each other with a slightly
modified scalar to the one used for control samples above:
iTRAQb,x,i × µ(iTRAQa,x,i)
µ(iTRAQb,x,i)
Where iTRAQx,i is the vector of the label intensities for each protein x, in iTRAQ a and
b, and µ is the mean.
4.6.4 Results
The control scaling and mean protein intensity scaling methods are shown here. For the
control scaling methods, the data was clustered after being scaled by control sample.
Since the method used identical samples across the two iTRAQs as the control, and the
datasets were scaled by mean of these two samples, the control samples from the first
experiment show very close clustering with their counterparts in the second experiment
– as can be seen in figure 4.9 p. 155). This finding shows that once corrected, the
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experimental variation for an identical sample is negligible. The other interesting finding
with this analysis was the consistent clustering between the biological replicates across
the two experiments, with the test cases clustering against each other more closely than
they did against the control samples.
This observation led to the question of whether the requirement for identical samples
across multiple experiments was truly necessary, or whether replicates were sufficient. A
follow-up experiment, therefore, was conducted on two experimental iTRAQs that had no
identical shared samples, but were full experimental replicates of the same experiment.
These samples were treated slightly differently to the case used in Pinto et al, as no
individual labels stood out as controls – since all the experimental replicates theoretically
had an equal similarity between their experimental counterparts. For this experiment,
the samples were therefore controlled against the mean of all intensities after median
correction (fig. 4.10 p. 156) – as described in the methods.
Following median correction, the data were scaled to balance the measured intensities –
as described in the methods. These were checked visually with a box-whisker chart to
ensure that the correction process had not disrupted the median correction applied in the
previous step, as shown in fig 4.11 (p. 157). As can be seen from the data, the median for
each label remained stable, however in certain cases the tails of the data moved. This was
to be expected, as the majority of proteins within the dataset should be present around
the centre of the data and should therefore not change significantly, whilst the proteins
changing by a significant amount move a much greater distance when a scalar is applied.
Whilst figures 4.10 (p. 156) and4.11 (p. 157) show an overview of the data, they do
not show the internal quantification relationships between the individual proteins. For
all datasets, the proteins quantifications were plotted against each other, as shown in
fig 4.12 (p. 158). In this graphics grid, the 4 test conditions are plotted against each
other, the first two rows showing internal comparisons. Note the final scatter-plot on the
second row shows more variation than the other seven comparisons on the first two rows,
reflecting the increased variation in the data seen prior to median correction in figure
4.10 (p. 156), where the dataset in question is the third box and whisker chart from the
right.
The third row of this figure shows the comparisons made between the two iTRAQs
prior to scalar correction, but after median correction has been applied. This shows the
large amount of variation seen, particularly in the lower-abundance proteins within the
sample. In this case, both control set labels from one iTRAQ were merged together and
plotted against the merged labels from the second iTRAQ, so these plots contain twice
as many data points as the graphs above. This break-down in relationship between the
samples shows the common problem when comparing quantitative data across separate
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Figure 4.9: Cluster plot taken from supplementary material in (Pinto et al., 2015). This
cluster plot was built through 2 replicates of a shared wild type (WT) samples across
the two separate iTRAQ experiments. These are labelled as WT1 and WT2, with a
and b denoting the iTRAQ experiment across all of the samples. After normalisation,
the samples clustered very closely together across the two iTRAQ experiments. Two of
the samples stood out during the analysis as containing a substantially different set of
proteins, mainly related to the cell membrane.













Figure 4.10: A box-whisker plot showing the range of peptide intensities (measured in
direct counts) before (top) and after (bottom) median correction. Post-median correction
values are in log space. Two iTRAQ 8-plex experiments were plotted side by side, the
first 8 from one experiment and the second 8 from the second. All values in the bottom
graph were normalised so that the median values were all equal, and so that the spread
of the centre 10% of the data fell within the same range. This transformation improves
the quality of the data in each experiment independently, but by itself doesn’t improve
the overall quality of comparison – please see fig 4.12 (p. 158).
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Figure 4.11: The same dataset from figure 4.10 (p. 156), scaled as described in the text.
The scalar transformation doesn’t affect the overall distribution of the data.
iTRAQ experiments from the literature. Even when the experimental conditions are
highly replicable, the lower-intensity proteins show a much wider range of variation than
the higher-abundance proteins.
In the fourth row, the same comparison was made as in the third row; however the
correction scalar described in the methods had been applied. This showed a complete re-
duction in the variation observed previously, enabling a much neater relationship between
the samples. It is important to note that whilst the variation seen in row two is dimin-
ished in this dataset, it has been diluted relative to the other measurements as there are
twice as many data-points in these plots.
The different experimental samples were clustered using principal component analysis,
and overlaid onto the same figure. As can be seen in figure 4.13 (p. 158), the sample that
had a lower initial mean intensity prior to correction (D4*) still showed large differences
compared to the other proteins in the sample despite the mathematical corrections that
had been applied. This suggests that a reduction in the initial extracted protein quality
generates a lasting and significant alteration to a proteomic data-set that cannot be
corrected in data analysis, demonstrating the importance for the reliable, repeatable
methods described earlier in this chapter.
Since clustering techniques like PCA determine relatedness between samples by looking
at differences between samples – taken as ‘components’, ‘outlier’ samples with many
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Figure 4.12: A graphs made up of 2 separate iTRAQ experiments. The first row and
second row are each of the 4 different test conditions plotted against each other, within
experiment 1 and 2, respectively. Row 3 is biological replicates plotted against each other
between experiment 1 and 2 before scaling; and row 4 is biological replicates plotted
against each other between experiment 1 and 2 after scaling.
Figure 4.13: A principal component analysis (PCA) on the dataset, where the letters refer
to experimental conditions and the numbers refer to replicates. 1 and 2 are replicates
from the first experiment, and 3 and 4 are replicates from the second experiment. In this
PCA analysis, sample D4 has been highlighted as an outlier.
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Figure 4.14: This PCA uses the same data as above, but with the proposed outlier D4
removed. As PCA is vulnerable to outliers, since they compress other effects in the data,
this re-analysis was important to ensure the close clustering observed was not an artefact
of the outlier.
more differences to the other experimental samples will therefore be responsible for a
much larger proportion of the variation observed. Since the x and y axis in this analysis
represent terms of variation, including outliers in an analysis of this type fundamentally
changes the axes, and therefore the metrics determining how the different samples cluster
together.
As can be seen, the first principal component – which is plotted on the x axis and explains
the largest amount of variation between the samples – shows a mild separation between
the A-C cluster and the B-D cluster, but shows a much clearer separation between sample
D4 and all other experimental data across the entire study. As a result, the D4 data point
was excluded and the clustering was re-calculated as shown in figure 4.14 (159).
After this correction was applied, the data showed a much more general separation across
the entire variation space rather than being much more strongly dictated by a single value.
The clusters in this case are therefore more diffuse, but enable an objective consideration
of how effectively the merging method brought the two iTRAQ datasets together.
In this case, the letters on each point describe the experimental condition, whilst the
numbers describe the replicate. All replicates denoted as 1 and 2 were taken from the first
iTRAQ and those denoted 3 and 4 were taken from the second iTRAQ. There are cases of
replicates taken from the same iTRAQ still show a closer relationship to each other than
160 CHAPTER 4. IMPROVING PROTEOMIC METHODS
to the second iTRAQ, such as C1&2 compared to C3&4 – due to inherent measurement
differences in the two spectrometer runs; however generally the clusters appear to form
independently of the iTRAQ, indicating a successful merging of the separate datasets.
4.6.5 Conclusions and Discussion
The methods described in this section show a clear ability to join multiple quantitative
mass spectrometry experiments together, using methods where there is a shared identical
sample across the experiments, as well as flat experimental repetitions. The potential
for these techniques to enable much broader analysis of multi-plexing tag experiments is
large, and the methods described here are relatively simple.
Generally, other studies into combining data from multiple quantitative proteomic tend
to either ignore the quantitative variation (Mota et al., 2015), or attempt to use the data
to create a general model for iTRAQ experiments (Hill et al., 2008). The issue with
either of these approaches is that they ignore the hierarchical variations introduced at
numerous different levels of the experiment, or try to generalise it – which can in turn
mask findings from lower-abundance proteins in a given experiment.
Whilst the quantitative data has been mathematically collapsed in this analysis, and
therefore cannot be used in a meaningful way across the experiments; the general direc-
tional changes – arguably the more useful feature of large datasets like proteomic analysis
– are maintained.
In real terms, this method produces a set of proteins showing a consistent change in
protein regulation; but escapes the pit-falls of targeted statistical analysis on a non-
independent dataset. As a result, data from multiple quantitative proteomic analyses
can therefore be used much more reliably for the commonly-used clustering methods,
such as PCA, KEGG pathway mapping, and heatmap analysis.
The statistically significant changes method is by far the most common method for detect-
ing changes within a proteome dataset (Pascovici et al., 2015), however it has a number
of issues related to it. Statistical tests in biological samples are faced with a significant
challenge: the relationships between different proteins are not completely independent;
and whilst there are a large number of individual aspects of the system to measure, but
there are generally a relatively small number of experimental replicates compared to the
number of tests being conducted. So on the one had, the researcher cannot really apply
parametric tests like the T-test – which assume an underlying independent, normal dis-
tribution – but many ‘omics-level experiments lack the sheer number of replicates needed
to conduct non-parametric tests, where generating the number of replicates needed to
increase the statistical power of these tests to produce meaningful results is prohibitively
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expensive.
Ultimately, many opt to use the parametric tests, but recognise that there may be addi-
tional factors that confound the findings of the study. This is why generally the findings
from proteomic experiments are verified by an additional experimental method, such as
an enzymatic or observational study.
Additionally, as a large number of proteins are detected during a proteomic experiment, a
multiple-test correction, such as the Holm-Bonferroni or Šidàk method is required (Abdi,
2007). These are good for reducing the number of false-positives observed in a sample,
however they assume independence between the tests, which is not the case in a biological
sample, and as a result generate a disproportionately high number of false-negatives.
Furthermore, even though the quantitative information is not compared across the stud-
ies, proteins that show a larger fold change in one experiment also show a stronger test
statistic, such as a P-value or Z-score. Since this can vary between experimental repeats
if it isn’t scaled out, as described here, it can introduce hidden bias into experimental
studies.
As a result of the issues associated with statistical significance; whilst having two separate
lists of differences, this scaled merging of the data ultimately provides a neater way
to merge experimental findings than the pre-existing methods. To address concerns of
scaling the numerical difference to match that of a single experiment, it is recommended
that the scalar method is run twice, with the scalar being calculated first for the second
experiment, then for the first experiment by reversing the datasets in the algorithm.
The effect of this would be to generate two separate states for the data, which could then
be compared to find differences, selecting only cases where the changes are consistent
between the two samples. The advantage of this method over just comparing statistical
tests and taking consistent changes, is that firstly a greater number of replicates are
available for analysis in each case, as the scaled datasets can be used for both comparisons.
In addition, truly inconsistent measurements remain inconsistent with linear scaling,
whilst small scale effects are amplified (or compressed).
This should result in a less stringent set of parameters for measuring changes, enhancing
the statistical power of the test and producing fewer false negatives whilst not dispropor-
tionately enhancing the number of false positives.
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4.7 Cluster analysis – using GO terms
The dataset used in this section was produced by Caroline Evans, Jen Parker, and Graham
Stafford as part of a CBMnet project with Fuji.
4.7.1 Abstract
Analysing an entire proteomic dataset can be challenging, particularly when limited or
conflicting information is available from the published genome. Gene ontology terms
are a collection of tags that give basic information about the properties a protein, or
proteins related to it through shared evolutionary history. In this section, a method for
clustering proteins together, determining grouping sizes, and assigning Gene Ontology
labels to each cluster is described. The features of the clusters can be combined with
the tags associated with them to produce a number of high-level statements to be made
about the data, similar to the way statements about the metabolism can be made with
KEGG pathway maps. Unlike KEGG, because of the broader reaching features listed in
GO terms it is possible to include structural and organisational information not normally
available in a summary analysis.
4.7.2 Introduction
As described in Chapter 1, GO terms are a useful convention that have been developed
to enable a better understanding of non-model genomes. Many of the emerging genomes
of interest within the field of industrial biotechnology, and particularly within the phyco-
logical branches of industrial biotechnology, are not model and are highly dependent on
carry-over studies on better understood plants, such as A. thaliana. Whilst GO terms are
a useful metric for determining the features of a proteome, it can be difficult to determine
what the changes within them mean on a case by case basis – especially when a whole-cell
system, or other similar large datasets tend to change in a systematic manner, with one
part affecting others.
A number of methods for analysing large datasets tend to look at methods for clustering
the data together into smaller groups. As described earlier in this chapter, these include
heatmap analysis, principal component analysis and KEGG map overlay for protein data.
Data clustering can be conducted in a number of unique methods, although ultimately
each of these follows the same basic philosophy. Two points within the dataset are
determined to be the closest together and are grouped, along with a metric indicating
how closely related they are. These are then considered as a single data point and
the process is repeated, until all data points and grouped data clusters in the set are
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paired together. Clustering can either be performed bottom-up, where all data points
are arranged into a hierarchy of relatedness, or top-down, where a number of clusters are
assigned to the data and the points are grouped together.
Bottom-up clustering
There are two key variations that can occur in this method, due to challenges associated
with clustering, the first is determining the most accurate final clustering, since pairing
the two closest samples at the first level may not produce the shortest links between
all data sets. Calculating the closest pattern of clustering is a problem that becomes
exponentially more difficult when either the number of points to be grouped increases,
and is often referred to as the ‘travelling salesman problem’, where a salesman needs to
visit all the cities in a country once, but also wants to take the shortest possible path
between all cities.
There are multiple proposed methods that address this problem, including brute-force
approaches – where every combination is tried, and the best outcome is determined at
the end by the closest clustering – however this is an exponential scaling problem that is
impractical for large datasets. Algorithmically faster methods have also been proposed,
such as the greedy algorithm – where every combination is tried at the first pairing and
the two closest clusters determined at this point are grouped. This is then repeated at
each subsequent pairing level, with a reducing number of comparisons to make each level.
The complexity involved with this problem increases as a triangular number, instead of
an exponential.
The second challenge is determining the ‘distance’ between two points in high-dimensional
space. In cases where there are many dimensions, but a point is only changing in a sys-
tematic way in few of those dimensions, stochastic error can result in similar points being
clustered far apart. In the case of proteomics, dimensions are considered to be different
iTRAQ labels; so this problem can be framed as follows: If two related proteins are chan-
ging in a fixed manner in 2 labels (one experimental condition), but vary randomly in the
other 6 labels, then the two proteins may end up clustered far away from each other, even
though there is a systematic effect on those two labels, due to the contributions from the
non-systematically changing labels.
The metric that determines how closely related two points are ultimately determines the
order and magnitude of clusters, and so using different clustering methods can produce
profoundly different clustering outcomes. In this thesis, all clustering was performed
using the Ward distance (Batagelj, 1988), where the distance between any two points is
considered in Euclidian space. This method considers a point – or the centre point of a
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cluster – in all dimensions, and mathematically connects it to its closest partner. In 2
dimensional space this could be considered as drawing a straight line on a graph between
2 points, then measuring the distance as the square drawn from that line (since the points
are varying in 2 dimensions).
This method was chosen as the author found it the easiest to relate to, and since linear
measurements of variation across scaled proteomic labels in n-dimensional space scaled
linearly with the increasing number of points in the dataset – which was a useful feature
when analysing proteomic data in fixed-label experiments such as iTRAQ 8-plex. Altern-
ative algorithms that scale more efficiently with progressively increasing dimensionality
(ie. for a 10-plex, or indeed even a 40-plex experiment) (Aggarwal et al., 1999). Whilst
these were not necessary for the work conducted within this thesis, they may be more
useful in cases where large numbers of proteomic experiments are merged together, using
the methods described in the previous section. This is important, because as the number
of dimensions increases, all points become further apart from each other, due to stochastic
variation.
Top-down clustering
Whilst bottom-up clustering methods are useful for creating a complete hierarchy, this is
not always useful in larger datasets. In this chapter, a machine-learning technique called
K-means clustering is also employed; where a fixed number of clusters (K) are requested
from a system. These are calculated by assigning K arbitrary values randomly into the
system and determining the distance between them and the data points – in this chapter
using the Ward method. The points that are closest to the values are grouped together
as K individual clusters, and the arbitrary value is changed to be the mean of all the
values in its cluster. The points closest to this new value are then re-assigned into the
cluster. The process repeats until the means no longer change, and then all points within
a given cluster are assigned and the calculation ends.
Heatmaps
Whilst clusters can be assigned as described above, visualising the data for a researcher
to gain meaningful understanding of the dataset on the basis of their scientific training
and accumulated knowledge is essential for generating understanding from the data. As
a result, a number of simple tools can be used to make the process simpler. The most
commonly-used method for interpreting patterns in large datasets is the heatmap.
A heatmap is essentially a large table of numerical results, however the values are con-
verted to colours to facilitate a fast-scan approach for understanding a dataset. In a
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randomised dataset, this is generally impossible for humans, as without blocks of colour
the trends are not readily visible – and so a heatmap is only a useful tool for visualising
data after a clustering transformation, not just a standard table of data. In addition, the
data must be appropriately scaled, otherwise a single high value may distort the heatmap
into a solid block of colour that cannot be interpreted by the human eye. As a result, data
in heatmaps is typically scaled by either the row or column, rather than being the raw
values from the entire dataset. Despite its limitations, by organising and scaling the data
appropriately, a heatmap can be a powerful tool for a researcher. They are particularly
useful for interpreting groupings in a complex dataset with multiple dimensions – such
as ‘omics data.
Outline of the GO clustering method
In this section, a novel method for visualising data features is described. In the method,
the data is clustered in a bottom-up hierarchical method and overlaid onto a heatmap.
The data is then limited to a fixed number of clusters, determined with a K-means
algorithm, to simplify the investigation. The most frequently appearing GO terms within
the dataset are then assigned, by relative frequency, to each of the clusters. The overall
output is a heatmap, with a series of GO tags associated with it. This enables a researcher
to pick out general effects in a heatmap cluster – such as a systematic change in proteins
under certain experimental conditions – and make statements about it on the basis of
gene ontology.
4.7.3 Methods
To begin the analysis, all peptide data are collapsed into protein quantifications as follows.
All code for this transformation is available on the accompanying digital code repository
(DOI: 10.15131/shef.data.5327524).
Each of the labels are median-corrected, as described in the previous section. The geo-
metric mean is taken (normal mean calculation on log transformed data) from the peptide
quantifications as the protein quantification. These data are then arranged into a numeric
matrix, with proteins listed in rows, and label quantification intensity in columns, using
the program R.
To determine the number of clusters to break the data into, an iterative K-means analysis
was conducted; where the data was clustered into a range of K clusters from 1 – 20. The
sum of squares error was calculated between the data points in a given cluster and the
cluster mean, summing multiple clusters together. These were plotted onto a graph,
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and a manual decision was made as to the ‘optimal number of clusters’, where the point
of diminishing return from an increasing number of clusters was reached. The optimal
number of clusters was then used as a cut-off point on the bottom-up hierarchical cluster
data, generating a number of subsets within the proteomic data.
This is the weakest step in this process, since despite numerous attempts, I have been
unable to automate this step of the analysis. As a result, it remains subjective and
requires tweaking by the user to determine the ‘right’ number of clusters.
The GO terms for the proteomic data being analysed were downloaded from the uniprot
website. Using the program Mathematica, these were linked to each of the proteins
inside the clusters. For simplicity in this analysis, only GO terms with more than 20
or more unique references within the dataset were extracted, and the remaining terms
were discarded. The set of all the remaining GO terms within each cluster – assigned by
protein – was tallied, resulting in a matrix indicating the number of proteins associated
with a given GO term in each cluster, with clusters being listed as rows and GO terms as
columns. Each of the GO tallies were divided by the sum total for each term, generating
a value between 0 and 1 for each term in each cluster. The clusters with the highest
proportion of counts for a given term was assigned with the GO tag.
This is biased towards larger clusters – for example, proportionally smaller clusters will
typically contain a lower GO tally count, by virtue of having fewer proteins overall. This
could have been normalised by dividing the number of counts by the number of proteins
in a given list, but this in turn causes a bias towards assignments in smaller clusters.
The data was then plotted in a heatmap, showing both the full level bottom-up clustering
and coloured groupings, and a bar chart highlighting the relative levels of GO terms in
each of the different clusters.
4.7.4 Results
A number of simulations for determining the optimum number of clusters were run.
Determining a useful cut-off is challenging, as it varies greatly from dataset to dataset.
In this case 8 clusters were chosen, based on accounting for an ≈ 90% reduction of the
variance observed in the initial analysis. In addition, it also translated as the last ‘linear’
point in error reduction, after the initial large drops attained in the first 4 clusters (Fig.
4.15, 167).
This was overlaid onto the the bottom-up cluster pairs to determine the distance between
the different branches that were being assigned, showing a similar pattern of diminishing
distance to that observed in the K-means clustering error (Fig. 4.15, 167). This indicated
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Figure 4.15: The error outputs from each of the K-means top-down cluster simulations
(left), and the hierarchical graph of the bottom-up paired clusters, resulting from the
selected K-pairs cut-off in the bottom-up clustering (right). The error within the dataset
shows a diminishing reduction in error as the number of clusters is increased. The selected
clusters in the hierarchical graph show this diminishing error is present in both bottom-up
and top-down calculations, as can be seen from the length of the edges in the graph.
that K-means is an appropriate proxy for determining the distance between the clusters,
however an algorithm for determining a suitable within-cluster distance for the optimum
user level is not forthcoming from this data.
This analysis was applied to the data from a study in E. coli, where the proteome had
been subsetted into investigations on a membrane protein fraction, a soluble protein
fraction, and an excreted protein fraction. The membrane fraction is shown here as an
example of how the GO terms were assigned to different clusters present in the heatmap
(Fig. 4.16, 168).
4.7.5 Conclusions and Discussion
The method in this section was devised as a completely novel method for interpreting
complex proteomic data using GO terms within a heatmap-based clustering tool. The
problem was not trivial, as proteins have multiple GO terms associated with them, and
unique GO terms can be assigned to multiple different proteins that could be changing in
different ways within a dataset. Whilst this method was applied to an industrial investig-
ation report with moderate success, it still requires further refinement and development,
particularly in the ‘optimal clusters’ processing.












































Figure 4.16: An example of how the output of the GO cluster tool would look when
applied to a dataset. The heatmap shows the different grouped clusters, each assigned
to a different colour (top). The GO analysis linked to the different clusters is displayed
in a bar chart, where the colours indicate the cluster the analysis is linked to (bottom).
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A major issue with the analysis in its current form is determining the cut-off point for a
given cluster. In this case a justification was determined through a statement about the
amount of error that had been explained and an arbitrary limit for diminishing returns;
however a similar justification could be applied for picking four clusters as the optimum
value, notably because they show the biggest reductions in overall data error.
In addition, from a visual point of view when overlaid on the heatmap they produce an
intuitive set of groupings – for example, if the cut-off was applied at 4, the groupings
would appear as (green, black), (yellow, red), (cyan), and (grey, purple, blue). These
groupings ‘appear’ to be simpler choices, however that assumption is made from a human
level observation. This is an interesting problem, as by using the clustering method it is
possible to pull out links occurring within the data that aren’t obvious to a researcher;
although since the decision is arbitrary it is also possible that the computation is being
over-complicated.
Determining how to assign the GO terms to the different clusters is a remaining challenge
that is not trivial to solve. The aim of the method used was to highlight clusters that are
relatively concentrated within a particular subset of the data, however different proteins
have a different number of GO terms associated with them – so better studied proteins will
tend to have a higher number of GO term tags. One option is to look at the proportion of
tags within a specific cluster, by dividing the GO term tags by total number of proteins
in a given cluster – normalising the relative levels by cluster size. This would work well
in the example put forward in this chapter – where the most abundant terms were the
only ones included – however one of the aims of this work was to make a generalisable
assignment that worked for all tags, not just the most frequently occurring. Ultimately,
with more time a more detailed investigation into developing the simplest and most
accurate assignment could have been conducted.
Another problem with this tool is making meaningful statements about the changes taking
place within a cluster from the protein-heatmap level. In this investigation there were
4 replicates of 2 test conditions, and so standard statistical methods would produce 3
clusters – increased protein levels in condition 1, decreased protein levels in condition
1, or undetermined. An advantage of this tool is that it can investigate more complex
relationships between samples within clusters, however in its current state the tool has no
capacity to simplify this process for the user. Ultimately, in its current form it provides
a simpler way of running a large number of tests as the number of comparisons increases,
where whilst 2 test conditions produces 3 different statistical states, even increasing this
to 3 test conditions could raise the number of states as high as 13 – when considering
direction of change and combinatorial effects.
The complexities in GO terms mean that whilst this tool has advantages, it is susceptible
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to the same errors that arise during a typical GO analysis, including human error in
assignment and the lack of directionality involved with some terms. For example, two
proteins may both be related to nitrogen metabolism; however individual investigation
into the publications for those proteins are needed to determine if they are involved with
increasing or decreasing the available levels of nitrogen (Ashburner et al., 2000).
Ultimately, despite its shortcomings and the need for further development, the GO cluster
performs the role it was originally intended for, which is to give the researcher a brief
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5.1 Chapter Background
Isobaric tags are an important tool in the proteomics toolkit for multiple protein com-
parisons in a multiplex format, which allows comparison between technical and biological
replicates. In this chapter the two most popular tagging systems, isobaric tags for relative
and absolute quantification (iTRAQ) and tandem mass tags (TMT), are compared in a
Synechocystis background against a controlled pseudo-complex model mixture. This is
important for making a rational choice about which tag set to use for a given experiment,
and highlights some of the issues that surround the choice of tag. This chapter also
covers an investigation into the proteomic background of Synechocystis, and looks at a
label-free emPAI model of a blind dataset to determine the median protein concentration
within the proteome. This background proteome investigation was used to determine the
best region to run a tag comparison, so that the findings were optimised for a typical
candidate protein within a proteomic investigation.
A number of individuals contributed to the work presented in this chapter. Andrew Landels
wrote the chapter, calculated background concentrations, performed in-silico analysis, de-
signed the experiment, created the proteomic background mix, assisted with the production
of the spike-in mix and analysed the data. Bagmi Patternak and Pia Lindberg provided
the dataset that was used to generate the in-silico analysis. Narciso Couto produced
the spike-in mix from proteomic standards, combined the spike-in and background mixes,
fractionated the samples by HPLC, and ran samples on the Maxis mass spectrometer.
Caroline Evans ran the samples on the Orbitrap mass spectrometer.
5.2 Abstract
Quantification in proteomics is important for generating understanding of the underlying
biology. Relative quantification with isobaric labels such as iTRAQ or TMT greatly
simplifies this, however a number of external factors can affect the values returned. Using
a controlled mix of four proteomic standards – ranging from 25 to 70 kDa – and a unique
experimental design covering a large range of relative quantifications – from 1 : 40 – we
performed a direct comparison between the two labelling systems. These comparisons
were performed over a range of different background conditions, from a small range (1 : 4)
in a protein-sparse ‘simple’ background, to an expanded range (1 : 40) in a protein-rich,
‘complex’ background.
An investigation of the proteomic background was performed using emPAI and a second-
ary dataset, to determine the appropriate quantity of protein to spike into the background.
This was done to ensure that it mimicked a typical protein in an experiment, but gener-
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ated enough identified peptides to enable more accurate quantification. In Synechocystis,
this was determined to be 0.5% of the total protein background by mass.
Both tags experienced compression in an increasingly complex background. The compres-
sion effect was found to be stronger in lower-concentration proteins, suggesting thatcom-
bining label-free quantification methods, such as exponentially modified protein abund-
ance index (emPAI), with quantitative proteomic methods could greatly improve the
confidence in observed results.
The key findings from this investigation suggest that TMT produces a more and precise
(variance) and accurate (mean) in a complex background, but the individual labels are
less precise and accurate in a simple background. This conflicting finding is driven by an
≈50% increase in the number of confident peptide IDs in TMT experiments compared to
iTRAQ experiments; and so whilst the tags are less effective on an individual level the
additional data makes up for this.
This raises questions around the trend towards increasing the number of labels within a
single experiment (TMT 2-plex, iTRAQ 4-plex, TMT 6-plex, iTRAQ 8-plex, TMT 10-
plex), where using multiple experiments and knitting the datasets together may provide
a more accurate set of data (See chapter 3).
5.3 Introduction
5.3.1 Background to isobaric tagging in proteomics
In bottom-up quantitative – or ‘shotgun’ – proteomics, tag-based stable isotope labelling
is widely employed. As evidence for this, a search on google scholar with the terms
proteom* iTRAQ OR TMT returns almost 18,000 publications citing the use of either
iTRAQ or TMT labelling (search date 18/10/2016 ), the two main covalent tagging tech-
nologies employed within the field (Noirel et al., 2011; Evans et al., 2012; Altelaar et al.,
2013b; Zhang et al., 2013b). This technique involves covalently linking a series of tags –
with identical chemistry, but varying internal mass distributions through the use of iso-
tope integration – to peptides generated from a number of different proteomic samples.
These different samples are then pooled together and run collectively. When the peptide
spectra are observed in the mass spectrometer, each tag produces a unique ‘reporter ions’
present within the spectrum that can be directly compared to give a ratio abundance
between the different samples.
For an introductory description to the field of quantitative proteomics, please see the
introductory review by Altelaar et al. (Altelaar et al., 2013b), and for a highly detailled
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review of this process, please see one of the following comprehensive assessments of the
field, by either Zhang (Zhang et al., 2013b) or Rauniyar and Yates III (Rauniyar and
Yates III, 2014).
iTRAQ and TMT are two different commercially available reagents used to label pep-
tides in proteomic experiments. The reagents bind via N-hydroxy-succinimide chemistry
(Thompson et al., 2003), and so the tag is attached to peptides at all free amine sites
– namely the N-termini of peptides and the epsilon amino group of lysine. Both tags
generate low mass reporter ions under tandem mass spectrometry fragmentation, which
produce a signal in a region of the mass spectra that is usually clear for peptides. Be-
fore undergoing this fragmentation step, the tags are all of equal mass (isobaric), where
the reporter group is balanced through distribution of isotopes in a separate balancer or
normaliser group. Isobaric labelling, in multiplex format, provides an additive effect on
precursor intensities as the ms1 signal is made up of the combined signals of 6 (in the
case of TMT 6-plex) or either 4 or 8 (in the case of iTRAQ 4-plex and 8-plex) combined
protein pools – (details shown in chapter 1), which theoretically increases the sensitivity
of detection.
Another similar tagging method is N,N-Dimethyl Leucine (DiLeu) tags, which like iTRAQ
and TMT are isobaric when measured at the MS1 level, but produce a range of 4 iden-
tifiable tags at the MS2 level (Xiang et al., 2010). Rather than being purchased from
a supplier, these tags offer an economic alternative, as they can be synthesised in the
laboratory at a greatly reduced price.
Issues relating to quantification accuracy with iTRAQ and TMT labels have led them to
mainly being used as lead generation or ‘discovery’ technologies in medical-based studies,
rather than confirming actual quantifications of proteins within a sample (Noirel et al.,
2011). Indeed in some cases no statistical repetition is performed within the experiment
until after potential leads have been identified, with 8 different samples being examined
on 8 different iTRAQ labels (Evans et al., 2012). Similar issues arise for TMT. They
are also employed for industrial production strain analyses (Landels et al., 2015). When
investigating the effectiveness of proteomic quantification methods, two main aspects are
typically studied – accuracy, or how close to a true value the measurements that are taken
are (Keshamouni et al., 2006; Glen et al., 2008; DeSouza et al., 2008; Bantscheff et al.,
2008; Kuzyk et al., 2009), and precision, or how closely grouped the measurements are
(Chong et al., 2006; Gan et al., 2007).
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5.3.2 Advantages of tag-based approaches
There are a number of advantages to using tag based quantification, it mitigates the
technical challenges associated with label-free methods for comparisons between separate
samples. Individual mass spectrometer ’runs’ can be affected by a wide variety of factors,
including stochastic variation arising from the physical measurements of the sample;
which means that although an identical sample may be injected into the machine one
two consecutive occasions, the chances of observing an identical data output are vanish-
ingly small. This can cause problems for direct comparisons between samples, as it is
challenging to determine where a sample difference is actually occurring between samples
and when it results from stochastic variation between sample measurements. As a result,
cases where label-free quantitative measurements tend to be more accurate are typically
‘targeted’ studies, which focus on a smaller number of peptides and infer information
about the sample from them (Blein-Nicolas and Zivy, 2016).
Label-free analyses require a minimum of 3 repeated runs on samples (Cox et al., 2014)
to generate the confidence required for these comparisons, which also has an operational
cost associated with each experimental measurement, for both the physical operation of
the machine and also the operator time requirements. As mentioned above, in label-
based proteomics the samples are pooled, and up to the point where they generate a
spectrum on the machine, are considered to be identical both chemically and by mass.
As a result, the different samples experience an identical set of analysis conditions, and
so each measured peptide can be compared directly to determine the relative abundances
between the level of the protein between the two samples. This translates to a physical
reduction in the required number of spectrometer runs and therefore the overall costs
associated with the experiment.
5.3.3 Ratio compression in tag-based approaches
Whilst tag-based proteomic studies generate large amounts of quantitative data more
efficiently and accurately, compared with spectral counting techniques, there are a number
of limitations that have been highlighted with the technique that need to be addressed.
One of these is the effect of ratio compression. In ratio compression, the ion count ratio
within the spectrum, which should be representative of the absolute abundance of the
peptide in the samples being compared, is underestimated in complex samples. The
phenomenon was initially documented by Bantscheff et al (Bantscheff et al., 2008) in an
attempt to generate a more robust and sensitive set of iTRAQ quantifications, and was
attributed to an issue called isotopic contamination – or contamination with molecules
that have a similar or identical mass. There are two main forms of isotopic contamination,
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the first is contamination with near isobaric masses – such as the case where the 115 mass
signal in the iTRAQ labels is inflated in arginine-containing peptides (Casado-Vela et al.,
2010) through the inclusion of a arginine-derived mass (Gehrig et al., 2004) that has a
mass to charge ratio of 115.08, whilst the iTRAQ 8-plex tag has a mass of 115.1 ± 0.01.
A second case of this is contamination with an isotope of the phenylalanine immonium
ion, which typically has a mass of 120.08, but due to the presence of naturally occurring
C13 within the peptide results in an isotopic contamination with the iTRAQ 8-plex 121.1
± 0.01 label (Ow et al., 2009). (Details of the full labelling regime are given in Chapter
1)
These examples of contamination presented here result in inflated values for an individual
label, which can skew findings especially when internal biological repeats (multiple labels
for the same experimental condition) or repeated experimental runs with randomised
labels (multiple iTRAQ kits used on the same experimental proteomic samples) are not
performed (Hill et al., 2008). These near-isobaric isotopes can be separated by high
resolution mass spectrometers. The second form of isotopic contamination is generated
from isobaric masses. This occurs in cases such as attempting to differentiate leucine
and isoleucine, where the two molecules have an identical mass but are different atomic
arrangement, or from attempting to perform quantifications on shared peptides – peptide
sequences that are identical in two different proteins (Jin et al., 2007; Zhang et al.,
2010; Dost et al., 2012). This type of contamination cannot be directly corrected for by
improving the machine resolution, but can sometimes be inferred from other information
in the dataset.
A number of studies demonstrated that where the physical ratios grew larger, the observed
ratios failed to keep pace, showing a reduced difference or ‘compression effect’ between
the samples (Pierce et al., 2008; Keshamouni et al., 2006; Glen et al., 2008; Bantscheff
et al., 2007, 2012). This effect was amplified by increasing the ratio difference between
the two proteins (Ow et al., 2009) and was shown to be a linear effect (Karp et al., 2010).
The majority of experiments investigating this effect use either a control mix of proteins
at known concentrations within a protein sample (Ow et al., 2009), or the same entire
protein sample compared at different concentrations; and showed that the more complex
the background proteome, and the higher the dynamic range of the sample (Bandhakavi
et al., 2009); the greater the rate of sample compression. The effect was found to be the
result of a phenomenon called co-isolation, where two peptides of similar mass were both
analysed at the same time (Ting et al., 2011; Christoforou and Lilley, 2011; Wenger et al.,
2011). This confounds the values that are measured, and because the measurement is
ratio driven any addition to the signal will result in a compression of values.
Since the majority of proteins within a proteome are expected to be unchanging (a 1:1
ratio), the majority of contaminants are expected to push towards this state resulting
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in compression. From a practical sense it helps to think about the phenomenon from
a mathematical point of view, where if you have two values, 1 and 9, and add 1 to
each, it reduces the ratio between the two values from 1:9 to 1:5; and if you add a value
greater than 1 to both then the compression effect is increased. This problem can be
solved through the use of MS3 – a technique where the MS2 scan fragmentation energy
is tuned to fragment the peptide to produce y and b ions, and then these fragments are
then further fragmented at a higher energy to release the isobaric tags in a separate scan
for quantification (Ting et al., 2011; Christoforou and Lilley, 2011). (b and y ions are
described in chapter 1)
Alternatively, a technique referred to as QuantMode employs proton-transfer gas phase
reactions to reduce the charge state of the target species and separate it from the inter-
fering m/z to improve quantification accuracy (Wenger et al., 2011). Ion mobility (IM)
separations coupled to Q-TOF instruments have the potential to mitigate MS/MS spectra
chimeracy, since the IM-MS has the ability to separate ions based on the collision cross
section, in addition to the m/z (Shliaha et al., 2014). Unfortunately, machines capable
of this level of analysis are still prohibitively expensive for many labs around the world
and as a result this solution is not currently widely applicable; as a result a number of
groups still work on alternative solutions to problems related with co-isolation, improving
quantification quality (Martinez-Val et al., 2016; Dowle et al., 2016; Brodbelt, 2015; He
et al., 2016; Cologna et al., 2015).
5.3.4 Reduced data return from tag-based approaches
Beyond ratio compression, a major issue with label-based techniques is the reduction in
the physical number of identified spectra, compared with label-free techniques. During
fragmentation of a tagged peptide, the collision energy in the mass spectrometer must
be tuned to liberate the isotopic label from the peptide, which is different to the op-
timal fragmentation energy for fragmenting a peptide at the peptide bond to produce
b- and y-ions – which are used for peptide identification; this reduces the efficiency of
the machine and also the quality of the data produced. In addition, there is ideally a
single fragmentation event at the MS2 level, which facilitates the peptide identification
stage of data analysis, however there is a finite amount of sample available at any given
time within the mass spectrometer and so if the sample must be divided between more
m/z signal outputs, then the signal in each of these outputs is reduced. This effect is
related to the effect seen when proline-containing peptides are fragmented; the major
signal observed is fragmentation at the proline residue, due to its capacity to stabilise
a charge more readily than a standard amino terminus, resulting in a diminished signal
from all other fragmentation events and an overall reduction in peptide identification
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quality (Hunt et al., 1986).
The reduction in the number of identified spectra from different labelling techniques has
been reported in the literature, where a label-free analysis showed a 40% higher incidence
of identified spectra when compared with an iTRAQ 4-plex experiment (Wang et al., 2011)
– although the comparison was performed on different spectrometers, with a higher-end
device being used for the label-free analysis which precludes a direct comparison (Evans
et al., 2012). Another study found that a metabolic labelling approach using SILAC
(stable isotope labelling by amino acids in cell culture) – a tag-free labelling technique –
resulted in 14% more protein identifications, but the tag-labelled samples demonstrated
both a higher level of precision and accuracy (Li et al., 2012).
The number of observed peptides also diminished as the ‘-plex’ number increased, with
iTRAQ 4-plex showing the highest rate of identification, followed by TMT 6-plex, and
then iTRAQ 8-plex (Pichler et al., 2010); whilst the study only identified a relatively small
number of proteins ( 70 proteins from 250 unique peptides in the highest case), the data
showed a successive reduction in the number of spectrum matches by 15% then a further
50% as the ‘plex’ level increased from 4, to 6, to 8 – although the exact reduction appears
to vary from study to study, where a more recent and statistically robust study found that
the level of reduction was 40%, not 60% (Mahoney et al., 2011). This effect was attributed
to both the effect described above and to other fragmentation events occurring within the
larger tags, as a result of higher-charged species resulting from the larger tag molecules
attached to the peptides. The study claimed that precision and accuracy were equivalent
between all cases, however due to the small sample size, finer details that are observable
statistically were not available within the scope of this study, suggesting that the study
we conducted here provides new information to the scientific community. Investigation
into the higher-charged species effect resulted in a dynamic or ‘on the fly’ correction
program to modify spectrometer operation, for parallel quantification and identification
of spectra (Mischerikow et al., 2010). This was ultimately was the same approach that
tackled the quantification compression effect mentioned above (albeit released earlier),
but is again limited by the availability of a high quality mass spectrometer.
Ultimately, these reductions in data quantity and quality raised the question of limits of
detection. A comprehensive study performed by Mahoney et al (Mahoney et al., 2011)
highlighted that a minimum fold-change limit of significance – a threshold very widely
used within the literature for a number of different studies – held little to no bearing
on whether the protein levels were changing between samples; and that the only way to
determine significance is statistically, however detecting changes below a 2-fold difference
were challenging, even with the most advanced statistical techniques of the time at the
researchers disposal (Oberg et al., 2008; Schwacke et al., 2009; Hill et al., 2008).
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Whilst it’s clear that labelled techniques reduce the number of identifications, a more
important question is whether it has a direct bearing on the outcome of a proteomic
investigation. A direct comparison between labelled and unlabelled techniques demon-
strated that whilst an unlabelled experiment confidently identified more peptides, and
therefore had more robust statistics, enabling the identification of 3-fold more statistically
significant changes; these two approaches ultimately provided the same biological story
and the additional quantifications gave no additional insights into the system being ana-
lysed (Neilson et al., 2011). This study can, in the context of the other research discussed
here, be considered to make a statement about the data analytical methods commonly
employed for proteomics, as discussed in chapter 3. Despite this, it is clear that having
higher quantities of higher quality data will always be beneficial, as long as the additional
cost is not too great.
5.3.5 This study
In this chapter, a direct comparison between the two most popular quantitative proteo-
mic labelling systems, iTRAQ 8-plex (Ross et al., 2004a) and TMT 6-plex (See chapter
1 - introduction), was carried out to identify three main points: initially to give an im-
pression of the relative benefits of quantification values between the two systems, given
the inherent differences in the systems. Beyond that, it was important to identify poten-
tial systematic effects present in Synechocystis samples, so that fairer comparisons could
be made between experiments using a different labelling system. Finally, if systematic
differences were identified it was important to see if they could be accounted for mathem-
atically or computationally to generate more accurate comparisons in post-experimental
data processing.
Unlike other experiments of this type that have been carried out previously in the literat-
ure, our approach had a combination of four unique selling points. Firstly, independently
varying protein quantifications were used for the spike in, rather than a simple dilution
series. This enabled us to control the concentrations of the different proteins on dif-
ferent labels independently – more accurately emulating the situation present in a real
sample. The previous methods in the literature investigated quantification bias by mak-
ing a standard mix of different proteins at the same concentration, which were added in
equal proportions to each of the labels being investigated – generating a 1:1 ratio across
all labels. The labelled protein mixes were then combined in different ratios to control the
levels of the spiked-in proteins. An advantage of this approach is that it enabling verific-
ation of proposed label-specific effects in the sample – for example, if the labels appear to
be showing a systematic bias it can be studied to ensure it isn’t just because it has a lower
concentration of protein present in the mix. This study is a natural progression of the
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field, and before publication of this work another group has independently approached
the same conclusions that we did and reported this novel methodology (Ahrné et al.,
2016).
Secondly, the protein levels were evenly balanced across all labels in the sample; so that
when quantifying the mix without the presence of background contamination standard
corrections, such as median correction or channel sum correction, could be applied to the
dataset without negatively affecting the results. Without this, using a normal analytic
technique such as standard software would re-balance a typical dilution series back to
a 1:1 ratio, to try and approximate even protein loading on each of the samples. This
is one of the fundamental assumptions in label-based relatively quantitative proteomics:
that the total quantity of protein present on each label is equal and what is interesting
to the researcher is the changing balance of the individual proteins within the sample,
rather than a physical change in loading levels. Incidentally, whilst this assumption is
generally held to be true, it is very rare for a ‘total protein quantification per cell’ value
to be given in proteomic experiments.
Thirdly, as the study was targeted to a single organism, Synechocystis, the background
spread of protein concentrations in a typical sample could be modelled to enable accurate
control of the spike-in concentration to give specific information about the precision
and accuracy of quantifications observed in proteins at different concentrations within
the sample. In this case, the label-free quantification method emPAI (Ishihama et al.,
2005) was used to calculate the distribution of proteins measured within a number of
Synechocystis proteomic samples. From this data, a distribution histogram was generated.
It showed a normal-like distribution that rapidly tailed off at the lower detection limit.
This leaves an open question about what the distribution of the low-abundance proteome
looks like in Synechocystis, however identifying the observable distribution provides a key
advantage. The sample proteins can be spiked in at a level typical of proteins within
the sample, reducing the risk of either swamping the sample by setting the spike-in
concentration too high, or failing to observe the proteins at all because they were spiked-
in at a concentration below detectable limits.
Ultimately, the main feature of this investigation was that for the first time the iTRAQ
and TMT labelling systems were measured in the same experimental framework, using the
same MS platform, enabling a direct comparison between the two systems in a controlled
manner. Whilst there have independently been studies into a variety of iTRAQ and TMT
labelling systems individually, this aspect of the experimental work is completely novel in
the literature. Due to fundamental differences in the labels – the most obvious being the
different number of labels in each of the systems, with iTRAQ having 8 and TMT having
6, some comparisons in this framework are obfuscated slightly; however the design has
been adapted to account for this as far as possible. These steps are highlighted in the
5.4. METHODS 181
iTRAQ Myo Cas CytC BSA Sum
113 3 0.8 1 2 6.8
114 3 0.8 2 1 6.8
115 2 1 3 0.8 6.8
116 2 1 0.8 3 6.8
117 1 2 0.8 3 6.8
118 1 2 3 0.8 6.8
119 0.8 3 2 1 6.8
121 0.8 3 1 2 6.8
Sum 13.6 13.6 13.6 13.6
TMT Myo Cas CytC BSA Sum
126 3 2 0.8 2 7.8
127 3 2 0.8 2 7.8
128 0.8 2 2 3 7.8
129 0.8 2 2 3 7.8
130 2 2 3 0.8 7.8
131 2 2 3 0.8 7.8
Sum 11.6 12 11.6 11.6
Table 5.1: Experimental design table showing the relative concentrations of the different
proteins in the master mix. Efforts were made to balance the mass of protein on each tag
and also the total mass of each protein in the sample to avoid bias so measured effects
could be generally applicable to other proteins.
methodology for this experiment.
5.4 Methods
5.4.1 Experimental design
4 common proteomic standards (BSA, Cyt C, Myo, B-Cas) were prepared at a concentra-
tion of 1 mg ml-1. These samples were then digested with trypsin, the disulphide cysteine
bridges were reduced and alkylated, and the peptides from each protein were combined
in a single pot for each label at the concentrations given in table 5.1 (p. 181).
The quantities of peptides were balanced for each label, so that an even mass of all
proteins was added to prevent concentration bias in the study. The base ratios covered
a range of 1:3.75; this range was chosen to look at the effects of differentiating iTRAQ
values that were close together. The labelling was performed as per the manufacturer’s
instructions. The set of labelled peptides was referred to as the ‘master mix’ and was
stored at -80 when not in use. Three experiments were performed, the first analysed the
mix itself, and so the labels were combined at a 1:1 ratio and run without a background
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iTRAQ Scalar Myo Cas CytC BSA Sum
113 10 30 8 10 20 68
114 10 30 8 20 10 68
115 5 10 5 15 4 34
116 5 10 5 4 15 34
117 2 2 4 1.6 6 13.6
118 2 2 4 6 1.6 13.6
119 1 0.8 3 2 1 6.8
121 1 0.8 3 1 2 6.8
Sum 85.6 40 59.6 59.6
TMT Scalar Myo Cas CytC BSA Sum
126 1 3 2 0.8 2 7.8
127 5 15 10 4 10 39
128 10 8 20 20 30 78
129 1 0.8 2 2 3 7.8
130 5 10 10 15 4 39
131 10 20 20 30 8 78
Sum 56.8 64 71.8 57
Table 5.2: Experimental design table showing the relative concentrations of the different
proteins after being applied to a scalar dilution. Where the scalar is stated, the concen-
tration was achieved through relative dilution of the other labels, so 10 refers to a 1010
dilution, or undiluted label mix, whilst 1 refers to a 110 dilution.
sample; this was done to verify the experimental accuracy of the operator, to ensure
that having a pseudo-complex mix wouldn’t provide interactions in an uncomplicated
background, and to generate correction factors to account for any effects seen as a result
of these two effects.
In the second experiment, the labels were combined at a dilution range of 1:10 without a
background, as shown in table 5.2 (p. 182). As with experiment 1, this enabled verification
of the experimental accuracy of the operator, and highlighted any further compression
observed by increasing the concentration range within the pseudo-complex sample. Due
to the experimental design, this step expanded the range significantly and uniquely for
each protein due to the varying concentrations of protein on each label, as can be seen
in figure 5.1 (p. 184), increasing it from 1 : 3.75 up to 1 : 37.5. Due to the experimental
design, a range of values and concentrations were measured in each of the individual
proteins, providing a broader set of values for assessing if the compression effect was
linear. These ratios were applied to the spike in proteins by mass in mg, the full list of
final mass of protein added in all experiments is available in table ?? (p. 183).
Finally, in the third experiment the labels were combined with the same dilution range
as experiment 2, but in reverse-order, both due to a limitation of available sample and
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Table 5.3: Table showing the amounts of protein, by mass, added to each experiment.
The values were calculated from the ratio-design tables shown in this section.
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Figure 5.1: These stacked bar charts show how
the internal protein concentrations within the ex-
periment are initially balanced in the iTRAQ ex-
periment, but are then expanded to a much larger
range through the use of a simple dilution step.
In this case, the different colours represent the
amounts of different protein labelled with each
iTRAQ tag. The top bar chart shows the master
mix, whilst the chart below shows the mix after
it has had a dilution step applied to it. This di-
lution step is the same as the one used in the
3rd experiment described here, and the chart in-
dicates the relative amounts of iTRAQ tag, and
the corresponding protein levels, spiked into the
complex background.
also to account for protein-specific effects, as shown in table 5.4 (p. 185). This sample
was spiked into a complex Synechocystis background at a concentration that was typical
of the majority of proteins within the background sample.
5.4.2 Calculating the background
To determine a suitable amount of protein mix to spike into the Synechocystis back-
ground, a statistical assessment was carried out on a sample dataset kindly provided by
B. Patternak and P. Lindberg from Uppsala university, Sweden.
An in-depth proteomic dataset, comprised of 2 8-plex iTRAQ experiments investigating
a mutant against WT Synechocystis under two different conditions, was generated on
a Q-Exactive HF mass spectrometer. Part of this dataset was analysed to generate a
distribution of protein concentrations within the proteome. The dataset was provided
blind, so the mutant, the conditions and the iTRAQ tag assignments are all unknown
to the operators to remove bias during analysis. To calculate the emPAI scores, the
‘observable’ peptide values were calculated as follows.
The complete proteome for Synechocystis PCC6803 – Kazusa strain, was downloaded
as a fasta file from uniprot (taxonomy:1111708 – accessed August 2015, 3517 protein
entries). This was then merged with the spike-in proteins to make a singular database for
analysing the data, by doing this, effects on statistical methods such as false discovery
were equal between all analyses. The fasta file was processed in Wolfram Mathematica
(version 10.1) to generate an in-silico digest of each of the proteins, excluding any peptides
that fell outside a 1000 – 7500 dalton window to replicate the presence of 2+ or 3+ ions
observable in the 500 – 2500 m/z window used during the mass spec experimental scan.
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iTRAQ Scalar Myo Cas CytC BSA Sum
113 1 3 0.8 1 2 6.8
114 1 3 0.8 2 1 6.8
115 2 4 2 6 1.6 13.6
116 2 4 2 1.6 6 13.6
117 5 5 10 4 15 34
118 5 5 10 15 4 34
119 10 8 30 20 10 68
121 10 8 30 10 20 68
Sum 40 85.6 59.6 59.6
TMT Scalar Myo Cas CytC BSA Sum
126 10 30 20 8 20 78
127 5 15 10 4 10 39
128 1 0.8 2 2 3 7.8
129 10 8 20 20 30 78
130 5 10 10 15 4 39
131 1 2 2 3 0.8 7.8
Sum 65.8 64 52 67.8
Table 5.4: Experimental design table, an inverse of table 5.2 (p. 182). In the iTRAQ
experimental labels, paired proteins have flipped concentration (magic square effect),
however the relative concentrations between the TMT labels have changed between the
diluted test mix and the complex background. This was a limitation of the 6-plex:4-
protein mix.
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Where Nobserved is the number of unique peptides observed for a given protein, and
Nobservable is the total number of unique peptides that could be observed for a given
protein.
This data was then graphed as a histogram to identify the protein concentration dis-
tribution and dynamic range. Dynamic range was calculated by taking the exponential
of the difference between the maximal and minimal emPAI values. The dynamic range
limit gave a practical minimum level for the spike-in data; for example if the observable
dynamic range was reported as 103 then the lowest concentration of any spike-in protein
should be greater than 1103 of the highest abundance protein in the sample. In Synecho-
cystis, it has been reported that the 4 phycobilisome proteins make up approximately
20% of the proteome (Gan et al., 2005). This can be seen clearly from any data involving
wild type cells grown in light conditions, with each of the proteins being approximately
equivalent in concentration, and so the highest protein concentration here was approxim-
ated as being 5% by mass of the total protein sample. As the total mass of the protein
sample injected into the mass spectrometer was known, the total amount to spike in was
calculated by:
max = 0.05× total
min = max× 11000
Wheremax is the highest estimated concentration for any individual protein in the sample
and min is the lowest detectable concentration of protein in the sample.
target = max50
target is the region of concentration the spike proteins should be in, as observed from the
data distribution in the histogram 5.4 (p. 192). The code from this analysis, along with
the code from all other analyses in this thesis, is available in the data repository <DATA
REPOSITORY ADDRESS AND DETAILS>.
HPLC Buffers A + B
The two HPLC buffers contain a high (A) and low (B) conentration of acetonitrile
(CH3CN). These are mixed within the instrument to produce an elution gradient for
evenly separating peptides into fractions, reducing the complexity of the mixture for
increased measurements in mass spectrometric analysis.
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1. Buffer A - 80% CH3CN
• 800 ml CH3CN
• 190 ml ms-grade H2O
• 10 ml 1M ammonium formate (NH4HCO2) at pH3
2. Buffer B - 5% CH3CN
• 50 ml CH3CN
• 940 ml ms-grade H2O
• 10 ml 1M ammonium formate (NH4HCO2) at pH4
As a result, 1 ug of the mix was added as a spike-in to each experiment. After being
combined, the samples containing the spiked-in labels were fractionated by HPLC (high
performance liquid chromatography), using a HyperCarb column over a 70 minute frac-
tionation program that had been standardised for Synechocystis samples. In total, 48
fractions were collected, one per minute at a flow rate of 0.2 ml.min−1 per minute, with
the first 16 minutes and final 6 minutes discarded.
For the samples without a complex background, the samples were pooled together in
groups of 12, producing a total of 4 fractions. This was done to reduce the overall
mass spectrometry data acquisition time, as from the simplicity of the samples they
were already fractionated sufficiently. In the spike-in experiment, 2 runs were performed
– one with oﬄine pre-fractionation and the other without. The effects of compression
exacerbation have been shown in the literature to be enhanced by a complex background
(Ow et al., 2009); however no data is available on whether iTRAQ and TMT labels
experience this compression effect to the same extent. To limit the differences between
the samples, the ‘unfractionated’ mix was in fact fractionated as described above, but an
aliquot containing all the collected fractions merged together was spiked into the machine.
In the fractionated mix, the samples were pooled together in groups of 8, producing a total
of 6 fractions for analysis. The samples were measured with both the maXis UHR ToF
and QExactive HF mass spectrometers (Bruker, Bremen, Germany; Thermo, Bremen,
Germany).
5.4.3 Data analysis
The data processing route was kept as close to a typical data processing run as possible.
As a result, the .raw data files were directly analysed with the program MaxQuant (ver-
sion 1.5.3.30), with the recommended settings for each analysis except where stated. In
addition to the standard post translational modifications, phosphorylation of serine was
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added to improve the quality of the beta casein protein identifications. The false discov-
ery rate (fdr) was set at 1%. The same fasta database from Uniprot used to produce the
emPAI background was used for analysing the proteome (taxonomy:1111708 – accessed
October 2015).
The evidence.txt files were analysed using the open source program R (version 3.2.2) to
interrogate the data. Figures were generated using the ggplot2 package (Wickham, 2009)
and the code used is available as an appendix. Briefly, msms scans from the spiked in
proteins were isolated from the dataset. Each MS/MS scan was converted to ratio values
by dividing the values for each label by the sum of all the label values. MS/MS scans
with missing labels were excluded from the analysis to prevent skewing of the results
away from the expected values.
5.5 Results
5.5.1 Background proteome distribution in Synechocystis
An in-silico investigation was carried out on the proteome initially to determine its fea-
tures. The main purpose of this was to identify an appropriate concentration to spike
the background protein mix for the tag comparison experiment, where it would be at a
level typical of an identified protein within the Synechocystis proteome. This was done
to ensure that the spike would be indicative of proteins normally present in the proteome
and to give a realistic comparison of the two tagging systems in physiological conditions.
In Synechocystis, 96.5% of the proteome is distributed over the 5 – 100 kDa range,
with a smaller number of very high mass proteins (fig. 5.2 (p. 189)). As expected, the
proteins show a linear mass to length relationship, however the variation between these
values increases at higher values, expressing minor heteroscadasticity. In our model we
consider this effect to be negligible within the range where the majority of the proteome
is expressed.
The linear relationship breaks down somewhat when considering the emPAI model, as
only peptides within the mass spectrometer range of 500 – 2500 m/z can be observed
during analysis. During data processing, spectra with a 2+ or 3+ charge are selected for,
as these peptides produce the best spectra for analysis; as a result only peptides with a
mass with the range 1000 ≤ x ≤ 7500 were considered ‘observable’. When considering
this mass distribution, the mass to unique peptide distribution contains more variation
fig. 5.3 (p. 191). It still shows a linear trend, with a practically observable maximum





































































































































































Figure 5.2: A scatter-graph showing the linear relationship between protein mass and
length in Synechocystis, and the corresponding histogram of protein masses. 96.5% of
proteins are present in the 5 – 100 kDa range. (Image created in Wolfram Mathematica,
data obtained from uniprot)
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protein mass and observable peptides is not as linear as the oversimplified version of the
algorithm used in the program Mascot would indicate.
The ‘blind Sweden’ dataset used for generating the background consisted of 20 high resol-
ution fractions from two iTRAQ 8-plex experiments of Synechocystis was analysed with
MaxQuant software, which identified 4332 unique peptides, mapping to 1182 proteins
present within the proteome downloaded from uniprot. In this data approximately 3% of
all possible observable peptides have been identified assuming every unique peptide was
present within the sample (123,860 possible observations), but equates to 9.24% of all ob-
servable peptides when considering only proteins where direct observed proof is available.
A histogram of the protein concentrations as calculated by emPAI in fig. 5.4 (p. 192))
shows that dynamic range of the measured sample observed here is 103, calculated by
converting the range of the histogram into linear values – this is described below.
ln(2.2− (−4.4)) = ln(6.6) = 103
where -4.4 was the lowest observed value, and 2.2 the highest observed value, as seen in
fig. 5.4 (p. 192
The observations of lower-abundance peptides drop off sharply at the left side of the
histogram, which may be either due to a limitation of the proteome itself – where the
physical limitation of the emPAI calculation has been reached due to the average number
of unique peptides per protein – or could be due to a stochastic feature relating to the
limits of the mass spectrometer used during measurement. As observable in fig. 5.3
(p. 191), with the exception of a single outlier with 335 unique observable peptides, the
upper limit of detection falls in the range of 175 – 195 unique peptides. When plugged
into the emPAI formula, this produces the range with an upper limit of 2.2 and a lower
limit of -4.4, suggesting a saturation of the values in the formula taking place. For this
proteome, using emPAI, the maximum practically observable dynamic range is 7.8× 102.
On the assumption that the true concentration distribution is symmetrical, the upper half
of the distribution can be used to estimate the true distribution more accurately than the
lower half of the distribution. The median of -1.64 suggests that this range could be more
accurately approximated as (2.2− (−1.64))× 2 = 7.68, suggesting that the full dynamic
range of the sample could be approximated to 2.2× 103, around 10-fold higher than the
measured value. Whilst this is lower than dynamic ranges reported in other organisms
including S. Cerevisiae (4.5×104) (Picotti et al., 2009) and E. coli (3×105) (Soufi et al.,
2015a), it is closer to the expected range of values and the reduced rate may result from
upper-limit saturation, which cannot be corrected for in this model.












































































































































































































































































































































































Figure 5.3: A scatter-graph showing the relationship between protein mass and the num-
ber of observable peptides within Synechocystis, and the corresponding histogram of
the number of observable unique peptides. The scatter-graph shows far more variation
between these values, compared with the length-mass relationship, despite this the re-
lationship between the two values is largely linear with more stochasticity present. The
majority of proteins are present in the 5 – 100 observable unique peptide range, and so in
figure 5.5 (p. 193), the higher value proteins have been excluded due to sparsity. (Image
created in Wolfram Mathematica, data obtained from uniprot)
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Figure 5.4: Protein concentration distribution, measured in natural log, generated by
the emPAI formula. The distribution is almost Gaussian, however left tail is cut down
and falls off abruptly. This is likely due to the fact that the proteins in this region
are approaching the lower detectable limits of the machine. (Image created in Wolfram
Mathematica.)
in fig. 5.3 (p. 191) and broken down into flat percentages within each histogram bin, we
can see that as expected, a lower percentage of smaller proteins, or proteins which gen-
erate fewer tryptic peptides, are observed compared with larger proteins or proteins that
generate more tryptic peptides fig. 5.5 (p. 193). The numbers become more stochastic
as higher values are reached, due to the smaller number of discoverable proteins of that
size, however the observed trend is fairly stable in proteins generating between 0 and 90
tryptic peptides and this range covers just over 95% of the complete observable proteome.
As mentioned previously, within Synechocystis there are 4 highly abundant proteins
present – the phycobilisome proteins – which make up 20% of the total proteome. In
the emPAI model of the background proteome presented here these proteins are assumed
to be at saturation level, but provide a reference for the rest of the proteome in relation
to the emPAI model. As the 4 antennae proteins are at an equivalent concentration to
each other, each of the proteins can be estimated as making up approximately 5% of
the total protein present by mass, so in the sample 5% of the total protein mass is the
highest point on the distribution. Given the values stated above, the highest and lowest
measurable protein concentrations in the dataset are as follows:
max = 0.05× total.protein
min = max× 11000












Histogram: Number of peptides per protein







Observation rates of proteins by number of tryptic peptides
Figure 5.5: At the top, the histogram shows observed proteins from the dataset against
all observable proteins in Synechocystis proteome, binned in groups of 5 by the number
of unique peptides per protein. The blue bars show an approximation to the protein
size distribution within the genome (see figure 5.2 (p. 189)), and the orange bars show
the number of identified proteins from each bin that were observed, demonstrating the
sampling distribution for the Synechocystis background. The observation rates are given
in the bar chart below. This figure shows that there is a bias against the identification of
very small proteins, with a general upward trend in the rate of identifications, until the
statistics become unstable in the sparser ‘higher-mass’ region of the proteome. (Image
created in Wolfram Mathematica.)
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10( 11 ) − 1 = 9
Where all observable peptides are seen in a dataset. The median emPAI value from the
data is 0.193, and so to match the median protein concentration the spiked protein should
be added at 0.1939 , or approximately
1
50 of max.
The spike-in mixture consisted of 4 proteins, however the internal variation on these
proteins means that for any given tag the protein concentration will range up to 140
below the original value. The aim of this experiment was to set up the proteins at a
concentration surrounding the median value to give the data values for a typical protein in
the experiment. The spike-in value was therefore added at a 20-fold higher concentration
than the median protein level after dilution, ensuring that the range of the concentration
would fall around the median value within the dataset. As a result of these observations,
the most practical concentration for spiking in the background proteins in the full-range
final mix was found to be:









The total protein added in each case is 25 mg per label, so 1 mg spike mix in iTRAQ
8-plex (200 mg total) and 0.75 mg in TMT 6-plex (150 mg total).
5.5.2 Direct peptide and protein counts
All proteins from the spike-in data were observed with at least 2 significant unique pep-
tides, and in the complex fractionated background collectively made up 0.77% (iTRAQ)
and 1.13% (TMT) of the overall quantified spectra. These values were expected to be the
same, and the difference between the two can directly be attributed to an experimental
error which occurred during the spike-in stage, as 1 mg of spike mix was added to both
the iTRAQ and TMT backgrounds, where 0.75 mg of spike mix should have been added
to the TMT mix. The spike-in concentration was high enough to ensure observation
that all the target proteins within the experiment were observed in every experiment,
including the complex unfractionated experiment; but were not the highest abundance
proteins in the sample according to an emPAI estimation. This findings suggests that
the estimations within the model were useful, however it seems unlikely that the spike-
concentration used in the experiment reflected the true median level of the sample – this
is discussed in more detail in the discussion section below.
As mentioned above, different tagging systems result in different numbers of peptide-
spectra matches. Table 5.5.2 (p. 195) shows the summary information for all of the
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Experiment ID’d spectra Quant spectra ID’d spike Quant spike Prots Frac
iTRAQ1 1218 845 1060 707 28 4
iTRAQ2 938 408 832 342 24 4
iTRAQ3 13717 11786 106 91 1073 6
iTRAQ4 3416 3025 39 35 583 1
TMT1 1874 1211 1661 1030 44 4
TMT2 1222 305 1119 256 27 4
TMT3 17791 15491 206 175 1229 6
TMT4 4539 4067 65 61 624 1
Table 5.5: Summary data of the number of peptide-spectral matches identified in each
experimental run. The experiments are grouped by 4, with the first 4 using iTRAQ tags
and the second 4 using TMT tags. The experiments in sequence are: (1) the spike in
mix without a complex background and without dilution (range 1:3.75), (2) the spike-in
mix without a complex background but with dilution (range 1:37.5), (3) the spike-in mix
in a complex background and with dilution, and (4) the spike-in mix in a complex back-
ground with dilution, but without LC fractionation to simulate an even more complex
background. ID’d spectra indicates the total number of spectra that were confidently
identified, Quant spectra indicates the number of spectra that retained intact quantifica-
tion data for all label channels, ID’d spike and Quant spike are similar to ID’d and Quant
spectra, but relate directly to spectra that match the spiked in peptides from the control
mix. Prots is the total number of proteins identified in the final mix, and Frac shows the
total number of fractions that were injected overall.
proteomic experiments carried out in this investigation. iTRAQ experiments resulted
in 75.9% of the spectra identified in TMT experiments on average – considering data
from 44,715 confident peptide spectral matches, which falls within the range of 12% -
50% reductions in identified spectra reported in studies previously. In the complex back-
ground experiments, 77.1% and 75.3% of the peptides were identified in the fractionated
and unfractionated experiments, respectively. This translated to the iTRAQ experiment
identifying 87.3% and 93.4% of the proteins identified in the fractionated and unfrac-
tionated TMT experiments, demonstrating that the difference between the two tagging
systems is exacerbated as the complexity in the sample reduces.
Interestingly, whilst both tagging methods show similar rates of quantification over the
entire set of experiments, iTRAQ shows a pronounced (18.6%) increase in spectra with
complete quantification information over TMT in the simple background experiments.
Whilst this difference vanishes completely in the complex background mixes, both sys-
tems show an increase in the rates of complete quantification as the complexity of the
background increases, suggesting that this increase resulted from an increased rate of
background co-elution. TMT also showed a lower level of tolerance to increasing ratios
between the individual labels; for example in the undiluted mix, 64.6% of the spectra that
were identified had a complete set of quantifications associated with them, whilst in the
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diluted mix this dropped to 25.0%. The same comparisons for iTRAQ were 69.4% and
43.5% respectively. In the diluted mixes, this actually translated to a larger number of
quantified spectra available in the iTRAQ data, despite the overall reduction in identified
spectra. As a result, it is likely that the extra quantifications in the TMT experiments
are actually a result of background contamination, and so the iTRAQ tags appear to
have a relatively better fidelity in quantification than the TMT tags in the experiment.
5.5.3 Quantification and compression
As mentioned above, a mixture of 4 proteins was spiked into different backgrounds for
iTRAQ and TMT tags. The proteins used in the mixtures below are abbreviated in
this section as follows: bovine serum albumin (BSA), bovine β casein (cas), equine cyto-
chrome C (cytC), and equine myoglobin (myo). In the undiluted, simple background
experiment, both tags showed an uncompressed linear relationship between the observed
and expected ratios, across the full range of the data. This uncompressed linear obser-
vation was maintained in the diluted, simple background experiment for the TMT tags,
but not in the iTRAQ tags experiment (fig. 5.6 p. 197).
In the iTRAQ experiment, both the BSA and, to a greater extent, the myo proteins show
an over-estimation of the true fold-change. As a result, this skewed the linear fit for
the whole dataset to suggest a general overestimation in iTRAQ labelling, but the effect
appears to be protein-specific. This overestimation may be attributed to minor errors
in dilution for the individual labels, and a dilution correction factor could be calculated
to make the samples more linear, however such a calculation is of limited general value.
This observation is interesting in the context of the data in table 5.5.2 (p. 195), which
indicated that the larger number of quantifications present was a beneficial feature of the
iTRAQ tags, as the increased observations seem to have increased the overall noise level
in the dataset and so the additional value they bring may be limited.
These data suggest that while there is a large visible spread of the individual data-
points, statistically the precision of the linear model is high, due to the concentration of
measurements around the expected ratio of the data. The data demonstrates a degree of
heteroscedasticity, with the higher ratio values having more spread than the lower values.
This would make sense as there is more likely to be deviation at the tails of the data,
and since the data are ratios relative to 1 the greatest variation would be visible in the
higher ratios. A log transformation of both the axes enables closer investigation of this
effect (fig. 5.7 p. 198).
Under log-transformed axes, a very clear skew is observable in the TMT diluted mix.













































































6 TMT Expanded Mix
Figure 5.6: A 2x2 grid showing the simple mixtures and their diluted expansions. In-
dividual proteins from the spike-in mix are highlighted in the corresponding colours in
the legend, these are bovine serum albumin (P02769, red), bovine β casein (P02666,
green), equine cytochrome C (P00004, blue), and equine myoglobin (P68082, magenta).
The solid black line shows the expected relationship between the observed and expected
ratios. The dotted line shows the best linear fit for the data when considering the entire
dataset. iTRAQ data are shown on the top row and TMT data are shown on the bottom
row. The shaded grey area around the lines indicates the variance in the linear models
applied to the data, the broader the shaded area, the lower the precision. The hollow
circles are individual data measurements and show the abundance and spread of the data
measured at each point for each protein. (Images created with the ggplot2 package in
R.)








































































6 TMT Diluted Mix
Figure 5.7: A 2x2 grid showing the simple mixtures and their diluted expansions from
figure 5.6 p. 197 under log-transformed axes. Proteins are bovine serum albumin (P02769,
red), bovine β casein (P02666, green), equine cytochrome C (P00004, blue), and equine
myoglobin (P68082, magenta). The solid black line shows the expected relationship
between the observed and expected ratios. The dotted line shows the best linear fit for
the data when considering the entire dataset. iTRAQ data are shown on the top row
and TMT data are shown on the bottom row. The shaded grey area around the lines
indicates the variance in the linear models applied to the data, the broader the shaded
area, the lower the precision. The hollow circles are individual data measurements and
show the abundance and spread of the data measured at each point for each protein.
(Images created with the ggplot2 package in R.)
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are tightly clustered together in the lower-ratio region of the data, it is actually a more
pronounced overall effect when considering the values purely from a ratio perspective.
The reduced abundance of tags with complete quantification information is likely to be
related to the low-abundance skew resulting in a general over-estimation of the ratio,
although this effect is the result of a tag-specific effect. On investigation of the effect, the
fault lies with quantifications from TMT tag 129, which makes up – due to a weakness
in the dilution design – the majority of the low-abundance quantifications in the simple
background diluted mix TMT experiment. Unfortunately, a flat scalar modification to
the values would, whilst improving the median value of the tag intensity, not correct
for the increased variance observed with the low-abundance tag. Fortunately, due to
the experimental design, in the complex background mixes this tag is present at high
abundances and the effect seen here is no longer present.
It is not clear from either figure 5.6 (p. 197) or 5.7 (p. 198), but there is a much higher
density of measurements in the base mix experiments compared with the expanded mix
experiments, as can be seen in table 5.5.2 (p. 195). This results in a very precise linear
model for both of the base mixes compared with their diluted variants, despite showing
what appears to be a larger amount of spread on the data. In the simple mixtures, the
iTRAQ data appear to be both more accurate, whilst the TMT tags are slightly more
precise, however this can be traced back to an issue with the TMT tag 129. On examin-
ation of the data, this same tag appears to be responsible for a large proportion of the
missing values, with tag 129 missing 72% of the quantifications for all confidently identi-
fied peptides labels; and as a result has directly contributed to the observed reduction in
full quantification data quality observed for the TMT tags seen in table 5.5.2 (p. 195).
When the mixtures are spiked into a complex background, the linear ratios seen exhibit
clear signs of compression, as shown in figure 5.8 (p. 200). This effect can be more
closely interpreted using a log-axes graph, as was used in the previous experiment (fig
5.9 (p. 201). There are a few different comparisons being conducted simultaneously, so
the figures can be challenging to interpret, however the core comparisons are as follows.
The iTRAQ data shows 3 different measurements regimes, the first is the full [1 : 2.5 : 12.5
: 37.5] range, highlighted by cas. Next is the [1 : 1.6 : 2 : 4 : 6 : 10 : 15 : 20] fold-change
range, with a high and low concentration protein generating the outputs, these are cytC
– which is a smaller protein and therefore has higher concentration peptides, (as equal
masses of protein were spiked in, not equal concentrations) and BSA – a larger protein
with therefore lower concentration peptides. Finally, is a low concentration compressed
range measuring from [1 : 1.3 : 1.6 : 2.6], at a concentration 3 fold lower than the median
range, highlighted by the myo protein. It is worth noting that as the same master mix
was used for all 4 experiments, there was a limited amount of material available. As
a result, the dilutions in the simple background and the complex background run anti-












































































8 TMT Complex Background − Unfractionated
Figure 5.8: A 2x2 grid showing the complex bg mixtures. Individual proteins from the
spike-in mix are highlighted in the corresponding colours in the legend, these are bovine
serum albumin (P02769, red), bovine β casein (P02666, green), equine cytochrome C
(P00004, blue), and equine myoglobin (P68082, magenta). The solid black line shows the
expected relationship between the observed and expected ratios. The dotted line shows
the best linear fit for the data when considering the entire dataset. iTRAQ data are
shown on the top row and TMT data are shown on the bottom row. The shaded grey
area around the lines indicates the variance in the linear models applied to the data, the
broader the shaded area, the lower the precision. The hollow circles are individual data
measurements and show the abundance and spread of the data measured at each point









































































8 TMT Complex Background − Unfractionated
Figure 5.9: A 2x2 grid showing the complex bg mixtures from figure 5.8 p. 200 under
log-transformed axes. Individual proteins from the spike-in mix are highlighted in the
corresponding colours in the legend, these are bovine serum albumin (P02769, red), bovine
β casein (P02666, green), equine cytochrome C (P00004, blue), and equine myoglobin
(P68082, magenta). The solid black line shows the expected relationship between the
observed and expected ratios. The dotted line shows the best linear fit for the data when
considering the entire dataset. iTRAQ data are shown on the top row and TMT data are
shown on the bottom row. The shaded grey area around the lines indicates the variance
in the linear models applied to the data, the broader the shaded area, the lower the
precision. The hollow circles are individual data measurements and show the abundance
and spread of the data measured at each point for each protein. (Image created with the
ggplot2 package in R.)
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parallel to each other – this means that whilst cas shows the 1 : 37.5 range in the
complex background and myo covers the 1 : 2.6 range, these proteins were switched in
the undiluted experiment. It has no effect on the bsa or cytC, with the exception of
switching the concentrations of iTRAQ reporter labels between the two proteins.
Looking at the protein-specific linear models, the three different regimes form three sep-
arate gradients on the figure. This occurs because to maintain the variance in all the
labels, each dataset was normalised by the median reporter value rather than division
by any given reporter in the dataset. As a result, the point at which each of the linear
models crosses the solid black line indicates the median reported ratio within the sample.
The gradient of the line indicates the level of compression, and so it can be seen that all
proteins with the exception of cytC undergo increased compression in the more complex
background mixture. It is interesting to note the the larger-ranged cas and shorter ranged
myo experience higher rates of compression than either bsa or cytC in the fractionated
iTRAQ background, as can be seen from the steeper gradient on the linear model. Cas
shows a linear concentration gradient across all samples, suggesting that label-specific ef-
fects did not appear to contribute significantly to the results, however they may become
apparent if more data points were available.
The shaded area indicates the precision of the linear model. This becomes broader for all
proteins in the unfractionated background, showing an overall reduction in precision. The
gradient on the bsa line drops in the unfractionated complex background compared with
the fractionated complex background, however the same effect is not seen for cytC. This
suggests that bsa was more affected by increasing isotopic contamination in a higher
complexity background than cytC. Whilst a compression effect is visible on the low-
abundance myo samples between the fractionated and unfractionated backgrounds, the
resolution between the different measurements is not high enough to classify the different
labels as significantly different from each other in either case. So whilst this observation
gives some impression of how the additional complexity blocks the observation of small
scale changes, this information makes little practical difference to analysis of a real biolo-
gical sample. Across the iTRAQ samples,there appears to be a small overall fold change
between the 1 : 37.5 range (5 : 30 observed min-max ratio) and the 1 : 20 range (3 : 15
observed min-max ratio). Within the ranges, the median 1 : 10 ratios were 3 : 9.7 and 5
: 11 respectively. These values suggested that the wider ranges were more susceptible to
compression, and so proteins with a wider spread of values recorded across all the iTRAQ
tags will have more internal compression as well.
The TMT data shows 2 different measurement regimes, the first spans the full 1 : 37.5
range, and is covered by myo [1 : 2.5 : 10 : 12.5 : 18.75 : 37.5] and bsa [1 : 3.75 : 5 :
12.5 : 25 : 37.5], with each protein taking different interval steps to highlight resolution
along the range. The second spans the smaller 1 : 10 range at regular intervals with 2
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Figure 5.10: A comparison between the
extended-range mix without the addition of a
complex background, with TMT on the top
row and iTRAQ on the bottom. The left
column are the data collected from the QEx-
active HF, whilst the right is data collected
from the maXis. In this figure, each clear
circle is a protein quantification for a single
label. All labels have been normalised to the
mean and put into a log scale, so the points
at the top and bottom of the image are from
proteins with the furthest spread in ratio (1
: 37.5) and the central points the smallest.
(Image created in R.)
protein replicates, ctyC [1 : 1.5 : 2 : 4 : 7.5 : 10] and cas [1 : 5 : 10]. Looking at
the protein-specific linear models, the 2 separate regimes form largely parallel gradients
in TMT. The compression affect appears to be much more uniform across all proteins,
whereas in iTRAQ this was not found to be the case. Specifically, the measured ratios
between 1 : 37.5 were 6 : 29 and 6 : 32, and between 1 : 10 were 3.5 : 7.5, showing far
more linearity between measurements.
Interestingly, TMT tags do not appear to experience an increase in average compression
with increasing complexity as iTRAQ tags do (dotted line comparison between fraction-
ated and unfractionated), although this may be related to a number of factors, including
the experimental design (2 proteins spanning the full range instead of 1), the more reg-
ular intervals between the low and high ratios in the TMT experiment, and the overall
higher number of matching spectra contributing to the models. Individually, myo ap-
pears to experience higher levels of compression, bringing it in line with bsa, and the 1 :
10 ratio appears to actually experiences a slight reduction in compression; however this
comes with a dramatic reduction in precision. It is interesting to note that TMT tags
in the fractionated mix appear to show more heteroscedasticity, with higher precision
being achieved at the low-ratio end, whilst iTRAQ variance is more homoscedastic in
the fractionated mix. Both samples are more homoscedastic in the unfractionated mix,
whilst displaying a reduction in precision.
A comparison was made between two mass spectrometers, the maXis UHR ToF and a
QExactive HF, to observe how changing the model and type of mass spectrometer affected
the different tags. This assessment was made on the extended mixture to determine
limitations on quantification in a relatively simple background – although it could be
argued that the background was pseudo-complex due to the protein concentration range
used. As can be seen in figure 5.10 (p. 203), even at this concentration gradient the
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maXis began to experience compression, however this is more noticeable in the iTRAQ
study, which covered the full range more comprehensively than the TMT study when the
data is investigated in this way.
This comparison was the first performed on the data, and demonstrates the difficulty
in designing a truly comparative experiment on two systems with different numbers of
replicates. The other comparisons in this section subdivided the data into protein group-
ings and made all values relative to the respective fold-changes around 1 in log space, as
would be more typical in a traditional proteomics quantification experiment. This figure
shows that when ignoring the protein concentration and performing a purely ratio-driven
experiment, compression affects both the upper and lower measurements. This follows,
as if the low measurements are abnormally high, and the sample is compared from the
middle, then the upper measurements will be relatively lower also.
5.6 Discussion
5.6.1 emPAI vs tag-based quantifications in Synechocystis
The maximal range measurable in Synechocystis is around 8 × 102, however due to the
rapid drop-off in measurements at the lower tail of the histogram, this suggests that
the lower tail observations are mostly driven by the maximal number of unique peptides
generated from the largest protein in the proteome. This in turn suggests that for accurate
determination of fold-change by the emPAI spectral counting method in Synechocystis,
we should either consider the median to maximum value, where this effect is not present –
which would result in a measurable range of 45-fold; or else consider the space before the
rapid drop-off occurred whilst the histogram is still symmetrical, suggesting a measurable
range of 90-fold.
Whilst this is still greater than the range accurate quantifications can be made in iTRAQ
or TMT systems, which is closer to 10-fold and suffers significantly from compression
effects, it still represents a limitation in the technology. These numbers give an indication
of practical measurement ranges within full-proteome studies, and can therefore be used to
better understand the limitations of pre-existing proteomic data. This will have important
ramifications for systems-level analyses, as there are previously reported incompatibilities
between proteome observations and transcriptomic/metabolomic observations.
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5.6.2 Features of the Synechocystis proteomic background
A dynamic range of 2.2×103 was estimated for Synechocystis, which is lower than both S.
Cerevisiae (4.5×104) and E. coli (3×105). Whilst the observed range is only half that of
the yeast proteome (Picotti et al., 2009), it is much lower than a similarly comprehensive
study conducted in E. coli (Soufi et al., 2015b). In the E. coli study, the largest copy-
number value they reported as 300,000, with no lowest value given. As a result of this, it
is difficult to determine if the lower cut-off should truly be assumed as 1 count (or possibly
even a fraction of this value), or if it should be considered to be higher as no definitive
cut-off value was given in the methods. A literature search did not produce evidence for
observations of single copy proteins when measuring the global cellular environment of a
population of cells.
Fractional values could theoretically be reported when considering a protein that is only
expressed by a subset of the cellular population, which would be a useful feature to
assess in a metaproteomic study. It does raise in interesting question of whether there
are stable single-copy protein systems present in nature. The difficulty of looking at
protein abundances in such cases, is that protein abundances within the cell are dynamic
by their very nature. As protein expression can be switched off completely, it follows
that at some points in time there is a single copy of that protein within the cell; however
if the single copy-number state is only a step to a different value, rather than a stably
expressed value, then its value is of limited practical use. There are also studies which
suggest that true genomic repression control is impossible, as all parts of the genome of
a cell are transcribed into RNA at some point, including the telomeres in linear genome
organisms. This is likely to be the reason why studies into on/off switches in Synthetic
biology focus on probabilistic threshold switches with the aim to replicate a binary effect,
rather than designing an absolute binary control system.
During the investigation, the high-abundance proteins were at the saturation level – where
all observable peptides were seen for the four most abundant proteins. This caused the
range between the median point and the upper limit of the model to be compressed.
From a practical sense, this resulted in the spike-in volume being higher than the true
median point of the dataset. Whilst this was a concern before starting the experiment,
it was impossible to correct for based on the data available during the method develop-
ment stage, however a suggested true value became apparent during data analysis. In
the iTRAQ dataset, the spiked-in peptide mix made up 0.77% of the dataset, or 125 of
max. Since the proteins were targeted to be spiked in at 150
th the max concentration,
this suggests that the saturated proteins are 2-fold higher than expected. Given the
earlier estimation using the median, this which would change the overall dynamic range
estimation for the Synechocystis proteome to 1 × 104 (4-fold increase as the right tail
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was used to approximate the left tail). This value is still lower than the dynamic range
observed for other proteomes, however, and Synechocystis would benefit from a dedic-
ated investigation to determine a better approximation of dynamic range of the sample
under different processing conditions. The Sweden dataset contains a large amount of
replicated mass spectrometer runs of the experimental data, and so could be used to
get a true impression of the range of the experiment – fractions of the dataset could be
sequentially added to the model until the high-abundance proteins first reach saturation;
although the data from this particular dataset may be too sparse for such an approach
to succeed, as despite the large amount of technical replication only 30% of the proteins
in the proteome were identified.
Within the proteome, as apparent in fig. 5.2 (p. 189) there are the 5 very high mass pro-
teins (> 300 kDa), which are still considered ‘predicted’ and have not been experimentally
verified. The two largest, slr0408 and slr1028, appear to be related only to each other
phylogenetically and so have no functions computationally assigned to them, whilst the
other three appear to be involved with cellular adhesion based on gene ontology matches.
Whilst the chances of observing these proteins should be high, within the Sweden dataset
only the two largest proteins, with unknown functions, were observed; suggesting a bias
in the protein extraction technique used against membrane-fraction proteins. In fig.5.3
(p. 191), the largest outliers in this plot fall in the high mass range of the proteome.
This suggests either a relative reduction in negatively charged amino acids in large pro-
teins (larger tryptic peptides), a concentration of such residues in close proximity in the
primary sequence (smaller tryptic peptides), or repeating/non-unique sequences within
these larger proteins. This would make an interesting further analysis on the proteins at
the upper limits of the synechocystis proteome, indeed of large proteins present in other
organisms as well, however such an investigation is beyond the scope of this study.
The number of proteins identified in the fractionated samples where the mix was spiked
into the background (1073 in iTRAQ and 1229 in TMT), are consistent with the dataset
used to generate the estimations (1182 in iTRAQ). This suggests that the spike-in did
not cause a significant reduction in the quality or quantity of the observations of the
background proteome, and suggests that the observations made of the spiked in proteins
are therefore typical of proteins within the Synechocystis proteome.
5.6.3 Minimum detectable limits
It is clear from the data presented in log scale that as the overall concentration of a
protein reduced in the mix, it hits a critical threshold below which it was impossible to
changes apart. From a ratio measurement perspective in this data the threshold appears
to be changes below 4-fold in the unfractionated sample, and between 2 and 3 in the
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fractionated sample.
In the iTRAQ diluted experiments, the small range protein ratio running from 1:2.6 had
a maximal concentration of ≈ 47% of the median protein concentration, and a minimum
of ≈ 17%. These values are calculated as follows:
conc = spiked
µ(spiked.base) × µ.conc
max.conc = 0.81.7 × µ.conc ≈ 0.47× µ.conc
min.conc = 0.31.7 × µ.conc ≈ 0.17× µ.conc
Where spiked is the ratio of the protein being looked at, µ(spiked.base) is the mean
concentration in the undiluted mix, which was made up at µ.conc, the mean protein
concentration within the sample (5.5.1, p. 194).
When comparing the fractionated and unfractionated samples, it is possible to determine
a slight ratio change between the lowest and highest concentrations – seen by the gradient
on the model, however the same is not true in the unfractionated experiment. This
demonstrates a possible concentration cut-off for complexity measurements and would
benefit from further investigation. By spiking in a median-concentration-balanced protein
standard with ratios in a ladder form, it may be possible to determine a cut-off point
for the concentration of the minimum detectable concentration within the sample. This
phenomenon is interesting, as the experiments that showed that MS3 analysis had the
capacity to remove ion interference worked on whole-proteome samples (Christoforou and
Lilley, 2011; Ting et al., 2011; Wenger et al., 2011), and so are likely biased as a result
by the presence high-abundance proteins where the whole proteome dataset is changing
concordantly, rather than in an individual protein study such as the one presented here.
It would be interesting to look at these advanced techniques in finer detail and see if
they do indeed have the capacity to differentiate between low concentration proteins as
effectively as high concentration proteins, or if they demonstrate the same levelling off
effect observed here.
The quality of our study could have been improved significantly by including more pro-
teins within the sample; increasing the number in the mix from 4 standards up to 12 or
even 24 standards would have enabled a balancing effect between the iTRAQ and TMT
designs and allowed for internal protein replicates. The experiment would also have be-
nefited significantly by including more repeated injections, which were not possible due
to machine-time limitations. Ideally, between 5 and 10 repeat injections of the samples
would have added another dimension to the experiment, where assessing how increasing
sampling rates affected all factors within the spectrometer, along with rates of detection.
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A further improvement to this design would be to compare repeat injections of an un-
fractionated sample to one which had been fractionated oﬄine, as fractionating a sample
innately adds repeat injections by the nature of the technique (each fraction must be
injected, therefore larger datasets are compared). In this experiment, the unfractionated
experiment was a simulation for increased complexity, but for a true comparison an even
number of injections for each sample, ie. 12 repeat injections of unfractionated sample
against 2 repeats from each of the 6 fractions used in the experiment.
5.6.4 iTRAQ vs TMT, which is better?
There doesn’t appear to be a clear singular winner in this contest. On one hand, the TMT
tags result in more overall quantifications, which in turn means larger amounts of data for
the researcher to work with; however on the other the results indicate that the iTRAQ
tags actually produce better quality data for larger ratio differences between proteins
in different conditions. As there is a hierarchy in the data, where the peptides need to
be identified before they can be quantified, it is generally favourable to have a higher
level of identification; even if this results in a lower proportion of quantifiable spectra.
In addition, as sample complexity reduces, the benefit of having a higher number of
identifications translates to a growing increase in the number of identified and quantified
proteins. It is possible that this skewed the observed results beyond the normal levels,
as there were more around data-points for the TMT values, and because the increased
number of spectral matches is non-linear with increasing concentration the 13 increase in
protein concentration translated to a 50% increase in the number of observed peptides in
the TMT experiments.
When comparing the base mix experiments to the expanded mix experiments, the pro-
portion of spectra that have quantifications for every label drop by more than 50%. This
shows that expanding the range of the concentration reduces the chances that the lowest-
intensity labels will be observed. This effect is more pronounced in the TMT samples
than the iTRAQ samples; however more MSMS spectra are confidently identified. It
is possible that this effect demonstrates the division of collision energy, between frag-
mentation of the peptide to generate fingerprint spectra and fragmentation of the label.
The same proportion of unquantified spectra is not observed in the samples which also
contain a complex background proteome sample. The quantification rates for the back-
ground samples increase from between 25 – 60% in the simple background up to 85 –
90% in the complex background. Similar values are observed when looking only at the
proteins from the spike mix (Table 5.5.2 p. 195). This is strong evidence of co-isolation
of tags (Karp et al., 2010), where in cases that the intensity of the tag would be too low
to detect in an uncomplicated sample, the background provides a baseline value. The
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method used to identify spectra with missing values excluded any msms spectra with a 0
intensity for any tag, so background interference in the label region of the spectra results
in fewer spectra excluded from the count. Since the same sample was spiked in to the
background and therefore it had the same labelling efficiency, it is possible to observe
rate of co-isolation in this dataset from the proportional increase in quantified spectra. In
this case an increase from 41% to 85% (fractionated) and 90% (unfractionated) labelling
efficiency was observed for iTRAQ, and an increase of 23% to 85% (fractionated) and
93% (unfractionated) in TMT.
The proportion of the spectra attributed to the target proteins from the spike-in mix
was extracted from the data. In the experiments without background, the proportions
of msms spectra attributed to the target proteins was similar between the two labels
– around 90% of identified and 85% quantified spectra. In the experiments where a
complex background was present, the target peptides made up between 0.7 and 1.5% of
all observed and quantified spectra.
5.6.5 Proportionally more of the spike in proteins present
As shown in the results, there were proportionally more of the spiked in protein pep-
tides present in the unfractionated background than the fractionated background. The
increased proportion of spiked in signal is a bit counter-intuitive at first glance, however it
is a function of the noise within the raw experimental data. By fractionating the samples,
the overall level of background noise is reduced. This enables lower-intensity peaks to
be identified, resulting in a larger number of peptide identifications from the sample and
therefore proportionally fewer identified spectra linked to higher-abundance peptides. It
has been stated that overall signal is consistently proportional to the amount of protein
present in the sample. From these data, this does not appear to consistently be the case,
as lower-abundance peptides are under-represented in the sampling process. This indic-
ates the level of the spike-in samples relative, to the median concentration of proteins
in the Synechocystis proteome. If the spike was at the median protein concentration
within the proteome, then the number of identifications should have reduced when the
complexity increased, as higher concentration proteins would be favoured.
As described in the methods section, the concentration of the spike proteins was balanced
at 0.5% of the total protein mix, to ensure observation of the proteins within the sample;
however once the dilution factors are applied to the simple mixture calculations, these
values reduce to 0.27% and 0.23% of the overall samples for TMT and iTRAQ respectively.
The observed proportions in the sample for each protein were 0.29% and 0.36% for TMT
and 0.19% and 0.29% for iTRAQ, fractionated and unfractionated respectively. The
iTRAQ values fall around the expected level, whilst the TMT values are abnormally
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high, due to the accidental over-dosing of the TMT experimental data, however once this
is corrected for the experimental observations match the expected values.
5.6.6 Balancing more replicates against fewer observations
Overall, whilst TMT generates more observations of the data per technical repeat, iTRAQ
has the advantage of 2 additional replicates within the sample. This equates to a 33%
increase in available data, which whilst not quite as high as the benefit observed from the
extra spectra has the advantage of being able to capture a wider range of experimental
conditions. As highlighted in chapter 3, methods which merge multiple mass spectrometer
experiments together result in a reduction in the number of identified proteins, and
this effect is more pronounced than the reduction in spectra. In addition, there is the
question of cost. Running a repeat injection, whilst still generating additional costs due to
additional mass spectrometer operation time, is much cheaper than running an additional
experiment and purchasing additional reagents, running additional fractionations, etc.
On balance, this suggests that if more experimental samples are available then an iTRAQ
experiment should be run with additional technical repeat injections to improve the
coverage lost due to reduced observations of the tagging system.
TMT tags show a reduction in complete quantification compared with iTRAQ tags.
Whilst it could be argued that this effect could actually be beneficial in reducing the
effect of compression, as the difference between the highest and smallest values would be
greater, it comes at a significant cost to accuracy when improvements to the spectrometer
operation are made, as isotopic contamination plays a more significant role in determining
the quantification that is observed.
A future expansion on this experiment would take the same experimental methodology
and do a systematic assessment on the systematically increasing ‘plex’ values to determine
if the effect could be predictably modelled. The literature suggests that this effect is
related to the label chemistry rather than the number of labels in the sample, as a
previous study carried out comparing iTRAQ 4-plex and iTRAQ 8-plex labels found that
the 8-plex had improved quantification accuracy for the same labels (Pottiez et al., 2012),
however an objective assessment on whether the number of labels present within a sample
affects the precision and accuracy of those quantifications has not yet been carried out. A
key experiment to demonstrate this would be to compare a series of labelling techniques
systematically – as described above, or to run a series of experiments in a single label
system – such as TMT – but incorporating different numbers of labels in each run (ie.
126 & 127; against 128, 129, 130 & 131 for example).
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General applicability of findings
This study has been focused primarily on Synechocystis, as that is the focus of this thesis,
however previous studies on the tag-based effects observed here have been carried out in
S. cereviseae, H. sapiens and E. coli. Whilst Synechocystis has the complicating factor
of high-abundance photo-system proteins generating an artificially high dynamic range,
the key findings are related to the data in general and how non-specific background noise
reduces the observed data quality. As the compression effect is observed across a number
of different species, and scales with the complexity of the sample, it seems fair to assume
that this is not a Synechocystis-specific effect. Inversely, whilst it was an expected finding,
this data definitively shows that Synechocystis is also subjected to the same compressive
effects that other tag-based analyses have shown.
5.7 Chapter conclusions
In this chapter, the following main findings were identified:
• The Synechocystis proteome has an estimated dynamic range of 1× 104, although
this is likely to be higher due to saturation effects within the model.
• The median concentration of protein within the Synehocystis proteome was estim-
ated to be 11000
th of the total protein in a sample by mass.
• Higher mass proteins (>120 kDa) in Synechocystis are incompatible with spectral-
counting methods of label-free quantification, due to large amounts of stochastic
variation in observable peptides.
– This finding should be generally applicable to higher-mass proteins in other
organisms, and also to proteins with a large number of splice variants in euk-
aryotes.
• In Synechocystis, the largest label-free fold change measurable with the emPAI
method of quantification is 8 × 102, however due to unreliable quantifications at
the lower tail, a practical, accurate fold-change measurement range is closer to 90,
around 10 fold lower than the max estimation.
• TMT tags produce larger amounts of noisier data in a proteomics experiment due to
an increased number of peptide spectral matches, this offers a larger amount of data
for the experimenter to work with which mitigates most of the issues seen between
the two tagging systems. This can be as high as 50% more available spectra in a
TMT experiment.
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– This effect results in a higher number of protein identifications from a dataset,
a result which is emphasised the larger the number of detected peptides is.
• TMT tags showed a higher rate of incomplete tags present at the 1:37.5 range in the
uncomplicated background, with the lower concentration tag not being observed in
75% of cases compared with 56.5% cases for iTRAQ.
– This suggests that iTRAQ tags has the potential to maintain better precision
and accuracy at a wider range of values, and in the case of cleaner signal
experiments (such as ms3 mass spec filtering) will likely produce higher quality
datasets due to more complete sets of quantification data.
– This also means that iTRAQ 8-plex as a tagging system has a higher absolute
range than TMT 6-plex.
• In the experiment, neither iTRAQ nor TMT methods offered suitable resolution to
detect small fold changes (difference of <2-fold) in a complex background similar
to a typical proteomic sample.
– This is emphasised by a combination of a limited number of data points and a
low level of relative precision in both tagging systems, however both systems
demonstrated the ability to differentiate between such cases without the pres-
ence of a complex background, and further investigation should be conducted
into the low fold-change range under ms3 filtering.
• To balance the difference between TMT and iTRAQ tags, more technical repeats
of injections of iTRAQ-labelled samples should be performed.
– An increase from 2 injections to 3 (or a 50% relative increase in injection num-
ber for iTRAQ experiments) should be sufficient to balance the observations
between the two systems, based on the number of observed peptide counts and
assuming accumulation of observations in subsequent experiments are linear.
• Both tagging systems showed a dramatic increase in the number of complete quan-
tifications (25% - 45% observations increasing to 85% - 90%) under a complex
background, demonstrating how pervasive the effect of isotopic contamination is
across both systems.
– This suggests that the majority of tag-based observations previously will only
have observed the very largest changes occurring in the proteome; and so there
is a strong case for re-analysing previously measured systems and conditions
• The compression effect observed under typical experimental conditions for both sets
of tags was similar, but TMT experienced a more pronounced compression effect




214 CHAPTER 6. CONCLUSIONS
6.1 Key findings from this study
Throughout this thesis, a number of novel methods were proposed for improving pro-
teomic investigations – mainly with the organism Synechocystis, but some of which were
generally applicable to proteomics for biotechnological production applications. In this
section, the key conclusions from this thesis will be summarised.
6.1.1 Energy
The key focus of the studies in this thesis were directed towards H2 production. Due to
limitations stated within chapter 1, including a lack of existing infrastructure, exceedingly
high costs, and the large amount of development still needed to make the technology
viable; it appears unlikely that biological H2 production in Synechocystis is a viable
method for producing energy – at least until the price of energy increases substantially
to make it cost effective.
Based on the literature review in chapter two, it seems that despite a number of invest-
igations taking place, it is unlikely that Synechocystis would be viable for organic biofuel
production either – due to a naturally low tolerance to alkane-based biofuels such as bu-
tane or hexane. There is scope for engineering the required resistances into the organism,
but given that other organisms show much more promise in this area it does not seem
like an effective line of investigation. It is possible that there is scope to produce fatty
acids for fuel, however it is more likely that these will be capitalised in another industrial
pipeline, such as animal feed, due to the relative costs involved in their production, and
slightly higher value when applied elsewhere.
Despite this, the natural hydrogenase properties in Synechocystis provide the possibility
for regenerating some energy costs, when considered as part of a holistic bio-production
strategy for animal feed, cosmetics additive production, or synthetic biology engineered
fine chemical production. Due to the large amount of investigation that has been carried
out on its background, Synechocystis has a lot of potential as an engineerable production
host, however as it currently lacks a current high-value market it is unlikely to be an
industrial production leader any time soon. It is, however, likely to provide the key
background findings that will drive forward investigations with other microalgae.
6.1.2 Proteomics
Synechocystis has traditionally posed a number of significant problems for proteomic in-
vestigations, however in the last 5 years many of these appear to have been overcome
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with the advent of advanced mass spectrometers. There are a number of solutions that
have been proposed in chapter 3 to improve the accuracy, repeatability, and quality of
proteomic data gathered from Synechocystis – these include a less biased protein quanti-
fication method (although this needs more robust experimental verification), an improved
extraction method (although this needs to be compared to other novel extraction methods
being utilised in the medical field such as FASP), and methodological tools for assessing
relatively low abundance peptides. When utilising these recommended changes, over a
3-fold increase was observed in the number of protein identifications; however this was
largely biased due to a change in the mass spectrometers over the course of the PhD.
In addition, a novel comparison of quantitative tagging technologies – iTRAQ 8-plex tags
and TMT 6-plex tags – was carried out, to determine which provided better quality data.
It was found that the iTRAQ tags could measure accurately over a broader range of
values, but produced a substantially lower number of peptide identifications, resulting in
an overall reduction of data quality. As a result, the take-home message from chapter 4
was that whilst iTRAQ tags have greater potential for precision, they ultimately lose out
to the TMT tags for statistical reasons on a like-for-like comparison. Performing multiple
injections may be suitable to recover this difference.
A novel informatic study of experimental data, to determine features of the proteomic
background of Synechocystis, was also conducted in chapter 4. This showed that whilst
the phycobiliproteins were by far in abundance, as had been determined in a number of
previous studies of the organism, the remaining proteins generally had a normal distri-
bution. The study could not determine any features about the range of lower-abundance
proteins within the cell, due to a limitation on detection within the proteome, however
a future study could correlate proteomic and transcriptomic findings to determine the
distribution of non-expressed proteins, proteins expressed at low levels, and the protein
distribution identified in this study.
This investigation also highlighted that the very largest proteins in the proteome were in
generally low abundance, however as these were mainly membrane-bound proteins, it is
possible that the experimental dataset – which was generated externally – may have had
some bias in extraction. A further investigation of the data may reveal this bias, and a
tool for detecting this form of bias as standard practice during proteome investigation
would likely be a valuable addition to the proteomic community.
In chapter 5, a novel investigation was carried out on the proteomic changes experienced
by cells under fermentative H2 producing conditions. The findings of this study generally
followed what was expected, based on background investigation into the literature. This
provides valuable information for the proteomic community, as it further verifies the
previous findings and adds to them slightly by considering Synechocystis in a state it
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may have held prior to the event leading to oxygenation of the atmosphere.
6.2 Contributions to science
A number of literature and bibliometric analyses were performed, synthesising new in-
formation from the pre-existing literature.
• One of these has been published, providing an overview to expand future proteomic
studies in biotechnological production. This will contribute to biologically engin-
eered solutions for industrial settings in the future, by linking the bleeding edge
studies in proteomics to industrial applications and synthetic biology.
• The remaining studies provided an in-house description of the current state of the
proteomic field in Synechocystis – whilst an alternative version has been made
available in the literature, it does not contain the same data tables, such as a
summary of all conditions that have been studied with proteomics to date, or a list
of all the methods used and the number of proteins that they generated, nor does it
contain a study on the improvement of proteomic techniques in Synechocystis over
time.
• The data tables described in the point above were used to develop a number of
novel methods described in chapter 3 of this thesis – including the protein extrac-
tion analysis. They also provided the evidence that whilst the field appears to be
advancing in general, the majority of the high-level studies that have been conduc-
ted in Synechocystis have all been conducted by a single lab in China with a high
quality triple-tof mass spectrometer.
Novel processing tools and methods have also been devised, laying the groundwork for
improved proteomic processing through:
• Production of a number of in-house processing scripts, facilitating analysis with
Principal Component Analysis, Heatmaps and clustering, statistical identification
of high abundance proteins, conversion between data formats during downstream
proteomic data analysis
• 3 tools which merge proteomic datasets from separate analyses (as described in
chapter 3, one of which has been included in a publication, and a second that was
emulated in a publication)
• A tool which assigns Gene Ontology terms in a cluster-based analysis, which after
further optimisation will be suitable for publication (chapter 3)
The work contained within this thesis has been put towards:
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• 3 published manuscripts (within chapters 2 + 3), 2 accepted book chapters (within
chapter 1), and 2 manuscripts currently being written (chapters 4 + 5)
• work conducted by 4 partner groups in an EU FP7 grant (Chapter 5 and appendices)
• An industrial summary report for production in E. coli
• Poster presentations at 5 national conferences
• Progress presentations at 5 consortium meetings
Over the course of this PhD, work carried out by the author has led to the propagation
and training of the scientists of tomorrow through:
• Organising, obtaining funding for, supervising, and teaching a team in the interna-
tional Genetically Engineered Machines (iGEM) competition, ultimately resulting
in being awarded a gold medal at the finals in Boston, USA
• Supervision of 4 masters student projects
• Provision of 3 MSc-level university lectures on the topic of computational biology,
synthetic biology, and data processing in proteomics
• Facilitation in the ‘Engineering – You’re hired’ event
• Over 100 hours of facilitator work in the chemical engineering department, including
teaching, introducing key concepts of the biological engineering module, devising a
marking scheme, and marking of lab reports and individual assessments. This was
done for first year, second year and masters level students.
6.2.1 Future work
If work on the topics described in this thesis were to continue and additional funding and
time were made available for experimental verification and further data processing, the
next steps would be:
• Finalisation of the practical methods identified in Chapter 3 – including verification
of the findings for the extraction methods through a robust experimental analysis
and of the protein quantification experiment through a broad-spectrum assessment
of the different methods available beyond the Bradford analysis.
• Completion of the bioinformatic tool for utilising GO terms in a cluster analysis
also described in Chapter 3. This will likely need a robust machine-learning aspect
to solve the optimal-cluster problem, which dictates how the solutions to other
problems would be determined
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• Verification of the background proteome analysis conducted in Chapter 4 with
transcript-level data from the same dataset. This would solve the low-abundance
cut-off issues encountered during the analysis and could also provide an interesting
assessment of the relationship between the RNA and protein levels in Synechocystis
• Inclusion of the other ’omics work described in the appendices within the body
of the thesis. The broad-reaching nature of this study meant that only a single
facet of the overall investigation could be included in the final thesis, however with
additional time to complete the analyses that are currently underway, it would be
helpful to generate a multi-level systems analysis of the many aspects of Synecho-
cystis in an industrial setting. These would include single-day variations occurring
to the background in a large-scale photo-bioreactor, the effects of increased sa-
linity and temperature, a kinetic metabolic assessment of the carbon flux under
light-harvesting mutants, the effects on metabolism of the organism in the event of
environmental release due to an industrial-level contamination event.
– The experimental work for many these studies has already been completed, but
a complete understanding of the body of data would probably require another
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7.1 Pre-amble
This chapter contains a summary of the code and datasets that this thesis is composed
of. The code and data for all methods described in this chapter are available from the
Sheffield University Online Research Data repository – managed through figshare, under
either the creative commons licence for data, or the MIT licence for code. If you need
any further information or data, please contact me by email on andrewlandels [at] gmail
[dot] com.
7.2 Synechocystis growth rates
Growth rates were taken from 50 ml culture grown in 250 ml shaking flasks in multiple
replicates over a period of 2 weeks. The cells were initially grown in BG11 media, then
subbed into BG11 media and Burrows media.
This data shows that switching to the Burrows media did not significantly impact the
rate of growth. Data DOI: http://10.15131/shef.data.5327482
7.3 Synechocystis proteomic data (H2 production)
Synechocystis PCC6803 was grown in two media conditions, standard BG11 and Burrows
media; in two different head-space gas mixtures, air and 100% nitrogen (anaerobic). The
experiment was continued until hydrogen gas was detected in the head-space, then the
samples were collected by centrifugation and flash-frozen in liquid nitrogen. Proteomic
analysis with iTRAQ labels was performed, the data was analysed with the EasyProt
software (Gluck et al., 2013).
The first sheet of this dataset contains the full list of all proteins identified in this ex-
periment, and the proceeding pages contain lists of proteins that were differentially reg-
ulated with statistical significance under the different environmental conditions (media
and headspace). Data DOI: http://10.15131/shef.data.5327476
7.4 Kalb protein quantification, data
A protein quantification method, devised by Kalb and Bernlohr, was utilised to remove
the influence of phycobilisome pigments on protein quantification prior to analysis. Con-
trol samples of bovine serum albumin (BSA) and bovine cytochrome c (cyt) were used
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as standards of known concentration to investigate this method and how it scaled for
individual proteins and mixtures of proteins.
This dataset shows that there was an over-estimation of cyt that scaled linearly, and a
slight underestimation of BSA that did not appear to scale. When combined together,
the effects of the linear scaling were still present, however were reduced by half. Data
DOI: http://10.15131/shef.data.5327485
7.5 Protein Quantification in Synechocystis
In this code, a series of plots (pdf files) were generated from the attached data. This
data was generated from a series of Bradford assays, which was performed as described
previously by Stoscheck.
The code is written in R, and uses the ggplot2 package. The points are plotted and
the lines of fit are generated using a linear model (polynomial, degree 3). The error
region is a dark-grey ribbon, and is generated using the default settings on ggplot. DOI:
http://10.15131/shef.data.5327488
7.6 Densitometry analysis of Synechocystis proteins
Proteins from BG11 and Burrows media were analysed by densitometry, using the soft-
ware imageJ to calculate values for the different protein lanes - briefly, areas were drawn
around regions on the plot and the density of the shading of the pixels was calculated
in these regions. The gel image used to generate this data is included in the online data
repository. The outputted densitometry values are reported in the csv file.
The code in the online repository is written in R, and uses the package ggplot2; initially
the code imports the data, finds the sums the regional densities from each of lanes on the
gel, then generates a bar chart from these values. DOI: http://10.15131/shef.data.
5327500
7.7 Poisson noise model for low-abundance labels in
iTRAQ
Proteomic iTRAQ analyses generate background noise, which can generate false positive
results in very low abundance analyses. In this analysis, a sample dataset (published in
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Chiverton et al) is used to generate a model for noise - this is possible because within the
experiment, two iTRAQ labels were strategically left blank.
This code, written in R, produces two figures. The first is a histogram of the empty
labels in the dataset; and the second is a histogram of a series of values produced using
a Poisson distribution of random noise. This comparison shows that due to the discrete
nature of mass spectrometer data at low intensities (on the scale of individual counts, as
opposed to hundreds or thousands in typical measurements), a Poisson model would need
to be used to accurately model the noise. DOI: http://10.15131/shef.data.5327503
7.8 Merging tag-based proteomic experiments
The code described in this section is split into two separate scripts, both written in
Mathematica. The first (MaxQuant_to_SignifiQuant) converts the data format of files
generated by the program MaxQuant and re-orders them into a format that can be
input to SignifiQuant - a program in the in-house proteomics pipeline available at the
Sheffield University Biological and Chemical Engineering Department. This code reads
one or more files within a relevant directory, collects all peptide information, and writes
a new file containing all required data. As such, it is both a conversion script and also a
data-collecting script.
The second script investigates methods for merging together two biologically replicated
datasets - specifically, one dataset represents a complete experimental replicate of the
other. The theory behind this methodology is described in chapter 4.6. Briefly, this
code examines the label intensity distributions, log-transforms the data, then utilises the
median correction method to generate a fixed median value (0) and scales the data to
generate an equal gradient between the 40th and 60th percentile.
The protein data in the repeat experiment are then scaled by the protein data in the
initial experiment. This slightly disrupts the balancing by median correction, however
not significantly. The data are then plotted against each other in a scatter plot, demon-
strating systematic improvement of the quality of the between-experiment repeatability.
A principal component analysis was then performed, showing a much closer clustering
by experimental condition (principal component 1) than of experimental replication de-
viations (principal component 2), demonstrating success of the method.
This method shows effective combination of two proteomic datasets that are completely
independent experimental repeats, demonstrating for the first time that this methodology
is feasible in tag-based proteomic investigations. DOI: http://10.15131/shef.data.
5327506
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7.9 Cluster Analysis - Using GO terms
This code attempts to cluster proteins by relative intensity under different conditions,
then assign frequencies of Gene Ontology (GO) terms to each of the clusters. The theory
behind the code in this section is described in detail in the aforementioned thesis in
chapter 4.7. The scripts in this section are written in R and Mathematica, and require
the use of the uniprot website to generate the GO terms.
The first part of this pipeline is written in R. The input to this code is tag-based pro-
teomic data, where the first column lists uniprot IDs for the identified proteins, and the
subsequent columns contain protein quantifications (these can be absolute or relative).
Initially, a list of unique proteins are output from the data. This list of uniprot IDs is then
uploaded into a uniprot search. The uniprot table is updated to include all GO terms, by
clicking on the ’columns’ button, selecting the GO Terms drop-down, and checking each
of the boxes. These settings are applied by clicking ’save’ in the top right-hand corner.
Once this is done, the data is downloaded for use further along in the pipeline.
The proteomic data read by the R script is clustered, and using a K-means analysis a
critical cut-off point for the number of clusters is selected. This value is chosen manually,
and is selected based on a "within-groups sum of squares" graph. This graph calculates
the sum of squares distance between all points to a central mean, then applies two means,
creates two clusters, and calculates the sum of squares again. This process is iterated
until 20 means have been applied to the data. This is plotted as the aforementioned
graph, where the analyst is aiming to have the minimum possible number of clusters, but
also the lowest sum of squares. In the worked example provided, 8 clusters were selected
(as highlighted by a verticle line on the plot).
The proteins were grouped into 8 clusters and assigned a side-colour. These clusters
were exported into a csv file for use later. Finally, a heatmap was generated, using the
gplots package, was used from the data. This heatmap had 2 dendrograms - one showing
relatedness of the labels, and the second for the proteins. The selected clusters highlighted
with side colours.
The next part of the analysis was performed in Mathematica. The GO Terms downloaded
from UniProt were linked to each of the proteins on the list. To de-clutter the data and
simplify the analysis, only GO terms with 20 or more unique references from the dataset
were extracted, and the remaining terms were discarded. The set of remaining GO terms
within each cluster were tallied, producing a matrix of GO terms and a count for each
cluster. The values for each cluster were divided by the sum of all observations, producing
values between 0 and 1 for each term in each cluster.
This list was then plotted to show the GO distribution across each of the selected clusters,
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enabling analysis of GO term concentration within clusters of the dataset. DOI: http:
//10.15131/shef.data.5327524
7.10 Proteomic background in Synechocystis with
emPAI
The code for the methodology described below was written in Wolfram Mathematica
(10.1) and the notebook file is "iTRAQ_TMT-complexity_emPAI.nb"
An in-depth proteomic dataset, comprised of 2 8-plex iTRAQ experiments investigating
a mutant against WT Synechocystis under two different conditions, was generated on a
Q-Exactive HF mass spectrometer (data not included in this repository due to size con-
straints). To calculate the emPAI scores, the ‘observable’ peptide values were calculated
as follows. The complete proteome for Synechocystis PCC6803 – Kazusa strain, was
downloaded as a fasta file from uniprot (taxonomy:1111708 – accessed August 2015, 3517
protein entries), which is available in this respository.
This was then merged with the spike-in proteins to make a singular database for analysing
the data, by doing this, effects on statistical methods such as false discovery were equal
between all analyses. The fasta file was processed in Wolfram Mathematica (version
10.1) to generate an in-silico digest of each of the proteins, excluding any peptides that
fell outside a 1000 – 7500 dalton window to replicate the presence of 2+ or 3+ ions
observable in the 500 – 2500 m/z window used during the mass spec experimental scan.





Where Nobserved is the number of unique peptides observed for a given protein, and
Nobservable is the total number of unique peptides that could be observed for a given
protein.
This data was then graphed as a histogram to identify the protein concentration dis-
tribution and dynamic range. Dynamic range was calculated by taking the exponen-
tial of the difference between the maximal and minimal emPAI values. DOI: http:
//10.15131/shef.data.5327539
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7.11 Comparing iTRAQ and TMT isobaric tags
The code presented here was written in R, and uses the ggplot2 package for generating
graphs. The data was generated a QExactive mass spectrometer, and was analysed in
MaxQuant software using the standard data processing pipeline. Included with the code
for this section are the output from the MaxQuant pipeline, namely the ’Evidence’ files,
which contain peptide information and raw/processed quantifications.
The code in this section is a little detailed, due to the style of the experimental design:
the experimental methodology is described in detail in chapter 5 of the aforementioned
thesis. The files have been named in such a manner that they contain a series of switch
identifiers (X_X_X, where X is either 1 or 0 and _ is an identifier for splitting the file-
name string with a regular expression). These were used to trigger switches in the code,
and determined if the dataset being analysed used iTRAQ or TMT tags, was a flat or
extended concentration range of the protein mix, and whether the extended concentration
mix was run in the forwards or reverse direction (the test proteins were flipped during
the experiment, to avoid protein-specific skew).
At the beginning of the code, a number of functions for applying different transformation
to the data are defined:
Tags() generates a matrix of expected tag values for the spike-in proteins.
Corrected.new() turns all the values into ratio values between 0 and 1, relating to the
sum of a given row.
Trim() removes the file extensions from the filenames, to enable correctly labelled graphs.
FlattenData() collects all peptides relating to the spike-in proteins from the data, and
correctly arranges formatting to collapse them into a single matrix where they are aligned
with the expected values based on the experimental design.
RemoveZeros() removes any rows containing 1 or more zeros.
PeptidesQuants() generates a table of spectral counts for: all peptides in a sample, just
the spike-in proteins, with and without 0-values removed. It also counts the number of
proteins identified and the total number of fractions the samples was measured across
(ie. relating to the degree of LC separation)
ScalingMatrix() calculates, based on the expected and observed quantifications from the
data, the scalar that is needed to be applied to the spike-in data to make it equal to the
expected values. This enables iterative investigation of the spiked in proteins, enabling
systematic experimental operator error to be measured by comparing the same mix within
the final experiment after it had been exposed to successive permutations (initial mixing,
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dilution, etc).
ScaleData() applies the scaling matrix to the data in the manner described above.
In the main body of the code, initially the names of the spike-in proteins are given, then
the summary table of counts is produced. After this, a series of plots are generated,
showing the data after successive manipulations have been performed on it. Finally,
the individual plots that make up the final plot from the previous section – where all
transformations have been applied to the data – are produced, in both linear space and
log space.
In the post-section of the code, a number of variations on the plots are produced. These
highlight other features that were explored during the data processing in order to produce










































































































































































































































Rank AC ID Descrip/on Protein Score % Coverage Protein Seq #PSMs #Pep/des #Ambiguous ProtsAmbiguous Prots#Sub‐Prots Sub‐Prots Protein PI Protein Mass (Da)Database GO terms Keywords Job IDs
1 P22358 DNAK2_SYNY3Chaperone protein dnaK2354,054 26,1 MGKVVGIDLGTTNSCVAVMEGGKPTVIANAEGFRTTPSVVGYAKNGDRLVGQIAKRQAVMNPGNTFYSVKRFIGRKFDEITNEATEVAYSVVKDGNGNVKLDCPAQGKQFAPEEISAQVLRKLVDDASKYLGETVTQAVITVPAYFNDSQRQATKDAGKIAGIEVLRIINEPTAASLAYGLDKKDNETILVFDLGGGTFDVSILEVGEGVFEVLATSGDTHLGGDDFDKKIVDFLAGEFQKAEGIDLRKDKQALQRLTEAAEKAKIELSGVSQTEINLPFITATQDGPKHLDTTLSRAKFEEICSDLIDRCGIPVENAIRDAKIDKSALDEIVLVGGSTRIPAVQEVVKKILGKDPNQGVNPDEVVAVGAAIQGGVLSGEVKDILLLDVSPLSLGVETLGGVMTKIIPRNTTIPTKKSETFSTAVDGQSNVEIHVLQGEREMANDNKSLGTFRLDGIPPAPRGVPQIEVTFDIDANGILNVTAKDRGTGKEQSISITGASTLPDTEVDRMVKEAESNAAADKERREKIDRKNQADSLVYQAEKQITELGDKVPAADKIKAEGLIKDLKEAVAQEDDAKIQTVMPELQQVLYSIGSNMYQQAGAEAGVGAPGAGPEAGTSSGGGDDVIDAEFSEPEK40 19 0 0 4,74 67614,221 SynechocystisATP binding (GO:0005524); protein folding (GO:0006457); response to stress (GO:0006950);ATP-binding; Chaperone; Complete proteome; Nucleo ide-binding; Phosphoprotein; Reference proteome; Stress response;[1390935826213]
2 Q55366 Q55366_SYNY3Ferredoxin--nitrite reductase248,233 26,49 MANKFETVKATKDGLAVRAELEHFAQIGWENIPEEDRDLRLKWLGIFFRPVTPGEFMLRFRIPHGLLTSQQLQVIGDIINRYGDRGNGDITTRQNLQVRGIKIEDIPDIFSKLESCGLTSVQSGMDNVRNITGSPVAGLEKDELIDTRDLVQGVQDMITNGGRGNPEFTNLPRKFNIAIEGSRDNSVHAEINDVAFVPAYREGILGFNVVVGGFFSSRRCEAAIPLDAWVQPDQQVVDLCRSILEIYRDHGLRANRQKSRLMWLIDEWGVAKFREEVAAKLPFPLLTAAPKDELDWDKRDHLGVHPQKQAGLNYVGLHVPVGRLYANDFFELSRLADTYGSGEVRLTVEQNLILVNVPDEKLEALLAEPLLTKFRVDPHNLQRSVVSCTGAQFCKFALIETKNRALAMVAALEKELTVPKPVRIHWTGCPNSCGQPQVADIGLMGTKVRKDGKTVDGADVYLGGKVGKDAHLGTCVHKSIPCDELQPLLAQILIEQFGAVRR26 13 0 0 6,3 55927,131 Synechocystis4 iron, 4 sulfur cluster binding (GO:0051539); heme binding (GO:0020037); metal ion binding (GO:0046872); oxidoreductase activity (GO:0016491);4Fe-4S; Complete proteome; Heme; Iron; Iron-sulfur; Metal-binding; Oxidoreductase; Reference pr t ome;[139093 826213]
3 P74227 EFTU_SYNY3Elongation factor Tu243,781 30,58 MARAKFERTKDHVNIGTIGHVDHGKTTLTAAITMTLAELGGAKARKYEDIDAAPEEKARGITINTAHVEYETDSRHYAHVDCPGHADYVKNMITGAAQMDGAILVVSAADGPMPQTREHILLAKQVGVPKLVVFLNKKDMVDDEELLELVELEVRELLSDYDFPGDDIPIVAGSALKAIEGEKEYKDAILELMKAVDDYIDTPEREVDKPFLMAVEDVFSITGRGTVATGRIERGKVKVGEEISIVGIKDTRKATVTGVEMFQKTLEEGMAGDNVGLLLRGIQKEDIERGMVLAKPGSITPHTEFEGEVYVLKKEEGGRHTPFFANYRPQFYVRTTDVTGTIKSYTADDGSAVEMVMPGDRIKMTVELINPIAIEQGMRFAIREGGRTIGAGVVSKILK23 13 0 0 5,21 43733,045 Synechocystiscytoplasm (GO:0005737); GTP binding ( O:0005525); GTPase activity (GO:0003924); translation elongation factor activity (GO:0003746); GTP catabolic process (GO:0006184);Complete proteome; Cytoplasm; Elongation f ctor; GTP-binding; Nucleotide-binding; Protein biosynthesis; Reference proteome;[1390935826213]
4 P29107 ILVC_SYNY3 Ketol-acid reductoisomerase226,607 38,37 MARMYYDQDANLDLLAGKTVAIIGYGSQGHAHALNLKDSGVNVVVGLYSGSKSVAKAEGAGLKVLSVAEAAKAADLIMILLPDEVQKTVYEAEIAPNLVAGNVLLFAHGFNINFAQIVPPADVDVVMAAPKGPGHLVRRTYEQGQGVPALFAVYQDASGQARDYAMAYAKGIGGTRAGILETTFREETETDLFGEQVVLCGGLTALIKAGFDTLVEAGYQPELAYFECLHEVKLIVDLIVEGGLAKMRDSISNTAEYGDLTRGPRIVTEETKAEMRQILDEIQSGQFAREFVLENQAGKPGFTAMRRRESEELIEEVGKDLRAMFSWLKDR27 12 0 0 4,97 35821,872 Synechocystiscoenzyme binding (GO:0050662); ketol-acid reductoisomerase activity (GO:0004455); isoleucine biosynthetic process (GO:0009097); valine biosynthetic process (GO:0009099);Amino-acid biosynthesis; Branched-chain amino id biosynthesis; Complet  proteome; Dir ct r tein sequencing; NADP; Oxid reductase; Reference proteome;[1390935826213]
5 Q55118 PPI3_SYNY3 Putative thylakoid lumen peptidyl-prolyl cis-trans isomerase sll0408226,464 30,87 MQIIKTPLGIITRRGLQLSLLSLLLTMLSLTWAMPGWSLPLNQPMLLGALAQGNAITDPNAILRYALPIDNPEVRRLQDSLEDISNHIRAKRWPAIKKDVRAANLTITLKEDKILAGVPADRQPEAETLLGSIKTDLTALTEAVEAKDKEQVISFRKSALTAIGDLEALMVTDFPFAIPEEFANLPQLKGRATVEMTTNKGPLTIVVDGYSAPINAGNFVDLVQRKFYDGLPFIRSEDFFVTQAGDPPGPEAGFIDPQTKEYRAIPLEILVKGEEGPIYGMTLEDAGMYLPELALPFNAYGAIALARPETEPNGGSSQFFFFKFDTELTPPGFNLMDGRYSVFGYVVDGKETLEQLSEGDKIVSAKVISGADNLVNGNS24 11 0 0 4,77 41385,521 Synechocystisthylakoid lumen (GO:0031977); peptidyl-prolyl cis-trans isomerase activity (GO:0003755); protein folding (GO:0006457); protein peptidyl-prolyl isomerization (GO:0000413);Complete proteom ; Isome ase; Reference proteome; Rotamase; Signal; Thylakoid;[1390935826213]
6 Q54714 PHCB_SYNY3C-phycocyanin beta chain213,284 46,51 MFDVFTRVVSQADARGEYLSGSQLDALSATVAEGNKRIDSVNRITGNASAIVSNAARALFAEQPQLIQPGGNAYTSRRMAACLRDMEIILRYVTYATFTGDASVLEDRCLNGLRETYVALGVPGASVAAGVQKMKEAALDIVNDPNGITRGDCSAIVAEIAGYFDRAAAAVA175 9 0 0 5,17 18126,475 Synechocystisphycobilisome (GO:0030089); mannitol transport (GO:0015797); oxidation-reduction process (GO:0055114); photosynthesis (GO:0015979); protein-chromophore linkage (GO:0018298);3D-structure; Bile pigment; Chromophore; Complete pro eom ; irect tein sequencing; Electron tra sport; Membrane; Methylation; Photosynth sis; Phycobilisome; Reference proteome; Thylakoid; Transport;[1390935826213]
7 Q55318 FENR_SYNY3Ferredoxin--NADP reductase208,108 24,21 MYSPGYVATSSRQSDAGNRLFVYEVIGLSQSTMTDGLDYPIRRSGSTFITVPLKRMNQEMRRITRMGGKIVSIKPLEGDSPLPHTEGIAKPSQSEGSGSEAVANPAPESNKTMTTTPKEKKADDIPVNIYRPKTPYIGKVLENYPLVREGAIGTVQHLTFDLSAGDLRYLEGQSIGIIPPGEDDKGKPHKLRLYSIASTRHGDFGDDKTVSLCVRQLEYQNEAGETVQGVCSTYLCNIKEGDDIAITGPVGKEMLLPPDEDANIVMLATGTGIAPFRAFLWRMFKEQHEDYKFKGLAWLIFGIPKSENILYKDDLEKMAAEFPDNFRLTYAISREQQNAEGGRMYIQHRVAENAEELWNLMQNPKTHTYMCGLKGMEPGIDEAFTALAEQNGKEWTTFQREMKKEHRWHVETY18 12 0 0 5,82 46359,554 Synechocystisphycobilisome (GO:0030089); ferredoxin-NADP+ reductase activity (GO:0004324);Complete proteome; FAD; Flavoprot in; Membrane; NADP; Oxidoreductase; Phycobilisome; Reference proteome; Thylakoid;[1390935826213]
8 P23353 AROC_SYNY3Chorismate synthase203,274 30,66 MGNTFGSLFRITTFGESHGGGVGVIIDGCPPRLEISPEEIQVDLDRRRPGQSKITTPRKEADQCEILSGVFEGKTLGTPIAILVRNKDARSQDYNEMAVKYRPSHADATYEAKYGIRNWQGGGRSSARETIGRVAAGAIAKKILAQFNGVEIVAYVKSIQDIEATVDSNTVTLEQVESNIVRCPDEECAEKMIERIDQVLRQKDSIGGVVECAIRNAPKGLGEPVFDKLEADLAKAMMSLPATKGFEFGSGFAGTLLTGSQHNDEYYLDEAGEWRTRTNRSGGVQGGISNGEPIIMRIAFKPTATIGQEQKTVSNIGEETTLAAKGRHDPCVLPRAVPMVEAMAALVLCDHLLRFQAQCKTL21 11 0 0 5,89 39287,632 Synechocystischorismate synthase activity (GO:0004107); aromatic amino acid family biosynthetic process (GO:0009073); chorismate biosynthetic process (GO:0009423);Amino-acid biosynthesis; Aromatic mino acid biosynthesis; Complete prot ome; Lyase; Reference prot ome;[139 935826213]
9 Q55436 Q55436_SYNY3Slr0848 protein 195,803 37,18 MTRRESANPEVTENSAVVPGQTVDFDIQQQLAELQELLYDSFHIPLTAWSVVDEEKILDQIDVIAEFIPGAVHRAIAILEREQQILQGAELEAQRMIEVAHQEAQRIKDESGIIQKAQYEADQYKAQVQQDCDALQRQVQQECEALQRQTQQECDTLRRQTMGELEQIKQVTHQEIQQFRQQTVQECEALQKQTEQEATEMQRDVDTYADRLLSRLEGELGQMMRSVSQSRQILYENSAEHNATITNRPPVATPSPVLPPSPGPKPPRGDRPRRRSR16 10 0 0 4,88 31790,463 Synechocystis Complete proteome; Reference proteome;[1390935826213]
10 P73971 AMPA_SYNY3Probable cytosol aminopeptidase193,748 25 MQIRGTDYTALTWQGDALALGFFENATEITGDLTQLDDRLEGVLRELIEEKEFKGKAGQKLVSRVGSKTPIKKLILVGLGEIEKFNSQVLGDGAAAIARLAKGEKVKTLGVSLPQREHDPAQTAAILTEGILLALHQDNRFKSDPEDKEIKLTTVELLGLGEQSTAIGKAEKIVSGVILAREMVAAPANEVTPLTFTEIATELAQTYGLELEVLGQTECEALGMGAFLGVAKASELPPQFIHLTYRPANPVKKLAIIGKSLTFDSGGLNIKGAGSGIETMKMDMGGGGATLGAAKAIAQLKPNVEIHFICAATENMISGTAMHPGDILTASNGKTIEVNNTDAEGRLTLADALVFAEKLGVEAIVDLATLTGACIVALGDDIGGLWSPNQELADELKVAADKAGEKFWQMPMESKYFEGLKSPIADMKNTGPRSGGSITAALFLQQFIKETPWAHLDIAGPVWTDKQNGVHNAGATGYPVRTLVQWVLGLAE23 11 0 0 5,05 52165,885 Synechocystiscytoplasm (GO:0005737); aminopeptidase activity (GO:0004177); manganese ion binding (GO:0030145); metalloexopeptidase activity (GO:0008235); proteolysis ( O:0006508);Aminopeptidase; Complete pro eome; Cytoplasm; Hydrol se; Manganese; Metal-binding; Prote se; Ref rence proteome;[1390935826213]
11 P73317 RL2_SYNY3 50S ribosomal protein L2192,431 32,97 MGIRNYRPMTPGTRQASVSDFTEITKSKPEKSLTTNRHDQKGRNNRGVITSRHRGGGHKKLYRIIDFKRNKQNIPARVAAIEYDPNRNARIALLFYTDGEKRYILAPAGLQVGMTVIAGEEAPFEIGNTLPLSRIPLGSEIHNVELVAGRGGQMVRSAGAFAQVVAKEGDYVTIKLPSKEVRMVRKECVATLGRVSNAEFRNLKLGKAGRKRHLGRRPHVRGSVMNPCDHPHGGGEGRAPIGRSGPVSPWGKPALGAKTRNKKKRSSALIVRRRTK16 9 0 0 11,29 30433,158 Synechocystislarge ribosomal subunit (GO:0015934); rRNA binding (GO:0019843); structural constituent of ribosome (GO:0003735); transferase activity (GO:0016740); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprotein; Rib somal protein; RNA-binding; rRNA-bindi g;[1390935826213]
12 P73853 P73853_SYNY3IMP dehydrogenase subunit181,707 25,58 MNITIGRGKTARRAYGIDEIALVPGVRTLDPALADTRWKVGAIEREIPIIASAMDGVVDSRMAVLLSELGALGVVNLEGIQTRYEDPNPILDRIASVGKTEFVGLMQELYAEPIKPELITKRIQEIQAAGGIAAVSLTPVGASKYASTVAEAGADLLFIQATVVSTAHLSPESVESLDLVKLCQEMPMPVVLGNCVTYEVSLELMRAGAAAVLVGIGPGAACTSRGVLGVGVPQPTAIADCAAARDDYLQETGRYVPVIADGGIITGGDICKCIACGADAVMIGSPIARAAEAPGRGFHWGMATPSPVLPRGTRINVGTTGTIREILVGPAKLDDGTHNLLGAIKTSMGTLGAKDMKEMQQVDVVIAPSLLTEGKVYQKAQQLGMGK19 10 0 0 5,32 40234,734 Synechocystisoxidoreductase activity (GO:0016491);Complete proteome; Oxidoreductase; Reference proteome;[1390 35826213]
13 P73722 P73722_SYNY3SOS function regulatory protein181,246 41,38 MEPLTRAQKELFDWLVSYIDETQHAPSIRQMMRAMNLRSPAPIQSRLERLRNKGYVDWTDGKARTLRILHQKPKGVSVIGELKGGELVEADAEEVEKIDFAPLMKKSSVFALRVMSNDLVDDFIVEGDMLILRSVTGEEEIEDGELVAASIKGGKIAIKRYYQDGTKVVLKASNNKGPGQELKASDVEIQGILMGVWRNFQGV34 10 0 0 6,21 22744,208 Synechocystis N  binding (GO:0003677); serine-type endopeptidase activity (GO:0004252); DNA repair (GO:0006281); D A replication (GO:0006260); proteolysis (GO:0006508); regulation of transcription, DNA-dependent (GO:0006355); SOS response (GO:0009432); transcription, DNA-dependent (GO:0006351);Complete proteome; DNA damage; DNA repair; DNA replication -binding; Hydrolase; Reference proteome; Repressor SOS response; Transcription; Tr nscription regulation;[1390935826213]
14 P80505 G3P2_SYNY3Glyceraldehyde-3-phosphate dehydrogenase 2180,048 28,49 MTRVAINGFGRIGRNFLRCWLGRTDSQLEVVGINDTSDPRTNAHLLRYDSMLGKLDADISADENSITVNGKTIKCVSDRNPLNLPWAEWNVDLVIEATGVFVTHEGATKHVQAGAKKVLITAPGKGPNIGTYVVGVNAHEYKHEEYEVISNASCTTNCLAPFGKVINDNFGIIKGTMTTTHSYTGDQRILDASHRDLRRARAAAVNIVPTSTGAAKAVALVIPELQGKLNGIALRVPTPNVSVVDLVVQVEKNTIAEQVNGVLKEAANTSLKGVLEYTDLELVSSDFRGTDCSSTVDGSLTMVMGGDMVKVIAWYDNEWGYSQRVVDLAEIVAKNWK17 10 0 0 6,19 36512,469 Synechocystiscytoplasm (GO:0005737); glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity (GO:0043891); NA  binding (GO:0051287); NADP binding (GO:0050661); glycolysis (GO:0006096);Complete proteome; Cytoplasm; Direc  protein sequencing; Glycolysis; NAD; Oxidoredu ase; Reference proteome;[1390935826213]
15 P73458 P73458_SYNY3Carboxyl-terminal protease179,382 25,06 MLKQKRSLILGTTALLLTTVAVTGVGLRLARSQGYLQDNPKELVDEVWQIVNRTYVDGTFNGEDWVAVRQDYLTRDYKNQEEAYTAIREMLEKLNDPYTRFMSPDEFQSMRIDTSGELTGVGIQITQDQDTKKIVVVAPIEDTPAYNAGILSKDVITKIDGKSTDGMEVDDAVKLIRGKPGTSVVLTIEREGQAIEYPLTRTLIEIHPVRAQVEDINGARVGYIRLNQFSAQASEEMRQAVQKLEKENVVGYIFDLRSNPGGLLYSSVDIARIWLDEGGIVSTVDRRGEVEQQSANKRQLSNRPLVVLVDGGSASASEIVSGALQDNQRAVIVGTKTFGKGLVQSVRELGDGSGMAVTIAKYLTPNGRDINKHGIDPDVEVELTDAQRKELQQNREKVGTLEDPQFARAYEVLMQQVNKTASK12 10 0 0 5,16 46832,931 Synechocystisouter membrane-bounded periplasmic space (GO:0030288); serine-type peptidase activity (GO:0008236); proteolysis ( O:0006508);Complete proteome; Hydrolase; Protease; Reference proteome; Serine protease;[1390935826213]
16 Q05971 CH10_SYNY310 kDa chaperonin 178,711 66,99 MAAISINVSTVKPLGDRVFVKVSPAEEKTAGGILLPDNAKEKPQIGEVVQVGPGKRNDDGTYSPVEVKVGDKVLYSKYAGTDIKLGGDDYVLLTEKDILASVA19 8 0 0 5,38 10859,425 Synechocystiscytoplasm (GO:0005737); ATP binding (GO:0005524); protein folding (GO:0006457); response to stress (GO:0006950);Chaperone; Complete proteome; Cytoplasm; Direct protein sequencing; Reference p oteome; Stress response;[1390935826213]
17 P22034 CH602_SYNY360 kDa chaperonin 2173,871 22,1 MSKLISFKDESRRSLEAGINALADAVRITLGPKGRNVLLEKQYGAPQIVNDGITVAKEIELSNPEENAGAKLIQEVASKTKEIAGDGTTTATIIAQALVREGLRNVAAGANPVALRRGIEKVTTFLVQEIEAVAKPVEGSAIAQVATVSSGNDPEVGAMIADAMDKVTKDGVITVEESKSLNTELEVVEGMQIDRGYISPYFITDSDRQLVEFDNPLILITDKKISAIAELVPVLEAVARAGRPLLIIAEDIEGEALATLVVNKARGVLNVAAIKAPAFGDRRKAVLQDIAILTGGSVISEDIGLSLDTVSLDQLGQAVKATLEKDNTILVAGADKRASAGVKERIEQLRKEYAASDSDYDKEKIQERIAKLAGGVAVIKVGAATETELKDRKLRIEDALNATKAAVEEGIVPGGGTTLIRLAGKIESFKAQLSNDEERVAADIIAKALEAPLHQLASNAGVEGSVIVEKVKEATGNQGYNVITGKIEDLIAAGIIDPAKVVRSALQNAASIAGMVLTTEALVVEKPEPAAPAMPDMGGMGGMGGMGGMGMM15 10 0 0 4,92 57774,336 Synechocystiscytoplasm (GO:0005737); ATP binding (GO:0005524); protein refolding (GO:0042026); response to stress (GO:0006950);ATP-binding; Chaperone; Complete proteome; Cyt plasm; Direct protein sequencing; Nucleotide-binding; Reference proteome; Stress response;[1390935826213]
18 P73304 RS5_SYNY3 30S ribosomal protein S5171,095 53,18 MAKRRKTSREKKEDTNWQERVIQIRRVSKVVKGGKKLSFRAIVVVGNETGQVGVGVGKAGDVIGAVRKGVADGKKQLIEVPLTKSNSITHITNGVSGGAKVVVRPAAPGTGVIAGGAVRTVLELAGVKNILAKQLGSNNPLNNARAAINALETLRTFSEVAEERGVSVEHLYT14 8 0 0 10,73 18241,106 Synechocystissmall ribosomal subunit (GO:0015935); rRNA binding ( O:0019843); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprotein; Rib somal protein; RNA-binding; rRNA-bindi g;[1390935826213]
19 P74689 ILVD_SYNY3 Dihydroxy-acid dehydratase168,078 18 MSNNPRSQVITQGTQRSPNRAMLRAVGFGDDDFTKPIVGIANGYSTITPCNMGINDLALRAEAGLRTAGAMPQLFGTITISDGISMGTEGMKYSLVSREVIADSIETVCNGQRMDGVLAIGGCDKNMPGAMIAMARLNIPSIFVYGGTIKPGHYAGEDLTVVSAFEAVGQYSAGKIDEETLYGIERNACPGAGSCGGMFTANTMSSAFEAMGMSLPYSSTMAAVDGEKADSTEESAKVLVEAIKKQILPSQILTRKAFENAIAVIMAVGGSTNAVLHLLAIANTIGVPLSLDDFETIRHKVPVLCDLKPSGKYVTTNLHAAGGIPQVMKILLVNGILHGDALTITGQTIAEVLADIPDQPPAGQDVIHSWDDPVYQEGHLAVLKGNLATEGSVAKISGVKKPVITGPAKVFESEEDCLEAILAGKIQAGDVVVVRYEGPKGGPGMREMLAPTSAIIGAGLGDSVGLITDGRFSGGTYGLVVGHVAPEAYVGGAIALVQEGDQITIDAGKRLLQLNISEEELAQRRAQWTPPQPRYPRGILAKYAKLVSSSSLGAVTDIDLF20 10 0 0 5,15 58646,222 Synechocystis4 iron, 4 sulfur cluster binding ( O:0051539); dihydroxy-acid dehydratase activity (GO:0004160); metal ion binding (GO:0046872); isoleucine biosynthetic process (GO:0009097); valine biosynthetic process (GO:0009099);4Fe-4S; Am o-acid biosynthesis; Branched-chain amino acid biosynthesis; Complet  proteome; Iron; Iron-sulfur; Lyase; Metal- indi g; Reference proteome;[139093 826213]
20 P73282 P73282_SYNY3Transketolase 165,345 15,37 MVVATQSLDELSINAIRFLAVDAIEKAKSGHPGLPMGAAPMAFTLWNKFMKFNPKNPKWFNRDRFVLSAGHGSMLQYALLYLLGYDSVTIEDIKQFRQWESSTPGHPENFLTAGVEVTTGPLGQGIANGVGLALAEAHLAATYNKPDATIVDHYTYVILGDGCNMEGISGEAASIAGHWGLGKLIALYDDNHISIDGSTDVAFTEDVSKRFEAYGWHVLHVEDGNTDLAAIAKAIEEAKAVTDKPSMIKVTTIIGYGAPNKSDTAGIHGAALGTDEVAATRKNLGWDYAPFEVPQEVLDYTRKAIERGASYEAEWNQAFAQYKTKYPTEAAAFERQLSGALPEGWDKTLASFTPDQKGLATRKYSEECLNALAPVLPELIGGSADLTHSNLTELHCSGDFQKGAYQNRNVHFGVREHAMGAICNGIALHGSGLLPFGATFLIFTDYMRAAIRLSALSEAGVIWVMTHDSIGQGEDGPTHQPIEVLASLRAIPNLTVIRPADGNETSGAYKVAIAKAKENAPTLLSLTRQAVPNLPGTSIDAVAKGAYTIVDSEGVPELILIGTGSEVQLCVAAAEKLAAQGKKVRVVSMPSWELFETQDAAYKESVLPKAVTKRLSVEAATNFGWHKYVGTEGDTVSIETFGASAPGGVCLEKFGFSVDNVLAKAKTLLS16 9 0 0 5,4 71725,256 Synechocystismetal ion binding (GO:0046872); transketolase activity (GO:0004802);Calcium; Complete proteome; Magnesium; Metal-binding; Reference proteome; Thiamine pyrophosphate; Transferase;[1390935826213]
21 P73479 P73479_SYNY3Succinate dehydrogenase flavoprotein subunit164,321 18,78 MLEQDVVIVGGGLAGCRAALEIKRLAPDTKVAIVAKTHPIRSHSVAAQGGIAASLKNVDAEDSWEAHAFDTVKGSDYLADQDAVEILTKEAPEVIIELEHLGVLFSRLPDGKIAQRAFGGHSHNRTCYAADKTGHAILHELVNNLRRNKVEIYDEWYVMKLIYEEGEAKGLVMYEIATGRIEIVRAKAVMVATGGYGRVYNTTSNDYASTGDGLAMAAIAGIPLEDMEFVQFHPTGLYPVGVLISEAVRGEGAYLINSEGRRFMEDYAPSRMELAPRDITSRAITLEIRAGRGVNADGSAGGPYVYLDLRHMGREKIMSRIPFCWEEAHRLVGIDAVEQPMPVRPTVHYCMGGIPVNTDGRVRKNANELTEGFFAAGECACVSVHGGNRLGSNSLLECVVYGRRTGRSIAEYVQGRSLPEIDEAVYKTEAQTRIDQLLNQQGTVRINTLRQAFQDCMTSHCGVFRSESFMAEGLEQVQNLKAQYGQIFLDDKQPQWNTEVIEALELQSIMAVGELILTSAIQRQESRGSHAREDFPSRDDEQFLRHTLASFDGEQIKVEYMPVVINRFEPKERKY12 10 0 0 5,51 63702,213 Synechocystisflavin adenine dinucleotide binding (GO:0050660); oxidoreductase activity, acting on the CH-CH group of donors (GO:0016627); electron transport chain (GO:0022900);Complete proteome; eference proteome;[1390935826213]
22 Q54715 PHCA_SYNY3C-phycocyanin alpha chain161,086 33,33 MKTPLTEAVSTADSQGRFLSSTELQIAFGRLRQANAGLQAAKALTDNAQSLVNGAAQAVYNKFPYTTQTQGNNFAADQRGKDKCARDIGYYLRIVTYCLVAGGTGPLDEYLIAGIDEINRTFDLSPSWYVEALKYIKANHGLSGDARDEANSYLDYAINALS48 6 0 0 5,79 17586,599 Synechocystisphycobilisome (GO:0030089); oxidation-reduction process (GO:0055114); photosynthesis (GO:0015979); protein-chromophore linkage (GO:0018298);3D-structure; Bile pigment; Chromo h r ; Complete proteome; Direc  protein sequencing; Electron transport; Membr n ; Photosynthesis; Phycobilisome; Reference proteome; Thylakoid; Transport;[1390935826213]
23 P77972 ENO_SYNY3 Enolase 155,833 21,76 MLSKVPATIEEIAAREILDSRGRPTIEAEVRLESGAHGIAQVPSGASTGSFEAHELRDGDPKRYDGKGVEKAVRNVTEKIAPVVEGLDAFDQMAVDQAMIDRDGTDNKKELGANAILGVSLATAKAAAAELAIPLYRYLGGPLANVLPVPMMNVINGGAHADNNVDFQEFMIMPVGAETFKEALRWGAEVFAVLGKVLKERKLLSGGVGDEGGYAPNLTSNQQALDILIEAIEQAGYKPGSQIALAMDIAASEFFKNGQYEYDGGSHSPQEFIDYQAKLVSQYPIVSIEDGLHEDDWESWKGLTTSLGTKTQLVGDDLMVTNPVRLQKSIDLGVANAILIKLNQIGTLSETLETISLATRHSYRSVISHRSGETEDTTIADLAVATRVGQIKTGSLCRSERVAKYNRLLRIEDELGDRAVYAPKIGLGPKHS14 9 0 0 5,07 46528,656 Synechocystiscell surface (GO:0009986); extracellular region (GO:0005576); phosphopyruvate hydratase complex (GO:0000015); magnesium ion binding (GO:0000287); phosphopyruvate hydratase activity (GO:0004634); glycolysis (GO:0006096);Complete proteome; Cytoplasm; lycolysis; Lyase; Magnesi m; Metal-binding; Ref rence proteome; Secret d;[1390935826213]
24 P23349 RL7_SYNY3 50S ribosomal protein L7/L12155,05 42,19 MSAATDQILEQLKSLSLLEASELVKQIEEAFGVSAAAPVGGMVMAAAAAAPAEAAEEKTEFDVILEEVPADKKIAVLKVVRTITGLGLKEAKELVESTPKAIKEATGKDDAEAIKKQIEEAGGKAAVK66 8 0 0 4,82 13259,308 Synechocystisribosome (GO:0005840); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Direct protein sequencing; Reference proteome; Ribonucleoprotein; Ribosomal protein;[1390935826213]
25 Q59978 GRPE_SYNY3Protein GrpE 153,865 37,35 MNEDQVSLENQTNPVSPEASDVPAVTPEESPQPTDAVLGEPSGEQSEDPRIGAATETEGGPLEQEKSSEEIIAILQKDLASHRQELAEQSEQLDSIKKRYVALAAEFDNFRKRTQREKEEQAKLIKGRTITELLPVVDNFERARTQIKPNSDGENQIHKSYQGVYKNLVDSLKGLGVAPMRPEGKPFDPKYHEAMLREPTAEYPEDTVIEELVRGYLLDDIVLRHSMVKVAVAPEEGAEVVNGEAGANP14 8 0 0 4,65 27567,598 Synechocystiscytoplasm (GO:0005737); adenyl-nucleotide exchange factor activity (GO:0000774); protein folding (GO:0006457); response to stress (GO:0006950);Chaperone; Complete pr eome; Cytoplasm; Reference proteome; Stress response;[1390935826213]
26 P73308 RL5_SYNY3 50S ribosomal protein L5150,692 38,89 MTQRLKTLYQETILPKLQEEFGYKNIHQVPKLTKVTVNRGLGEASQNAKALESSLTELATITGQKPVVTRARKAIAGFKIREGMPVGVMVTLRSERMYAFLDRLINLALPRIRDFRGISPNSFDGRGNYSLGIREQLIFPEIDYDTIDQIRGMDVSIITSAQTDEEGRALLKALGMPFRS14 7 0 0 9,81 20230,434 Synechocystisribosome (GO:0005840); rRNA binding (GO:0019843); structural constituent of ribosome (GO:0003735); tRNA binding (GO:0000049); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprot i ; Ribosomal protein; RNA-binding; rRNA-binding; tRNA-binding;[1390935826213]
27 P77969 HEM2_SYNY3Delta-aminolevulinic acid dehydratase149,742 24,46 MFPTIRPRRLRQTDVLRRMVRENTLTVNDLIYPLFAVPGNAIAKEVVSMPGVYQLSVDKIVDEAKEVRDLGIPAIILFGIPEDKDTDATGAWHDCGIVQKATEAVKKAVPDLVVIVDTCLCEYTNHGHCGYLETGDLTGRVLNDPTLELLKKTAVSQANAGADVIAPSGMMDGFVQAIREALDDHDFQNIPILSYAAKYASAYYGPFRDAADSSPQFGDRRTYQMDPGNSREALKEVELDLLEGADMVMVKPALSYMDIIWRIKEMTNLPVAAYNVSGEYSMVKAAALNGWIDEQKVTLETLTSFKRAGADLILTYHAKDAARWLQD13 9 0 0 4,94 36163,346 Synechocystismetal ion binding (GO:0046872); porphobilinogen synthase activity (GO:0004655); protoporphyrinogen IX biosynthetic process (GO:0006782);Complete proteome; Heme bi synthesis; Lyase; Magnesium; Metal-binding; Porphyrin biosynthesis; efe ence proteome; Zinc;[1390935826213]
28 P72839 P72839_SYNY3Slr1301 protein 148,307 17,2 MLYLAEIKKQTKNFLGGYKTELKLLACQHSDQTWSALPNEENFQTDDMGEAREGTLWILNLSNSRSLQGTPEVAAPELVRQLQKLSRLSEKLKEQQSEIERWRESLTFQFQELSQREMEIEAKESEVEDRANQLAQVEQQRYEVEQARQRLEGEREQLTELQQQFGSLLENSAENREVLQGILHRLGAYPEAIPALFTAAANAQQSTDQQQQIFNDHWQMVTSAEQELGRNQALIQQKQELLVIHGQELDAIAQELAKAKVQLTVEQEGVVNGQKLLTQLKAEIAAAESLQTNLYRLATGAMSVDKDHQIDVQHLEQLPLGELEETVKALQTDMQKLARFVNDQEEELTLQCEEVEAIQARLEAADEYSRLTIEEELNEEQERKRMLDETLIGQRRNLKERQEVLLQHLKILRRRQGIVEIDDSIPNIDLDPVIQQLEGRKHKLQEEKNKLEQNLQSTRQGLAEIETMIASLDQQYQAKKTNFEQNRREVEDLQKQTAALEAQGRLLRAALQPLQDQLDVMKPRLQEMQTLLFGG12 8 0 0 4,83 61692,317 ynechocystis Complete proteome; Reference proteome;[1390935826213]
29 Q55707 Y617_SYNY3Uncharacterized protein sll0617145,883 32,21 MGLFDRLGRVVRANLNDLVSKAEDPEKVLEQAVIDMQEDLVQLRQAVARTIAEEKRTEQRLNQDTQEAKKWEDRAKLALTNGEENLAREALARKKSLTDTAAAYQTQLAQQRTMSENLRRNLAALEAKISEAKTKKNMLQARAKAAKANAELQQTLGGLGTSSATSAFERMENKVLDMEATSQAAGELAGFGIENQFAQLEASSGVEDELAALKASMAGGALPGTSAATPQLEAAPVDSSVPANNASQDDAVIDQELDDLRRRLNNL13 7 0 0 5,02 28905,339 Synechocystis Coiled coil; Complete proteome; Reference proteome;[1390935826213]
30 P72761 CCMK2_SYNY3Carbon dioxide-concentrating mechanism protein CcmK homolog 2145,777 53,4 MSIAVGMIETRGFPAVVEAADSMVKAARVTLVGYEKIGSGRVTVIVRGDVSEVQASVSAGIEAANRVNGGEVLSTHIIARPHENLEYVLPIRYTEEVEQFRTY22 6 0 0 5,66 11134,696 Synechocystis 3D-structure; Complete proteome; Reference proteome;[1390935826213]
31 Q55665 GSA_SYNY3 Glutamate-1-semialdehyde 2,1-aminomutase145,131 21,71 MVNATPFITTKSEEIFAAAQHLMPGGVSSPVRAFKSVGGQPIVFDRVEGAQIWDVDGNQYIDYVGTWGPAICGHAHPDVISALKQALDKGTSFGAPCAQENVLAEMVIDAVPSIEMVRFVNSGTEACMSVLRLMRAFTGREKIIKFEGCYHGHADMFLVKAGSGVATLGLPDSPGVPSNTTKATLTAPYNDLEAVKALFVENPDSIAGVILEPVVGNAGFILPDAGFLEGLRELTKEYGALLVFDEVMTGFRVSYGGAQARFGITPDLTTLGKVIGGGLPVGAYGGREEIMAMVAPAGPMYQAGTLSGNPLAMTAGIKTLEILQKPGSYEYLDKITKRLVDGLLAAAQDAGHEVCGGSISAMFGIFFAPGPVRNYEDAKLADTNKFARFHRGMLERGIYLAPSQYEAGFPSLAHTQEQIDQTIAVAKEVFATL20 8 0 0 5,21 45891,634 Synechocystiscytoplasm (GO:0005737); glutamate-1-semialdehyde 2,1-aminomutase activity (GO:0042286); pyridoxal phosphate binding (GO:0030170); transaminase activity ( O:0008483); chlorophyll biosynthetic process (GO:0015995); protoporphyrinogen X biosynthetic process ( O:0006782);Chlorophyll biosynth sis; Compl te proteome; Cytopl m; Isomerase; Porphyrin biosynthesis; Pyridoxal phosphate; Reference proteome;[1390935826213]
32 P73728 Y1621_SYNY3Putative peroxiredoxin sll1621144,654 31,75 MTPERVPSVVFKTRVRDESVPGPNPYRWEDKTTEQIFGGKKVVLFSLPGAFTPTCSSNHLPRYEQLFEEFQALGVDDIICLSVNDAFVMFQWGKQIGADKVKLLPDGNGEFTRKMGMLVEKSNLGFGMRSWRYSMFVNDGKIEKMFIEPEFGDNCPVDPFECSDADTMLAYLKGAEAPGVSEPVKAFVG18 7 0 0 5,04 21167,235 Synechocystisperoxidase activity (GO:0004601); peroxiredoxin activity (GO:0051920);Complete proteome; Oxidoreductase; Peroxidase; Redox-active center; Reference proteome;[1390935826213]
33 P52231 THIO_SYNY3 Thioredoxin 141,198 67,29 MSATPQVSDASFKEDVLDSELPVLVDFWAPWCGPCRMVAPVVDEISQQYEGKVKVVKLNTDENPNTASQYGIRSIPTLMIFKGGQRVDMVVGAVPKTTLASTLEKYL18 6 0 0 5 11748,533 Synechocystisprotein disulfide oxidoreductase activity (GO:0015035); cell redox homeostasis (GO:0045454); glycerol ether metabolic process (GO:0006662);C mplete proteome; Direct protein sequencing; Disulfid  bond; Electron transport; R dox-active center; Refer nce proteome; Transport;[1390935826213]
34 Q01952 PHAB_SYNY3Allophycocyanin beta chain141,198 44,1 MQDAITAVINSADVQGKYLDGAAMDKLKSYFASGELRVRAASVISANAATIVKEAVAKSLLYSDVTRPGGNMYTTRRYAACIRDLDYYLRYATYAMLAGDASILDERVLNGLKETYNSLGVPISSTVQAIQAIKEVTASLVGADAGKEMGVYLDYICSGLS25 6 0 0 6,25 17215,645 Synechocystisphycobilisome (GO:0030089); oxidation-reduction process (GO:0055114); photosynthesis (GO:0015979); protein-chromophore linkage (GO:0018298);Bile pigment; Chromophor ; Complete proteome; Direct protein sequencing; Electron transport; Membrane; Methylation; Photosynthesis; Phycobilisome; Reference proteome; Thylakoid; Transport;[1390935826213]
35 P73057 Y1847_SYNY3Nucleoid-associated protein slr1847140,73 55,26 MAQGKGFGFGLGKIKELQEAFQKAQQVQEGAKVLQEELERMEIPGKSADGLVTVLMSGNQEPLSIEIDPSALEKGAEGLSASVTEAMKAAYAESTETMRSKMEELTSGLNLPGM19 7 0 0 4,71 12134,819 Synechocystisbacterial nucleoid (GO:0043590); cytoplasm (GO:0005737); DNA binding (GO:0003677);Complete proteome; Cytoplasm; DNA-binding; Reference proteome;[1390935826213]
36 P73530 RS1A_SYNY330S ribosomal protein S1 homolog A140,238 23,17 MVSQTSTATIGFTLEDFAALLDKYDYHFSPGDIVAGTVFSMESRGALIDIGAKTAAYIPIQEMSINRVDDPEEVLQPNETREFFILTDENEDGQLTLSIRRIEYMRAWERVRQLQAEDATVRSNVFATNRGGALVRIEGLRGFIPGSHISAREAKEDLVGEDLPLKFLEVDEERNRLVLSHRRALVERKMNGLEVAQVVVGSVRGIKPYGAFIDIGGVSGLLHISEISHDHIDTPHSVFNVNDEIKVMIIDLDAERGRISLSTKQLEPEPGAMLKDRDLVNEMADEMAEIFRQKRLAEAQGIPYEPPTSVDDTDDEEDESLAVSAVDE9 8 0 0 4,56 36570,064 Synechocystisribosome (GO:0005840); RNA binding (GO:0003723); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference proteome; epeat; Ribonucle p otein; Ribosomal protein; A-binding;[1390935826213]
37 P73418 DBH_SYNY3 DNA-binding protein HU136,95 40 MNKGELVHAVTDKAKEQLGESITKKEVDAVISAAIDCIMEVVAEGEKVTLVGFGSFEARERKEREGRNPKTGDKMLIPATKVPAFSAGKMFKDKVAPEKK42 7 0 0 9,04 10890,647 SynechocystisDNA binding (GO:0003677); chromosome condensation (GO:0030261);Complete proteome; DNA condensation; DNA-binding; Reference proteome;[1390935826213]
38 P74281 P74281_SYNY3Soluble hydrogenase 42 kD subunit136,127 24,22 MDNKQMLMIPGPTPVPEKVLLAMAKHPIGHRSGDFSKIIAELTANLKWLHQTENDVLMLTTSGTGAMEASIINFLSPGDRVLVGNNGKFGDRWVKVAKTFGLAVEEIKAEWGKALDPNDFKTLLEADSDKTIKALIITHSETSTGVLNDLAAINAAAKAHGGALMIVDAVTSLGATPVAIDDLGLDVVASGSQKGYMIPPGLGFVSVSAKAWQAYETATIPRFYLDLKKYKKSTDEDSSPFTPPINLMYGLQASLQMMKAEGLDAIFTRHQRHTNATRGAMKALNLPLFAPDNAASNAITAVAPLGVEAEKIRSTMRKKFDIAMAGGQDHLKGKIFRIGHLGFVCDRDILSCIGALEATLIELGYEGVTPGSGVAAAAGVLAKG19 8 0 0 7,13 40768,131 Synechocystiscatalytic activity (GO:0003824); pyridoxal phosphate binding (GO:0030170);Complete proteome; Pyridoxal phosphate; Reference proteome;[1390935826213]
39 P74229 RS7_SYNY3 30S ribosomal protein S7132,427 46,15 MSRRGNVKKRPVPPDPVYNSTLLSMTIRRVMRSGKKSLASSIVYNALASVGEKTGEDPLEVFEKAIKNLTPLVEVKARRVGGATYQVPMEVRPARGTALALRWLVHFSRARGGRTMESKLANEIMDAANETGAAIKKREETHRMAEANKAFAHYRY19 7 0 0 10,57 17384,149 Synechocystissmall ribosomal subunit (GO:0015935); rRNA binding (GO:0019843); structural constituent of ribosome (GO:0003735); tRNA binding (GO:0000049); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprotein; Rib somal protein; RNA-binding; rRNA-binding; tRNA-binding;[1390935826213]
40 P72870 PHAC_SYNY3Allophycocyanin subunit alpha-B132,221 39,75 MSVVSQVILQADDQLRYPTSGELKGIQAFLTTGAQRIRIAETLAENEKKIVDQAQKQLFKKHPEYRAPGGNAYGQRQYNQCLRDYGWYLRLVTYGVLAGNKEPIETTGLIGVKEMYNSLNVPVPGMVDAVTVLKDAALGLLSAEDANETAPYFDYIIQFMS16 6 0 0 5,86 17923,451 Synechocystisphycobilisome (GO:0030089); oxidation-reduction process ( O:0055114); photosynthesis (GO:0015979); protein-chromophore linkage (GO:0018298);Bile pigment; Chromophor ; Complete proteome; Electron transport; M mbrane; Methylation; Photosynthesis; Phycobilisome; Reference proteome; Thylakoid; Transport;[1390935826213]
41 P74392 P74392_SYNY3Sll0274 protein 128,793 31,63 MLMNFLVICQKFFTPNLFPWKAIARVQREKPQSLGRWQFVVRTGILVATFILALGSLASPSLALDYNRGNLVGADFSHQDLRGSIFDHANLRGADFTGANLQGARFFSANMDGAILEGADARGVDFESARLTHANLRNARLEGSFGTNTKFGEVDIEGADLTDIILRPDTEDYLCGLAKGTNPVTGRETKETLFCP12 6 0 0 6,3 21473,395 Synechocystis Complete proteome; Reference proteome;[1390935826213]
42 P72827 FUTA1_SYNY3Iron uptake protein A1128,589 20,28 MVQKLSRRLFLSIGTAFTVVVGSQLLSSCGQSPDAPIADTPGEQQEINLYSSRHYNTDNELYAKFTAETGIKVNLIEGKADELLERIKSEGANSPADVLLTVDLARLWRAEEDGIFQPVQSEILETNVPEYLRSPDGMWFGFTKRARVIMYNKGKVKPEELSTYEELADPKWKGRVIIRSSSNEYNQSLVASLVVADGEESTLAWAKGFVSNFAREPQGNDTAQIEAVSSGEADLTLANTYYMGRLLESEDPAQKAIAENVGVFFPNQEGRGTHVNVSGVGVVKTAPNREGAVKFIEFLVSEPAQAFLAQNNYEYPVLAGVPLNKSVASFGEFKSDTTSLDKLGPALAPATKIMNEAGWK13 8 0 0 4,92 39370,263 Synechocystisplasma membrane (GO:0005886); thylakoid membrane (GO:0042651); metal ion binding (GO:0046872); ion transport (GO:0006811); iron ion homeostasis (GO:0055072);3D-structure; Cell membrane; Co plete proteome; Ion transport; Iron; Iron transport; Lipoprotein; Membrane; Metal-binding; Palmitate; Reference proteome; Signal; Thylakoid; Transport;[1390935826213]
43 P52415 GLGC_SYNY3Glucose-1-phosphate adenylyltransferase127,816 19,13 MCCWQSRGLLVKRVLAIILGGGAGTRLYPLTKLRAKPAVPLAGKYRLIDIPVSNCINSEIVKIYVLTQFNSASLNRHISRAYNFSGFQEGFVEVLAAQQTKDNPDWFQGTADAVRQYLWLFREWDVDEYLILSGDHLYRMDYAQFVKRHRETNADITLSVVPVDDRKAPELGLMKIDAQGRITDFSEKPQGEALRAMQVDTSVLGLSAEKAKLNPYIASMGIYVFKKEVLHNLLEKYEGATDFGKEIIPDSASDHNLQAYLFDDYWEDIGTIEAFYEANLALTKQPSPDFSFYNEKAPIYTRGRYLPPTKMLNSTVTESMIGEGCMIKQCRIHHSVLGIRSRIESDCTIEDTLVMGNDFYESSSERDTLKARGEIAAGIGSGTTIRRAIIDKNARIGKNVMIVNKENVQEANREELGFYIRNGIVVVIKNVTIADGTVI11 8 0 0 6,23 49366,439 SynechocystisATP binding (GO:0005524); glucose-1-phosphate adenylyltransferase activity (GO:0008878); glycogen biosynthetic process (GO:0005978);TP-binding; Carbohydrate met bolism; Complet  proteome; Glycogen biosynthesis; Glyc ge  metabolism; Nucleotide-binding; Nucleotidyltransferase; Reference proteome; Transferase;[1390935826213]
44 P72704 PPI1_SYNY3 Probable peptidyl-prolyl cis-trans isomerase sll0227126,968 28,46 MRILPNISRATWFVGIFFVVNILLTACNQPSANSSAEPSPTETNSPVAQVTTDPYKDYKPRLNGKATVEMMVNGQPIIIEVDGENAPITAGNFVDLVEQGFYNGLTFHRVVDGFVAQGGDPKGDGTGGYVDKNTQRPRNIPLEIKVDPAVENAPETPVYSRALGNQAGFPVMLPHKTGAVAMARSQMPDSASSQFYFTLSDETGFLDGDYAVFGYVTQGMDVVLKIKQGDKIQSAKVITGQNNLEK18 6 0 0 5,1 26580 Synechocystisouter membrane-bounded periplasmic space (GO:0030288); peptidyl-prolyl cis-trans isomerase activity (GO:0003755); protein folding (GO:0006457); protein peptidyl-prolyl isomerization (GO:0000413);Complete proteome; Isomerase; Reference prot ome; Rotama e; Signal;[1390935826213]
45 P73152 Y982_SYNY3Uncharacterized thylakoid-associated protein sll0982124,302 46,09 MTTNNSTLLDTIQQGFRITVGATASLVETLQDPQKRQGTFQDLQQEWDQRASQWAQKGTTTETEARQYVDQLLAQWRQSLPNPLSKTTATGSNNIIDFATAKRELDRLTEEIATLKGELAQDKPGTEG8 5 0 0 4,95 14282,752 Synechocystisthylakoid membrane (GO:0042651);Coiled coil; Complete proteome; Membrane; Reference proteome; Thylakoid;[1390935826213]
46 P74456 RRF_SYNY3 Ribosome-recycling factor122,287 30,77 MKLAELKDHMQKSVEATQRSFNTIRTGRANASLLDRITVEYYGAETPLKSLATIGTPDASTIVIQPFDMGSIGTIEKAISLSDLGLTPNNDGKVIRLNIPPLTAERRKELVKVAGKLAEEGKVAIRNIRRDAVDEVRKQEKNSDISEDEARDLQEEIQKLTDQSTKRIDELLAAKEKDITTV23 7 0 0 6,01 20185,962 Synechocystiscytoplasm (GO:0005737); translational termination (GO:0006415);Complete proteome; Cytoplasm; Protein biosynthesis; Reference proteome;[1390935826213]
47 Q01951 PHAA_SYNY3Allophycocyanin alpha chain121,168 31,68 MSIVTKSIVNADAEARYLSPGELDRIKAFVTGGAARLRIAETLTGSRETIVKQAGDRLFQKRPDIVSPGGNAYGEEMTATCLRDMDYYLRLVTYGVVSGDVTPIEEIGLVGVREMYRSLGTPIEAVAQSVREMKEVASGLMSSDDAAEASAYFDFVIGKMS37 5 0 0 4,98 17411,829 Synechocystisphycobilisome (GO:0030089); oxidation-reduction process (GO:0055114); photosynthesis (GO:0015979); protein-chromophore linkage (GO:0018298);Bile pigment; Chromophor ; Complete proteome; irect protein sequencing; Electron transport; Membrane; Methylation; Photosynthesis; Phycobilisome; Reference proteome; Thylakoid; Transport;[1390935826213]
48 P10549 PSBO_SYNY3Photosystem II manganese-stabilizing polypeptide120,632 21,9 MRFRPSIVALLSVCFGLLTFLYSGSAFAVDKSQLTYDDIVNTGLANVCPEISSFTRGTIEVEPNTKYFVSDFCMEPQEYFVKEEPVNKRQKAEYVKGKVLTRQTTSLEQIRGSIAVGADGTLTFKEKDGIDFQPITVLLPGGEEVPFFFTVKNFTGTTEPGFTSINSSTDFVGDFNVPSYRGAGFLDPKARGLYTGYDNAVALPSAADKFRTNKKETPLGKGTLSLQVTQVDGSTGEIAGIFESEQPSDTDLGAKEPLDVKVRGIFYGRVDTDV21 7 0 0 4,89 29911,705 Synechocystiscell outer membrane (GO:0009279); extrinsic to membrane (GO:0019898); integral to membrane (GO:0016021); photosystem II oxygen evolving complex (GO:0009654); plasma membrane-derived thylakoid photosystem II (GO:0030096); calcium ion binding (GO:0005509); photosynthesis (GO:0015979); photosystem II stabilization (GO:0042549);Complete proteome; Manganese; hotosy thesis; hotosystem II; Reference proteome; Signal;[1390935826213]
49 P73319 RL4_SYNY3 50S ribosomal protein L4119,934 24,76 MVDCIVKNWQGEEVGNASLTLRVAKEENAAHIVHRALVRQQNNARQGNASAKTRAEVRGGGRKPWKQKGTGRARAGSIRSPLWRGGGVIFGPKPRDYSQKMNRKERRLALRTAIASRADNMVVVEAFGDQFSQPKTKELATALTRWGAKPEKRVLLILDEIPENVFLSGRNIPYLKILRADNLNIYDVLVADTIVATATALEKIQEVYGE12 8 0 0 10,3 23355,84 Synechocystisribosome (GO:0005840); rRNA binding (GO:0019843); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprot i ; Ribosomal protein; RNA-binding; rRNA-binding;[1390935826213]
50 P74494 NDK_SYNY3 Nucleoside diphosphate kinase119,869 39,6 MERTFIMIKPDGVQRQLIGEIVGRFEKKGFKLVAMKVMTVSQELAEKHYEALNDKPFFSGLVNFICSSPVVAMVWEGNSIVSTSRQMIGATDPHAAAPGTIRGDYGVSVGRNIIHGSDAIETAKREISLWFKDEEVNEWDATLNPWLYE18 5 0 0 5,6 16692,117 Synechocystiscytoplasm (GO:0005737); ATP binding (GO:0005524); metal ion binding (GO:0046872); nucleoside diphosphate kinase activity (GO:0004550); CTP biosynthetic process (GO:0006241); GTP biosynthetic process (GO:0006183); UTP biosynthetic process (GO:0006228);ATP-binding; Complete proteome; Cytoplasm; Direct protein sequencing Kinase; Magnesium; M tal-binding; Nucleotide metabolism; Nucleotide-binding; Phosphoprotein; Reference proteome; Transferase;[1390935826213]
51 P74410 RS16_SYNY330S ribosomal protein S16116,577 51,22 MIKLRLKRFGKKREVSYRIVAMHSTTRRDGRPLEELGFYNPRTDETRLDVPAIVKRLKEGAQPTDTVRSILTKAQVFEQLKA14 6 0 0 10,73 9556,168 Synechocystisribosome (GO:0005840); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference prote me; Ribonucleoprotein; Ribos mal protein;[1390935826213]
52 P73488 P73488_SYNY3Sll1130 protein 113,437 46,96 MNTIYEQFDVVIVPVPFTDRQSDIRRPALILSDAPAFNNRIGHSVMAMITSAKNAPWPLDTPIEDTRSAGLFTPSVVRMKLFTLEHKYILDCVGSLSKQDRLMVKSAFPHVFKLG28 5 0 0 9,3 12933,084 Synechocystisplasma membrane-derived thylakoid photosystem II (GO:0030096); DNA binding (GO:0003677);Complete proteome; Reference proteome;[1390935826213]
53 P73826 FABG2_SYNY3-oxoacyl-[acyl-carrier-protein] reductase 2113,389 24,17 MLSLGLEDKVIVVTGGNRGIGAAIVKLLQEMGAKVAFTDLATDGGNTEALGVVANVTDLESMTAAAAEITDKLGPVYGVVANAGITKDNFFPKLTPADWDAVLNVNLKGVAYSIKPFIEGMYERKAGSIVAISSISGERGNVGQTNYSATKAGVIGMMKSLAREGARYGVRANAVAPGFIDTEMTLAIREDIREKITKEIPFRRFGKPEEIAWAVAFLLSPVASSYVTGEVLRVNGAHHT17 7 0 0 6,76 25333,131 Synechocystis3-oxoacyl-[acyl-carrier-protein] reductase (N DPH) activity (GO:0004316); fatty acid biosynthetic process (GO:0006633);Complete proteome; F tty acid biosynthesis; Fatty acid metabolism; Lipid biosynthesis; Lipid metabolism; NADP; Oxidoreductase; Reference proteome;[1390935826213]
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54 P73603 P73603_SYNY3Slr1852 protein 113,238 31,91 MSSRKNYYLGLKADYSQPGLVPDTLKEKLIAEGIAYVAQKEATLPAIDDSYTLEVIEQENKDWWPTHCEALRQGRGDILTGEYREDLVYFCQDGPYSGLEQQQEREKHWWALIAQPGVTMVWPIVMFYGEHTFFEWKCVDDETHETIAKGNVTWVRRGHRGGCYLKTEQLTFYRDVFAPDSLLKLITT12 6 0 0 5,15 21834,664 Synechocystis Complete proteome; Reference proteome;[1390935826213]
55 P73320 RL3_SYNY3 50S ribosomal protein L3109,664 32,39 MSIGILGTKLGMTQIFDQESGISIPVTVVQAGPCPVTQVKTQDTDGYNAIQVGFLPVKEKALSKPELGHLKKSNTDPMRHLKEYRLTDAPNLQPGDAVTADIFQAGDLVDVAGQSMGRGFAGYQKRHNFRRGNMTHGSKNHRLPGSTGAGTTPGRVYPGKRMAGQYGASQVTVRRLTVVRVDAERNLLIIKGALPGKPGTLLNITPAKTVGRG16 6 0 0 10,22 22741,131 Synechocystisribosome (GO:0005840); rRNA binding (GO:0019843); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprot i ; Ribosomal protein; RN -binding; rRNA-binding;[1390935826213]
56 Q55499 SSB_SYNY3 Single-stranded DNA-binding protein108,596 34,71 MSVNSIHLVGRAGRDPEVKYFESGNVVCNFTLAVNRRTSKKDEPPDWFDLEIWGKTAEIAGNYVKKGSLIGIQGSLKFDHWEDRNSGTPRSKPVIRVNNLDLLGSKRDNAEATMNNYPEEF13 5 0 0 7,86 13656,307 Synechocystissingle-stranded DNA binding (GO:0003697); DNA repair (GO:0006281); DNA replication (GO:0006260);Complete proteome; DNA damage; DNA repair; DNA replication; DNA-bi ding; Reference proteome;[1390935826213]
57 P72864 P72864_SYNY3Carboxysome formation protein107,723 21,65 MIVVMKVGTPEIEIERIGKEFAERGLTPEKIVGKHKVVMGLVGETAGLDPLQIQEVSPWIEDVLRVEQPFKRASLTFRHGEYSEVIVSTPAGPVAIGKNHPVAVVAGPCSVENETMIVETARRVKAAGAQFLRGGAFKPRTSPYAFQGHGESALGLLAAAKEATGLGIITEVMDAADLEIIAEVADVIQVGARNMQNFSMLKKVGAQDKPVLLKRGMAATIDEWLMAAEYILAAGNPNVILCERGIRTFDGHYTRNCLDLSVLPVLRSLTHLPIMIDPSHGTGKSEYVPSMAMAAIAAGTDSLMIEVHPNPAKAMSDGPQSLTPDRFDETMKQLAVIGQTVGRWPKVAALA10 7 0 0 6,1 37633,72 Synechocystisaldehyde-lyase activity (GO:0016832); transferase activity (GO:0016740); aromatic amino acid family biosynthetic process (GO:0009073);Complete proteome; Referenc  proteome; Transferase;[1390935826213]
58 Q05972 CH601_SYNY360 kDa chaperonin 1 06,719 12,75 MAKSIIYNDEARRALERGMDILAEAVAVTLGPKGRNVVLEKKFGSPQIINDGITIAKEIELEDHVENTGVSLIRQAASKTNDVAGDGTTTATVLAHAIVKEGLRNVAAGANPISLKRGIDKATDFLVARIKEHAQPVGDSKAIAQVGAISAGNDEEVGQMIANAMDKVGQEGVISLEEGKSMTTELEITEGMRFDKGYISPYFVTDAERMEAVLEDPRILITDKKINLVQDLVPILEQVARQGKPLLIIAEDIEKEALATLVVNRLRGVLNVAAVKAPGFGDRRKQMLEDIATLTGGQVISEDAGLKLESATVDSLGSARRINITKDNTTIVAEGNEAAVKSRCEQIRRQIEETDSSYDKEKLQERLAKLAGGVAVIKVGAATETEMKDRKLRLEDAINATKAAVEEGIVPGGGTTLAHLAPQLEDWATGNLKDEELTGALIVARALPAPLKRIAENAGQNGAVISERVKEKEFNVGYNAASLEYVDMLAAGIVDPAKVTRSALQNAASIAGMVLTTECIVVDKPEKEKAPAGAPGGDFDY12 7 0 0 5,04 57652,746 Synechocystiscytoplasm (GO:0005737); ATP binding (GO:0005524); protein refolding (GO:0042026); response to stress (GO:0006950);ATP-binding; Chaperone; Complete proteome; Cyt plasm; Direct protein sequencing; Nucleotide-binding; Reference proteome; Stress response;[1390935826213]
59 P49433 G3P1_SYNY3Glyceraldehyde-3-phosphate dehydrogenase 1106,271 18,58 MLKIGINGFGRIGRLVARIAMANPQVTLVGINDLVPASNLAYLFKYDSTHGSYGGTVVAKEEGIVIDDQFIPCFSQRNPAQLPWGDLGADYVVESTGLFTTYATAENHLKAGAKRVIISAPSKDPEKIPTFVVGVNHLNYNADTDKIVSNASCTTNCLAPIAKILDDNFGIVEGLMTTVHAMTATQPTVDGPSKKDFRGGRGAAQNIIPSSTGAAKAAALVLPQLKGKLTGMAFRVPTPNVSVVDLTFKTEKATSYEEICAAMKTAAEGELKGILGYTADDVVSMDFRTDPRSSIFDAGAGIGLNSNFFKVVSWYDNEWGYSCRVIDLMLTMASKDGLV17 6 0 0 6,12 36146,339 Synechocystiscytoplasm (GO:0005737); glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity (GO:0004365); NAD binding (GO:0051287); NADP binding (GO:0050661); glycolysis (GO:0006096);Complete proteome; Cytoplasm; Glycolysis; NAD; Oxidoreductase; Reference proteome;[1390935826213]
60 P72854 SIR_SYNY3 Sulfite reductase [ferredoxin]104,342 10,87 MVTTPTAAPRKPSKVEGIKERSNYLREPLATELLNDANYFTDDAVQILKFHGSYQQDNRDNRVKGQEKDYQFMLRTRNPGGLIPAQLYTALDDLSKTHGNQTLRVTTRQGLQIHGIVKKDLKMAIATVVNNLGSTLGACGDINRNVMAPAAPFRDKPEYGYAWDYANKVADLLSPQSGAYYEIWLDGEKVISGEEAPEVKAARQKDLNGTNLNDPKEPIYGQQFMPRKFKISVTVPGDNSIDVYTHDISLVVITDRHGELRGFNVLAGGGLGRTHNKEETFARAADPIGYVSKDDVYDLVKAIVATQRDYGDRHNRRHARMKYLLADWGVEKFRKQVETYMGKPFQSFKPLPAWRYQDYLGWHEQGDGKLFFGLSVENGRIKDEGDFQLKTALRKVVDQFQLPLRLTANHNILLYDINAQDKAAIEQIFQQHGVVTDPEAIDTLVRYSMACPALPTCGLAVTESERIMPSVNARLRDLLNSLDLPNESIVTRMTGCPNGCARPYMAEIGFVGSAPNSYQVWLGGSPNQERLAAAYTEKMPLEQLESLFEPLFVYFKQSRKGKESFGDFCHRVGFTALREFSHGYTAPAKGGKNRKNQRRVSLSDEMYAQLKARSERDNCPMNQIVQQALTAYLGK7 7 0 0 8,74 71441 Synechocystis4 iron, 4 sulfur cluster binding (GO:0051539); heme binding ( O:0020037); metal ion binding (GO:0046872); sulfite reductase (ferredoxin) activity (GO:0050311);4Fe-4S; Complete proteome; Heme; Iron; Iron-sulfur; Metal-binding; Oxidoreductase; Reference proteome; Thioether bond;[139093 826213]
61 P74232 PUR2_SYNY3Phosphoribosylamine--glycine ligase104,156 16,23 MKVAVIGSGGREHTLAWSLVRSPEVSHCYCLPGNGGTAGLPKTENVAIAVDQLGEICEFCQTEKINLVVVGPELPLTLGLTDQLQALGIKVFGPTKAGAELEASKSWTKQLLIEAGVPTAFGETFTEPAPAQAYATKMGAPIVVKADGLAAGKGVIVAQTSAEATTAIAELFDQGFEKIVVEEFLPGEEVSVLALCDGKTVIPLLPAQDHKRIGEGDQGLNTGGMGAYCPAPIAPPAVIDQVQKQILQPTANALAKRGIDYRGVLYAGLMVSPTGEIKVLEYNCRFGDPETQAVLPLLATPLEKVLMACVEQNLEQLGPLQWHSGNAVCVVVAAGGYPGSYRKGDEINGLAEAEAQDVKVFHAGTELKEGKVLTNGGRVLGVTALGKDLSTAIATAYRGVEQIDFDGMYYRRDIGHKAL8 7 0 0 5,06 44016,57 SynechocystisATP binding (GO:0005524); magnesium ion binding (GO:0000287); manganese ion binding (GO:0030145); phosphoribosylamine-glycine ligase activity (GO:0004637); 'de novo' IMP biosynthetic process (GO:0006189); purine nucleobase biosynthetic process (GO:0009113);ATP-binding; Complete proteome; Ligase; Magnesium; Mangan se; Metal-binding; Nucleotide-binding; Purine biosynthesis; Ref rence proteome;[1390935826213]
62 P73643 P73643_SYNY3Sll1762 protein 104,01 18,06 MICSATPDRPCKPAGKATTGQDCKIFNPLRVINSGSPGPTLTPWRMPKVIESDCDNVCNSSLLYRGKSRSILDWTQTFWLINAMLKQFSATFIGLLLATVGAQAAIAETVMEKIIRTGNLTIGANLDNVPFSYINDNNEVVGYSIDIADRIREEVGKELGRDVVLQIVEVQDMSDALPKLKTGELDIVCDTAFTWERDRYVDFTVSYAVAGIQLLVPNDTPINSRETLMGRRVAMVPNTIVEDAVKIVQNEIEVVPVTSVRAGMEALKKGTVDAVAGDGIQLAGLRQVLDMPDTKVIPQPAETRYGVGCMVREDNPGFLRLANRALVRLAEGYVQGDPEDVAIVDKWIGTEGIVPVDNDNLRQFFNYLVITHEQVMEPKNGQ11 7 0 0 4,85 41985,163 Synechocystisouter membrane-bounded periplasmic space (GO:0030288); transporter activity (GO:0005215);Complete proteome; Reference proteome;[1390935826213]
63 Q55759 GCH1_SYNY3GTP cyclohydrolase 1103,865 21,37 MTIASSHSINNGMNTGKLVNQLSSLPDRNTHNGQEVKYHPENVELNKEKMMDAVRVMLESVGEDPEREGLLKTPKRVAEAMQFLTQGYDQSLEKLVNGAIFDEGHNEMVLVRDIDFFSLCEHHMLPFMGKAHLAYIPNQKVVGLSKLARIVEMFSRRLQVQERLTRQIAEAVQEILDPQGVAVVMEATHMCMVMRGVQKPGSWTVTSAMIGSFQNEQKTREEFLNLIRHQPNFY11 6 0 0 6,31 26639,633 Synechocystiscytoplasm (GO:0005737); GTP binding (GO:0005525); GT  cyclohydrolase I activity (GO:0003934); zinc ion binding (GO:0008270); 7,8-dihydroneopterin 3'-triphosphate biosynthetic process (GO:0035998); one-carbon metabolic process (GO:0006730); tetrahydrofolate biosynthetic process (GO:0046654);Complete proteome; GTP-binding; Hydrolase; Metal-binding; Nu leotide-binding; One-carbon metabolism; Reference proteome; Zinc;[1390935826213]
64 P73312 RL29_SYNY350S ribosomal protein L29103,15 69,86 MALPNIADARKLGDEELATEILATKQRLFQLRFQQATRRPENPHEFKHARHRLAQLLTVERERQLENSPSEEA17 5 0 0 8,31 8545,648 Synechocystisribosome (GO:0005840); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference prote me; Ribonucleoprotein; Ribos mal protein;[1390935826213]
65 P73922 FBSB_SYNY3D-fructose 1,6-bisphosphatase class 2/sedoheptulose 1,7-bisphosphatase103,104 16,23 MDSTLGLEIIEVVEQAAIASAKWMGKGEKNTADQVAVEAMRERMNKIHMRGRIVIGEGERDDAPMLYIGEEVGICTREDAKSFCNPDELVEIDIAVDPCEGTNLVAYGQNGSMAVLAISEKGGLFAAPDFYMKKLAAPPAAKGHVDIDKSATENLKILSDCLNRSIEELVVVVMDRPRHKELIQEIRNAGARVRLISDGDVSAAISCAFSGTNIHALMGIGAAPEGVISAAAMRCLGGHFQGQLIYDPEVVKTGLIGESREGNLERLASMGIKNPDQVYNCEELACGETVLFAACGITPGTLMEGVRFFHGGVRTQSLVISSQSSTARFVDTVHMKESPKVIQLH13 7 0 0 5,17 37074,514 Synechocystisfructose 1,6-bisphosphate 1-phosphatase activity (GO:0042132); metal ion binding (GO:0046872); sedoheptulose-bisphosphatase activity (GO:0050278); gluconeogenesis (GO:0006094); glycerol metabolic process (GO:0006071); reductive pentose-phosphate cycle (GO:0019253);3D-structure; Calvin cycle; Carbohydrate metabolis ; Complete proteome; Hydrolase; Manganese; Metal-binding; Reference proteome;[1390935826213]
66 P73911 KATG_SYNY3Catalase-peroxidase102,823 9,68 MGTQPARKLRNRVFPHPHNHRKEKPMANDQVPASKCPVMHGANTTGQNGNLNWWPNALNLDILHQHDRKTNPMDDGFNYAEAFQQLDLAAVKQDLHHLMTDSQSWWPADWGHYGGLMIRMAWHAAGTYRIADGRGGAATGNQRFAPLNSWPDNVNLDKARRLLWPIKKKYGNKLSWGDLIILAGTMAYESMGLKVYGFAGGREDIWHPEKDIYWGAEKEWLASSDHRYGSEDRESLENPLAAVQMGLIYVNPEGVDGHPDPLCTAQDVRTTFARMAMNDEETVALTAGGHTVGKCHGNSKAELIGPEPEGADVVEQGLGWHNQNGKGVGRETMSSGIEGAWTTHPTQWDNGYFYMLFNHEWELKKSPAGAWQWEPVNIKEEDKPVDVEDPNIRHNPIMTDADMAMIKDPIYRQISERFYREPDYFAEVFAKAWFKLTHRDLGPKSRYLGPDVPQEDLIWQDPIPPVDYTLSEGEIKELEQQILASGLTVSELVCTAWDSARTFRSSDYRGGANGARIRLEPQKNWPGNEPTRLAKVLAVLENIQANFAKPVSLADLIVLGGGAAIAKAALDGGIEVNVPFLPGRGDATQAMTDAESFTPLEPIHDGYRNWLKQDYAVSPEELLLERTQLMGLTAPEMTVLIGGMRVLGTNHGGTKHGVFTDRVGVLSNDFFVNLTDMAYQWRPAGNNLYEIGDRQTGEVKWTATKVDLVFGSNSILRSYAEVYAQDDNREKFVRDFVAAWTKVMNADRFDLPRG11 7 0 0 5,5 84445,906 Synechocystiscatalase activity (GO:0004096); heme binding (GO:0020037); metal ion binding (GO:0046872); hydrogen peroxide catabolic process (GO:0042744);Complete proteom ; Heme; Hydrogen peroxide; Iron; Metal-bi ding; Organic radical; Oxidoreductase; Per xidase; Reference proteome;[1390935826213]
67 P26290 UCRIB_SYNY3Cytochrome b6-f complex iron-sulfur subunit 2102,427 32,78 MTQISGSPDVPDLGRRQFMNLLTFGTITGVAAGALYPAVKYLIPPSSGGSGGGVTAKDALGNDVKVTEFLASHNAGDRVLAQGLKGDPTYIVVQGDDTIANYGINAVCTHLGCVVPWNASENKFMCPCHGSQYNAEGKVVRGPAPLSLALAHATVTDDDKLVLSTWTETDFRTDEDPWWA8 5 0 0 5,02 18996,356 Synechocystisintegral to membrane (GO:0016021); thylakoid membrane (GO:0042651); 2 iron, 2 sulfur cluster binding (GO:0051537); electron transporter, transferring electrons within cytochrome b6/f complex of photosystem II activity (GO:0045158); metal ion binding (GO:0046872); plastoquinol--plastocyanin reductase activity (GO:0009496); ubiquinol-cytochrome-c reductase activity (GO:0008121); photosynthesis (GO:0015979);2Fe-2S; Complete proteome; Disulfide bond; Electron transport; Iron; Iron-sulfur; Membrane; Metal-binding; Oxidoreductase; Reference prot ome; Thylakoid; Trans mbrane; Transmembrane helix; Transport;[1390935826213]
68 P73348 P73348_SYNY3Rehydrin 102,378 26,54 MALQLGDVVPDFTQESSQGPISFHEWAGDSWVVLFSHPADYTPVCTTELGTVAKLKPEFDKRNVKVIALSVDDVESHKGWICDIDETQNTTVNYPILADGDKKVSDLYGMIHPNALNNLTVRSVFIIDPAKKLRLTFTYPASTGRNFDEILRVIDSLQLTDYHQVATPANWQDGDKCVVVPSISTEDAKVKFPKGVEEIKPYLRLTPQPNK15 6 0 0 5,2 23559,723 Synechocystisantioxidant activity (GO:0016209); peroxiredoxin activity (GO:0051920);Complete proteome; Reference proteome;[1390935826213]
69 Q55552 Q55552_SYNY3IMP dehydrogenase100,994 28,39 MSRTVGEVMTPNPITVKPDTPLQDAIRLLAENRISGMPVLDDQEKLVGVISDTDLMWQESGVDTPPYVMLLDSIIYLQNPARHERELHKALGQTVGEVMNDVPISILPTQTLREAAHLMNEKKIRRLPVLNVESRQLIGILTQGDIIRAMARGEA14 5 0 0 5,37 17270,028 Synechocystisadenyl nucleotide binding (GO:0030554); catalytic activity (GO:0003824); metabolic process (GO:0008152);Complete proteome; Reference proteome;[139093 826213]
70 P42352 RL9_SYNY3 50S ribosomal protein L9100,448 25,66 MAKRVKVVLNETINKLGFTGDLVEVAPGYARNYLIPKGLGVVATPGILRQVEQRRLKELERLKAEKDAAEARKVALETIGRFVIKKQVGEAEAIFGTVTTQEVADAVEAATNQSLDRRGISLPDIHKTGFYQAQIKLHPEVIATVEVQVAPL21 5 0 0 9,39 16641,321 Synechocystisribosome (GO:0005840); rRNA binding ( O:0019843); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprot i ; Ribosomal protein; RNA-binding; rRNA-binding;[1390935826213]
71 P74122 ARGJ_SYNY3Arginine biosynthesis bifunctional protein ArgJ99,283 14,04 MADWQVIEGNITAPKGFKAAGITAGLKPSGSPDLSLIYSETEAIAAGVFTTSQVRAACVDYCRQRLQAKASARAILVNSGQANAGTGKQGWDDAVESAQLLAQGLNISPESILLASTGVIGQRIKMEQLRQGITPLIQSLAPNGGDKAARAIMTTDLVPKTIALETEIDGRPVRMGGIAKGSGMIHPNMATMLAFVTCDAAVSTALWQQMLSRATQKTFNQVTVDGDTSTNDSLFALANGESRTAAITEMGPNAEKLEAMLTAVCQHLAKAIARDGEGATCLMEIQVTGAPDDQSARAVARTIAGSSLVKSAVFGRDPNWGRIAGAAGRAGVKFDQNNLLIKLGNYVLMDQGQPLEFDRPGASNYLKQAASGAYLEQDTVLIQVDLGTGSGQGTAWGCDLSYDYVRINADYTT8 6 0 0 5,43 43320,09 Synechocystiscytoplasm (GO:0005737); acetyl-CoA:L-glutamate N-acetyltransferase activity (GO:0004042); glutamate N-acetyltransferase activity (GO:0004358); arginine biosynthetic process (GO:0006526);Acyltransfer s ; Amino-acid biosynthesis; Arginine biosynthesis; Autocatalytic cleav ge; Compl e proteome; Cytoplasm; Multifunctional enzyme; Reference proteome; ransferase;[1390935826213]
72 P73565 P73565_SYNY3Sll0872 protein 98,098 33,08 MAGGILKTGNQFCSMELELIINSENLEKSMLLPMKSILKSAVLALACTLTTFASFSGLSAQTMTDTPASQVSPEKLEVLEKLGAILNEQQKGKLEAGLAQGQEVKAILPTLDLSPQQKIQVLKVLESVKK17 5 0 0 7,72 13929,416 Synechocystis Complete proteome; Reference proteome;[1390935826213]
73 P72586 P72586_SYNY3GDP-D-mannose dehydratase97,467 16,3 MSKSKVVLLTGITGQDGSYLSELLLEKGYQVHGIIRRTSTFNTDRIDHLYVDPHDLEAKLRLHYGDLTDGTTLRRILEDVKPTEIYNLGAQSHVRVSFDSPEYTVDSVAMGTLRLLEAIRDYQHRTGIQVRFYQAGSSEMFGKVQEIPQKETTPFYPRSPYACAKVYGHWQTVNYRESYDLFACNGILFNHESPRRGETFVTRKITRAIARIVAGTQKKLYLGNIDSKRDWGYAKDYVRAMWAMLQQEQPDDYVVATGETHEVKEFLEIAFGYVNLNWQNYVAFDERYLRPAEVDLLIGDPAKTKAQLGWEPSVTFTELVHLMVEADLAVLGLTSPNQSGRIKELMAQDMAFIRSQNGHAVD12 7 0 0 6,14 41333,809 ynechocystisintracellular (GO:0005622); coenzyme binding (GO:0050662); GDP-mannose 4,6-dehydratase activity (GO:0008446); GDP-mannose metabolic process (GO:0019673);Complete proteome; Lyase; NADP; Reference proteo e;[1390935826213]
74 P80046 IDH_SYNY3 Isocitrate dehydrogenase [NADP]95,383 13,26 MYEKLQPPSVGSKITFVAGKPVVPNDPIIPYIRGDGTGVDIWPATELVINAAIAKAYGGREEINWFKVYAGDEACELYGTYQIFPEDTLTAIKEYGVAIKGPLTTPVGGGIRSLNVALRQIFDLYTCVRPCRYYPGTPSPHKTPEKLDIIVYRENTEDIYLGIEWAEGTEGAKKLIAYLNDELIPTTPALGKKQIRLDSGIGIKPISKTGSQRLVRRAILHAKRLPKAKQMVTLVHKGNIMKFTEGPFRDWGYELATTEFRAECVTERESWICGNKESNPDLTIEANAHMIDPGYDTLTEEKQAVIKQEVEQVLNSIWESHGNGQWKEKVMVNDRIADSIFQQIQTRPDEYSILATMNLNGDYLSDAAAAVVGGLGMGPGANIGDSAAIFEATHGTAPKHAGLDRINPGSVILSGVMMLEFMGWQEAADLIKKGIGAAIANREVTYDLARLMEPKVDKPLKCSEFAQAIVSHFDD10 7 0 0 5,48 52274,791 Synechocystiscytoplasm (GO:0005737); isocitrate dehydrogenase (NADP+) activity (GO:0004450); magnesium ion binding (GO:0000287); NAD binding ( O:0051287); glyoxylate cycle (GO:0006097); tricarboxylic acid cycle (GO:0006099);Complete proteome; Cytoplasm; Dir ct protein sequencing; Glyoxylate bypass; Magnesium; Manganese; Metal-binding; NADP; Oxidoreductase; Phosphoprotein; Reference proteome; Tricarboxylic acid cycle;[1390935826213]
75 Q55497 OTC_SYNY3 Ornithine carbamoyltransferase92,168 17,21 MGIKALAGRDLLAIADLTIEEMKSLLQLAADLKSGVLKPHCRKILGLLFYKASTRTRVSFTAAMYQLGGQVLDLNPSVTQVGRGEPIQDTARVLDRYIDILAVRTFKQTDLQTFADHAKMPIINALSDLEHPCQILADLQTIKECFGKLEGLTVTYLGDGNNVAHSLILGGVMMGMTVRVATPKNYEPLAEIVQQAQQIAAPGGKVELTDDPKAAAQGSHILYTDVWASMGQEDLADSRIPIFQPYQINQELLALADPEAIVLHCLPAHRGEEITDAVMEGPQSRLWDQAENRMHAQKALMVALLGLV6 5 0 0 5,5 33615,934 Synechocystiscytoplasm (GO:0005737); amino acid binding (GO:0016597); ornithine carbamoyltransferase activity (GO:0004585); arginine biosynthetic process (GO:0006526);Amino-acid biosynthesis; Arginine biosynthesis; Compl te prote me; Cytoplasm; Reference proteome; ransferase;[1390935826213]
76 P73037 P73037_SYNY3Peptidyl-prolyl cis-trans isomerase92,134 20,4 MRGRTHGIIRPTLLRPIFLMKFFTAMRDILISLTVVTFFSLVLISVAIFGKSSPSAIAAPQEVKPVQIAQASALQTPEPSPMTAENSANIVTTESGLQYIDEVVGEGPSPTKGQKVEVHYTGRLTDGTKFDSSVDRNKPFTFTIGVGQVIKGWDEGVATMQVGGKRKLIIPPDLAYGSRGAGGVIPPNATLEFEVELLGIK17 5 0 0 9,22 21554,986 Synechocystisouter membrane-bounded periplasmic space (GO:0030288); peptidyl-prolyl cis-trans isomerase activity (GO:0003755); protein folding (GO:0006457); protein peptidyl-prolyl isomerization (GO:0000413);Complete proteome; Isomerase; Reference prot ome; Rotama e;[1390935826213]
77 P36239 RL19_SYNY350S ribosomal protein L1991,567 34,43 MTMNAQAIINSIEAEFLKEDLPTIHVGDTIKVGVKIVEGGKERIQPYEGTVIAKRNGGISETITVRKIFQGVGVERVFLLHSPRVASIKVLRRGKVRRAKLYYLRDRVGKATRIKQRFDRAL6 5 0 0 10,82 13786,243 Synechocystisribosome (GO:0005840); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference prote me; Ribonucleoprotein; Ribos mal protein;[1390935826213]
78 P72673 Y729_SYNY3Thylakoid-associated protein slr072990,358 45,54 MTSTTPEIEALAADIGEQIAIDVAKWNLFLAEAHLHIPLAERVYPLLEKDELGRAGVEAALKDLSVAIGGGKVNISLLDALSSTMVNRLLTLLEEYQSKNF8 5 0 0 4,75 10946,61 Synechocystisthylakoid membrane (GO:0042651);Complete proteome; Membrane; Reference proteome; Thylakoid;[1390935826213]
79 P74226 RS10_SYNY330S ribosomal protein S1089,7 9 48,57 MATLQQQKIRIRLKAFDRRLLDTSCDKIVDTANRTNAAAVGPIPLPTKRKIYCVLRSPHVDKDSREHFETRTHRRIIDIYQPSSKTIDALMKLDLPAGVDIEVKL8 5 0 0 9,94 12037,049 Synechocystisribosome (GO:0005840); structural constituent of ribosome (GO:0003735); tRNA binding (GO:0000049); translation (GO:0006412);Complete proteome; Reference prote me; Ribonucleoprotein; Ribosomal protein;[1390935826213]
80 P74008 SAHH_SYNY3Adenosylhomocysteinase89,269 14,82 MVATPVKQKYDIKDISLAPQGRQRIEWAAREMPVLKQIRERFAQEKPFAGIRLVACCHVTTETANLAIALHAGGADSLLIASNPLSTQDDVAACLVADYGIPVYAIKGEDNETYHRHVQIALDHRPNIIIDDGSDVVATLVQERQHQLSDIIGTTEETTTGIVRLRAMFNDGVLTFPAMNVNDADTKHFYDNRYGTGQSTLDGIIRATNILLAGKTIVVAGYGWCGKGVAMRAKGMGADVIVTEISPVPAIEAAMDGFRVMPMAEAAHQGDIFITVTGNKHVIRPEHFAVMKDGAIVCNSGHFDIEIDLKSLKEQAKEVKEVRNFTEQYILPNGKSIIVIGEGRLVNLAAAEGHPSAVMDMSFANQALACEHLVKNKGQLEPGMHSIPVEVDQEIARLKLQAMGIAIDSLTPEQVEYINSWASGT10 5 0 0 5,55 46213,906 Synechocystiscytoplasm (GO:0005737); adenosylhomocysteinase activity (GO:0004013); one-carbon metabolic process (GO:0006730);Complete prot ome; Cytopla m; Hydrolase; NAD; One-carbon met bolis ; Reference proteome;[1390935826213]
81 P73309 RL24_SYNY350S ribosomal protein L2489,084 34,78 MTKTKPAPHRVKMHVKKGDTIQVISGKDKGKVGEVLRTIPSHSQVVVKGVNIRTKHVKPRQEGESGQISSYEAPIHSSKVMLYSTKEKIASRICYTVTDDGRKVRMLKKTGEIID7 5 0 0 10,17 12823,004 Synechocystisribosome (GO:0005840); rRNA binding (GO:0019843); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprot i ; Ribosomal protein; RNA-binding; rRNA-binding;[1390935826213]
82 P73303 RL15_SYNY350S ribosomal protein L1588,092 35,37 MNLSELSPKDGAKKRRRRVGRGIAAGQGASCGFGMRGQKSRSGTGTKAGFEGGQMPLYRRLPKLKHFPLYNPKHFTVVNVGKLAGLAPNTVVTLESLMEAGIVTSNDGPLKVLGNGELAVALTVHAPCSKAAQAKIEAAGGSVVAQG8 5 0 0 10,52 15194,626 Synechocystislarge ribosomal subunit (GO:0015934); rRN  binding (GO:0019843); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprotein; Rib somal protein; RNA-binding; rRNA-bindi g;[1390935826213]
83 P74694 P74694_SYNY3Slr0455 protein 87,298 26,95 MKTTLFSVRIIMLRDLVQKAVYLGVGIASYAAETANSNIKELGNHAQKLVDTLVERGEMNAEEARRYVDELIREAQGEAIAHGEGENKQPRRIEIITDEEEANPDPLAQKTPAQSQTEDVEALRRQVAALQAELQRLNRQP6 4 0 0 5,17 15790,765 Synechocystis Complete proteome; eference proteome;[1390935826213]
84 Q55013 CY550_SYNY3Cytochrome c-550 86,307 25,62 MKRFFLVAIASVLFFFNTMVGSANAVELTESTRTIPLDEAGGTTTLTARQFTNGQKIFVDTCTQCHLQGKTKTNNNVSLGLADLAGAEPRRDNVLALVEFLKNPKSYDGEDDYSELHPNISRPDIYPEMRNYTEDDIFDVAGYTLIAPKLDERWGGTIYF14 3 0 0 4,89 17884,109 Synechocystisplasma membrane-derived thylakoid photosystem II (GO:0030096); thylakoid membrane (GO:0042651); electron carrier activity (GO:0009055); heme binding (GO:0020037); iron ion binding (GO:0005506); cytochrome c-heme linkage (GO:0018063); photosynthesis, light reaction (GO:0019684); respiratory electron transport chain (GO:0022904);3 -structure; Complete proteom ; Direct protein sequencing; Electron transport; Heme; Iron; Membr ne; Me al-binding; Photosynthesis; Photosystem II; Reference proteome; Signal; Thylakoid; Transport;[1390935826213]
85 P73253 P73253_SYNY3Sll1911 protein 86,052 39,06 MAGLFGLFGKKAQYVEDIEANPSPQPEKKEAFFLESDDAKSLGNAEYMRTPIKIKRSFPKTLNSQGGEVVKEISAMEVKKIQANGQPAPSTKMDSAPSQANSTPANNDRRSNDNSLDMFRQMAKDLKK7 5 0 0 9,33 14125,969 Synechocystis Complete proteome; Reference proteome;[1390935826213]
86 P72740 DLDH_SYNY3Dihydrolipoyl dehydrogenase84,55 12,03 MSQDFDYDLVIIGAGVGGHGAALHAVKCGLKTAIIEAKDMGGTCVNRGCIPSKALLAASGRVREMSDQDHLQQLGIQINGVTFTREAIAAHANDLVSKIQSDLTNSLTRLKVDTIRGWGKVSGPQEVTVIGDNETRILKAKEIMLCPGSVPFVPPGIEIDHKTVFTSDEAVKLETLPQWIAIIGSGYIGLEFSDVYTALGCEVTMIEALPDLMPGFDPEIAKIAERVLIKSRDIETYTGVFATKIKAGSPVEIELTDAKTKEVIDTLEVDACLVATGRIPATKNLGLETVGVETDRRGFIEVNDQMQVIKDGKPVPHLWAVGDATGKMMLAHAASGQGVVAVENICGRKTEVDYRAIPAAAFTHPEISYVGLTEAQAKELGEKEGFVVSTAKTYFKGNSKALAEKETDGIAKVVYRQDTGELLGAHIIGIHASDLIQEAAQAIADRKSVRELAFHVHAHPTLSEVLDEAYKRAV7 5 0 0 5,41 50832,255 Synechocystisplasma membrane (GO:0005886); dihydrolipoyl dehydrogenase activity (GO:0004148); flavin adenine dinucleotide binding ( O:0050660); cell redox homeostasis (GO:0045454); glycolysis (GO:0006096);Cell inner membrane; Cell membrane; C mplete pro eome; Direct protein sequenci g; Disulfide bond; FAD; Flavoprotein; Glycolysis; Me brane; NAD; Oxidoreductase; Redox-active center; Reference proteome;[1390935826213]
87 Q55641 Q55641_SYNY3Ribonuclease D 83,372 22,12 MPSADTLSQFEVFDYDLPEDVCQQLLACKEVAVDTETMGLNPHRDRLCLVQICDPEGNVTALRIAKGQEEAPNLTRLMEDPGITKIFHFARFDTAQLKHTFDIKTYPIFCTKIASKIARTYTSHHGLKTLVQELVGVELDKSSQCSDWGNAANLSKAQLAYAANDVRYLIPLRHKLEKMLAREDRLRLAQRCFECLPVMVTLDLGMYGNVFEHGGPG10 5 0 0 5,98 24403,059 Synechocystis3'-5' exonuclease activity (GO:0008408); nucleic acid binding (GO:0003676);Complete proteome; Referen e proteome;[1390935826213]
88 P54205 RBL_SYNY3 Ribulose bisphosphate carboxylase large chain82,886 12,34 MVQAKAGFKAGVQDYRLTYYTPDYTPKDTDLLACFRMTPQPGVPAEEAAAAVAAESSTGTWTTVWTDNLTDLDRYKGRCYDLEAVPNEDNQYFAFIAYPLDLFEEGSVTNVLTSLVGNVFGFKALRALRLEDIRFPVALIKTFQGPPHGITVERDKLNKYGRPLLGCTIKPKLGLSAKNYGRAVYECLRGGLDFTKDDENINSQPFMRWRDRFLFVQEAIEKAQAETNEMKGHYLNVTAGTCEEMMKRAEFAKEIGTPIIMHDFFTGGFTANTTLARWCRDNGILLHIHRAMHAVVDRQKNHGIHFRVLAKCLRLSGGDHLHSGTVVGKLEGERGITMGFVDLMREDYVEEDRSRGIFFTQDYASMPGTMPVASGGIHVWHMPALVEIFGDDSCLQFGGGTLGHPWGNAPGATANRVALEACVQARNEGRNLAREGNDVIREACRWSPELAAACELWKEIKFEFEAMDTL7 6 0 0 5,86 52490,698 Synechocystismagnesium ion binding (GO:0000287); monooxygenase activity (GO:0004497); ribulose-bisphosphate carboxylase activity (GO:0016984); photorespiration (GO:0009853); reductive pentose-phosphate cycle (GO:0019253);Calvin cycle; Carbon dioxide fixation; Complete proteome; Disulfide bond; Lyase; Magnesium; Metal-binding; Monooxygenase; Oxidoreductase; Photorespiration; Photosynth sis; Referen e proteome;[1390935826213]
89 P72707 P72707_SYNY3Sll0224 protein 82,872 17,11 MKKFACLALSVLLSGAASLPSWAGEVLDRIEQTGVINAGTRKDAVPFAYVDDQGEWVGFSIDLLELIRQEAEARLGKPIKLNMVEATADNRFDLITNQTIDLECASSTFTWNRTAVVDFSVSYFADGTKIITGVDSDLESADSLAGRAIGVIPDTTNAKAILDFQPGATIVEVKDQADGMAKLEAGEIEAFAGDGIVLAGLKKTSDNPQQWKVVPNFPYQYEAYACLLPKDDSDWRNLVNYSLVKYMEGVISDQTAAVEIYERWFDEETGVAPYPRETINDYYQGIVDSFEWIPIVSY7 4 0 0 4,28 32829,904 Synechocystistransporter activity (GO:0005215);Complete proteome; Reference proteome;[ 390935826213]
90 Q55511 TIG_SYNY3 Trigger factor 82,711 11,89 MKVTQEKLPDSQVGLEIEIPATASKKVYENVVKKLTRTVNIPGFRRGKVPRAIVIQRLGQSYIKATAIEELIDDSIKAAVKQEELPIIGNFSLRSDMENLIQIFDPEAPLTIKVAADVFPEAEYEPESYKKITAQAEEIEYSADAVDQWLKGEQEKRATLVPVEDRPAALGDLAIVDYAAFQVAEDGQAGEAIAEVKGSDFEVTLEDGRFVAGIVDGIVGMAVDETKLIPVTFPEDYPLEAVAGEDVLFEIKLKEIKFRELPELDDDFAEDVSEFETMAELKADLEKQFQEQAKQRTDDNIKAAIKKKLGELFTGDLPETMIKQECDRLVAQTAMELERMGLDVSQLFRQGDDMLQTLKDNSRPEAIANLKTDLMIGAIAKEEKIQPTEAEVKERCDELRQEFKGEKIDESRLVNFVESSLTESKVLDLLKEWADVELLPEGSLSQTEEDTPDDDAEEEAIVDVEATSDEE6 5 0 0 4,31 52610,253 Synechocystiscytoplasm (GO:0005737); peptidyl-prolyl cis-trans isomerase activity (GO:0003755); cell cycle (GO:0007049); cell division (GO:0051301); protein folding (GO:0006457); protein peptidyl-prolyl isomerization (GO:0000413); protein transport (GO:0015031);Cell cycle; Cell division; Chapero e; Complet  proteome; Cytoplasm Isomerase; Reference prot ome; Rotamase;[1390935826213]
91 P73628 Y1769_SYNY3Probable thylakoid lumen protein sll176982,327 37,14 MQNQVLQAFFLGRAFAEVLSEKVEDGVTNALSELGKFDAEQRENLRQFIAEVQSRAANDVTQEGAAIATVDGPVSADELQETLDKLRAEIASLKSELKNYRDNQG10 4 0 0 4,54 11557,781 Synechocystisthylakoid lumen (GO:0031977);Coiled coil; Complete proteome; Reference proteome; Signal; Thylakoid;[1390935826213]
92 P74485 P74485_SYNY3Sll1863 protein 82,239 33,64 MRITFMSNPTTMTAQEKEAYKEKVRAKIDKLNAQIDQMTAEAREKAADANVNYQKSLKDLQAQRDALMGKWHDLQQSGEAAWEELQAGLEKSWNELSNTFEQVEKQF13 4 0 0 5,47 12353,832 Synechocystis Complete proteome; Reference proteome;[1390935826213]
93 P73299 RS13_SYNY330S ribosomal protein S1380,092 33,07 MARIAGVDLPRDKRVEIALTYLYGIGLSRSHEILDATGVSPDVRVKDLSDEDALKLRTYIDENYEIEGDLRRWEAMNIKRLGDIGTYRGRRHRQGLPVRGQRTRTNARTRRGRRLTVAGKKKTPAKK8 4 0 0 10,75 14571,723 Synechocystisribosome (GO:0005840); rRNA binding (GO:0019843); structural constituent of ribosome (GO:0003735); tRNA binding (GO:0000049); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprot i ; Ribosomal protein; RNA-binding; rRNA-binding; tRNA-binding;[1390935826213]
94 P24602 BFR_SYNY3 Bacterioferritin 79,782 28,21 MKGKPAVLAQLHKLLRGELAARDQYFIHSRMYQDWGLEKLYSRIDHEMQDETAHASLLIERILFLEETPDLSQQDPIRVGKTVPEMLQYDLDYEYEVIANLKEAMAVCEQEQDYQSRDLLLKILADTEEDHAYWLEKQLGLIEKIGLQNYLQSQMS8 4 0 0 4,78 18330,861 Synechocystisferric iron binding (GO:0008199); ferroxidase activity (GO:0004322); cellular iron ion homeostasis (GO:0006879); iron ion transport (GO:0006826);Complete proteome; Direct protein sequencing; Heme; Iron; Iron st rage; Metal-binding; Oxidoreductase; Reference proteome;[1390935826213]
95 P73311 RS17_SYNY330S ribosomal protein S1779,659 48,15 MAIKERVGIVVSNKMDKTVVVAVESRSPHPKYGKIVVKTKKFKAHDEENQCQEGDKVRIQETRPLSKTKRWQVINIMSHSS4 4 0 0 10,07 9288,824 Synechocystisribosome (GO:0005840); rRNA binding (GO:0019843); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprot i ; Ribosomal protein; RNA-binding; rRNA-binding;[1390935826213]
96 P73660 HEM3_SYNY3Porphobilinogen deaminase79,361 13,12 MTVSTSAPTVRIGSRKSQLALVQTYWVQEELQKHFPDRQFDVETMETQGDKILDVALAKIGDKGLFTQELEDGMLGKRTDLAVHSLKDLPTNLPAGLMLGCVTKRVNPADALVLNAKHQGKDLASLPEGAVIGTSSLRRLAQLRYHFPHLTFKDVRGNVNTRLAKLDSNEYDAIILAAAGLERLDMANRIDQLIPPEISLHAVGQGALGIECREGDQEILSLLKVLEDENSRDRCLAERAFLRQLEGGCQVPIGVNTHLDGDNLTLTGMVASLDGQRLIKDTLSAPRKEAEKLGQDLALKLREQGAGEILAEILAEAGRG12 5 0 0 5,6 34893,948 Synechocystishydroxymethylbilane synthase activity (GO:0004418); chlorophyll biosynthetic process ( O:0015995); peptidyl-pyrromethane cofactor linkage (GO:0018160); protoporphyrinogen IX biosynthetic process (GO:0006782);Chlorophyll biosyn hesis; Complete proteome; Porphyrin biosynthesis; eference proteome; Transferas ;[1390935826213]
97 P19569 PSAD_SYNY3Photosystem I reaction center subunit II78,667 30,5 MTELSGQPPKFGGSTGGLLSKANREEKYAITWTSASEQVFEMPTGGAAIMNEGENLLYLARKEQCLALGTQLRTKFKPKIQDYKIYRVYPSGEVQYLHPADGVFPEKVNEGREAQGTKTRRIGQNPEPVTIKFSGKAPYEV9 4 0 0 9,16 15643,774 Synechocystisphotosystem I reaction center (GO:0009538); plasma membrane-derived photosystem I (GO:0030094); photosynthesis (GO:0015979);Complete proteome; Direct protein sequencing; Photosynthesis; Photosystem I; Reference proteome;[1390935826213]
98 P73305 RL18_SYNY350S ribosomal protein L1878,001 30,83 MKSTRKSATQRRHRRLRRHLSGTSERPRLAVFRSNDHIYAQVIDDVAQHTLAAASTLDPDLKKSLSSTATQEASAEVGKLVAQRAIAKGINQVVFDRGGKLYHGRVKALAEAAREAGLNF7 4 0 0 11,14 13204,003 Synechocystisribosome (GO:0005840); rRNA binding (GO:0019843); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprot i ; Ribosomal protein; RNA-binding; rRNA-binding;[1390935826213]
99 P54691 ILVE_SYNY3 Probable branched-chain-amino-acid aminotransferase77,517 16,72 MHKFLPIAYFEDKFVPFEDAKISVATHALHYGTAAFGGLRGIPDPEDPGTILLFRLDRHGDRLSKSAKFLHYDISAEKIKEVIVDFVKKNQPDKSFYIRPLVYSSGLGIAPRLHNLEKDFLVYGLEMGDYLAADGVSCRISSWYRQEDRSFPLRGKISAAYITSALAKTEAVESGFDEAILMNSQGKVCEATGMNVFMVRNGQIVTPGNEQDILEGITRDSILTIAADLGIPTCQRPIDKSELMIADEVFLSGTAAKITPVKRIENFTLGGDRPITEKLRSVLTAVTENREPKYQDWVFKIPLNG7 5 0 0 6,12 33950,938 SynechocystisL-isoleucine transaminase activity (GO:0052656); L-leucine transaminase activity (GO:0052654); L-valine transaminase activity (GO:0052655); isoleucine biosynthetic process (GO:0009097); leucine biosynthetic process (GO:0009098); valine biosynthetic process (GO:0009099);Amino-acid biosynthesis; Aminotransferase; B ched-chain am no acid biosynthesis; Complete proteome; Pyridoxal phosphate; Reference proteome; Transferase;[1390935826213]
100 P52208 6PGD_SYNY36-phosphogluconate dehydrogenase, decarboxylating77,49 9,75 MQFNVAIMTKRTFGVIGLAVMGENLALNVESRGFPIAVFNRSPNKTEKFMAERAVGKDIKAAYTVEEFVQLLERPRKILVMVKAGGPVDAVINELKPLLEEGDMIIDGGNSLYEDTERRTKDLEATGLGFVGMGVSGGEEGALLGPSLMPGGTPAAYKELEPILTKIAAQVEDPDNPACVTFIGPGGAGHYVKMVHNGIEYGDMQLIAEAYDILKNGLGLSNEQLHEVFGQWNQTDELNSFLIEISTDIFAKKDPETGGHLIDYILDAAGQKGTGRWTVMSGLELGVPIPTIYAAVNARVMSSLKEERVAASGQLSGPSKTFSGDVEAWIPKVRDALYCSKMCSYAQGMALIAKASQEFGYDVNLPEIARIWKGGCIIRAGFLDKIKKAFKDNPQLPNLLLAPEFKQSILDRQGPWREVLMLANEMGIAVPAFSSSLDYFDSYRRAVLPQNLTQAQRDYFGAHTYERTDKPRGEFFHTEWLD8 5 0 0 5,16 52873,54 SynechocystisNA P binding (GO:0050661); phosphogluconate dehydrogenase (decarboxylating) activity (GO:0004616); -gluconate metabolic process (GO:0019521); pentose-phosphate shunt (GO:0006098);Complete proteome; Gluconate utilization; NADP; Oxidoreduct se; Pen ose shunt; Reference prote me;[1390935826213]
101 Q55531 Q55531_SYNY3Sll0301 protein 77,133 26,04 MSSFLVFSWRRWLQILILAIALVLLWAPSALAQANTVNYTYGDLARSDFSHQDLNKAVFAAADLRESNFEGSDLSFSILTDAVFLHASLRGANLSGSLVDRVTLDFADLRDTIFTEAIATRTRFYDTDITGADFSDAVIDAYQVKLMCERAEGVNPVTGVATRDSLGCR6 4 0 0 4,77 18611,017 Synechocystis Complete proteome; Reference proteome;[1390935826213]
102 P74729 P74729_SYNY3HrEpiB 76,946 17,63 MIMKILITGGGGYIGSVLTPTLLAAGYQVTVIDNFMFQQNSLAECCQYETFNVIRGDCRKEDLIKEQLKTADVIIPLAALVGAPLCSRDQIGTKTTNQTAVEMICQLASPQQRILMPVTNSGYGIGEKGKFCTEESPLRPISLYGVTKVEAEKAVLARDNSMTFRLATVFGMAPRMRVDLLVNDFVYRAFYDRAVVIFEGHFKRNYIHIRDVAKVFLHGLENFESMKGKPYNVGLEDANLSKLELCAEIRKYLPNFVYLEAPIGEDPDKRDYIVSNQRILSTGFTPDWSLGRGIQELIKGYTILRNSVYSNV6 5 0 0 8,07 34951,479 Synechocystiscatalytic activity (GO:0003824); coenzyme binding (GO:0050662); cellular metabolic process (GO:0044237);Complete proteome; Refer nce proteome;[1390935826213]
103 P73306 RL6_SYNY3 50S ribosomal protein L674,739 18,99 MSRIGKRPIPLPAKVSVDIQGSHLSVKGPKGSLERQLPEKVIVAQEGETITVTRQDESRTARERHGLVRTLVANMVDGVAQGFERRLEIQGVGYRAQAQGNKLTLNVGYSKPVEMTMPQGIEVKVENNTQVIVSGIDKELLGNTAAKIRAVRPPEPYKGKGIRYQGEYVRRKAGKTGKK8 5 0 0 10,27 19666,721 Synechocystisribosome (GO:0005840); rRNA binding (GO:0019843); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprot i ; ibosomal protein; RNA-binding; rRNA-binding;[1390935826213]
104 P72760 CCMK1_SYNY3Carbon dioxide-concentrating mechanism protein CcmK homolog 173,263 32,43 MSIAVGMIETLGFPAVVEAADSMVKAARVTLVGYEKIGSGRVTVIVRGDVSEVQASVTAGIENIRRVNGGEVLSNHIIARPHENLEYVLPIRYTEAVEQFREIVNPSIIRR14 4 0 0 6,74 12101,966 Synechocystis 3D-structure; Complete proteome; Direct protein sequencing; Reference proteome;[1390935826213]
105 P73463 P73463_SYNY3Slr1220 protein 73,072 15,14 MTIDNIRLRNEFINTEVITRSSGKKLGVVKEVLVDVDQREIVALGLRDNFLSLTGMPQYLYLNSIVQTGDVVLVENDDVFELVEVDLYSPLVNSEVVTETGEPLGRVRDFQFDLATGKVSSIIIASLGLPQIPDQLISTYELSIDEVVSSGPNRLIVFEGAEERLNQLSVGLLERLGIGRPSWERMEEDLYYPPTTRPENQLGSGIPVRPPVQVRQPEPVLEERWNEDDWQDTRPAPPPRREVAPLRYPEPEYEDDYEVDNWGEASSRSSAPEPDYDYEDGVAGDVWDDDEAPAPYSPPRVNIPETRREKMPEYYEE6 5 0 0 4,21 36009,011 Synechocystis Complete proteome; Reference proteome;[1390935826213]
106 P74390 P74390_SYNY3Negative aliphatic amidase regulator72,736 9,19 MTNPFGRRKFLLYGSATLGASLLLKACGGGTEPTTEPTAEPTESPTTGTAPTGEPIKVGLLHSLSGTMAISETTVVEAAELAIEEINAAGGVLGRPIEAIKEDGASDWPTFAEKAAKLIDQDKVPVVFGCWTSASRKAVLPVFEAKNHMLWYPVQYEGQECSKNIFYTGAAPNQQIEPAVDWLLENKGNKFFLVGSDYVFPRTANTIIKEQLKAKGGETLGEDYLPLGNTEVTPIITKIREALPDGGVIFNTLNGDSNVAFFKQIQAAGLTPDKYPVMSVSVAEEEVRQIGKEYLLGQFASWNYFQSVDTPANQKFVAAFKAKYGEDRVTNDPMEAAYISVYLWKAAVEAAGDVGETPEGLEKVRAAAIGKTFDAPEGMVTMQPNHHISKTVRIGEVNDEGQFTIVWSSDGPVDPIPWNQFVPETKGFTCDWTRTDVENPGKFKAS8 5 0 0 4,86 48359,627 Synechocystisouter membrane-bounded periplasmic space (GO:0030288); amino acid transport (GO:0006865);Complete proteome; Reference proteome;[1390935826213]
107 P36265 NUSG_SYNY3Transcription antitermination protein NusG72,095 22,44 MSFTDDQSPVAEQNKKTPSEGHWFAVQVASGCEKRVKLNLEQRIHTLDVADRILQVEIPKTPIVKIRKDGARVQGEEKIFPGYVLIRMIMDDDAWQVVKNTPHVINFVGSEQKRHYGRGRGHVLPMPLSHGEVERIFRHVDEQEPVVKIDMEIGDHIMVLSGPFKDFEGDVIEVSPERSKLKALLSIFGRETPVELEFTQVEKQN8 4 0 0 6,08 23415,828 SynechocystisDNA-dependent transcription, termination (GO:0006353); regulation of DNA-dependent transcription, elongation (GO:0032784); transcription antitermination (GO:0031564);Complete pr teome; Reference proteome; Transcription; Transcription an itermina ; Tra scription regulation; Transcription term natio ;[1390935826213]
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108 P74185 P74185_SYNY3Slr1273 protein 70,269 24,66 MFLTALRSFLLFLAVTCLSLAIAMPAWALTEVPLTEIDYKPCPADLAEGNVGSGSSSPANCFLVTGIANNRTGKTVYDADVFGRIYDANHEPAMQNRTRLGNIAEIPPGKSDFEVRISVPAQQPLPLQLEQFKASGFSAKIRGQAL5 4 0 0 6,56 15714,07 Synechocystis Complete proteome; Reference proteome;[1390935826213]
109 P73294 RL13_SYNY350S ribosomal protein L1369,72 23,18 MNKTVLPTIDNLDHKWYVIDAEGQRLGRLATEVATILRGKNKPTFTPHMDTGDFVIIINAEKIEVTGRKREQKLYRRHSGRPGGMKEETFEKLQVRLPERIVESAVRGMLPKNSLGRKLFTKLKVYAGPSHPHAAQQPETLVINTIPAGAN11 4 0 0 10,09 16990,692 Synechocystisribosome ( O:0005840); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference prote me; Ribonucleoprotein; Ribos mal protein;[1390935826213]
110 P73600 P73600_SYNY3Sll1785 protein 69,016 16,79 MLLKVKLWGIGLVLTLTLGTILFLQNFSVAAETEIHTFDDIPMPKLADPLLIYTPANEIFDIASCSAKDIGFAIAHAQIPPGGGPMPHIHYFINEWFWTPEGGIELFHSTKQYPNMDELPVVGGAGRGDLYSIQSEPKQLIYSPNHYMHGFVNPTDKTLPIVFVWMRNEVAPDFPYHDGGMREYFQAVGPRITDLNNLPELTNAQRAAFASEAPKYGINQSSYFMEYVNTISDKLPAQIAKLKNDKDLERMVEVIEAFNRGDKSVTCS5 4 0 0 5,23 30011,352 Synechocystisouter membrane-bounded periplasmic space (GO:0030288); metal ion binding (GO:0046872);3D-structure; Chloride; Complete proteome; Copper; Metal-b ding; Reference proteome; Zinc;[1390935826213]
111 P26527 ATPB_SYNY3ATP synthase subunit beta68,92 11,8 MVAVKEATNVGKITQVIGPVIDAQFPSGKLPRIYNALKVQGRNSAGNEVAVTCEVQQLLGDNQVRAVAMSSTDGLVRGMDVVDTGAPISVPVGTGTLGRIFNVLGEPVDNKGPVPAGETFPIHRPAPKLVDLETKPQVFETGIKVIDLLTPYRQGGKIGLFGGAGVGKTVIMMELINNIAIQHGGVSVFGGVGERTREGNDLYNEMIESNVINADKPEESKIALVYGQMNEPPGARMRVGLTALTMAEYFRDVNKQDVLLFIDNIFRFVQAGSEVSALLGRMPSAVGYQPTLGTDVGDLQERITSTKEGSITSIQAVYVPADDLTDPAPATTFAHLDGTTVLSRGLAAKGIYPAVDPLDSTSTMLQPSIVGSEHYDTAREVQSTLQRYKELQDIIAILGLDELSEEDRLTVDRARKIERFLSQPFFVAEVFTGAPGKYVSLADTIKGFKAILAGELDDLPEQAFYLVGDIEEAKAKGAKLKEG5 4 0 0 4,93 51733,036 ynechocystisplasma membrane proton-transporting AT  synthase complex ( O:0045260); proton-transporting ATP synthase complex, catalytic core F(1) (GO:0045261); thylakoid membrane (GO:0042651); AT  binding (GO:0005524); proton-transporting ATP synthase activity, rotational mechanism ( O:0046933); ATP hydrolysis coupled proton transport (GO:0015991); plasma membrane AT  synthesis coupled proton transport (GO:0042777);ATP synthesis; ATP-binding; CF(1); Complete proteome; Hydrogen ion tr s rt; Hydrolase; Ion trans ort; Membrane; Nucleotide-binding; Reference proteome; Thylakoid; Transport;[1390935826213]
112 P73960 LEU3_SYNY33-isopropylmalate dehydrogenase68,414 10,22 MSQTYNVTLLPGDGIGPEIMAVAVAVLGKVADQFGFAFNFQEALIGGAAIDATGQPLPEATLAQAKDSDAVLLAAIGGYAWDNLPRSQRPETGLLAIREGLGLFANLRPATIFPQLIDASSLKREVVEGVDIMVVRELTGGIYFGKPKGIFETETGEKRGVNTMAYTVGEIDRIAKVAFETARKRRGQLCSVDKANVLDVSQLWRDRVMAIAVDYPDVELSHLYVDNAAMQLVRSPRQFDTIVTGNLFGDILSDIAAMLTGSIGMLPSASLGSDGPGLFEPVHGSAPDIAGQDKANPLAQVLSAAMMLRYGLDQPQAADRLEDAVKKVLEQGYRTGDILSPGTQLVGCRQMGEQLLSILDEM7 5 0 0 4,72 38667,3 Synechocystiscytoplasm (GO:0005737); 3-isopropylmalate dehydrogenase activity ( O:0003862); magnesium ion binding (GO:0000287); NAD binding (GO:0051287); leucine biosynthetic process (GO:0009098);Amino-acid biosynthesis; Branched-chain mino ac d biosynthesis; Co plet  prote me; Cytoplasm; Leucine biosynthesis; Magnesium; Manganese; Metal-binding; NAD; xidoreductase; eference proteome;[1390935826213]
113 P74070 EFTS_SYNY3 Elongation factor Ts 68,182 19,72 MAEITAQLVKELREKTGAGMMDCKKALKENEGDLEKSIEWLRQKGIASADKKSGRTAAEGLVHSYIHFGGRIGVLVEVNCETDFVARGDRFKDLVNDVAMQIAACPNVEYVSVADIPQEMVAKEKEIEMGRDDLGKKPANIKEKIVQGRIDKRLKELSLLDQPYIKDQNLTIEELVKQAIAELGENIQVRRFIRFNLGEGIEKAETNFAEEVAAAAKG7 4 0 0 5,5 24230,824 Synechocystiscytoplasm (GO:0005737); translation elongation factor activity (GO:0003746);Complete proteome; Cyt plasm; Direct pro ein sequencing; Elongation factor; Protein biosynthesis; Reference proteome;[1390935826213]
114 P73213 P73213_SYNY3Ssr2857 protein 67,721 37,5 MTIQLTVPTIACEACAEAVTKAVQNEDAQATVQVDLTSKKVTITSALGEEQLRTAIASAGHEVE6 3 0 0 4,53 6685,548 Synechocystiscopper ion binding (GO:0005507); metal ion transport (GO:0030001);3D-structure; Chloride; Complete proteome; Copper; Metal-binding; Reference proteome;[1390935826213]
115 P73789 PPI2_SYNY3 Peptidyl-prolyl cis-trans isomerase slr125167,685 23,39 MMSKVFFDITIGSDTAGRIVMELFDEVTPKTAENFRALCTGEKGVGKAGKPLHFKGSHFHRVITDFMAQGGDFTRGNGTGGESIYGEKFADENFQLKHDRPGLLSMANAGPNTNGSQFFLTFVPCPWLDGKHVVFGEVVEGLEILEQLEANGSQSGQTKQAIVISDCGEIK10 4 0 0 5,52 18534,946 Synechocystispeptidyl-prolyl cis-trans isomerase activity (GO:0003755); protein folding (GO:0006457); protein peptidyl-prolyl isomerization (GO:0000413);Complete prot om ; Isomerase; Reference proteome; Rotamase;[1390935826213]
116 P73335 Y1786_SYNY3Uncharacterized deoxyribonuclease sll178667,474 16,86 MHLVDTHVHINFDVFAADLDQLQHRWRQAGVVQLVHSCVKPQEFDQIQSLADRFPELFFAVGLHPLDAEDWQDNTAGQILAYAKADDRVVAIGEMGLDFFKADNRDHQIEVFRAQLAIARELNKPVIIHCRDAAQTMRQVLTDFQAESGPVAGVMHCWGGTPEETQWFLDLGFYISFSGTVTFKKAEGIQASAQMVPPDRLLVETDCPFLAPVPQRGKRNEPAFVRHVAEAIAALRHVPLETLAQQTTTNARNLFKLPVPA6 4 0 0 5,62 29258,318 Synechocystisendodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888); metal ion binding (GO:0046872); nucleic acid phosphodiester bond hydrolysis (GO:0090305);Complete proteome; Hydrolase; Metal-binding; Nuclease; Reference prote me;[1390935826213]
117 P73527 RISB_SYNY3 6,7-dimethyl-8-ribityllumazine synthase67,381 24,39 MTVYEGSFTPPARPFRFALVIARFNDLVTEKLLSGCQDCLKRHGIDVDPAGTQVDYIWVPGSFEVPLVTRKLAVSGQYDAIICLGAVIRGQTPHFDFVAGEAAKGIAAIASQTGVPVIFGILTTDTMQQALERAGIKSNHGWGYAMNALEMASLMRAMAPLTEG5 4 0 0 6,27 17617,379 Synechocystisriboflavin synthase complex (GO:0009349); 6,7-dimethyl-8-ribityllumazine synthase activity (GO:0000906); transferase activity (GO:0016740); riboflavin biosynthetic process (GO:0009231);Complete proteome; Reference proteome; Riboflavin biosynthesis; Tr nsferase;[139 935826213]
118 P73875 P73875_SYNY3Ssl0467 protein 67,154 40,85 MSTQDKARELLAKERQNEQQLHENMAARAAETELTVAEDLDEKARELLAEERQQEKHVEETMLSRSTEELS15 3 0 0 4,71 8254,047 Synechocystis Complete proteome; Reference proteome;[1390935826213]
119 Q55513 DAPA_SYNY34-hydroxy-tetrahydrodipicolinate synthase66,849 13,29 MADFVSTSPFGPVLTAMVTPFNADGGVDYGVAEKLADHLITHGSDGLVVCGTTGESPTLSWEEEHELFRVVKQTVGDRGSVIAGTGSNCTREAMEATQIAAKLGVDGSLQVVPYYNKPPQEGLLAHFQAIANCAPELPLMLYNIPGRTGQSLAPETVYRLAEVENIVAIKEATGSLEQASLIRAHTPDDFAIYAGDDVLTLPLLAVGGAGVVSVASHLVGDRLQAMVQHFAQGATAQALEIHLQLIPLFKILFCATNPIPVKTALGLQGWPVGSFRPPLCALSPGHTEQLRDVLRDLALLP6 4 0 0 5,02 31821,46 Synechocystiscytoplasm (GO:0005737); 4-hydroxy-tetrahydrodipicolinate synthase (GO:0008840); amine-lyase activity (GO:0016843); diaminopimelate biosynthetic process (GO:0019877); lysine biosynthetic process via diaminopimelate (GO:0009089);Amino-acid biosynthesis; Complete proteome; Cytoplasm; Diaminopimelate biosynthesis; Lyase; Lysine biosynthesis; Ref rence proteome; Schiff base;[1390935826213]
120 P48949 RS21_SYNY330S ribosomal protein S2165,4 1 45 MTQVVVGQNEPIESALRRFKRQVAKAGIYTDFKKHQFFETPQEKHKRKEATRRRQRSRRR5 3 0 0 11,78 7341,444 Synechocystisribosome (GO:0005840); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference prote me; Ribonucleoprotein; Ribos mal protein;[1390935826213]
121 Q55585 GABD_SYNY3Probable succinate-semialdehyde dehydrogenase [NADP(+)]65,322 9,47 MAIATI PATGQTVQTFIAHSQVEVNAKLDLAQETFQSFRHLPFAQRGQWLRKAADILEQRRDEWAALMTLEMGKSIPQAIAEVNKCALVCRFYADKAEEYLADEVVTTDASQSFIAYQPLGVILAVMPWNFPFWQVFRFAAPALMAGNVGLLKHASNVPQCALAIAEIFQTAGFPEGAFQTLLIGGKVASELMADDRIQAGTLTGSEPAGASFASAAAGQIKKTVLELGGSDPFIVLEDADLDQALKVAVPARMQNNGQSCIAAKRFIVQASVAEEFFQRLTKAFQALKVGDPSLSTTDIGPLATPDILADIVAQVEQTIAAGAHCRCGGQALDQPGNYYPPTLLTDVPPNAPTYRQEFFGPVALGFTVDNLEEAIALANDIPFGLGASAWTTNPENQQKLIRGIEAGAVFINGMTKSDPRIPFGGIKRSGFGRELGRMGILEFVNAKTVWIA8 5 0 0 5,08 48748,802 Synechocystisoxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620); gamma-aminobutyric acid catabolic process (GO:0009450);Complete proteome; N DP; Oxidoreductase; Reference prote me;[1390935826213]
122 Q6ZEL1 Q6ZEL1_SYNY3Slr5119 protein 65,069 12,11 MFDNLCKFLAESFSEDYAAWLLGRPIKLTKLSPTELSLEPIRADSLILEQSEDLVLHLEFQTEPDPTMGFRMLDYRVRVYRRFPQKTMHQFVIYLKRSNNDLVYQDSFQLRETLHRYQVIRLWEQSSETFLQSSGLLPLAVLTQTSDPTLKLREVATALEQIEDNRVKANLMAATSVFGGILLAPELIKTILRSEIMKESAVYQEILREGEQRGLLKGKLETIPLLKKLGLTIAEIAKELDIDVELVNRFVANQNN8 4 0 3 Q6ZEQ3,P73838,P728225,6 29502,151 Synechocystis Complete proteome; Plasmid; Reference proteome;[1390935826213]
123 P74551 APCF_SYNY3Allophycocyanin subunit beta-1865,043 23,08 MRDAVTTLIKNYDLTGRYLDRNAMDELKAYFESGSARIAAAAMINANSATIVKRAAAQLFEEIPELIRPSGNAYTTRRFSACLRDMDYYLRYASYALIAADNNVLDERVLQGLRETYNSLGVPIGPTVRGIQIMKEMIEAMAEDSSLNSTDFIASPFDHMTRELSELSV4 4 0 0 5,09 18892,452 Synechocystisphycobilisome ( O:0030089); oxidation-reduction process (GO:0055114); photosynthesis (GO:0015979); protein-chromophore linkage (GO:0018298);Bile pigment; Chromophor ; Complete proteome; Electron transport; M mbrane; Methylation; Photosynthesis; Phycobilisome; Reference proteome; Thylakoid; Transport;[1390935826213]
124 P73596 P73596_SYNY3Sll1307 protein 63,855 18,29 MLKFTFTPLLTTIALTGLALPALALEETPVLPAEIAIKAAQSAIAACRQEGYGVTATVVNPEGNVLVVIRSDGALVHTVQTSFNKAYSAVTLATNHNLDRTSGILASMQAKGAQGVGTWPMPADPLTGITLFPGGVTLISQGKVVGGLGVSGTPIGMVDEGCAIKGRDAVLPDLR4 3 0 0 6,72 17848,738 Synechocystisouter membrane-bounded periplasmic space ( O:0030288);Complete proteome; Reference proteome;[1390935826213]
125 Q55648 Q55648_SYNY3Sll0314 protein 63,732 13,38 MLVFLTRFTPMNLIRNRWAQIFTQSILGVLIAGGTAWAGDPFRPNNPHNIGDQTEAAFEAIFRDGNYRGAEEILAGAIQAEPNEPLVYAMQASFAYDANDMEGMRKYAQQTLESAQRLAPSDPLRGNLYIAVGHFLEGSYLLKKGSYLQAVGKTGTVFEHLDKASAINPNDPELNLLRGYLDLFLSRYTPFSQSEQVISRFEQYAAPDYLRYRALATTYRDLEKYDLAMANIDRALAITPDNPELQYLKGQFLRNEGRRSMDLGKLQQAQQYYAMALQKQDQLSRALVVQLNHENNAVVDEIQKLAQNPSLKGF6 4 0 0 5,89 35444,109 Synechocystisouter membrane-bounded periplasmic space (GO:0030288);Complete proteome; Reference proteome; Repeat; TPR repeat;[1390935826213]
126 P73599 Y1304_SYNY3Uncharacterized protein sll130463,426 13,59 MISSPKIKFGVHTFIWKKEFLGNEEYVFQDAKRWGFDGIEIATHYFDQIDPLQLKSYGEKYGVELTFCTSLPRGLSLTTKDEDCWRESIAYLERAIKFCQQCGIIQLSGPFPHPVGYLSGEPLQKRENVRMQEAFKLVAETLIKTDLKFAVEPLNRFQGYALNTVAQGLELLDAVDCPQLGLLLDLFHMNIEEKDVIKAFLQASNHCFHIHACAKDRGTPGSDSFAWGHWFKALQTMDYQGWVTIESFNFEDKELANGARLWRTVAPSNEALAQDGLKFLRQTYQTN4 4 0 0 5,79 32848,47 Synechocystis Complete proteome; Reference proteome;[1390935826213]
127 P72817 Y1654_SYNY3Universal stress protein Sll165463,315 22,29 MSINCWRSPNRAIGKSSGGVIMFKTILFPLDRSREARDAAQMVADLVKIHQSQLILLSVVEKNPPGQDHEAHGMDSPEAVAKLLEAAQAVFSQQGIATKTIEREGMASFTICDVADEVNADLIVMGCRGLGLTTEGVAESVTARVINLSPCPVLVVP7 3 0 0 5,58 16769,378 Synechocystisresponse to stress (GO:0006950);Complete proteome; Reference proteome;[1390935826213]
128 Q55730 Q55730_SYNY3Slr0650 protein 62,991 20,9 MFEDFEQDALFTPDQLLENRGRVAIFIDGSNLFYAALQLGIEIDYTKLLHCLTGGSRLLRAFFYTGVDRSNEKQQGFLLWMRRNGYRVIAKDLVQLPDGSKKANLDVEIAVDLMSLVGSYDTAVVVSGDGDLAYAADAVSYRGARIEVVSLRSMTSDSLINVSDRYVDLDSIKEEIQKQPRPNSGYRNVNPLPIFSQEKSS6 4 0 0 4,98 22501,444 Synechocystis Complete proteome; Reference proteome;[1390935826213]
129 P73302 KAD1_SYNY3Adenylate kinase 1 62,456 18,92 MAKGLIFLGAPGSGKGTQAVGLAETLGIPHISTGDMLRQAIADGTELGNQAKGYMDKGELVPDQLILGLIEERLGHKDAKAGWILDGFPRNVNQAIFLDELLVNIGHRTHWVINLKVPDEVIVERLLARGRADDNETTIRNRLLVYTEQTAPLMAYYQEQGKLYSLDGNQPVEAIATNLEKLVKP5 3 0 0 5,59 20251,24 Synechocystiscytoplasm (GO:0005737); adenylate kinase activity (GO:0004017); ATP binding (GO:0005524); AMP salvage (GO:0044209);ATP-binding; Compl te prot ome; Cytoplasm; Kinase; Nucleotide biosynthesis; Nucleotide-binding; Reference proteome; Transferase;[1390935826213]
130 P73061 URE1_SYNY3Urease subunit alpha61,918 8,08 MSYRMDRHSYAHTFGPTVGDKVRLADTELFIEVEQDYATYGDEVKFGGGKVIRDGMGQSPLSRAEGAVDVVITNALILDWWGIVKADVGIKNGRIYAIGKAGNPHIQDNVSIIIGPSTEAIAGEGMILTAGGIDAHVHFICPQQIETALASGVTTLVGGGTGPAAGTKATTCTPGAWNIHRMLQAADGFPINLGFLGKGNGSQPAALAEQIKAGAIGLKLHEDWGTTPAAIDNCLGVAEDYDVQVAIHTDTLNEAGFVETTIAALKNRVIHTYHTEGAGGGHAPDIIKICGELNVLPSSTNPTRPYTINTLEEHLDMLMVCHHLHRNIPEDVAFAESRIRRETIAAEDILHDLGAFSIISSDSQAMGRVGEVICRTWQTAHKMKVQRGQLPGETGNNDNLRAKRYVAKYTINPAITHGISEEIGSVEVGKLADLCLWSPAFFGVKPELVIKGGIVAYAQMGDANASIPTPQPVHMQPMFANYGGAIAATSVTFVSQKAAKKDIGEKLGLSKPLVAVKNIRQLTKRDLKLNNYLPHIEVDPETYEVRADGELLTCEPASVLPMAQRYFLF7 5 0 0 5,86 61037,598 Synechocystiscytoplasm (GO:0005737); nickel cation binding (GO:0016151); urease activity (GO:0009039); urea catabolic process (GO:0043419);Complete proteome; Cytoplasm; Hydrolase; Metal-binding; Nickel; Reference prot ome;[1390935826213]
131 P74035 RIMM_SYNY3Ribosome maturation factor RimM61,215 16,22 MAEPMTEQQKTENWLEIGTIVAAQGIQGEVRVLSASDFPARFLTKGQRWIRKTPQETPQPLTLKKGKQIPGKNLYILRFTEITDRNQAEALVNYQLLVPATDRLPLEPGEFHVTDLLGLIVYDHDNGDRLGIVTDFYSAGNDLLGITLDKNPDKEVLVPFVEAIVPTVELAEQRLEIKTIPGLLD5 4 0 0 4,89 20715,757 Synechocystisribosome (GO:0005840); ribosome binding ( O:0043022); ribosomal small subunit biogenesis (GO:0042274); rRNA processing (GO:0006364);Chaperone; Compl te proteome; Cytoplasm; Reference proteome; Rib some biogenesis;[1390935826213]
132 P73310 RL14_SYNY350S ribosomal protein L1460,59 26,23 MIQQQTYLNVADNSGARKLMCLRVLGTGNCTYGGIGDQIIAVVKDALPNMPIKKSDVVRAVIVRTKQPLRRASGMSIRFDDNAAVIINAEGNPRGTRVFGPVARELRDKNFTKIVSLAPEVL5 3 0 0 10,28 13294,538 Synechocystislarge ribosomal subunit (GO:0015934); rRNA binding (GO:0019843); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprotein; Rib somal protein; RNA-binding; rRNA-bindi g;[1390935826213]
133 P72659 PNP_SYNY3 Polyribonucleotide nucleotidyltransferase59,844 7,52 MQEFDKSISFDGRDIRLKMGTLAPQAGGSVLIQSGDTAVLVTATRAKGRDGIDFLPLTVDYEGRLYAAGRIPGGFLRREGRPPEKATLISRLIDRPLRPLFPHWLRDELQIVATTLSMDEEVPPDVLAVTGASVAVILAQIPFKGPMAAVRVGLVGDDFIINPTYREVHNGDLDLVVAGTPAGIVMVEAGANQLPEQDIIEAIDFGYEAVQDLINAQRELMTDLGITLATSEPPPVNTAVEEFIANRASKKIITVLGQFDLGKDGRDAALDEIKATEVETAIAELPETDPVKQSVEEDPKLVGNLYKALTKKLMRKQIVDDGVRVDGRKLEQVRPISCEVGFLPRRVHGSGLFNRGLTQVLSLATLGSPGDAQDLADDLHPEDEKRYLHHYNFPPYSVGEARPMRSPGRREIGHGALAERAIIPVLPPQEDFPYVVRVVSEVLSSNGSTSMGSVCGSTLALMDAGVPIKKPVSGAAMGLIKEGDEIRILTDIQGIEDFLGDMDFKVAGTDSGITALQMDMKIDGLSMEVVSKAIMQALPARLHILDKMLATIREPRPELSPFAPRLLTLKIEPEHIGMVIGPGGKTIKGITEQTSCKIDIADDGTVTIASSEGERAERARQMIYNMTRKLNEGEVYLGRVTRIIPIGAFVEVLPGKEGMIHISQLTEGRVGKVEDEVGVGDEVIVKVREIDSKGRLNLTRLGIHPDEAAEARRNASRG5 5 0 0 5,17 77831,425 Synechocystiscytoplasm (GO:0005737); 3'-5'-exoribonuclease activity (GO:0000175); magnesium ion binding (GO:0000287); polyribonucleotide nucleotidyltransferase activity (GO:0004654); RNA binding (GO:0003723); mRNA catabolic process ( O:0006402); RNA processing (GO:0006396);Complete proteome; Cytoplasm; Magnesium; Metal-binding; Nucleotidyltra sferase; Reference proteome; RNA-binding; Transfera e;[1390935826213]
134 Q55664 ALF2_SYNY3Fructose-bisphosphate aldolase class 259,418 9,75 MALVPMRLLLDHAAENGYGIPAFNVNNMEQIISIMQAADETDSPVILQASRGARSYAGENFLRHLVLGAVETYPHIPIAMHQDHGNSPATCYSAIRNGFTSVMMDGSLEADAKTPASFEYNVNVTAEVVKVAHSVGASVEGELGCLGSLETGQGEAEDGHGFEGKLDHSQLLTDPEEAVEFVNKTQVDALAVAIGTSHGAYKFTRKPTGEVLAISRIEEIHRLLPNTHLVMHGSSSVPQEWIDMINEFGGAIPETYGVPVEEIQKGIKSGVRKVNIDTDNRLAITAAFREAAAKDPKNFDPRHFLKPSIKYMKQVCADRYQQFWTAGNASKIKQLTLDDYAAKYAKGELTATSRTSVAV4 4 0 0 5,55 38971,984 Synechocystisfructose-bisphosphate aldolase activity (GO:0004332); zinc ion binding (GO:0008270); glycolysis ( O:0006096);Compl te proteome; Direct protein sequencing; Glycolysis; yase; Metal-binding; Reference proteome; Zinc;[1390935826213]
135 Q01903 SUBI_SYNY3 Sulfate-binding protein59,153 11,08 MARSAFGWGFSVIAVLMVGSITACNTTTTTEPGQGENASQAPANLTLVSYAVTRDAFEKIIPKFTEEWKSKTGQDVTFEQSYGGSGSQTRAVVDGLEADIVALALSSDVQKIESAGLIQPGWEQEAPNGSIVTNSVIAFVTKASDNIKVEKWADLANPEVKVITANPKTSGGARWNFLGIWGSVTKTGGTEEQAFDFAGKVLANAPVLPKDARESTDVFYKQGQGNVLLNYENEVLLAKQKGENQPYIIPQDFNVSISGPVAVVDTTVDKKGTREVRDAFVQYLFTPEAQQIFAETGFRPVNEEVLAKFASQYPKVENLATIEEFGGWKKAQAEFFDEGGIFDKVITKIGRQ7 4 0 0 4,86 38127,811 Synechocystisouter membrane-bounded periplasmic space (GO:0030288); secondary active sulfate transmembrane transporter activity ( O:0008271); sulfate transmembrane-transporting ATPase activity (GO:0015419); response to stress (GO:0006950); sulfate transport (GO:0008272);Complete proteome; Peri l sm; Reference prot ome; Signal; Stress r sponse; Sulf te transport; Tr nsport;[1390935826213]
136 Q55385 RRP3_SYNY3Probable 30S ribosomal protein PSRP-359,036 31,25 MTTAEAASTVHTSFILKVLWLDQNVAIAVDQIVGKGTSPLTSYFFWPRADAWQQLKDELEAKHWIAEADRINVLNQATEVINFWQDLKNQNKQISMAEAQGKFPEVVFSGSN7 3 0 0 5,24 12638,271 Synechocystisribosome (GO:0005840); structural constituent of ribosome (GO:0003735); translation (GO:0006412);3D-structure; Comp ete proteome; Reference proteome; Ribonucleoprotein; Ribosomal protein;[1390935826213]
137 Q55765 Q55765_SYNY3RNA-binding protein 58,009 31,13 MSIRLYVGNLPKESIEREALQEVFAEANAVVSTKVIKDRKTGKCRGFAFVTVSTDEAADEFIEKYNGQSFMDSPLKIEKANPRSKDDEEGGSETPVASGEKTKQPRTDKKRTNKKAAATSTNTSTASEGFQPDPRWADQLAQLKEKLTAAQ5 3 0 0 8,6 16616,542 Synechocystisnucleic acid binding (GO:0003676); nucleotide binding (GO:0000166);Complete proteome; Referenc proteome;[1390935826213]
138 P74470 P74470_SYNY3Ssl0242 protein 57,158 23,08 MYNPSLRREARYEPAAVLPVTREQSLIDWLESNNRLIYREIEEGTTSNMSDEDVDIAELMDGDDNLYGDDGSDDMDED6 3 0 0 3,76 8976,591 Synechocystis Complete proteome; Reference proteome;[1390935826213]
139 Q55113 Q55113_SYNY3Slr0431 protein 56,726 14,8 MRPKFFSRRPTMGISKLSKFSASVLLSGAILTTLPPSPLWANEMQQLLTVTGQASESVPTTLTEAQLTVEVQADTADQVQTAIAERSNRLVAYLRSQRVDKLQTQGLQLQPNYVYSNNERRLEGYIGSNTVSFQYPSDQVGKILDEAVRAGASRIDGIRFIATPETLKAAEQKALVAATADAQAQARVVLSSLNLTPQNIVRIVINPSPDQPMPLFRGALAASPMAESAPTPIISGDQTVQATVTLEIAY5 4 0 0 8,92 27011,788 Synechocystis Complete proteome; Reference proteome;[1390935826213]
140 P73283 FABF_SYNY33-oxoacyl-[acyl-carrier-protein] synthase 256,561 10,82 MANLEKKRVVVTGLGAITPIGNTLQDYWQGLMEGRNGIGPITRFDASDQACRFGGEVKDFDATQFLDRKEAKRMDRFCHFAVCASQQAINDAKLVINELNADEIGVLIGTGIGGLKVLEDQQTILLDKGPSRCSPFMIPMMIANMASGLTAINLGAKGPNNCTVTACAAGSNAIGDAFRLVQNGYAKAMICGGTEAAITPLSYAGFASARALSFRNDDPLHASRPFDKDRDGFVMGEGSGILILEELESALARGAKIYGEMVGYAMTCDAYHITAPVPDGRGATRAIAWALKDSGLKPEMVSYINAHGTSTPANDVTETRAIKQALGNHAYNIAVSSTKSMTGHLLGGSGGIEAVATVMAIAEDKVPPTINLENPDPECDLDYVPGQSRALIVDVALSNSFGFGGHNVTLAFKKYQ5 4 0 0 5,58 44004,116 Synechocystisbeta-ketoacyl-acyl-carrier-protein synthase II activity (GO:0033817); fatty acid biosynthetic process (GO:0006633);3D-structure; Acyltransferase; Complete proteome; Fatty acid biosynthesis; Fatty acid metabolism; Lipid biosynthesis; Lipid metabolism; Reference proteome; Transferase;[1390935826213]
141 P74795 P74795_SYNY3Ssl0352 protein 56,432 44,83 MIFPGATVRVTNVDDTYYRFEGLVQRVSDGKAAVLFENGNWDKLVTFRLSELEAVKPI3 3 0 0 6,12 6577,517 Synechocystis 3D-structure; Complete proteome; Reference proteome;[1390935826213]
142 P27320 FER_SYNY3 Ferredoxin-1 56,086 17,53 MASYTVKLITPDGESSIECSDDTYILDAAEEAGLDLPYSCRAGACSTCAGKITAGSVDQSDQSFLDDDQIEAGYVLTCVAYPTSDCTIETHKEEDLY44 3 0 0 3,78 10363,281 Synechocystis2 iron, 2 sulfur cluster binding (GO:0051537); electron carrier activity (GO:0009055); metal ion binding (GO:0046872); electron transport chain (GO:0022900);2Fe-2S; 3D-structure; Complete proteome; Di ect protein sequencing Disulfide ond; Electron transport; Iron; Iron-sulfu ; Metal-binding; Reference proteome; Transport;[139093 826213]
143 P26533 ATPE_SYNY3ATP synthase epsilon chain55,886 24,26 MTLTVRVITPDKVVWDEEVQELILPSTTGQLGILSNHAPLLTALEIGVMRVRPGKDWQNIAVMGGFAEVENNEVKVLVNGAELGTTIDAESARQAYTAAQGALEEANRGEDKPNQLKASNNYKKARARLQAAGGAV5 2 0 0 5,46 14580,536 Synechocystisplasma membrane proton-transporting TP synthase complex (GO:0045260); proton-transporting ATP synthase complex, catalytic core F(1) (GO:0045261); thylakoid membrane (GO:0042651); ATP binding (GO:0005524); proton-transporting ATP synthase activity, rotational mechanism (GO:0046933); proton-transporting ATPase activity, rotational mechanism (GO:0046961); plasma membrane ATP synthesis coupled proton transport (GO:0042777);ATP synthesis; CF(1); Complete prot ome; Direct protein sequencing; Hydrogen ion transport; Ion transport; Membrane; Reference proteome; Thylakoid; Transport;[1390935826213]
144 P73609 P73609_SYNY3Stage II sporulation protein55,644 29,63 MAFNIESEIINNAAKLTLIGELDGGTAPLFKEKIEEVAQAEISKLVLMMDQLEYMSSAGLRILVFAKQKMGSGVEIFLVGTQEMVNDTIEQTGLHHSFHLVESYDFHS5 3 0 0 4,8 11989,777 Synechocystisregulation of transcription, DNA-dependent (GO:0006355);Complete proteom ; Reference proteome;[1390935826213]
145 P73318 RL23_SYNY350S ribosomal protein L2353,9 9 31,68 MSKVIDQRRLADLIIKPIVTEKATLQLEDNKYVFDVRPEATKPEIKAAIELLFDVKVTGVNTARMPRRKKRVGRFMGFKAQVKRAVVTLKEGDSIQLFPDV5 3 0 0 10,18 11525,663 Synechocystisribosome (GO:0005840); nucleotide binding (GO:0000166); rRNA binding (GO:0019843); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprotein; Ribosomal protein; RNA-binding; rRNA-binding;[1390935826213]
146 P72606 P72606_SYNY3Slr1485 protein 53,407 10,32 MFKFAQIIFLAGSMVCLSSLGHQSLAGNLTLPDGSKCEGQISNGALNGQGTCQFTNGDRYEGQFVEGEKKGQGKYIFADGGYFEGVFEDDQMGSKGVRVYASQDRYEGEFVDGQPHGQGIYTTAAGLRYEGEFVDGQPTGKGTFIYTNGDRCSGTVVQGELNGSGKCEYNNGDQYEGTLKNGQPDGEGIFRFAAGGEYEGEFQSGEFSGQGTRIFANGNRFQGQFKQGLPSGQGQYNFADGASYQGEIRDGQPAGEGIYTFANGNRYQGQFVAGKFAGEGAFIFANGDRCQGQFSNNQLQGMATCDYVNGDTFEGIFEQGKKNGKGVYSFADGTRLEGVWKDDQYQERG6 4 0 0 4,67 37586,756 Synechocystisouter membrane-bounded periplasmic space (GO:0030288);Complete proteome; Reference proteome;[1390935826213]
147 P73289 RL25_SYNY350S ribosomal protein L2553, 44 26,53 MALSIECQQRPEKVNPRALRREGLIPATLYGHNGAESISLVVDHKTAITMLRSVTVKETPIEVKIPHLSWEGEAVVQEIQCHPWRRNLYHLAFFAGKK8 3 0 0 9,39 11140,952 Synechocystisribosome (GO:0005840); 5S rRNA binding (GO:0008097); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprote n; Rib somal protein; RNA-binding; rRNA-binding;[1390935826213]
148 P73602 Y1783_SYNY3Uncharacterized protein sll178353,233 17,01 MRADFFLSDNRAALLKRGLTIILSFLVFTSIFLLPSPSLAEDVKGADDPIVVAGNIKVKPDKKEEFIALSQTFIEPSRSEPGCISYSFYEDETEDNSFLFFEVWRNRAALDYHFQTPYFHEFVEKSPDLLAKPAEIKIYKIAETQTL5 3 0 0 4,95 16822,206 Synechocystis Complete proteome; Reference proteome;[1390935826213]
149 P73066 P73066_SYNY3cf23 protein 53,13 14,92 MSANLAQLHQALENRTALKVISGLNNFDSANVLAVARAAQAGGATFVDIAADRQLIQQVRHAIDLPICVSAVEAELLAEAVAAGADLVEIGNFDSFYAQGRRFEGPEVLALTKATRQLLPHTLLSVTVPHILALDEQVQLAEALVAAGADIIQTEGGTSAEPHHPGVLGLIEKAAPTLAAAHAISRAVNVPVLCASGLSDVTVPMAIAAGASGVGVGSAINQLNDQVAMVAAVRRLADALVAQPVRVA3 3 0 0 5,27 25366,097 Synechocystiscatalytic activity (GO:0003824); metabolic process (GO:0008152);Complete proteome; Reference proteome;[1390935826213]
150 P32422 PSAC_SYNY3Photosystem I iron-sulfur center53,128 27,16 MSHSVKIYDTCIGCTQCVRACPLDVLEMVPWDGCKAAQIASSPRTEDCVGCKRCETACPTDFLSIRVYLGAETTRSMGLAY4 3 0 0 6,51 8828,238 Synechocystisphotosystem I (GO:0009522); thylakoid membrane (GO:0042651); 4 iron, 4 sulfur cluster binding (GO:0051539); electron carrier activity (GO:0009055); metal ion binding (GO:0046872); oxidoreductase activity (GO:0016491); photosynthetic electron transport in photosystem I (GO:0009773);4Fe-4S; Complete proteo ; Direct protein sequencing; Electron t anspo t; Iron; Iron-sulfur; Membrane; Met l-binding; Oxidoreductase; Pho osynthesis; Photosystem I; Reference proteome; Repeat; Thylakoid Transport;[1390935826213]
151 P74769 P74769_SYNY3Ssr1528 protein 52,66 23,4 MANTTKGADAIDQAIAAGIDFDGSAIPEAKLELYHQVMGLEAGRQRSGVSNTMRSRIVRIGAKHIVQAELDQKLIDAGFAPLKDKEIAFFYGAK7 3 0 0 8,05 10118,58 Synechocystis Complete proteome; Reference proteome;[1390935826213]
152 P74308 P74308_SYNY3Aldehyde reductase 52,166 8,87 MQSFNRINSMKYFPLSNGEQIPALGLGTWKSSPQVVGQAVEQALDLGYRHLDCAAIYGNEAEIGATLANAFTKGVVKREELWITSKLWSNAHHPDAVLPALEKTLQDLGLDYLDLYLIHWPVVIQPDVGFPESGDQLLPFTPASLEGTWQALEKAVDLGLCHHIGVSNFSLKKLEMVLSMARIPPAVNQVELHPYLQQSDLLTFANSQNILLTAYSPLGSGDRPAAFQQAAEPKLLTDPVINGIAAEQGCSAAQVLLAWAIQRGTVTIPKSVNPERLEQNLRAADITLTDSEMAKIALLDRHYRYVSGDFWTMPGSPYTLQNLWDEI4 4 0 0 5,07 36014,105 ynechocystisoxidoreductase activity (GO:0016491);Complete proteome; Reference proteome;[1390 35826213]
153 P23350 RL10_SYNY350S ribosomal protein L1050,923 18,5 MGRTRENKATVISDVQELFQDAQMTVIIDYQGLTVAEITDLRNRLRPLGGTCKIAKNTLVRRALAGQEAWSPMEEFLTGTTAILVLKEDLGGAIKAYKKFQKDTKKTELRGGVLEGKSLTQADVEAIGDLPSKEQLMGQIAGGINALATKIALGIKEVPASVARGLQAHVDKE3 3 0 0 8,99 18675,593 Synechocystisribosome (GO:0005840); LSU rRNA binding (GO:0070180); structural constituent of ribosome (GO:0003735); ribosome biogenesis (GO:0042254); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprotein; Ribosomal prot in; RNA-binding; rRNA-bind n ;[1390935826213]
154 P73201 SYS_SYNY3 Serine--tRNA ligase 50,864 10,7 MLDLKQIRENPTAIQNRLNQRGGGASYDLEPILAIAAEQKAKESERTVLQSRSNEIGKLIGQKIGQGADPKGEEIQTLREEGNSLKIQLADLEPQEKDLKEQLQKLLLELPNLPCETTPIGASEADNIEVKRWGDQYLKAETVGILPHWEIGEKLGIIDSERGVKVAQSRFISLMKAGAALERALINFMLERHIGVGYQEIMPPILVNSDSLLGTGQLPKFAEESFQCRGDDLWLIPTAEVPVTNLYRDEVLDLEQLPIKHCAYTPCFRREAGSYGRDTKGLIRLHQFNKVELVKLVKPEESAAEHQALVADAEAILQALELPYRVVELCTGDLGFGAAKCYDLEVWLPSANTYREISSCSNFHDFQARRANIRYKEKGKKGTQFVHTLNGSGLAIGRTMAAILENYYEPSSGQVKVPVVLQDFLKRDYL7 4 0 0 5,53 48037,921 Synechocystiscytoplasm (GO:0005737); ATP binding (GO:0005524); serine-tRNA ligase activity (GO:0004828); selenocysteine biosynthetic process (GO:0016260); selenocysteinyl-tRNA(Sec) biosynthetic process (GO:0097056); seryl-tRNA aminoacylation (GO:0006434);Aminoacyl-tRN  synthetase; ATP-binding; Complete proteome; C toplasm; Ligase; Nucleotid -binding; Protein bi synthesis; Reference proteome;[1390935826213]
155 P74233 P74233_SYNY3Slr1160 protein 50,86 19,12 MLQRLVHILALTVCGLAVVSSLTPSVRGQGVTEVEEVIIEGSGPENSREFRPLNQEGSILSVGAGRRLMNEANEAINLNQYTVALEKLQEARKIFNQLSNFHLQLANSFSGINTVIFEEQRIAALETGQLRDEATYRLALVHRANNEPALAVPLLLQIIRSQNPTTDLGRKSYQQLYELGFVASPFEGPTPTGTNAAPTAPVVN3 3 0 0 5,68 22261,29 Synechocystisouter membrane-bounded periplasmic space (GO:0030288);Complete proteome; Reference proteome;[1390935826213]
156 P73481 YHIT_SYNY3 Uncharacterized HIT-like protein slr123450,746 22,81 MAEDTIFSKIIRREIPAAIVYEDDLCLAFKDVNPQAPVHVLLIPKKPLPQLSAATPEDHALLGHLLLKAKEVAADLGIGDQFRLVINNGAEVGQTVFHLHLHILGGRPFSWPPG7 3 0 0 6,27 12456,532 Synechocystiscatalytic activity ( O:0003824); metabolic process (GO:0008152);Complete proteome; Reference proteome;[1390935826213]
157 P73244 P73244_SYNY3Slr2025 protein 50,168 17,65 MTMASPTPELANPTMDEMTPASHHDVVETVISGMAQENSAFVQDNDQGSIWKFAYGSVEVLVQLTGEGENDLFRVWAEVMPLPTDPGQLLAEVMQLNWSDTFEACFALRENHLVALHQRTVADLSPSEISRAITLVATLADDHDDRLKEKYGA2 2 0 0 4,35 16887,893 Synechocystis Complete proteome; Reference proteome;[1390935826213]
158 P48946 RS18_SYNY330S ribosomal protein S1849,358 35,21 MNYYRKRLSPLPPNQPIDYKDTELLRKFITERGKILPRRITGLTAKQQRDLTTAVKRSRLVALLPFVNKEI4 3 0 0 11,02 8380,926 Synechocystisribosome (GO:0005840); rRNA binding (GO:0019843); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprot i ; Ribosomal protein; RNA-binding; rRNA-binding;[1390935826213]
159 P74341 P74341_SYNY3Sll1537 protein 49,236 20,86 MPPQFPLATVGALVTAPDGRVLIVKTTKWRGTWGVPGGKVEWGETLEAALKREFQEEVGLDLREIKFALVQEAVNDEQFHCPAHFVLLNYYARCESTQVIPNEEIVEWEWVTPLEALDFPLNSFTKLLLEDYQQRFMSI5 3 0 0 4,75 15937,264 Synechocystishydrolase activity (GO:0016787);Complete proteome; Hydrolase; Reference proteome;[1390935826213]
160 P73055 Y3122_SYNY3Uncharacterized protein ssr312248,828 37,65 MISLDQVKQQIQAALPDAEVMVNDLGGGDHLEAVVVSSAFTGQSRVKQHQMVYGALKDALASEAIHALALKTFTPEAWAVARQTA4 3 0 0 5,8 9045,316 Synechocystis Complete proteome; Reference proteome;[1390935826213]
161 P74135 P74135_SYNY3Sll1873 protein 48,622 27,27 MLKKLFGAKKEFYVQLDESQAPAQVEEADVAIVKSEVAPVEKPAPTTSKKTSIKKKSATKAAAPVETPASAPVAPAPKAKVDPSQVAFASGDPIPQNVARRTPGPSLNRFKEMARQVKVKR10 2 0 0 10,09 12905,989 Synechocystis Complete proteome; Reference proteome;[1390935826213]
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162 P72985 P72985_SYNY3Slr1600 protein 48,485 17,45 MDDTNTTLLLKRPVALKVIVTPRWKEEMQQQLQAQVGQMDNQVQQLDAQSQRAIAEIKKQSLVPLPPSVSQQIENIQMQVNQQKSEILEQKNQALQQMQQVQLLELNQEVIQGQMESFFRIQKGDNLVQKMGVELVLRDGVVEEIRGEL7 3 0 0 5,07 17129,696 Synechocystis Complete proteome; Reference proteome;[1390935826213]
163 P74061 RPE_SYNY3 Ribulose-phosphate 3-epimerase48,416 12,61 MSKNIVVAPSILSADFSRLGEEIKAVDEAGADWIHVDVMDGRFVPNITIGPLIVDAIRPLTKKTLDVHLMIVEPEKYVEDFAKAGADIISVHVEHNASPHLHRTLCQIRELGKKAGAVLNPSTPLDFLEYVLPVCDLILIMSVNPGFGGQSFIPEVLPKIRALRQMCDERGLDPWIEVDGGLKPNNTWQVLEAGANAIVAGSAVFNAPNYAEAIAGVRNSKRPEPQLATV6 3 0 0 5,37 24970,857 Synechocystismetal ion binding (GO:0046872); ribulose-phosphate 3-epimerase activity (GO:0004750); pentose-phosphate shunt (GO:0006098);3D-structure; Carbohydrate metabolism; Cobalt; Complete proteome; Direct protein sequencing; Iron; Isomerase; Manganese; Metal-binding; Reference proteome; Zinc;[1390935826213]
164 P74002 Y1322_SYNY3Uncharacterized protein slr132248,067 7,16 MPPTLLLSQDLPSLNYTTPGDRLDGRWRESLSTLLGLGRAAGADFVEFFLEKVNYVSCLAEDDAITSLTPRLSSGCGVRVYKGKGDCYVSTNDISFNGLRTALEKGLSILGLTLPAGQSFVPELNLEMLRDYAGAKEKDQWLHRCSPMQEMSDILLGANQKLDHYASHAQSRRAAYFRDWQEVLVAASDGTFARDIRLTQSVGFSLFCADGEHRTSIGKRSGDTSNPDYLRTWDAETSAQEVAESAGKMLYADYVESGNYPIIMANQFGGVIFHEACGHLLETTQIEHKTTPFLDKKGEKIAHENLTAWDEGLTDNAFGTIDMDDEGMPTQRTLLIENGILKNFIADRTGSIRTGHPRTGSGRRQSYAYAAASRMRNTYIAPGNYSVDDIFNSVEKGIYCKQMGGGSVGATGEFNFAVSEAYLVENGKLTKPLKGATLIGTATEIMNKISMSSQDLGLAAGFCGSVSGSVYVTVGQPHIKVDGITVGGR3 3 0 0 5,48 53129,717 Synechocystis Complete proteome; Reference proteome;[1390935826213]
165 P73204 PYR2_SYNY3Phycobilisome 32.1 kDa linker polypeptide, phycocyanin-associated, rod 247,655 11,36 MTSLVSAQRLGIVAVDEAIPLELRSRSTEEEVDAVILAVYRQVLGNDHLMSQERLTSAESLLRGREISVRDFVRAVALSEVYRQKFFHSNPQNRFIELNYKHLLGRAPYDQSEIAFHTDLYHQGGYEAEINSYIDSVEYTENFGDWVVPYFRGFATQRNQKTVGFSRSFQVYRGYATSDRSQGNGSRSRLTRELARNTASPVYAGSTAESLRGTSAGSRNQMYRLQVIQGAAPGRGTRVRRGKAEYLVSYDNLSAKLQQINRQGDTVTMISLA3 3 0 0 9,51 30797,389 Synechocystisphycobilisome (GO:0030089); photosynthesis (GO:0015979);3D-structure; Complete proteome; Membrane; Photosynthesis; Phycobilisome; Reference proteome; Thylakoid;[1390935826213]
166 P73929 P73929_SYNY3Slr2101 protein 47,645 20,28 MKFISSFFALATVLACQPTVFAFEPAEAIKVETILKTETSWDGQPLAYPEGQAEITGMMIEIAPGAETGWHSHPVPSFGILLEGELEVTLLNGQKKLIKTGDAIAEVVNTVHNGRNVGEGPVKILVFYAGAKDLPVTVKDQPN3 3 0 0 4,99 15348,676 Synechocystis Complete proteome; Reference proteome;[1390935826213]
167 P72866 RS15_SYNY330S ribosomal protein S1547,542 23,6 MSLTQIRKQELMTEYQAHETDTGSADLQVAFLTERITQLTGHLKANPKDHASRRGLLKMIGRRKRLLSFINAREPERYQALIKRLGIRR6 3 0 0 11,16 10373,062 Synechocystisribosome (GO:0005840); rRNA binding (GO:0019843); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprot i ; Ribosomal protein; RNA-binding; rRNA-binding;[1390935826213]
168 P72753 UPP_SYNY3 Uracil phosphoribosyltransferase47,005 14,35 MASQLRVYVPEHPLIKHWLGVARDENTPPVLFKTAMGELGRWLTYEAARYWLPTVDTEVKTPLAIAKASLIDPQTPFVIVPILRAGLALVEGAQGLLPLAKIYHLGLVRNETTLEPSLYLNKLPERFAPGTHLLLLDPMLATGNTIMAALDLLMARDIDANLIRLVSVVAAPTALQKLSNAHPNLTIYTAMIDEQLNDRGYIVPGLGDAGDRCFGT3 3 0 0 6,2 23637,675 SynechocystisGTP binding (GO:0005525); magnesium ion binding (GO:0000287); uracil phosphoribosyltransferase activity (GO:0004845); UMP salvage (GO:0044206); uracil salvage (GO:0006223);Allosteric enzy e; Complete proteome; Glycosyltransferase; GTP-binding; Magn sium; Nucleotide-binding; Reference proteome; Transferase;[1390935826213]
169 P72871 METK_SYNY3S-adenosylmethionine synthase46,875 7,75 MRGLKTLSKRYLFTSESVTEGHPDKVCDQISDTILDALLTLDPNSRVAAETVVNTGLTLVTGEITSQAHINFVELIRQKIAEIGYTNADNGYSANSCAVMLAIDEQSPDISQGVTAAQEQRHALSDDELDKIGAGDQGLMFGYACNETPELMPLPISLAHRIALRLSEVRKSGQLAYLRPDGKTQVSILYEDGSPVAIDTILISTQHDEHIGDITDNDAVQAKIKADLWDVVVGHCFSDIALKPTDKTRFIVNPTGKFVVGGPQGDAGLTGRKIIVDTYGGYSRHGGGAFSGKDPTKVDRSAAYAARYVAKNIVAAGLADKCEVQVSYAIGVARPVSVLIDTFGTGKVDEEKLLEVVLANFELRPAGIIQSLNLRNLPAERGGRFYQDVAAYGHFGRNDLDLPWEYTDKVDVLKAAFASSPQAVAV5 3 0 0 5,14 45865,812 Synechocystiscytoplasm (GO:0005737); ATP binding (GO:0005524); magnesium ion binding (GO:0000287); methionine adenosyltransferase activity (GO:0004478); one-carbon metabolic process (GO:0006730); S-adenosylmethionine biosynthetic process (GO:0006556);ATP-binding; Co alt; Complete proteome; Cytoplasm; Magnesium; Metal-binding; Nucleotide-bi ding; One-c rbon metabolism; Potassium; Refere ce proteome; Transferase;[1390935826213]
170 Q55332 PSBU_SYNY3Photosystem II 12 kDa extrinsic protein46,648 16,79 MKFISRLLVACSLLIGLMGFLGADLAQALTPNPILAELNAVDAKLTTDFGQKIDLNNSDIRDFRGLRGFYPNLASEIIKNAPYDTVEEVLDIPGLSETQKSRLEANLGSFTVTEPSIELTSGDDRINPGVY16 3 0 0 4,53 14245,243 Synechocystisextrinsic to membrane (GO:0019898); photosystem II oxygen evolving complex (GO:0009654); plasma membrane-derived thylakoid photosystem II (GO:0030096); nucleotidyltransferase activity (GO:0016779); oxidation-reduction process (GO:0055114); photosynthesis (GO:0015979); photosystem II stabilization (GO:0042549);Compl te proteome; Direct protein sequencing; Electron transport; Membrane; Photosynth sis; Photosystem II; Reference proteo e; Signal; Thylakoid; Transpo t;[ 390935826213]
171 Q6YRS8 Q6YRS8_SYNY3Sll6017 protein 46,52 12,5 MFDNLCKFLAESFSEDYAAWLLGRPIKLTKLSPTELSLEPIRADSLILEQSEDLVLHLEFQTEPDPTMGFRMLDYRVRVYRRFPQKTMHQFVIYLKHSNNDLVYQDSFQVGETVHRYQAIRLWEQSSDAFLQSPGLLPLAVLTQTSDPTLKLREVATVLEQIEDNRVKANLMAATSVFGGILLSPDIIKTILRSEIMKESAVYQEILEEGKIAGKLEGKLETIPLLKKLGLTIAEIAKELDIDVELVNRFVANQNN6 3 2 Q6ZEP8,Q6ZEK6 4 Q6ZEQ3,P72822,P73620,Q6ZEL25,18 29211,736 Synechocystis Complete proteome; Plasmid; Reference proteome;[1390935826213]
172 Q55450 GATC_SYNY3Glutamyl-tRNA(Gln) amidotransferase subunit C45,961 17,31 MLDQSQVQKIAHLARLEITPEEESQFASQLSSILDYFDQLNELPTEGVEPTTRAIELSNIVRGDRQISWDGDNAATTRQALLDNAPEPEGDFFRVPRIMGGDEA6 3 0 0 4,25 11615,791 SynechocystisATP binding (GO:0005524); glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity (GO:0050567); regulation of translational fidelity (GO:0006450); translation (GO:0006412);ATP-binding; Complete proteome; Ligase; Nucleotide-binding; Protein biosynthesis; Reference proteome;[1390935826213]
173 P54386 DHE4_SYNY3NADP-specific glutamate dehydrogenase45,594 7,71 MAGSLFADASKRLEKALKYVAISDDAGERLKYPKTSLSVSIPVRMDDGSLKIFPGYRVRYDDTRGPGKGGVRYHPNVTMDEVQSLAFWMTFKCALLNLPFGGAKGGITLNPKELSRAELERLSRGYIEAIADFIGPDIDILAPDVYTNEMMMGWMMDQYSIIRRKISPAVVTGKPVTMGGSQGRNTATGTGAFYIMQGMLPKFDQYPENTTVAVQGFGNAGMVVAECLYQDGYKVVAISDSQGGIYNEQGIDIPAVIDYKQRHRTLAGMYCDQAICDLGENQQISNAELLALDVDVLIPAALENQITRDNADQVRARYIFEVANGPTTTAADDILASKGIYVFPDILVNAGGVTVSYFEWVQNRSGLYWSAKEVNDRLKEKMVEEAEHVWNITQELDVNVRTAAYIHALNRLSEAMDAKGTRDYYQDS4 3 0 0 5,05 47312,712 Synechocystiscytoplasm (GO:0005737); glutamate dehydrogenase (NADP+) activity (GO:0004354); glutamate biosynthetic process ( O:0006537);Complete proteo e; NADP; Oxidoreductase; Reference proteome;[1390935826213]
174 P73354 HTRA_SYNY3Putative serine protease HtrA45,532 9,07 MSAQAVFPIAPHRADFFPRFVLSNSSANKCHQAMKDVSLHSPKQTPSKISLAYLGLVLVGMGIGAGGTFVLTNPQWADHLTNNSVISPLVTNQSIAPANESLATNLQSRLSPREPSNFVVDVVESTGPAVVRINAQKTVKSQVPQAFNDPFLQRFFGSQMPPMPNERVQRGTGSGFIVSNDGKIFTNAHVVDGADEVTVTLKDGRSFPGRVMGSDPSTDVAVVKIEAGDLPTVALGDSDHLQVGEWAIAIGNPLGLDNTVTTGILSATGRRSADIGVPDKRVEFIQTDAAINPGNSGGPLLNADGQVIGMNTAIIQNAQGIGFAIPINKAQEIAQQLIATGKVEHAYLGIQMVTMTPELQSQIRQETGMNIPVDKGVVIMQVMPNSPAAIAKLEQGDVLQSLQGQPVENAEQVQSLVGKLAVGDEVELGILRNGQQQNLTVTIGALPSAPPQ4 3 0 0 5,42 47656,158 Synechocystiscell outer membrane (GO:0009279); integral to membrane (GO:0016021); serine-type endopeptidase activity (GO:0004252); proteolysis (GO:0006508);Cell outer membrane Comple e proteome; Hydrolase; Membrane; Protease; Reference proteome; Transmembran ; Transmembrane helix;[1390935826213]
175 P73604 P73604_SYNY3Slr1853 protein 45,495 24,78 MSEFKNAVLDDKDLQAGLGGINPKFGDFCTRVAGEAWGLPLIDQKTKALIVIAVDVANQTLSGPFQAHVDMALKQGATKEEIEEVLSFMCVYGGFNKAAGAFAALKEIFEQNS8 3 0 0 4,87 12110,863 Synechocystisperoxiredoxin activity (GO:0051920);Complete proteome; Reference proteome;[1390935826213]
176 Q6ZEP2 Q6ZEP2_SYNY3Slr5088 protein 45,451 12,61 MKLMVIGASKGLGKAFVEGLCSDGDMVIGVSRSQPQDLRLPESILLDWIEADLEKPLQAIQILKKYTPNELDVLIYNLGIWEKTAFSEEYSFLDDEDKSLIDMVNVNITSAILVLKHLIPRLLKSSQPRLILTGSTSGLRQSGRPEVTFGASKFALSGIADALRESFRSEGLGVTCLQLGYLNTEDSLQVPVAEAAQRGNGELIPLHDVINLVKAIINMSKASYVRELVLPAIQDERF5 3 0 0 5,1 26170,277 Synechocystisoxidoreductase activity (GO:0016491); oxidation-reduction process ( O:0055114);Complete proteome; Plasmid; Reference prote me;[1390 35826213]
177 P73293 RS9_SYNY3 30S ribosomal protein S944,86 18,98 MQANDSSNKVVYWGTGRRKAAIARVRLVPGQGEVIVNGKPGEIYFNRIANYIQSLKAPLETLGLEGEYNILVNAHGGGLTGQADAVKLGVARALCQLSPENRQPLKAEGYLTRDPRAKERKKYGLHKARKAPQYSKR6 3 0 0 10,22 15086,339 Synechocystisribosome (GO:0005840); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference prote me; ibonucleoprotein; Ribos mal protein;[1390935826213]
178 P72851 RL28_SYNY350S ribosomal protein L2844,107 28,21 MARRCQLTGKKANNGFAVSHSHRRTKKLQQANLQWKRVWWPEGNRFVRLRLSTTAIKTLESKGINAMAKEAGINLNKF3 3 0 0 12,02 8993,49 Synechocystisribosome (GO:0005840); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference prote me; Ribonucleoprotein; Ribos mal protein;[1390935826213]
179 P73202 PYS1_SYNY3Phycobilisome 8.9 kDa linker polypeptide, phycocyanin-associated, rod43,398 30,12 MLGQSSLVGYSNTQAANRVFVYEVSGLRQTDANENSAHDIRRSGSVFIKVPYARMNDEMRRISRLGGTIVNIRPYQADSNEQN6 2 0 0 9,8 9322,352 Synechocystisphycobilisome (GO:0030089); photosynthesis (GO:0015979);Complete proteome; Direct protein sequencing; Membrane; Photosynthesis; Phycobilisome; Reference proteome; Thylakoid;[1390935826213]
180 Q55770 Q55770_SYNY3Sll0185 protein 43,276 7,64 MAKEDRPSLKDMTLRQLRRVASECNISRYSRMRKSQLLAEVEKALNKPAPAPFSVKPLNRPQEEQAVEASKFELGQDDKVGAPLTAVDEVLGDLPGGYGESRITLMPRDPQWAYAYWDIPKEHKDALRSQGGQQLALRLYDVTDLDWQTASPHSVQEYLCDELAREWYLPIPVSDRDYALDIGYRTFDGRWLTLARSTPIRIPPVYPSDWVEEVFVTVNWDEDLQGKTIYQLVPPSKRPVGVSTAVYDQVFDMAQGAEAMRMAGSLYGSMQHVPGSITHEQTLSSYVFPSGVGLWAAPNVSGLNMSGIGMGYGLSSREFMASEAPVRPRQFWLVADAELIVYGATEPDATVTIGGRPIKLNEDGTFRFQMSFQDGLIDYPIVAVAVDGEQTRNVHMKFTRETPSRNTNTKEEAVPEWFS4 4 0 0 5,04 46994,054 SynechocystisDNA-dependent transcription, termination (GO:0006353);Complete pr teome; Reference proteome;[1390935826213]
181 P73946 P73946_SYNY3Slr1506 protein 43,25 5,14 MEKKITLRWGQWQQNCLELAQVSCPLLQSSNLVDPPPLINLDIASMVTFPLNLRRWLQSVCLGALTAIAVQLPGKTAENIFFTYGPIKLTVRVESLERFVQDGTVDSNLSFLFNLVGASEEKLAKLREIMGLRAEVDPVVLSNFFNTSLGEDSLARAAVILNAPWGANSKYGIRAAIVQAAEDPEGGLSLINFIKKYPTDIHFQGEVVEERARAVELLVKASEHFIDKMIALSEIEAASEGDINFSALPDPTEMGPYGVAPKETWWLNDQSRNRRFYVDVYRPQRWKEGKTPVLVFSHGLASRPEDFDNAAEKMASYGFVVALPQHPGSDILQAQALLNRTSRQGYYPTEFIDRPKDISYVIDELERRNASEFGDRLNLTQVGVGGHSFGGYGALAVAGATIDWDFLKSECRIGQGVPNTALLLQCDALTLPRSDYDFRDPRVVAVLAANPVNSAIFGVSGLHKVTVPVLLLGGSYDPATPFVLEQARSFPRLASRDKYLTLMEGQAHVDFSKIDANIKNVVESVEAVSLKLPDPNLLHTYGSAVMVPFFQLYVAGDESFRPLVENGAAHAAYLSRDQEFKFYLISQKSEGALIKDIEEFRRTNGLTPPPNEFPPQTISDNF4 4 0 0 5,21 68847,364 Synechocystis1-alkyl-2-acetylglycerophosphocholine esterase activity (GO:0003847); lipid catabolic process (GO:0016042);Complete prote me; R f rence proteome;[1390935826213]
182 P73328 P73328_SYNY3Slr1900 protein 42,843 10,93 MGSYSQLDLDISLCTKYRLLCNAGDSLISLLPHPMTATVTAQEAFRAAYENRYTWDENFPGYRAHLTVTQGDERYEGEVEVKADYTVTVTGFSDETVQESVYNQMRDIVTHRKQGNFEKSHGKNEFSFGETDASGAIAIDVKGDAMGSNYKIRGTEICQVSRVMGPVAFTINTEESLDTGSGYIAIKYNAIFKDPKTDTLKGKRDFTETYGELGGYYLPTQQTVEAIAAGGEKIFTDFSFTNLELLA4 3 0 0 4,82 27406,459 Synechocystis Complete proteome; Reference proteome;[1390935826213]
183 Q55447 Q55447_SYNY3CheY subfamily 42,641 19,33 MGSALVIDDSSTERSIISDFCQKLGINVTTAISGEEALEKLSQAVPDVIILDIVLPGRSGFEICRELKDKDRTKSIPIILCSTKATDMDKFWGKRQGADAYITKPIDQEEFNTVIKQFI5 2 0 0 4,97 13181,153 Synechocystisphosphorelay response regulator activity (GO:0000156); intracellular signal transduction (GO:0035556); regulation of transcription, DNA-dependent (GO:0006355);Complete proteome; Reference proteome;[1390935826213]
184 P73601 P73601_SYNY3Sll1784 protein 41,845 10,11 MKTLRLSPLLSKLCLILLIVLGTLTIAIPKALAISTLDNFPHPNIEKTEKILGPAGEIFEFSTCNADGIGFTIAEAQIPPGAGPLPHIHHYTNEWFWTPKGGLQLFQSVKEYPDLENPATDEQAGNTTVYTVNTEPNQIVYGPKYRVHGFANTTTETRPLTFIWLEDGISPEYELHDGGIREYFQDVGIPIKDLKHLPAITEESKIEFVSHAPLYGINQSYYFFEYVDGVSGKLPTSLTKLENDQSLNRIIDTINAYNQGDATVKCF4 3 0 0 5,07 29757,788 Synechocystisouter membrane-bounded periplasmic space (GO:0030288);Complete proteome; Reference proteome;[1390935826213]
185 P74645 KAIB_SYNY3 Circadian clock protein KaiB41,646 23,81 MSPFKKTYVLKLYVAGNTPNSVRALKMLKNILEQEFQGVYALKVIDVLKNPQLAEEDKILATPTLAKILPPPVRKIIGDLSDREKVLIGLDLLYDEIREREAEDQ3 3 0 0 7,9 11935,026 Synechocystiscircadian rhythm (GO:0007623);3D-structure; Biological rhythms; Complete proteome; Reference proteome;[1390935826213]
186 P73597 P73597_SYNY3Sll1306 protein 41,466 8,06 MQRRDLFKYGLATGAGAIASYALMGNKPLLAQQSSNRGGKFWPDNIRLPISLSLMFETGSQPAKGAPTPFGNFTPPPDYYDMPTITWYRYGYTEGVPRILDLLDKYKIKITSHMSGRTVEMYPDRAKEIVQRGHEAAAHGWDWDNEFNMTAPQERDFIQRNVDIILKVTGQRAVGYNAPGLRGSVNILTVLNELGFVYHIDDVSRDEPFIVNLNNGKSIMVVPYAVYLNDIRAYEARFFSSGQYLTELKNSFDRLYEEAAYRRRMMAVTMHDRLQRPEHVYVFEDFLKYVMAKPGVAFMKKIDIANFALNDPNTIREDIQNVYPNVPNFVPSATS4 3 0 0 8,49 38270,621 Synechocystisouter membrane-bounded periplasmic space (GO:0030288); hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds (GO:0016810); carbohydrate metabolic process (GO:0005975);Complete proteome; Reference proteome;[1390935826213]
187 P72642 DAPB_SYNY34-hydroxy-tetrahydrodipicolinate reductase41,225 12 MANQDLIPVVVNGAAGKMGREVIKAVAQAPDLQLVGAVDHNPSLQGQDIGEVVGIAPLEVPVLADLQSVLVLATQEKIQGVMVDFTHPSGVYDNVRSAIAYGVRPVVGTTGLSEQQIQDLGDFAEKASTGCLIAPNFAIGVLLMQQAAVQACQYFDHVEIIELHHNQKADAPSGTAIKTAQMLAEMGKTFNPPAVEEKETIAGAKGGLGPGQIPIHSIRLPGLIAHQEVLFGSPGQLYTIRHDTTDRACYMPGVLLGIRKVVELKGLVYGLEKLL3 3 0 0 5,45 29090,618 Synechocystiscytoplasm (GO:0005737); 4-hydroxy-tetrahydrodipicolinate reductase (GO:0008839); NAD binding (GO:0051287); NADPH binding (GO:0070402); oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor (GO:0016726); diaminopimelate biosynthetic process (GO:0019877); lysine biosynthetic process via diaminopimelate (GO:0009089);Amino-acid biosynthesis; Complete proteome; Cytoplasm; Diaminopimelate iosy thesis; Lysine biosynthesis; NAD; NADP; Oxidoreductase; Referen e proteome;[1390935826213]
188 P73296 RL17_SYNY350S ribosomal protein L1741, 08 21,55 MRHRCRVPQLGKPADQRKALLRALTTELIRHGQIKTTKARAKAVRSEVDRMITLAKDGSLAARRRALGYMYDKPTVHALFADAPSRYKDRDGGYTRIIRTLRRRGDNAEMAVIELV4 3 0 0 11,22 13228,444 Synechocystisribosome (GO:0005840); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference prote me; Ribonucleoprotein; Ribos mal protein;[1390935826213]
189 P72776 PDXJ_SYNY3 Pyridoxine 5'-phosphate synthase40,832 10,74 MLTLGVNIDHVATIRQARQTVMEPDPIAAAVLAELAGADGITAHLREDRRHIQERDVEILRKTVRTHLNLEMAATKEMVEIALNLKPDYVTLVPERREEVTTEGGLDVAGNLNYLLGVVEQLQSRHIPVSLFIDPDVAQLKASAQTGAKFIELHTGKYANAPTADDQARELGSLAIACDIALELGLRINAGHGLTYWNVRPVAELPGMEELNIGHSIMSRAILVGMERAVREMKLAMLGLPF3 3 0 0 5,51 26518,63 Synechocystiscytoplasm (GO:0005737); pyridoxine 5'-phosphate synthase activity (GO:0033856); pyridoxine biosynthetic process (GO:0008615);Complete proteome; Cytopla m; Pyridoxine biosynthesis; Reference rote me; Transferase;[139093 826213]
190 Q55953 Q55953_SYNY3Sll0781 protein 40,758 15,48 MTTPLVPPFTKEIAIAKVRMAENAWNGRNPDKVCMAYTEDSFWRNRAEVFQGREKIREFLRRKWDKELNYRLVKELWAFGENRIAVRFQYEWQDDAGQWYRAYGNENWEFDEAGLMRRREASINDKPIAESERRFFWDAPGDRPLDHPGLINTPE5 2 0 0 6,63 18633,936 Synechocystis Complete proteome; eference proteome;[1390935826213]
191 P73921 P73921_SYNY3Sll1979 protein 40,58 18,31 MTESVISPEDAFNQAIARYNGGEGPETLIPVFKDIADSSPKNATVWACLAWLYLLDDKPTLAFKAAQRSVKIDGYHPQARINYALAMLANKKTGVREQVELAAQMMSFDQEIAAGVMESLDDGLERKPDWRDIERIKKWLTE2 2 0 0 5,01 15946,176 Synechocystis Complete proteome; Reference proteome;[1390935826213]
192 P74102 OCP_SYNY3 Orange carotenoid-binding protein40,302 10,41 MPFTIDSARGIFPNTLAADVVPATIARFSQLNAEDQLALIWFAYLEMGKTLTIAAPGAASMQLAENALKEIQAMGPLQQTQAMCDLANRADTPLCRTYASWSPNIKLGFWYRLGELMEQGFVAPIPAGYQLSANANAVLATIQGLESGQQITVLRNAVVDMGFTAGKDGKRIAEPVVPPQDTASRTKVSIEGVTNATVLNYMDNLNANDFDTLIELFTSDGALQPPFQRPIVGKENVLRFFREECQNLKLIPERGVTEPAEDGFTQIKVTGKVQTPWFGGNVGMNIAWRFLLNPEGKIFFVAIDLLASPKELLNFAR3 3 0 0 5,03 34658,816 Synechocystisphycobilisome (GO:0030089); chloride ion binding (GO:0031404); light absorption (GO:0016037); transport (GO:0006810);3D-structure; Complete proteome; Direct protein sequencing; Membrane; Phycobilisome; Reference proteome; Thylakoid;[1390935826213]
193 Q55602 Q55602_SYNY3NifS protein 40,193 9,33 MERPLYFDNHATTALDPRVLEAMLPYLTEQYGNAGSAHFYGWQASAAIKQARQEIAETMGAQPEEIIFTSGATEANNLAIRGVAEAYFAQGKHLVTVETEHQAVLAPCRYLETLGFEVTYLSVQSSGLVDLTELEKALRPDTILVSVMAANNEIGVLQPLKEIGALCRQRSIIFHCDGAQALGKIPLDVHQLNIDLLSFTGHKIHGPKGIGGLYRRQNPGVRLAPQLLGGGQEGNFRSGTLPVPLIVGLAKALTIAGETLVSEGDRQRQLRDQLWQGLAKISGVVLNGDYEQRLPGNLNVSITGVDPKALLTTLQPRLALSSGSACSSYRTEASHVLYALGRDKTSAQASLRFGLSRFTTEIEIDQAIAIVTDTVARLRADASNQS3 3 0 0 6,16 41682,432 Synechocystiscatalytic activity (GO:0003824); pyridoxal phosphate binding (GO:0030170);Complete proteome; Pyridoxal phosphate; eference proteome;[1390935826213]
194 P74112 P74112_SYNY3Ssr3341 protein 40,174 27,14 MSRFDSGLPSVRQVQLLIKDQTPVEIKLLTGDSLFGTIRWQDTDGLGLVDDSERSTIVRLAAIAYITPRR4 2 0 0 8,25 7830,983 Synechocystis 3D-structure; Complete proteome; Reference proteome;[1390935826213]
195 P72848 HEM6_SYNY3Coproporphyrinogen-III oxidase, aerobic39,766 9,41 MTVSPTTQPQTNHSLPPADAKQRVSQFMQTLQDEICQGLEALDGKGKFQEDSWQREEGGGGRSRVLADGDFLEQGGVNFSEVWGKSLPPSILKQRPEAEGHEFYATGTSMVLHPKNPYIPTVHLNYRYFEAGPVWWFGGGADLTPYYPFAEDAAHFHHTLKNACDQTHGEFYPVFKRWCDEYFYLKHRQEMRGIGGIFFDYQDGNAPLYRGPDPNGPAAQYSNQLAPIEPLGWEDLFSFAQRCGRAFLPAYSPIVEKRRNTEYGDRQRQFQLYRRGRYVEFNLVYDRGTIFGLQTNGRTESILMSLPPLVRWQYCYSPEAGSPEAELTEKFLVPQDWVNS6 3 0 0 5,65 38937,441 Synechocystiscytoplasm (GO:0005737); coproporphyrinogen oxidase activity (GO:0004109); protein homodimerization activity (GO:0042803); protoporphyrinogen IX biosynthetic process (GO:0006782);Complete proteome; Cytoplasm; Oxidoreductase; Porphyrin biosynthesis; Reference pr teome;[1390935826213]
196 P73298 RS11_SYNY330S ribosomal protein S1139,694 21,54 MARPTRKTGPKKAKKNVPSGVAHIQSTFNNTIVTISDIRGDVISWASAGSSGFKGAKKGTPYAAQTAADSAARRAMEQGMRQLEVMVSGPGAGRETAIRALQGAGLEITLIRDVTPIPHNGCRPPKRRRV3 2 0 0 11,53 13761,844 ynechocystisribosome ( O:0005840); rRNA binding (GO:0019843); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; eference proteome; Ribonucleoprot i ; Ribosomal protein; RNA-binding; rRNA-binding;[1390935826213]
197 P48959 RL35_SYNY350S ribosomal protein L3539,5 7 26,87 MPKLKTRKAAAKRFRPTGSGKKIIRRKAFKNHLLEHKSSEQKHRRLSNLALVHEADEKNVRLMLPYM4 2 0 0 11,6 7891,402 Synechocystisribosome (GO:0005840); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference prote me; Ribonucleoprotein; Ribos mal protein;[1390935826213]
198 Q55629 Y782_SYNY3Uncharacterized protein slr078238,976 5,52 MVIRSGKTNLNPPCALMAPSSSCDCIIVGSGLSGLIAARNLSRVNYSVLVIEAQERLGGRMYGEYLPSGQWIDRGGQWVGPTQDRFLALLNEYNIERFPSPADGLKVLLFDGKRYEFDGFFQGVFQGEAPKISSDEWNDAMVAWEKFNTLAQSLDEQHPEATPENKKLDSQTFADWIKENTHTAFGHWYFSYMCRAVGFLGPAEPSQVSLLHILWGHKSASQGENPEAELLHGGAGQIPQKIAAELGNSILLGEPVIHIAQDDKGVEVTTTTGKYQGKFAIVATPPHLAGRITYSPPMPPLRQQLTQRVPMGTCCKLLISYDRPFWREKGLAGIGLGNTTWIELCADSSDPTTGVGVIASFVVGDRYGKWIAMGEAERRQGVLSDLALYFGEEALSPETYDEVDWPSEQWVGGGYAAFMPPGVWTSFGQALSAPVGRIHWAGTEIAPRWAGFFDGAIRTGEAAAKAIIGLL6 3 0 0 5,25 51404,269 Synechocystisoxidoreductase activity (GO:0016491);Complete proteome; FAD; Flavoprotein; Oxidoreductase; Reference proteome;[1390 35826213]
199 P72781 P72781_SYNY3NarL subfamily 38,687 10,99 MGLSLLRPRLVFLEFIPRDRLMGGGISQSGNLLRSPPTKPPYLPLHDCITAMAEPISLLLVDDEPGVRESVQAFLEDSGDFKVDLAANATEAWDYLQHHLPALVISDIMMPQVDGYQFLQKLREDARFQSLPVVFLTARGMTGDRIQGYQTGCDAFLSKPFDPDELEAIVRNLLARQQASSDAGSESAKLQEIYQEIRALKEQIGQPSGIHTTPSPIKLDFTPREQSVLDLVSQGLMNKEIAAQLKTSVRNVEKYVSRLFTKTGTNSRTELVRFALQHGLTE4 3 0 0 5,45 31394,893 SynechocystisDN  binding (GO:0003677); phosphorelay response regulator activity (GO:0000156); sequence-specific DNA binding transcription factor activity (GO:0003700); intracellular signal transduction (GO:0035556); transcription, D A-dependent (GO:0006351);Complete proteome; DN -binding; Phosphoprotein; Reference proteome; Tra scription; Transcriptio  regulation;[1390935826213]
200 P73746 P73746_SYNY3Sll0854 protein 38,671 10,39 MAFFKEDPALGDMAQAILETTWQTFPQLQRDQIALTWLVYDAPVVVNTGGAIAANEFWQYPVRGFSYRGIERIYPASVVKLFYLVAMAEWLEGGMVNDSPELDRAVRDMIVDSSNDATSLVVDILTGTSSGPMLPPGPFETWQQQRNIVNRYFQSLGWEELQNINVNQKTWGDGYYGRERAFVGELYEQRNMLTTNAVARLLHSIIGGVAVSSTRSQQMMQLLKRDLTAAPAPLGEDNQITGFLGEPLPKDAQMWSKAGWTSQVRHDCAYIEIPHQSPYLLVVFTENSALAGNRRLLPFISQAFANAH4 3 0 0 5,08 34527,165 Synechocystis Complete proteome; Reference proteome;[1390935826213]
201 P72699 Y230_SYNY3UPF0045 protein sll023038,629 17,36 MCQNLGKFEIVVSHYRRVKAMNVIVDLCVVPLGVGVSVGQYVAACQKVLAEAGLKHTMHAYGTNIEGDWDEVFAAVKACHEAVHALGAPRITSSMRFGTRTDRPQTMDEKVKSVETWLENS9 2 0 0 7,72 13305,347 Synechocystis Complete proteome; Reference proteome;[1390935826213]
202 P72798 P72798_SYNY3Ssr2998 protein 38,535 36,92 MTIEIGQKVKVYRLRDRVSPDVVGKLGKVGVVKDFKMTDGSGIGAVVSFDDRTATWFFEDELKAI5 2 0 0 9,16 7220,373 Synechocystis Complete proteome; Reference proteome;[1390935826213]
203 P36237 RL11_SYNY350S ribosomal protein L1138,271 16,31 MAKKVVALIKLALPAGKANPAPPVGPALGQHGVNIMAFCKEYNAKTADKPGMIIPVEISVFEDRSFTFILKTPPASVLIRKAAGVEKGSSEPNKNKVASITREQLREIAQTKLPDLNANDIDAAMNIIEGTARNMGITVNS6 3 0 0 9,63 14977,503 Synechocystisribosome (GO:0005840); LSU rRNA binding (GO:0070180); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Methylation; Reference proteome; Ribonucleoprotein; Ribosomal protein; RNA-binding; rRNA-binding;[1390935826213]
204 P74486 P74486_SYNY3Sll1862 protein 38,114 17,48 MGSLQGNYLLSLDGGLSMDNQNVALAKETNAKNSHGQHFSDGSDLIPSEVAAKGLTEREKPLTPESEMKETTGKANAPSSPNVEPAYRITDSGLINAYPVSPPVSEIDPNSKKQFRRNLIGFGLAANLALALIVIVLSITGRF3 2 0 0 6,1 15194,154 Synechocystis Complete proteome; Reference proteome;[1390935826213]
205 P73605 P73605_SYNY3Slr1854 protein 37,813 13,64 MTTTKGKIGVLIEEHFDGTEYRWFNEYFPAQGYEVEYISHLWGQPELKFGSNPENDQVEYHVTVTTEVNDIDPKDYKGIIAIGAYAMDRLRYQATVKKGEKNQAPAVIFLRKAAATEGLKLGTICHSLWLFCADPDLLKDKKVTCAHNIICDVENAGADVVYEEDQTAELVIDGDLITGKHPGMIEEFVKTFVEQIEA4 3 0 0 4,79 22293,203 Synechocystis Complete proteome; Reference proteome;[1390935826213]
206 P77961 GLNA_SYNY3Glutamine synthetase 37,72 6,34 MARTPQEVLKWIQDENIKIIDLKFIDTPGIWQHCSFYYDQLDENSFTEGIPFDGSSIRGWKAINESDMCMVPDPNTATIDPFCKEPTLSMICSIKEPRTGEWYNRDPRTIAAKAVEYLRGTGIADTVYFGPEAEFFLFDDIRFGQTENSSYYFADSVEGRWNTGREEEGGNLGYKPGYKQGYFPVAPTDTAQDIRTEMLLTMAGLCVPIEKHHHEVASGGQNELGIKFDKLVNSADNLMIYKYVIKNVAKKYGKTVTFMPKPIFNDNGSGMHVHQSLWKDGQPLFAGDKYAGFSQMGLWYIGGILKHAPALLAFTNPTTNSYKRLVPGFEAPVNLAYSQGNRSASVRIPLSGGNPKAKRLEFRCPDATSNPYLAFAAMLCAGIDGIKNQIDPGEPLDVDIYDLSPEELAKIPSTPGSLEAALEALEKDHEFLTGTGVFSPDFVESWIEYKLDNEVNPMRLRPHPYEFSLYYDC5 3 0 0 5,02 53025,941 Synechocystiscytoplasm (GO:0005737); ATP binding (GO:0005524); glutamate-ammonia ligase activity (GO:0004356); glutamine biosynthetic process (GO:0006542); nitrogen fixation (GO:0009399);3D-structure; A P-binding; Complete proteome; Cytoplasm; L ; Nucleotide-binding; Reference proteome;[1390935826213]
207 Q55841 Q55841_SYNY3Arabinofuranosidase 37,408 15,25 MKLLPLLPLFGLTVALAIPSMAILGGPRQIQAQSPYVRYESVNYPQRYIRHRNYLGYIEPVKTSLDELDSSFRVTTGLANPNCISLESRNFPNYFLRHRNYRIILSANENNDLFRQDATFCPRNGLNSQGGVSFESNNYPGHYIRHRNFELWLDKFSGFTESTIFRNDATFIQRDVP2 2 0 0 9,39 20485,176 Synechocystisalpha-N-arabinofuranosidase activity (GO:0046556); L-arabinose metabolic process ( O:0046373);Complete proteome; Reference proteome;[1390935826213]
208 P74421 PGK_SYNY3 Phosphoglycerate kinase37,291 6,73 MLSKQSIANLTEADLAGKRVFVRVDFNVPLDNGSITDDTRIRAALPTIKDLLSKGAKVILGSHFGRPKGKVVDSMRLTPVGDRLGELLGQPVVKCDDCIGAEVTAKIASLPNGGVALLENLRFHAGEEGNDAEFAKALAANADLYVNDAFGTAHRAHASTEGVTHFLSPNVAGYLIEKELQFLQGAIEAPKRPLVAIVGGSKVSSKIGVIETLLDKCDKLIIGGGMIFTFYKAQGLNTGKSLVEEDKLDLAKSLMAKAKEKGVEFLLPTDVVVADNFAPDANAQTVGVDAIPDGWMGLDIGPDSVKTFQDALAGCGTVIWNGPMGVFEFDKFAVGTEAIACSLAELTASGTVTIIGGGDSVAAVEKVGVAEKMSHISTGGGASLELLEGKVLPGIAALDDR3 3 0 0 5,09 41783,949 Synechocystiscytoplasm (GO:0005737); ATP binding (GO:0005524); phosphoglycerate kinase activity (GO:0004618); glycolysis (GO:0006096);ATP-binding; Complete proteome; Cytoplasm; Glycolysis; Ki ; Nucleotide-binding; Reference proteome; Transferase;[1390935826213]
209 P73954 Y1513_SYNY3Membrane-associated protein slr151337,171 17,27 MAKPANKLVIVTEKILLKKIAKIIDESGAKGYTVMNTGGKGSRNVRSSGQPNTSDIEANIKFEILTETREMAEEIADRVAVKYFNDYAGIIYICSAEVLYGHTFCGPEGC3 2 0 0 7,67 12006,814 Synechocystisplasma membrane (GO:0005886); thylakoid membrane (GO:0042651);Cell membrane; Complete proteo e; Direct protein sequencing; Membrane; Reference proteome; Thylakoid;[1390935826213]
210 P73742 P73742_SYNY3Sll0858 protein 36,932 13,71 MVTKRSPTGIRQFVLFNHFSVNFLRNLLIMKNIIIAGLLSGLACTVSTMPAMAQNQNLDLHWQSGDTSEQMLAQWGWGNKKGGQGQWMESLDLTDSQKQQLEAIRQKYQGQMQSLSEQMRTSQNELRTLMSGNGSDSEIRAKHNQVANLRQQLGELRFNSMLESRQVLTPEQRQKFSQLMQERRNSRQGRRGMGNQQ3 3 0 0 10,65 22600,669 Synechocystisperiplasmic space (GO:0042597);Complete proteome; Reference proteome;[1390935826213]
211 P73452 NRTA_SYNY3Nitrate transport protein NrtA36,664 6,28 MSNFSRSTRRKFMFTAGAAAIGGVVLHGCTSPTTTSTGTGTGSSTDQAISPLVEGENAPEVTTAKLGFIALTDAAPLIIAKEKGFYAKYGMPDVEVLKQASWGTTRDNLVLGSASGGIDGAHILTPMPYLITMGTVTDGKPTPMYILARLNVNGQGIQLGNNYKDLKVGTDAAPLKEAFAKVTDPKVAMTFPGGTHDMWIRYWLAAGGMEPGKDFSTIVVPPAQMVANVKVNAMESFCVGEPWPLQTVNQGVGYQALTTGQLWKDHPEKAFGMRADWVDQNPKAAKALLMAVMEAQQWCDQAENKEEMCQILSKREWFKVPFEDIIDRSKGIYNFGNGQETFEDQEIMQKYWVDNASYPYKSHDQWFLTENIRWGYLPASTDTKAIVDKVNREDLWREAAQALEVPADQIPSSPSRGIETFFDGITFDPENPQAYLDSLKIKSIKA3 2 0 0 5,27 48966,606 Synechocystisplasma membrane (GO:0005886); nitrate assimilation (GO:0042128); transport (GO:0006810);3D-structure; Cell inner m mbrane; Cell membrane; Complete proteome; Membrane; Nitrate assimilation; Reference proteome; Signal; Transport;[1390935826213]
212 P74746 P74746_SYNY3Slr0600 protein 36,543 11,04 MKLSSKNLDARLDTVYDAIVLGGGMGGLSAAIYLARYGLKCLVVEKGRGRSFWMQDLRNYVGLDPDTPGRDIITHSTQQALHWGADLLRGYVEDVTDEGDTLAVKVKVGKKDSLYPIFRTKYVIAATGIIDNLPQLEDMQNVYDYAGYTLHVCMICDGFDMWDQKAVLIAGTEGQINAAFVLNWFTPYITVLTHGLCTVGDEMKAKLADHGYPLHEAAITKFLGEDHKMSGVELVDGTVVEATTGLINMGSVYHNHYLKGIEGLEWDGENLVTNDMAQTSHPRIFALGDLKKGLNQVSVAVADGTLAATQIWRNIRRASEPRKWIH3 3 0 0 5,75 35993,138 Synechocystisoxidoreductase activity (GO:0016491);Complete proteome; Oxidoreductase; Reference proteome;[1390 35826213]
213 P73579 P73579_SYNY3Slr0890 protein 36,53 22,9 MGLVYANIELINPKEQALQPMKVNALVDTGAITLCIPEHVVIQLKLETLEQREVTTADSKKRLVDYVGPVQVRFGNRNCFTGALVLGDAVLLGAVPLEDMDLVISPRSQTITVNPESPNIPAALVKTALEI2 2 0 0 5,1 14187,587 Synechocystis Complete proteome; Reference proteome;[1390935826213]
214 Q6YRU9 Q6YRU9_SYNY3Sll6055 protein 36,311 14,47 MVVNAQQFRIQVDQQQLMIPDPVPTGRQILEIAQKRPADEFLVFYLLPSGQLEEIRLDETVDLRQTGIERFITFRSDRSFRFVIDGRRFEWGIPLISGLKLKQLAQVSPQAYGVWLEVRGGEDRPIADHETVNLEAPGVERFFTGKKTTTEG3 3 0 0 5,52 17443,927 Synechocystis Complete proteome; Plasmid; Reference proteome;[1390935826213]
215 P74447 P74447_SYNY3Ferredoxin 36,308 14,52 MTMPPLWNCSVANRVNAIVASTKEDCVAKTIKLDPIDLKVAIETNDNLLSGLLGQDLRIMKECGGRGMCATCHVYITAGMESLSPLNRREQRTLEVITTHNRYSRLACQARVLDEGVVVELPAGMYVSEIEDIEELIGRRAEENILNPRDGSILVEKGKLITRSMISQLDDQLQAAKIQIVNDTDE4 3 0 0 5,02 20624,746 Synechocystiselectron carrier activity ( O:0009055); iron-sulfur cluster binding (GO:0051536); metal ion binding (GO:0046872);Complete proteome; Iron; Iron-s lfur; M tal-binding; Reference prot ome;[1390935826213]
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216 Q55356 PSB28_SYNY3Photosystem II reaction center Psb28 protein36,308 16,07 MAEIQFSKGVAETVVPEVRLSKSKNGQSGMAKFYFLEPTILAKESTDDITGMYLIDDEGEIITREVKGKFINGRPTAIEATVILNSQPEWDRFMRFMERYGAENGLGFSKSE7 2 0 0 5 12590,31 Synechocystisphotosystem II oxygen evolving complex (GO:0009654); plasma membrane-derived thylakoid photosystem II (GO:0030096); photosynthesis (GO:0015979);3D-structure; Complete proteome; Direct protein sequencing; Membrane; Photosyn hesis; Photosystem II; Reference prot ome; Thylakoid;[1390935826213]
217 P74386 URE2_SYNY3Urease subunit beta 36,29 20 MATMIPGEIITPEGDIELNVGRSTCTINVANTGDRPIQVGSHYHFYEVNAALQFDRDLAKGMRLDIPAGTAVRFEPGDEKNVNLVAYAGSREIYGFNGLVNGPLE3 2 0 0 4,76 11381,794 Synechocystiscytoplasm (GO:0005737); urease activity (GO:0009039); urea catabolic process (GO:0043419);Complete prot ome; Cytoplasm; Hydrolase; Reference proteome;[1390935826213]
218 P73424 P73424_SYNY3Slr1540 protein 36,176 9,32 MRILIMGGTRFIGIHLCRVLVAQGHEVVLFNRGNRPDPVNGVAQIHGDRRVAEQLREKLEKEEFDVIFDNNGRELSDTQPLVDLYNGRVQQFVYMSSAGVYQASSQMPHRETDAVDPQSRHKGKFETERYLAQSGIPWTAIRPTYIYGPHNYNALESWFFDRLVRGRAIPIPGNGQYITQLGHVEDLAIAMAKTIVTPAAIGQIYNISGDRYVTMNGLAQACATAAGLDPQGVKLVHYDPKDFDFGKRKAFPLRQQHFFADIQKAQDHLDWHPNYGLVEGLKNSFQLDYLPSGKGEEKGDFDLDEQILAFS3 3 0 0 6,26 35092,64 Synechocystis Complete proteome; Reference proteome;[1390935826213]
219 P73637 P73637_SYNY35-oxo-1,2,5-tricarboxilic-3-penten acid decarboxilase/isomer35,964 10,51 MVQRYVRIQADSGTVHYGLFQLDHSVILLSAAPWLGGQALDVAVSEGDYRLLAPCEPSKIVAVGRNYRAHAAELGNDVPAEPLLFFKPPSAIAADQEEIVYPSQSQRVDYEGELAVIIGKQVKDITEEEAASAIWGYTIANDITARDLQRQDSQWTRAKGFDGFCPLGPWVVRHIDPEAHLETTVNDEETPRQATAISDMVFTPPVLVSYISRVMTLYPGDVILTGTPEGISALQVGDKVEVEIEGIGNLTNTIIAPPLTAPELAETVELEVEADN2 2 0 0 4,4 30049,837 Synechocystiscatalytic activity (GO:0003824);Complete proteome; Reference proteome;[1390935826213]
220 P74162 P74162_SYNY3Sll1380 protein 35,797 12,15 MTTATHLLKLAATVLLGSLVTTAPLVRAQFTAPAPQNNTSTPIPKVELNFQPLETALASQQFSQANEITRRLLLAATNRTLQGWLTTDTIEQIPCQDLKTIDQLWLQHSNNRFGFTPQLEAFLATGNRPGRLMSPESYDQFGDRIGWRKENQWVIFKKNLDFTLNAPAGHLPSPRDEYQINGGRLEYTALMGRFQVCQSGQVPTAPVRFTPFGS2 2 0 0 9,34 23884,179 Synechocystisouter membrane-bounded periplasmic space (GO:0030288);Complete proteome; Reference proteome;[1390935826213]
221 Q55541 Q55541_SYNY3Slr0333 protein 35,706 16,04 MTLDKLGSAFLLGIALASLGVPALARGISTLRAADPNTRINVRTQPTIKSSAPQYGLPGDKVEVIKCVQDKDTQNSDLNWCEVKFVKSKAVGWIRSDFIIFADGGE4 2 0 0 9,06 11406,143 Synechocystis Complete proteome; Reference proteome;[1390935826213]
222 P74396 P74396_SYNY3Slr0280 protein 35,605 5,08 MALGDLLKMVNWTRNWFGFSCLFVLTLAVMLGLKLFLPSPVVAQSSSDFIQQGNQISIDGKSYPVAWGQWQEGGQTRTGLGDTGAMQFLGLDLLDNTSPNQQPVQWFSGDRQTLNARFVAPNRYLDVTSLLQGFGPLQAQGNTLVMPNTNAQILTVRDGRQSWGERVVLELSQPAFWQVSQAREEAVVTINASSTIGSQGNANAPGLQAIDQDDLGGKTSGGQQIRYRLERSGASSKVHFQLPVGYKLQVSTLTSPFRLVIDARADAPPVKTINWTEGITWQQRFVNISGGQFPVTTVTINPRSPGISLRPLMANPTMAQGTAPLVTIARDQRAAVAINAGFFNRNNQLPLGAVWSQQNWRSGPILNRGAIAWNDQGQTTFGRLSLSEIITTGSGQRLTANYLNSGYVQRGIARYTPAWGPSYIPLSDNEQVYVVQNSQVTAQYPLPKAGQQQMPIPSDGYLIIDRGNQIPAGVLAVGTTLNVNGRSTPEAFNAFPNGMGAGPLLIDQGRMVLNATGEGFSSAFQQQRASRSAIAVDRNGNIILVASHNRVGGAGASLGEFAQILQQLGAVNALNLDGGSSTSLALGGQLLDRSPVTAARVSNAIGVFVR3 3 0 0 9,85 65405,879 Synechocystis Complete proteome; Reference proteome;[1390935826213]
223 P73316 RS19_SYNY330S ribosomal protein S1935,01 29,35 MGRSLKKGPFVAASLLRKIDKLNDKGDKQVVKTWSRASTILPQMVGHTIAVHNGRQHVPVFVSEQMVGHKLGEFAPTRTFRSHSKSDKKARK4 2 0 0 11,42 10290,017 Synechocystissmall ribosomal subunit (GO:0015935); rRNA binding (GO:0019843); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprotein; Rib somal protein; RNA-binding; rRNA-bindi g;[1390935826213]
224 P73704 P73704_SYNY3General secretion pathway protein G34,815 19,05 MASNFKFKLLSQLSKKRAEGGFTLIELLVVVIIIGVLAAIALPNLLGQVGKARESEAKSTIGALNRAQQGYFTEKGTFATDTETLEVPAPDGNFFSFAVNTADNTEAIQDATALNWEADGTRSMSGGTFYDSGTRAFSTVVCRAEAGSEDTPPTPGGANDCGGAEVIK4 2 0 0 4,78 17573,691 Synechocystistype II protein secretion system complex (GO:0015627); protein transporter activity ( O:0008565); protein secretion by the type II secretion system (GO:0015628);Complete proteome; M thylation; Reference proteome;[1390935826213]
225 Q55247 GLNB_SYNY3Nitrogen regulatory protein P-II34,508 17,86 MKKVEAIIRPFKLDEVKIALVNAGIVGMTVSEVRGFGRQKGQTERYRGSEYTVEFLQKLKIEIVVDEGQVDMVVDKLVSAARTGEIGDGKIFISPVDSVVRIRTGEKDTEAI4 2 0 0 7,95 12397,38 Synechocystisenzyme regulator activity (GO:0030234); nucleotide binding (GO:0000166); regulation of catalytic activity (GO:0050790); regulation of nitrogen utilization (GO:0006808); regulation of transcription, DNA-dependent (GO:0006355); transcription, DNA-dependent (GO:0006351);3D-struc ure; Complete proteome; Nucleotide-binding; Phosphoprotein; Reference proteome; Transcription; Transcriptio  re ulation;[1390935826213]
226 Q6ZEU7 Q6ZEU7_SYNY3Sll5033 protein 34,42 12,29 MKSILSFIKSVFILGILVGVLIINLAVSPAQAVIRQLEEAPGPTVYQSEISKSRQILKDQQGGSWQAIAFERTIPDHEDSIYLRLVDFPGTANIDHSKPLIITNMMSETLSAVNVSEDMFMDKTKMSPDAGEYDLQPILMQLESAIPLRLILPTLDQQKIVLNVSPAVVEEWQSLTTQK5 2 0 0 4,89 19892,094 Synechocystis Complete proteome; Plasmid; Reference proteome;[1390935826213]
227 Q55171 Q55171_SYNY3Slr0476 protein 34,253 15,44 MTEEQQGPNTTPNEETASKTTAANRSRRPRAGSSKDESALVKPKHIGGLDLLPTPKGMPTNRPIEASKIHVVSTYGSMGATRPVGASTMEVSSTMTVSGNRPIALSHLHISEITAGNRPVASNEIDDPNTLMGYLD5 2 0 0 8,11 14394,113 Synechocystis Complete proteome; Reference proteome;[1390935826213]
228 P73654 P73654_SYNY3Ssl3364 protein 33,918 27,03 MSNIQEKIEQELANARQVCSTDEASPAECAAAWDAVEELEAEAAHQRQQHPTQTTLEKFCDENPDAAECRIYDD6 2 0 0 4,14 8294,914 Synechocystis Complete proteome; Reference proteome;[1390935826213]
229 P74352 RPOZ_SYNY3DNA-directed RNA polymerase subunit omega33,89 28,95 MTKRSNLDSNHIIYRSEELLGAASNRYNITVRVAKRAKENRSEDFDSIDDPNMKPAIRAIIEMSDELTRPEIISDN3 2 0 0 5,77 8736,766 SynechocystisDNA binding (GO:0003677); DNA-directed RNA polymerase activity (GO:0003899); transcription, DNA-dependent (GO:0006351);Complete proteome; DNA- irected RNA polymerase; Nucleotidyltransfera e; Reference prot ome; Transcription; Transferase;[1390935826213]
230 P72775 P72775_SYNY3Alanine dehydrogenase33,52 6,39 MEIGVPKEIKDQEFRVGLTPSSVRALLSQGHQVFVEEGAGVGSGFPDGAYAKAGAELVATAKEAWNRELVVKVKEPLPEEYEYLTLPKLLFTYLHLAAERTLTEALIKSGITAIAYETVELADGQLPLLAPMSRIAGRLAVQMGAHYLEKQQGGRGVLLGGVPGVKAGQVTILGGGVVGTEAAKMAIGLGAMVTILDINVDRLNQLGELFGSRVDLRYSNASQIEDLLPHTDLLIGAVLITGKRAPVLVSRQEVEQMLPGAVIMDVAIDQGGCVETLRVTSHSQPSYIEAEVVHVGIPNMPGATPWTATQALNNSTLRYVLKLANLGEQAWENDLPLAKGVNVQAGKLVQGAVKTVFPDL3 3 0 0 5,4 38267,216 Synechocystisalanine dehydrogenase activity ( O:0000286); L-alanine catabolic process (GO:0042853);Complete proteome; NAD; Oxidoreductase; Reference proteome;[1390935826213]
231 P73796 URE3_SYNY3Urease subunit gamma33,017 16 MQLSPQEKDKLLIFTASLVAERRKARGLKLNYPEAVAYISAAILEGARDGRTVAELMNYGATLLSRDEVMEGVPEMLPEVQVEATFPDGTKLVTVHEPIR3 2 0 0 5,41 11055,78 Synechocystiscytoplasm (GO:0005737); nickel cation binding (GO:0016151); urease activity (GO:0009039); urea catabolic process (GO:0043419);Complete proteome; Cytoplasm; Hydrolase; Reference proteome;[1390935826213]
232 P74428 P74428_SYNY3Slr0398 protein 32,921 13,66 MTTIMVNLAHLLGKPNLTEEIISMAQDSPSSLSQEALTIAHLQGVQERRQEERMLAFCQVFDMEGELVGVSFDLTRNGICVSVPNDWPQDTDFTVKLRRMDNEALPTITIKLTPMWRQSRNESFDEIGGKIIEVDCPEAFSTFLQYCQQAGPSGLVERPTS3 2 0 0 4,66 18079,558 Synechocystis Complete proteome; Reference proteome;[1390935826213]
233 P73495 P73495_SYNY3Naphthoate synthase32,791 9,82 MDWHIAKHYDDILYYKAGGIAKIVINRPHKRNAFRPQTVFELYDAFCNAREDNRIGVVLLTGAGPHSDGKYAFCSGGDQSVRGEGGYIDDQGTPRLNVLDLQRLIRSMPKVVIALVAGYAIGGGHVLHLVCDLTIAADNAIFGQTGPKVGSFDGGFGSSYLARIVGQKKAREIWYLCRQYSAQEAERMGMVNTVVPVDRLEEEGIQWAKEILSKSPLAIRCLKAAFNADCDGQAGLQELAGNATLLYYMTEEGSEGKQAFLEKRPPDFSQYPWLP4 3 0 0 6,6 30307,536 Synechocystis1,4-dihydroxy-2-naphthoyl-Co  synthase activity (GO:0008935); menaquinone biosynthetic process (GO:0009234);3D-structure; Chloride; Complete proteome; Reference proteome;[1390935826213]
234 P73406 CCMK3_SYNY3Carbon dioxide-concentrating mechanism protein CcmK homolog 332,64 18,45 MPQAVGVIQTLGFPSVLAAADAMLKGGRVTLVYYDLAERGNFVVAIRGPVSEVNLSMKMGLAAVNESVMGGEIVSHYIVPNPPENVLAVLPVEYTEKVARFRT2 2 0 0 6,56 11002,866 Synechocystis Complete proteome; Reference proteome;[1390935826213]
235 P72759 CCML_SYNY3Carbon dioxide concentrating mechanism protein CcmL32,622 18 MQLAKVLGTVVSTSKTPNLTGVKLLLVQFLDTKGQPLERYEVAGDVVGAGLNEWVLVARGSAARKERGNGDRPLDAMVVGIIDTVNVASGSLYNKRDDGR2 2 0 0 9,52 10638,205 Synechocystis 3D-structure; Complete proteome; Reference proteome;[1390935826213]
236 P74591 AROE_SYNY3Shikimate dehydrogenase32,611 11,03 MPSITGKTKLLGVIGYPVGHSLSPVMHNAALQAMASDYAYVAFPIAPEDLTIAIAGLGASGVQGLSVTIPHKQVVMPLLTQITETARQVGAVNTLWRDGHGWQGTNTDVEGFLAPLLELKQDWSGRTAVILGYGGAARAVVVGLTQLGCPEIIVVGRSQEKLAQFANSWTDPKIKQALQVLPWEALSTVIPKASLLINSTPVGMAPHPKQSPLDQSLVEKLPPTAIAYDLIYTPRPTRFLQHAQERGLVTIDGAEMLVQQGAAALKIWLQQEVPVDVMRQALLHHLEKSA2 2 0 0 7,1 31099,118 SynechocystisNADP binding (GO:0050661); shikimate 3-dehydrogenase (NADP+) activity (GO:0004764); aromatic amino acid family biosynthetic process (GO:0009073); chorismate biosynthetic process (GO:0009423); shikimate metabolic process (GO:0019632);Amino-acid biosynthesis; Aromatic ami o acid biosynthesis; Complete proteome; N DP; Oxidoreductase; Reference teome;[1390935826213]
237 Q55561 Q55561_SYNY3Sll0167 protein 32,344 14,02 MFTKIRDLASPLPLMAAMAALGGMLFAPVVRSQETIFQESVQSQTTFAAQQCSVKLTDPSEEMAMDCNQLSITEGDGTINFHYDDGDVMGFSFVLEYNDDPILVNGKINSNQYNVIGTFLWTAEDGIVDETLTEATGNCRATPAQVVCQATIDNTMKVEAVVDF2 2 0 0 4 17865,116 Synechocystis Complete proteome; Reference proteome;[1390935826213]
238 P26287 CYF_SYNY3 Apocytochrome f 32,002 6,71 MRNPDTLGLWTKTMVALRRFTVLAIATVSVFLITDLGLPQAASAYPFWAQETAPLTPREATGRIVCANCHLAQKAAEVEIPQAVLPDTVFEAVVKIPYDLDSQQVLGDGSKGGLNVGAVLMLPEGFKIAPPDRLSEGLKEKVGGTYFQPYREDMENVVIVGPLPGEQYQEIVFPVLSPDPAKDKSINYGKFAVHLGANRGRGQIYPTGLLSNNNAFKAPNAGTISEVNALEAGGYQLILTTADGTETVDIPAGPELIVSAGQTVEAGEFLTNNPNVGGFGQKDTEVVLQNPTRIKFLVLFLAGIMLSQILLVLKKKQIEKVQAAELNF4 3 0 0 5,17 35230,565 Synechocystiscytochrome b6f complex (GO:0009512); integral to thylakoid membrane (GO:0031361); electron carrier activity (GO:0009055); heme binding ( O:0020037); iron ion binding (GO:0005506); oxidation-reduction process (GO:0055114); photosynthesis (GO:0015979);Complete proteome; lectron transport; Heme; Iron; Membrane; Metal-binding; Photosynthesis; Reference proteome; Signal; Thylakoid; Transmembrane; Transmembrane helix; Transport;[1390935826213]
239 P74426 P74426_SYNY3Sll0359 protein 31,826 11,61 MLYFILCRLLKKTSPRNQASFNGKNNPMPNASTALTGKALLNKVKELSHLPRRETAKACGYYSTSKEGQVRVNLTDFYDAVLAAKGVPLDPSGTKDGRGREPTFRVSVHKNGQIVIGSTYTQEMGLKSGDEFEIKLGYKHIHLKQITDSDDEEEV2 2 0 0 9,32 17218,594 Synechocystis Complete proteome; Reference proteome;[1390935826213]
240 P73824 P73824_SYNY3Glutathione peroxidase31,592 14,94 MPLPTSLTTLDGTPLAPEVIADKVVLFVNVASKCGLTPQYSGLVALDKAYGEKGLVIIGVPCNQFGAQEPGSPEEIKDFTKTKYDVDFTLLEKQDVNGPNRSPLYQFLVGDGEDISWNFGKFLIGRDGQVVARFDPQTKPDDTNLKAAIEKALG5 2 0 0 4,72 16645,96 Synechocystisglutathione peroxidase activity (GO:0004602); response to oxidative stress (GO:0006979);Compl te proteome; NA P; Oxidoreductase; Peroxidase; Reference proteome;[139093582 213]
241 P73439 P73439_SYNY3Sll1461 protein 31,567 5,91 MVIAPHRTIIYPDSDGQPMADNTEQFQWIVLLKENLECLFAQDDNVFVAGDLLWYPVEGHPEIRVAPDAMVALGRPKGKRGSYRQWEEDNIAPQVVFEILSPGNRAKEMIRKLQFYERYGVNEYYVYDPDDNELTGLQRGENGLEVIETIEDWTSPLLGIRFFLTPDTLQIYYPDGRKFLTTVELDREMVKEKQRANEEQQRADRLAAKLKELGVDPEEI2 2 0 0 4,63 25524,816 Synechocystis Complete proteome; Reference proteome;[1390935826213]
242 P73126 Y997_SYNY3Probable thylakoid lumen protein sll099731,264 6,49 MAPYQSFHIGLLGLALASVWPLSACAITPSFPPAVEQNQQVNGDRQEVQLAQNSDTYTFETFDPNSDEPKLNGKVEKGDVSASISYRQEKHDGYESWFPTVTVKFKNKIVATLEGSESPMPIALLQITDMDRDNPYPAVLFATYTGGAHCCNEVKVFTSNQNGSDWSVRDFGFFNGGPHPAEDLNNDGWDEYVEVDNRFLYLFSSYAGSAAPAQIWALQNGQVVDVSFEPSFQFIHRENAQSMEKDLPEIVAQDSEKNGFLAAYVANKALIGELDEGWQTMLKYYDRESDWGLTNCLEYDDQSNCLNEVKYDSYPDALRAFLVEAGYIEAKFEAENNTL2 2 0 0 4,32 37962,856 Synechocystisthylakoid lumen (GO:0031977);Complete proteome; Reference proteome; Signal; Thylakoid;[1390935826213]
243 P20804 ACP_SYNY3 Acyl carrier protein 31,185 19,48 MNQEIFEKVKKIVVEQLEVDPDKVTPDATFAEDLGADSLDTVELVMALEEEFDIEIPDEVAETIDTVGKAVEHIESK12 2 0 0 3,98 8589,581 Synechocystiscytoplasm (GO:0005737); ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process (GO:0000036);Complete proteome; Cyt lasm; Dir ct protein sequ nci g; Fatty acid biosynthesis; Fatty acid metabolism; Lipid biosynthesis; Lipid metabolism; Phosphopantetheine; Reference proteome;[1390935826213]
244 P74138 P74138_SYNY3CheY subfamily 30,968 13,01 MESMAKVLLVEDNEMNRDMLSRRLIRKGYEVVIAVDGEQAVTMAISESPQLILMDMSLPIIDGWTATKQIKGHPDGAHIPIIALTAHAMASDRERAIAAGCDDYDTKPIEIKRLLQKMEALIN2 2 0 0 5,32 13658,94 Synechocystisphosphorelay response regulator activity (GO:0000156); intracellular signal transduction (GO:0035556); regulation of transcription, DNA-dependent (GO:0006355);Complete proteome; Reference proteome;[1390935826213]
245 P36236 RL1_SYNY3 50S ribosomal protein L130,69 10,08 MTKKLSKRMQAAIAKVDDSKLYSPLEAMELLKETATAKFDETAEAHIRLGIDPKYSDQQIRTTVSLPKGTGQTVRVAVLARGEKVKEATDAGADIAGSEELIEEIQKGMMDFDVLIATPDMMPKIARLGKQLGPRGLMPSPKGGTVTADLAAAVNEFKAGKLEFRADRTGIVHVMFGKASFSADDLLANLKALQETIDRNRPSGAKGRFWRTVFVSSSMGPSIPVDINALRDLKFEDN2 2 0 0 8,98 25851,796 Synechocystislarge ribosomal subunit (GO:0015934); rRNA binding (GO:0019843); structural constituent of ribosome (GO:0003735); tRN  binding (GO:0000049); regulation of translation (GO:0006417); translation (GO:0006412);Complete proteome; Reference proteome; Repressor Ribon cleopro ein; Ribosomal protein; RNA-binding; rRNA-binding; Translation r l ti ; tRNA-bindi g;[1390935826213]
246 Q55120 Q55120_SYNY3Biotin carboxyl carrier protein of acetyl-CoA carboxylase30,675 13,64 MAINFTELRELLGVISQSNITEFSLKSGDFEVSVRKDGMAGGISVVPQAIAPQPAPVVSASVPSPEVAAPSPADQKWTAIVSPMVGTFYRAPAPDEPPFVEVGDAVSKGQGVCIIEAMKLMNEIEAEVAGQVMEIVVENGEPVEYGQTLMWIKP2 2 0 0 4,34 16312,736 Synechocystisacetyl-CoA carboxylase complex (GO:0009317); acetyl-CoA carboxylase activity (GO:0003989); fatty acid biosynthetic process (GO:0006633);Biotin; Complet  proteome; Reference proteome;[1390935826213]
247 P72890 P72890_SYNY3Slr1612 protein 30,662 8,39 MSAITAQELEAQMPDASQLLSDEPEMESSLHYMQLLLLVTCLELAWQDRNDFFIGANLTIYFSRQQLKSHDFRGPDFFLVKNTARKPRKSWVVWEEDGRYPDLIIELLSDSTADTDRHLKRDLYAERFHTPEYFYFSPDTLELAGFRLDGDKYQPIIPNDQGWLWSKVLGFFLGIEGQELRYFTLEGAVLPTPQEAVRIEVDKGMAMVEQERLKAIQAEQDAEQERLKATQAQQDAEQERLKAIQAQQDAEQERLKAIQAQQDAEQAKAELQKLQDKVRSLGISID2 2 0 0 4,68 33045,19 Synechocystis Complete proteome; Reference proteome;[1390935826213]
248 Q55744 Q55744_SYNY3Sll0381 protein 30,601 9,52 MPPRKSMRSPFKSGWSLVSLLFVLLSGCGGENLSSPEMNASPSANQGTLTVRANGEERAREGLTTKDGWVLDFNHVYVSLADINAYQVGSAFDASTDASLPETAVAIAMPGPTVVDLAMTGKDAETVLVGETPAPAGKFNALSWQMPLATEGPAQGYSILLEGMATKDGQTIPFKLGVKKELGFVCGDFVGDERKGILTAGGKADLEATFHLDHLFGDGQEPVDSDINLSAFGFDPLAALAGEKGIDLNSQDLQARLGAADYQTFLQVLANLGHVGEGHCRQTKAFTTITSFNL2 2 0 0 4,76 30984,932 Synechocystis Complete proteome; Reference proteome;[1390935826213]
249 Q55149 Q55149_SYNY3Slr0058 protein 30,482 12,68 MVFAMVDEKGKEQWSRHSSPQLSANFQLCSIPQPSMDTNDWLKQLLMIGVGTTTLVAEKLSDVSDQWVKEGKINADQATAFVDDLMNQIKNEQGQIEANLERQLRNMLQDLGLPRQSEMDELRGRIDRLERQIRDLENQRWR2 2 0 0 5,07 16485,639 Synechocystis Complete proteome; Reference proteome;[1390935826213]
250 P74324 F16PA_SYNY3Fructose-1,6-bisphosphatase class 130,143 7,49 MTVSEIHIPNSLLDRDCTTLSRHVLQQLNSFGADAQDLSAIMNRIALAGKLIARRLSRAGLMADVLGFTGETNVQGESVKKMDVFANDVFISVFKQSGLVCRLASEEMEKPYYIPENCPIGRYTLLYDPIDGSSNVDINLNVGSIFAIRQQEGDDLDGSASDLLANGDKQIAAGYILYGPSTILVYSLGSGVHSFILDPSLGEFILAQENIRIPNHGPIYSTNEGNFWQWDEALRDYTRYVHRHEGYTARYSGALVGDIHRILMQGGVFLYPGTEKNPDGKLRLLYETAPLAFLVEQAGGRASDGQKRLLDLIPSKLHQRTPAIIGSAEDVKLVESFISDHKQRQGN2 2 0 0 5,5 38262,298 Synechocystiscytoplasm (GO:0005737); fructose 1,6-bisphosphate 1-phosphatase activity (GO:0042132); magnesium ion binding (GO:0000287); reductive pentose-phosphate cycle ( O:0019253);Calvin cycle; Carbohydrate metabolism; Com lete proteome; Cytoplasm; Hydrolase; Magnesium; Metal-binding; Reference prot ome;[1390935826213]
251 P74060 Y821_SYNY3Putative sulfur carrier protein slr082130,141 16,51 MVSPALPRLSNPLFFANIMTVKVLIPTPLQKFTSGQATIDCEAANVGQLIEALEANCPGIKARLCDEEGKPRRFLNFYVNEEDIRFLEGTDTALSAGDEVSIVPAVAGG5 2 0 0 4,71 11694,429 Synechocystis Complete proteome; Reference proteome;[1390935826213]
252 P73107 P73107_SYNY3Sll1837 protein 29,674 15,17 MVNKGLWSAAVMVLGSTLVGSVFAPTPAIAGKSCNYLNTNLFMAQGYENPNGIWVSEGWWVVEPGECVVYSDSAFTYFKISDGVAPNRKAIAEMAGSESIKLCQVNDRFTVFQSDSGAVCRNAGGNNQTFINPGANLELIESTSP5 2 0 0 4,8 15467,443 Synechocystisouter membrane-bounded periplasmic space (GO:0030288);Complete proteome; eference proteome;[1390935826213]
253 P72914 P72914_SYNY3Ssr1766 protein 29,654 21,05 MSNLPSVQAKDFIRVIKKLGFFLERQKGSHAIYKNTQGNRVVVPIHPGKDLKQGTLMGMIKDIGLEKEKFFDLLQK3 2 0 0 10,14 8670,288 Synechocystishydrolase activity, acting on ester bonds (GO:0016788); mRNA binding (GO:0003729);Complete proteome; Reference proteome;[1390935826213]
254 P74011 P74011_SYNY3Sll1233 protein 29,634 8,5 MATYRIEHHTEYRFNQPVYLRPHRLRLRPRSNGWQNLLTYNLTIDPLPAGLAEITTLDGNGEQKVWFTDPTEKLAIAVESFVQTTMENPFNFLLEPWALKLPFDYPQSLAQQLRGYLVPYEGRLDPVAVELAQDIAHDCQRQPIAFLQNLTQKLYEHCTYTVRAIGEPWEAGVTWRSREGSCRDLTVLFMEVCRAMGLAARFVSGYEVGDPEISQWELHAWAEVYLPGAGWRGYDPTHGLAVGDRHIALVASAIPAYCSPVGGEVAPVKTFLETGLTVQSELETEVKITAVNDI2 2 0 0 5,22 33204,735 Synechocystis Complete proteome; eference proteome;[1390935826213]
255 P72845 P72845_SYNY3Sll1188 protein 29,471 12,2 MKKEINYWVEKLELLPHPEGGFYKETYRSPVEANFAGFDGSRNVVTGIYFLMTKDNFSAFHRIKSDEMWHFYAGDSLEIYWFSPQGELEVISLGLDLEKGEVPQAVVLKDGWFASRVKNGGDYALVGCTVAPGFDFQDFELANREDLLKLYPRSAEIINQLTRQ3 2 0 0 5 18816,275 Synechocystis Complete proteome; Reference proteome;[1390935826213]
256 P74367 PS11_SYNY3Photosystem II 11 kDa protein29,38 14,93 MSFLKNQLSRLLALILVVAIGLTACDSGTGLTGNYSQDTLTVIATLREAIDLPQDAPNRQEVQDTARGQINDYISRYRRKGDAGGLKSFTTMQTALNSLAGYYTSYGARPIPEKLKKRLQLEFTQAERSIERGV2 2 0 0 9,56 14785,839 Synechocystisplasma membrane-derived thylakoid photosystem II (GO:0030096); thylakoid lumen (GO:0031977); thylakoid membrane (GO:0042651); photosystem II assembly (GO:0010207); photosystem II repair (GO:0010206);3D-structure; Complete proteom ; Direct protein sequencing; Lipoprotein; Membrane; Palmitate; Photosynthesis; Photosystem II; Reference proteome; Signal; Thylak id;[1390935826213]
257 P73203 PYR1_SYNY3Phycobilisome 32.1 kDa linker polypeptide, phycocyanin-associated, rod 129,377 7,56 MAITTAASRLGVAPYNESRPVELRPDFSLDDAKMVIRAVYRQVLGNDYIMDSERLKGAESLLTNGSISVREFVRTVAKSELYKKKFLYNNFQTRVIELNYKHLLGRAPFSEDEVIFHLDLYENQGFDADIDSYIDSVEYQENFGENIVPYYRFNNQVGDRTVGFTRMFRLYRGYANSDRSQLERSSSRLATELGQNTVSAIVGPSGSNAGWAYRPSRAGNTPAKALGGTVPFGQASKLFRVEITAISAPGYPKVRRSNKAVIVPFEQLNQTLQQINRLGGKVASITPASLS2 2 0 0 9,45 32520,679 Synechocystisphycobilisome (GO:0030089); photosynthesis (GO:0015979);3D-structure; Complete proteome; irect protein sequencing; Membrane; Photosynthesis; Phycobilisome; Reference proteome; Thylakoid;[1390935826213]
258 Q55766 RPIA_SYNY3 Ribose-5-phosphate isomerase A29,086 9,36 MAELDAANLMKQAVGKAAADRVKSNTIVGLGTGSTTAYALEFIGDRLKKGELENVVGIPTSFQAEVLARKYGIPLTTLDVADRIDIAIDGADEVDPQKNLIKGGGAAHTREKIVDALAETFLVVVDSGKLVDKLGSTFLLPVEVIPMALTPVMRALAKLGGKPELRMGVKKAGPVVTDQGNLVIDVKFDAITNPAELEKTINNLPGVLENGLFVGVADVILVGEIIDGQPTVREF3 2 0 0 4,99 24752,741 Synechocystisribose-5-phosphate isomerase activity (GO:0004751); pentose-phosphate shunt, non-oxidative branch (GO:0009052);Complete p oteome; Isomerase; Reference proteome;[1390935826213]
259 P54206 RBS_SYNY3 Ribulose bisphosphate carboxylase small chain28,952 15,04 MKTLPKERRYETLSYLPPLTDQQIAKQVEFLLDQGFIPGVEFEEDPQPETHFWTMWKLPFFGGATANEVLAEVRECRSENPNCYIRVIGFDNIKQCQTVSFIVHKPNQNQGRY4 2 0 0 5,67 13239,043 Synechocystismonooxygenase activity (GO:0004497); ribulose-bisphosphate carboxylase activity (GO:0016984); reductive pentose-phosphate cycle (GO:0019253);Calvin c cle; Carbon dioxide fixation; Com lete prote me; Ly se; Monooxygenase; Oxidoreductase; Phot ynth sis; Reference proteome;[1390935826213]
260 P73410 CYSK_SYNY3Cysteine synthase 28,865 7,37 MKIASNITELIGRTPLVRLNRIPLLEGCGAKIVVKLEGMNPAASVKDRIGINMINRAEQEGLIEPGKTLLIEPTSGNTGIALAMVAAAKGYQLILTMPETMSQERRAMLKAYGAKLELTPGSEGMGGCIRRAQELAESLPNAYMLQQFDNPANPQIHQQTTALEIWQDTDGAIDFLVAGVGTGGTITGVASVLKEKKPSFQAIAVEPQNSPVLSGGKPGPHKIQGIGAGFIPEVLDVNLIDEVIAVTDEEAIAYGRRLAREEGILSGISTGAALAAAIKVAKRPANKDKLIVMIQPSFGERYLSTPLFQDLE3 2 0 0 5,87 33173,448 Synechocystiscysteine synthase activity (GO:0004124); transferase activity (GO:0016740); cysteine biosynthetic process from serine ( O:0006535);Amino-acid biosynthesis; Complete proteome; Cysteine biosynthesis; Pyridoxal phosphate; Reference proteome; Transferase;[139 935826213]
261 P55038 GLTS_SYNY3Ferredoxin-dependent glutamate synthase 228,736 2,31 MSFQYPLLAPMTNSSVATNSNQPFLGQPWLVEERDACGVGFIANLRGKPDHTLVEQALKALGCMEHRGGCSADNDSGDGAGVMTAIPRELLAQWFNTRNLPMPDGDRLGVGMVFLPQEPSAREVARAYVEEVVRLEKLTVLGWREVPVNSDVLGIQAKNNQPHIEQILVTCPEGCAGDELDRRLYIARSIIGKKLAEDFYVCSFSCRTIVYKGMVRSIILGEFYLDLKNPGYTSNFAVYHRRFSTNTMPKWPLAQPMRLLGHNGEINTLLGNINWMAAREKELEVSGWTKAELEALTPIVNQANSDSYNLDSALELLVRTGRSPLEAAMILVPEAYKNQPALKDYPEISDFHDYYSGLQEPWDGPALLVFSDGKIVGAGLDRNGLRPARYCITKDDYIVLGSEAGVVDLPEVDIVEKGRLAPGQMIAVDLAEQKILKNYQIKQQAAQKYPYGEWIKIQRQTVASDSFAEKTLFNDAQTVLQQQAAFGYTAEDVEMVVVPMASQGKEPTFCMGDDTPLAVLSHKPRLLYDYFKQRFAQVTNPPIDPLRENLVMSLAMFLGKRGNLLEPKAESARTIKLRSPLVNEVELQAIKTGQLQVAEVSTLYDLDGVNSLETALDNLVKTAIATVQAGAEILVLTDRPNGAILTENQSFIPPLLAVGAVHHHLIRAGLRLKASLIVDTAQCWSTHHFACLVGYGASAICPYLALESVRQWWLDEKTQKLMENGRLDRIDLPTALKNYRQSVEAGLFKILSKMGISLLASYHGAQIFEAIGLGAELVEYAFAGTTSRVGGLTIADVAGEVMVFHGMAFPEMAKKLENFGFVNYRPGGEYHMNSPEMSKSLHKAVAAYKVGGNGNNGEAYDHYELYRQYLKDRPVTALRDLLDFNADQPAISLEEVESVESIVKRFCTGGMSLGALSREAHETLAIAMNRLGAKSNSGEGGEDVVRYLTLDDVDSEGNSPTLPHLHGLQNGDTANSAIKQIASGRFGVTPEYLMSGKQLEIKMAQGAKPGEGGQLPGKKVSEYIAMLRRSKPGVTLISPPPHHDIYSIEDLAQLIYDLHQINPEAQVSVKLVAEIGIGTIAAGVAKANADIIQISGHDGGTGASPLSSIKHAGSPWELGVTEVHRVLMENQLRDRVLLRADGGLKTGWDVVMAALMGAEEYGFGSIAMIAEGCIMARVCHTNNCPVGVATQQERLRQRFKGVPGQVVNFFYFIAEEVRSLLAHLGYRSLDDIIGRTDLLKVRSDVQLSKTQNLTLDCLLNLPDTKQNRQWLNHEPVHSNGPVLDDDILADPDIQEAINHQTTATKTYRLVNTDRTVGTRLSGAIAKKYGNNGFEGNITLNFQGAAGQSFGAFNLDGMTLHLQGEANDYVGKGMNGGEIVIVPHPQASFAPEDNVIIGNTCLYGATGGNLYANGRAGERFAVRNSVGKAVIEGAGDHCCEYMTGGVIVVLGPVGRNVGAGMTGGLAYFLDEVGDLPEKINPEIITLQRITASKGEEQLKSLITAHVEHTGSPKGKAILANWSDYLGKFWQAVPPSEKDSPEANGDVSLTGEKTLTSV3 3 0 0 5,53 169499,084 Synechocystis3 iron, 4 sulfur cluster binding (GO:0051538); glutamate synthase (ferredoxin) activity (GO:0016041); metal ion binding (GO:0046872); glutamine metabolic process (GO:0006541); L-glutamate biosynthetic process (GO:0097054);3 -structure; 3Fe-4S; Amino-acid biosynthesis; Complete proteome; FAD; Flavoprotein; FMN; Glutamate biosynthesis; Gluta ine amidotransferase; Iron; Iron-sulfur Metal-binding; Oxidoreductas ; Reference proteome;[139093 826213]
262 Q55233 DRGA_SYNY3Protein DrgA 28,676 9,52 MDTFDAIYQRRSVKHFDPDHRLTAEEERKLHEAAIQAPTSFNIQLWRFLIIRDPQLRQTIREKYGNQAQMTDASLLILVAADVNAWDKDPARYWRNAPREVANYLVGAIASFYGGKPQLQRDEAQRSIGMAMQNLMLAAKAMGYDSCPMIGFDLQKVAELVKLPADYAIGPMVAIGKRTEDAPGKRRSNSPGRIPLGKLLCLTKVWCLAI8 2 0 0 9,4 23703,443 Synechocystisoxidoreductase activity (GO:0016491); response to herbicide (GO:0009635);Complete proteome; Direct rotein sequencing; Flavoprotein; FMN; Herbicide resistance; NAD; N DP; Oxidoreductase; Reference proteome;[1390 35826213]
263 P74789 P74789_SYNY3Sll0319 protein 28,464 7,07 MNWKFFPHPFLAMAVGAILAPFTPVSASTFTETAIDQTEVIAVARPYGVETTKYDLLVIEQIPGKNKCWDVTPGAPAMVDPLLLNFDFTGHCRRATDSNGYSIRIDGQDYGLDYLLRLVPRGNELVLVATSRNGRGPELVVGSTKGIGAGFMQVQLNPGWQFTKRTYEGQVLGHYYISGTQAAILGGTAVSPVGPEPITPEKQELIAPEPVQTLENNPNPTPTEVTETGTEIIIKQEVPEVPANEQSGMVMEEESVSTVTEENSVAKEMETVTPKPALVVKPNPPRRRTPTPADFRP2 2 0 0 4,94 32315,724 Synechocystisouter membrane-bounded periplasmic space (GO:0030288);Complete proteome; Reference proteome;[1390935826213]
264 P74510 P74510_SYNY3Dihydrolipoamide acetyltransferase component (E2) of pyruvate dehydrogenase complex28,236 5,54 MIYDIFMPALSSTMTEGKIVSWTKSPGDKVEKGETVLVVESDKADMDVESFNEGYLAAILVPAGEEAPVGATLGLVVETEAEIAEAQAKAGSGGGSSAAPTATPAPQQPEPVAIASATAIETTPAPSSNGNGKGSGRIIASPRAKKLAKELKVDLATIAGTGPHGRIVAADIESAAGKPVTASIAAPSAPAPKTSPAPTPRVTSTPSVPVGQTVPLTTFQKALVQNMVAAMAAPTFRVGYTITTDGLDQLYKQIKGKGVTMTALLAKAVALALKKHPIVNASYTDQGIIYHKDVNIALAVAMPDGGLITPVLQNADQVDIYSLSRRWKELVERARAKQLQPEEYSTGTFTISNLGMFGVDRFDAILPPGQGGILAVGASRPQVVANEEGLIGTKRQMAVNVTCDHRVIYGAHAAAFLKDLAVIIEENAQSLTM2 2 0 0 6,04 44898,455 Synechocystistransferase activity, transferring acyl groups (GO:0016746);Acyltransferase; Complete proteome; Lipoyl  Pyruvate; Reference proteome; Transferase;[1390935826213]
265 P74220 Y1534_SYNY3Putative carboxypeptidase slr153428,231 8,97 MSSLPKNFLQPLPLQPGDRLTVVSPSGSLRELADLQKGVDIWRSWGYEVIFSQGYHNRFGYLAGTDQQRRQDLLHAWLDPQCKGILCSRGGYGSARLLEDWQWPAISQPKWVLGFSDVTGILWSLLKSGIISLHGPVLTTLSDEPDWALERLRGHLQGLPLAPLTGNSWQKGMARGRLVAGNLTVATHFLGTEWQPDFENVILAIEDVTESPYRIDRMVTQWRASGNLSQVAGIALGRFSECEAPAGFPSWTVEEVLGDRLGDLGIPVVADLPFGHGGVNAILPVGSKAELDGDAGTLSFL3 2 0 0 5,38 32906,437 Synechocystiscarboxypeptidase activity (GO:0004180); serine-type peptidase activity (GO:0008236); proteolysis (GO:0006508);Carboxypeptidase; Complet  proteome; y rolase; Protease; Reference proteome; Serine protease;[139 935826213]
266 P72807 P72807_SYNY3Sll1663 protein 28,113 10,45 MSDSLTAIKALLGSDNFSDKVRGLNQLRALEPAEAFPLLKPLVNDANPRIRYAAVSQLDPVGKADLEQSLQLLRDRLFNDPEIDVQSVAADVIGGLKLTAAYPDLQKAYEETPEWLLQMSIVATLGEMGDRRGFDLLKIALDSENSLIRTAAISALGELGNPEALPLLASLVQDEDWQVRYRLALAVGHLEHPDRQSLLQQLAQDQVEQVANTAQELLTA3 2 0 0 4,54 24104,385 Synechocystis Complete proteome; Reference proteome;[1390935826213]
267 Q55734 Q55734_SYNY3Sll0395 protein 28,045 8,49 MTLNLYFLRHGETTSSQTGTFCGRLDIDLTSHGYQMAHQFAEAYKDVSWTAIFASPLHRTMATATPLSKLINLPIQKRDGLKEIAYGEWEGKTPAEVNQQFHDDYVRWLADPGWNAPSGGEKGIDIARRSSEVLEEIERTFTTGNVLVVSHKSTIRIMLCSLLGIDIGRFRDRIGMPVAAVSIVTMSEHGPLIEVMGDRSHLNQDLRDRYGT2 2 0 0 6,24 23751,95 Synechocystis Complete proteome; Reference proteome;[1390935826213]
268 P73045 P73045_SYNY3Slr1767 protein 27,97 18,75 MNIWVDAQLPPTLADWLSSNFDLEASALRDLGLRDARDIEIFDAARVANSVIMTKDSDFVDLVCRLGIPPQIIWLTCGNVTNRNLRRILSSTLPQALEKLQAGEIIIEISNS2 2 0 0 4,63 12464,317 ynechocystis Complete proteome; Reference proteome;[1390935826213]
269 Q55387 Q55387_SYNY3Periplasmic binding protein of ABC transporter for natural amino acids27,961 5,95 MNNLVGDFFRMRLFWPQSRRRLTAIALNLALAGTTAGLMFACAEPEPTPGDGASQPSTGGEGGALKLGALLPATGDLSSIGQNMPLAVQLAVDTINACGGVNGQDVTVVIEDDQTDPTAGVSAMTKLAEADQVAGVVGSFASSVSSAAVPIAVRNNIMMISPGSTSPVFTDQAKKGEFKGFWARTAPPDTYQAQALAALAKKQGFTDAATVVINNDYGVGFEKVFVESFTADGGNVTNKDNPVRYDPKAATLDTEAAQGFANSPDAVAAILYADTGSVLVQSAYRQGLMDGVTLLLTDGVYSPDFVEKVGKDANGVSLLSGALGTVPGADGKSLEAFTAQWKDATGGKDVTAFVPHTYDATVLMMLAAEAAKSNTGAGIQSKIRDVSNGPGEEVTDACEAIAMVREGKDINYQGASGNVDIDENGDVVGTYDVWTVKGDGTLEVIDKVTPGSGS3 2 0 0 4,38 46672,172 Synechocystisouter membrane-bounded periplasmic space (GO:0030288); amino acid transport (GO:0006865);Complete proteome; Reference proteome;[1390935826213]
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270 P73056 YC64L_SYNY3Uncharacterized monothiol glutaredoxin ycf64-like27,306 14,02 MNPETKARIDQLVTANKVMVFMKGTKLMPQCGFSNNVVQILNMLGIPFETLDVLADAEIRQGIKEYSNWPTIPQVYVNGEFVGGSDIMIELYQNGELQEMLEVALAS4 2 0 0 4,53 11939,839 Synechocystis2 iron, 2 sulfur cluster binding (GO:0051537); electron carrier activity (GO:0009055); metal ion binding (GO:0046872); protein disulfide oxidoreductase activity (GO:0015035); cell redox homeostasis (GO:0045454);2Fe-2S; Complete proteome; Iron; Iron-sulfur; Me al-binding; Redox-active center; Reference proteome;[139093 826213]
271 P73594 Y1409_SYNY3Uncharacterized WD repeat-containing protein slr140927,136 6,75 MRIFPVFLLTFSLFLIKEEIVTAEVKVSAPVVNQSGIKLNLERQFTGSDVAINRIHFSPDGQFLLTAAADGVGTLWTKEGEMLGQLQGQKPPMFNARLSPDRQILITTGYDGTIRLWNLQGELLEEQQPHRAAVADAIFSPDSQIIVTCSDDGQTKIFTRQGQEIASVLKSGTARNLAYHPQGLLIASVSDSGSLHLINPNGKIEREISTGQGRINNVNFSPNGEQLLTSGINGSAKLWNLAGELIHEYKVVPTGWVNSAQFYPKGEWLATASDDGTIRFWQKDGQLIYELPLVNARLTSLSFSPDGKQLAATSSQGQVWVFNLSY2 2 0 0 5,78 35759,527 Synechocystisouter membrane-bounded periplasmic space (GO:0030288);Complete proteome; Reference proteome; Repeat; WD repeat;[1390935826213]
272 P48957 RL20_SYNY350S ribosomal protein L2027,026 12,82 MTRVKRGNVARKRRKKILKLAKGFRGSHSKLFRTANQQVMKALRNAYRDRRKRKRDFRRLWITRINAAARQEGMSYSKLTGQLKKANIEINRKMLAQLAVLDPAAFSEVVKVAATAK3 2 0 0 12,11 13553,122 Synechocystisribosome (GO:0005840); rRNA binding (GO:0019843); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprot i ; Ribosomal protein; RNA-binding; rRNA-binding;[1390935826213]
273 P73093 P73093_SYNY3Phycobilisome rod-core linker polypeptide CpcG26,997 8,09 MRVEGYEIGSEEKPVVFTTENILSSSDMDNLIEAAYRQIFFHAFKWDREKVLESQLRNGQITVRDFVRGLLLSNTFRNSFYEKNSNYRFVEHCVQKILGRDVYSEREKIAWSIVVATKGYQGLIDDLLNSDEYLNNFGYDTVPYQRRRNLPGREAGELPFNIKSPRYDAYHRRQLGFPQIVWQNEVRRFIPQEKKLTAGNPMNFLGMARSINPAANTIPKVSAQNINIEASVPRR2 2 0 0 9,38 27392,019 Synechocystisphycobilisome (GO:0030089); photosynthesis (GO:0015979);Complete proteome; Reference proteome;[1390935826213]
274 Q55547 Q55547_SYNY3Sll0293 protein 26,959 9,41 MPNIRPLTASLSLLTTAFVGLTPALYATIAEAQDPPATTYQPGFWQPVGRFDPKKPVKVKLVNKTDVALDYDISNLESFPPASVAPGETVLLENFGDNAYIMVYPENATPSTPEQSFLLKFTVPVDARTQMVGADNVAVITVTKGDVNIEERFYGHRSINLQPTGAIFFY3 2 0 0 4,91 18583,19 Synechocystis Complete proteome; Reference proteome;[1390935826213]
275 Q55484 DCDA_SYNY3Diaminopimelate decarboxylase26,891 5,97 MLSTEMPLPTTGSTLLKTPASPSPNQNLLPLTAVINKNGELEIGGCSVPALVEQFGSPLYILDETTLRQAAQQYRQSFQAHYPGSSQVIYASKAWSCLAVVAIAAQEGLGFDVVSGGELFTTVSALKQLGWDEAEIAEKIYFHGNNKSVQELQEAIAINCTIIVDNWLELETLTKLAADSGAPVKIMLRLTPGIECHTHEYIKTGHLDSKFGFDPNQLEAVFTYIAQQPSLHCLGLHAHIGSQIFERQPHKDLGEVLVQWFTKGLTYGLPLTELNIGGGLGICYTESDDPPSIEEWAQVAAISVAKACDRQNIPYPKLIAEPGRSLVGSACVTAYRVGGRKVVPNIRTYISVDGGMSDNPRPITYQSVYRVALANRMNDEITETVTVAGKHCESGDILVKDVALPAAEPGDIMVVAATGAYNHSMASNYNRLGRPAAVLVNQGQANLILQRETYTDLLRQDCLPNRLLS2 2 0 0 5,35 50847,936 Synechocystisdiaminopimelate decarboxylase activity (GO:0008836); pyridoxal phosphate binding (GO:0030170); lysine biosynthetic process via diaminopimelate (GO:0009089);Amino-acid bio ynthesis; Complete proteome; Decarboxyl se; Lyase; Lysine biosynthe s; Pyridoxal phosphate; Reference prot om ;[1390935826213]
276 P74563 P74563_SYNY3Sll0630 protein 26,736 13,1 MGYCRFLPTCLIGVLLSSLMAIAPANAGKIQYCYPVEKSRTLRDPGSHPQAYDDGYREGAAAARDKKPFEPRSAGGEFARGFEDGYYGRTYGGQENVVPDRTDTYTTNQCRTYEYNDGDSVEQTLKRVLDDFQRDLRRDWNINVR3 2 0 0 6,58 16468,238 Synechocystis Complete proteome; Reference proteome;[1390935826213]
277 Q55862 Q55862_SYNY3Sll0588 protein 26,616 9,8 MSLFPLLTALLGIMPANTIEQVPAVVEAEARPFLVSQANSADILVKLPRPQGSPKNVGSMFMANAYGQQGLNFQAQGKPAPTVKFYQDALTKMGYAERTINTTQGDWGFSIVFDTPATLTLTPKDSSKAVVLVIQGTMLGPDTINLNLRFEEI5 2 0 0 6,21 16516,086 Synechocystis Complete proteome; Reference proteome;[1390935826213]
278 P73130 P73130_SYNY3Sll0995 protein 26,572 8,23 MTVALDREIIYPDSDGQPMADNTEQFEWIVLLKENLECLFAHNPDVFVGGDLLWYPVEGHPEIRVAPDVMVALGRPKGKRGSYRQWQENNQAPQVVFEILSPGNTLKEMTKKLKFYDHHGVEEYYVYDPDDNELTGLQRIGGELTIIEEMAHWVSPLLGIKFELSAETLRVYYPDGRPFLSTVALATQAEQASQRANEEAQRAEREKLRAELAEAENDRLKALLAEAGIDV2 2 0 0 4,7 26229,554 Synechocystis Complete proteome; Reference proteome;[1390935826213]
279 P74267 RL27_SYNY350S ribosomal protein L2726,512 10,34 MAHKKGTGSTRNGRDSNAQRLGVKRYGGQTVTAGSIIVRQRGTQVHPGNNVGRGKDDTLFALIDGVVKFEHKTRSRRKVSVYPATAE3 2 0 0 11,47 9448,664 Synechocystisribosome (GO:0005840); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference prote me; Ribonucleoprotein; Ribos mal protein;[1390935826213]
280 P74371 CPXT_SYNY3Chromophore lyase CpcT/CpeT26,438 8,67 MSHSTDLSALARWMAADFSNQAQAFENPPFYAHIRVAIRPLDQAKFGDRLLFLEQAYDFMLQRPYRLRVLKLKVVEDHIEIENFKVKDEEKFYGAARDLGKLAQLTPADLEPMHGCDMIVEWTGTSFKGEVQPGRQCRVMRDGKETYLENSFEVSETGLISLDRGYDPETNERVWGSVAGAFHFVRWQSFADEVSF3 2 0 0 5,29 22578,511 Synechocystislyase activity (GO:0016829); protein-phycocyanobilin linkage (GO:0017009);Complete proteom ; Lyase; Reference proteome;[1390935826213]
281 P74230 RS12_SYNY330S ribosomal protein S1226,4 7 12,7 MPTIQQLIRSERSKVQKKTKSPALKQCPQRRGVCTRVYTTTPKKPNSALRKVARVRLTSGFEVTAYIPGIGHNLQEHSVVLIRGGRVKDLPGVRYHIVRGTLDATGVKDRKQGRSKYGTKREKAKK4 2 0 0 11,37 14176,627 Synechocystissmall ribosomal subunit (GO:0015935); rRNA binding (GO:0019843); structural constituent of ribosome (GO:0003735); tRNA binding (GO:0000049); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprotein; Rib somal protein; RNA-binding; rRNA-binding; tRNA-binding;[1390935826213]
282 P73180 P73180_SYNY3Slr1391 protein 26,28 8,33 MSDPRTIYFQPRKPENSPKGGKFWGVLLWLSLLSMMPVQGCAPADQGLSPEGQNSPAIATPSSSPSSLISQSPMLPQAIADKIIADLAQRTGEPASAFAVQSSENKTWPDSCLGLAQEGQMCAQVMTPGWQVTVQSGQKNWVYRTNQNGRTILLES3 2 0 0 7,68 16806,079 Synechocystis Complete proteome; Reference proteome;[1390935826213]
283 Q55887 Q55887_SYNY3Slr0111 protein 26,194 10,4 MARKSLSDLLKQEVKAQSQPELDAGISPDLEPTPEASVPEPTADLAELQAQLNSIKAALQAEKNQGEKLKEQLQQEKKAQEKVKQLEQSLKQEQARVKELQNEVQLVEKLQTELKEEKNLVGKLYSKIQDLEEDLAPQVSAALTTLPRAMPVRYVAPKQPPTNLSDEDIGWFD2 2 0 0 4,86 19376,955 Synechocystis Complete proteome; Reference proteome;[1390935826213]
284 P73807 HIS8_SYNY3 Histidinol-phosphate aminotransferase25,997 5,44 MVSIRPSVRHTPAYVPGEQPQTNDFIKLNTNENPYDPPAQVLAAVAAELPKVRLYPDPVSTQLRQAAADLYGVDLNQVLAGNGSDDILNIVVRTFVDPGETVAFLDLTYSLYETIASVHGAKVQKIATDANFDLTGPVICPEAKLIFLASPNPPKGKHLNREFLWQTCAQAEGVVVIDEAYGDFSDEDHWDFLQEFDNVIISRTLSKSYSLAGMRVGLAIAAPALIEEMDKVRDSYNLDRLAQVLGTAALRNQAEFVPLWEKVRHTRTRLMEQLAELDFQVCPSDANFVFAAPRWMAAADLYQALKEKKILVRYFNHPRITDYLRITVGTDGEIDQLLLAIASLKGSLG2 2 0 0 5,01 38702,127 Synechocystishistidinol-phosphate transaminase activity (GO:0004400); L-phenylalanine:2-oxoglutarate aminotransferase activity (GO:0080130); pyridoxal phosphate binding (GO:0030170); histidine biosynthetic process (GO:0000105);Amino- cid biosynthesis; Aminotransferase; Complete proteome; His idin  biosyn hesis; Pyridoxal phosphate; Reference proteome; Transferase;[1390935826213]
285 P48944 RS14_SYNY330S ribosomal protein S1425,984 14 MAKKSMIERDKRRSRLVAKYAAKREALKEEFRQAETLEDKLAVHQKLQDLPRNSAPNRRRNRCQVTGRPRSYYRDFGLCRNVLREWAHQGLLPGVTKSSW4 2 0 0 10,94 11853,651 Synechocystisribosome (GO:0005840); rRNA binding (GO:0019843); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprot i ; Ribosomal protein; RNA-binding; rRNA-binding;[1390935826213]
286 Q6ZEQ0 Q6ZEQ0_SYNY3Non-heme chloroperoxidase25,929 9,85 MSTITTKDGTEIYYKDWGSGQPITFSHGWPLSADAWESQMFFLASHGYRCIAHDRRGHGRSSQPWNGNDMDTYADDLAELFEALDLKDVVMIGHSTGGGEVARFIGRHGTQRVSKAVLMGAVPPLMLKTEANPGGLPIEVFDGFRAAFLADRSQFFLDIASGPFFGFNRPGAKVSQGLIYSWWMQGMMAGHKNAYDCIKAFSETDFTEDLKKFDVPTLIIHGDDDQIVPIGASALLSAKLVKNSILKIYPGGSHSLGDTSKEQLNADLLEFVES2 2 0 0 5,43 30077,979 Synechocystisperoxidase activity (GO:0004601); metabolic process (GO:0008152);Complete proteome; Oxidoreductase; Peroxidase; Plasmid; Reference proteome;[1390935826213]
287 Q59994 TPIS_SYNY3 Triosephosphate isomerase25,798 8,68 MRKIIIAGNWKMHKTQAEAQAFLQGFKPLIEDAAESREVVLCVPFTDLSGMSQQLHGGRVRLGAQNVHWEASGAYTGEISAAMLTEIGIHYVVIGHSERRQYFGETDETANLRVLAAQKAGLIPILCVGESKAQRDAGETEQVIVDQVKKGLVNVDQSNLVIAYEPIWAIGTGDTCAATEANRVIGLIREQLTNSQVTIQYGGSVNANNVDEIMAQPEIDGALVGGASLEPQSFARIVNFQP2 2 0 0 5,17 26158,648 Synechocystiscytoplasm (GO:0005737); triose-phosphate isomerase activity (GO:0004807); gluconeogenesis (GO:0006094); glycolysis (GO:0006096); pentose-phosphate shunt (GO:0006098);Complete proteome; Cytoplasm; Gluconeogenesis; Glycolysis; Isomerase; P ntose shunt; Reference proteome;[1390935826213]
288 P74741 PUR9_SYNY3Bifunctional purine biosynthesis protein PurH25,716 4,11 MARLALLSVSDKSGIVELAQRLVNEFQFDLISSGGTAKTLKEAGVPVTKVSDYTGAPEILGGRVKTLHPRIHGGILARRDLPSDQADLEANDIRPLDLVVVNLYPFEQTIAKPGVTVAEAVEQIDIGGPAMIRATAKNFAHTTVLTNPNQYEAYLQALQEQGEIPLALRQQFAGEAFALTNAYDQAIANYFSGLSGDSANQFGLSGTLRQPLRYGENPHQSAGWYQTGREATGWAKAEKLQGKELSYNNLVDLEAARRIINEFDVREPAAVILKHTNPCGVALAPTLVEAYQKAFNADATSAFGGIVALNQPLDGPTAAAMVKTFLECIVAPGCDAEAQEILAKKNNLRVLILPDLATGPSQTIKAIAGGFLVQSADDEREDPSTWQVVTEKQPSGEELAELAFAWKVCKHVKSNAITITKNKTTLGVGAGQMNRVGSVEIALKQAGTEAQGACLASDAFFPFDDSVRTAAAAGITTIIQPGGSMRDQDSIQAANELGLVMIFTGVRHFLH3 2 0 0 5,29 54564,872 SynechocystisIMP cyclohydrolase activity (GO:0003937); phosphoribosylaminoimidazolecarboxamide formyltransferase activity (GO:0004643); 'de novo' IMP biosynthetic process (GO:0006189);Comple e proteome; Hydrolase; Multifunctional enzyme; Purine biosynthesis; Reference proteome; ransferase;[139 9 5826213]
289 P73133 ARGD_SYNY3Acetylornithine aminotransferase25,661 4,43 MTYSPVVESVEAQAFAVTDLSPAAEFKTADFDTYVMNTYGRFPIAIARGQGSTLWDTEGKSYLDFVAGIATCTLGHAHPALVRAVSDQIQKLHHVSNLYYIPEQGELAKWIVEHSCADRVFFCNSGAEANEAAIKLVRKYAHTVLDFLEQPVILTAKASFHGRTLATITATGQPKYQQYFDPLVPGFDYVPYNDIRSLENKVADLDEGNSRVAAIFLEPLQGEGGVRPGDLAYFKRVREICDQNDILLVFDEVQVGVGRTGKLWGYEHLGVEPDIFTSAKGLAGGVPIGAMMCKKFCDVFEPGNHASTFGGNPLACAAGLAVLKTIEGDRLLDNVQARGEQLRSGLAEIKNQYPTLFTEVRGWGLINGLEISAESSLTSVEIVKAAMEQGLLLAPAGPKVLRFVPPLVVTEAEIAQAVEILRQAIATLV3 2 0 0 5,17 46567,179 Synechocystiscytoplasm (GO:0005737); N2-acetyl-L-ornithine:2-oxoglutarate 5-aminotransferase activity (GO:0003992); pyridoxal phosphate binding (GO:0030170); arginine biosynthetic process ( O:0006526);Amino-acid biosynthesis; minotransferase; Arginine biosynthesis; Complete proteome; Cytoplasm; Pyridoxal phosphate; Reference proteome; Tran ferase;[1390935826213]
290 Q55758 PYRR_SYNY3 Bifunctional protein PyrR25,581 10,11 MAAQIIEILSPEEIRRTLTRLASQVIEKNSDLSELVLLGIYTRGVPLAHQLAQQIEMLEQVKVPVGAIDVTLYRDDLKRIKTRTPAKTKIPLSLTGKRVVLVDDVIYKGRTIRAALNAVTEYGRPQVIRLLTLVDRGHRELPIHPDFVGKILPTAAEEQVKVYLQDPDGRDTVELIKG2 2 0 0 9,36 19946,349 Synechocystisuracil phosphoribosyltransferase activity (GO:0004845); nucleoside metabolic process (GO:0009116); regulation of transcription, DNA-dependent (GO:0006355); transcription, DNA-dependent (GO:0006351);Comp ete proteome; Glycosyltransferase; Ref renc pro eome; Transcription; Transcription regulation; Transferase;[1390935826213]
291 Q6ZEQ5 Q6ZEQ5_SYNY3Sll5075 protein 25,428 12,23 MKEDFGFTHIALFAKNIDLSISFYNRYANMSIVHERLDKDTGKRVVWLSDKIRPFVLVLVQDENPTPILGPFAHLGIGCKDKSEVDYLCEQARQEGILAKDATDSGYPVGYWAFINDPDGHTLEVSYGQEIGLTIDKPA2 2 0 0 5,1 15621,719 Synechocystis Complete proteome; Plasmid; Reference proteome;[1390935826213]
292 P73510 P73510_SYNY3Sll1358 protein 25,419 5,33 MVNSVIGWLRRRFLLVGLSVLLITFLGIFTPTIAQSEQWRSLSNVVWGKDLPAFTYAFSKTPLVLYDGGTTKQVGTYNFPVSKGMAGVYMSLEPGAIRELHWHANAAEWAYVMEGRTRITLTSPEGKVEIADVDKGGLWYFPRGWGHSIEGIGPDTAKFLLVFNDGTFSEGATFSVTDWLSHTPIAWVEENLGWTAAQVAQLPKKQVYISSYGPASGPLASATPQGQTAKIEVPHTHNLLGQQPLVSLGGNELRLASAKEFPGSFNMTGALIHLEPGAMRQLHWHPNADEWQYVLDGEMDLTVFASEGKASVSRLQQGDVGYVPKGYGHAIRNSSQKPLDIVVVFNDGDYQSIDLSTWLASNPSSVLGNTFQISPELTKKLPVQDTIFSLPTQP2 2 0 0 5,93 43150,995 Synechocystisouter membrane-bounded periplasmic space (GO:0030288); metal ion binding (GO:0046872); nutrient reservoir activity (GO:0045735);3D-structure; Complete proteome; Manganese; Metal-binding; Reference proteome;[1390935826213]
293 P73732 P73732_SYNY3Extracellular solute-binding protein25,341 4,3 MLLNLPATVKSRSCQKLIGGLLPLLLFACGSPNVGNGNSQQNGQETLKILSWQAPTILNPHLATGFKDAEASRIALEPLASFDQEGNLVPFLAAEIPSVENGGVAADGLSVTWKLKPDVLWSDGQPFSAEDVAFTYKFLSDPKTGATSTGTYEAIAKVEALDKNTVKITFKEPNPAWFLPFVGSEGMILPQHIYKDFVGEKARQAPANLLPIGTGPYRVTSFKPGDVVLYEVNPHYRDRKNIGFQQVEIKGGGDATSAARAVLQTGDADFALNLQVEDNILQSLAQGGKGEIVADLGSLSERVIFNLSDPDPARTNGDRSSVKFPHPFLQDPLVRKAITLGIDRDLIAKQLYGVTGQPTANVLVLPQQYASQNTSFQFNPTEAQQLLDQAGWKDSNGNGIRDKDGIELQMVFQTSVNPLRQKTQQVIKQTLQAIGVGVELKSIDPSVFFSGDPANPDTLERFQGDLSMFTTGNTNPDPSKYMQTFTCGAIPTAENQWSGDNYGRYCSAEYDQLWQKAVAELDPEKRQQLFIQMNDLLVDDYILVPVVHRASVVGVGDRLDGVALTPWDRPTWNIKDWQPKAK2 2 0 0 5,06 63606,86 Synechocystistransporter activity (GO:0005215);Complete proteome; Reference proteome;[ 390935826213]
294 P73426 ISPF_SYNY3 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase25,306 12,42 MTALRIGNGYDIHRLVGDRPLILGGVTIAHHLGLDGHSDADVLTHALMDALLGALSLGDIGHYFPPSDARWQGADSLKLLAQVHQLILERGWRINNLDNVIVAEQPKLKPHIQAMKENLAKVLTIDPDLIGIKATTNERLGPTGREEGIAAYSVALLIKEG2 2 0 0 6,22 17411,088 Synechocystis2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase activity (GO:0008685); metal ion binding (GO:0046872); isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway (GO:0019288); terpenoid biosynthetic process (GO:0016114);Complete proteome; Isopren  biosynth sis; Lyase; Metal-binding; Reference proteome;[1390935826213]
295 P73862 P73862_SYNY3Rubisco operon transcriptional regulator25,176 8,23 MQATLHQLKVFEATARHGSFTRAAEELYITQPTVSSQIKQLSKTVGLPLFEQIGKRLYLTEAGQELLVTCQDIFQRLDNFAMKVADIKGTKQGRLRLAVITTAKYFIPRLLGEFIQKYPGIEVSLKVTNHEQIRHRMQNNEDDLYIVSEPPEEIDLNYQPFLDNPLVVIARRDHPLAGKSNIPITALNDEAFIMREKGSGTRLAVQNLFHRHYVDVRVRLELGSNEAIKQAIAGGMGISVLSQHTLVSEGARSELTILDIDEFPIKRRWYVANLAGKQLSVITQTFLDYLMAVTKNMPAPFAEQLTTQQTPVKLVL2 2 0 0 8,82 35696,25 SynechocystisDNA binding ( O:0003677); sequence-specific DNA binding transcription factor activity (GO:0003700); transcription, DN -dependent (GO:0006351);Complete proteome; D A-binding; Reference proteome; Transc iption; Transcription regul tion;[1390935826213]
296 P73736 P73736_SYNY3N-acetylmuramoyl-L-alanine amidase25,166 3,7 MSRLPGFALTFLSVLLTSLPAMAGQLVNWNFNASQNRLTFYTDSRVQPTAQLIPNPTRIVVDLPGTTLRGPTVRQAGGGRVREIRIGEPDSFTTRVVIELDAGYTVDPQQVKVRGITPTQWVVELPTPELAPASNNNAPGPNPDGSSLPTQNLSAANPPSTGQQYLQVTGNGLFVRLDKNGDNSGIRIQPNARQSTVNFELNGAVLPESLVGQSLPVGQYGVEEIKFSDNPNNPRLSLALADSGGGWNAYYSRVGGGVVLLPKQISRSGGANPAPGSAAVPVSNNTSNSSPSSSGNRSPNDRLVSQASNRNLANITAIEVTRDDSQLIIRGDRQINARGNFNRLTGNYEIRLDRAQLSPQFQSPELATGGPLYQLNISQETNDSVLILVRPNTGRRFGRLFRSGGSLYALELISDTTASRPTGNLPANNPPRGNSGDQISIAVQPPPANATPSFPPEWSNPPAGNLPSVPRGGRLVVVDPGHGGKDPGAIGIRGVQEKDVVLAVSQYLQRYLEQQGVRVLMTRTGDYFISLQGRTDMANRAGADLFVSIHANSMGMGRPDVNGFEIYYHGNAGLSQAIHRNVVNSLNVRDRRVRQARFYVLRNSRMPSTLVEMGFVTGNEDNYKLTDPNFQQQMAQAIARGVLEYLQQR2 2 0 0 9,9 70011,438 Synechocystisouter membrane-bounded periplasmic space (GO:0030288); N-acetylmuramoyl- -alanine amidase activity (GO:0008745); peptidoglycan catabolic process ( O:0009253);Complete proteome; Reference proteome;[1390935826213]
297 P74338 NDHM_SYNY3NAD(P)H-quinone oxidoreductase subunit M25,159 14,88 MLVKSTTRHVRIFSAEVQGNELIPSNNVLTMDVDPDNEFVWNEDALQQVYRRFDELVESYSGEDLTDYNLRRIGSDLEHFIRDLLQAGKVSYNLDCRVLNYSMGLPKVENQETAGKYWLDN2 2 0 0 4,64 14077,676 Synechocystisthylakoid membrane (GO:0042651); oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655); quinone binding (GO:0048038); transport (GO:0006810);Complete proteome; Direct protein quencing; Membrane; NAD; NADP; Oxidoreductase; Plastoquinone; Quinone; Reference prot ome; Thylakoid; Transpo t;[1390935826213]
298 P74500 P74500_SYNY3Slr1940 protein 25,059 4,77 MPQFPMGFCIVRRINLRFASILALAIPLNLVASSLTAAPLTNGECLLLAQASQRRNVGSIGAPGARGVDGQDGANTDDLTVFSDGSPMTLNLAGRDGAPGTPGAEGSPANCPALDTSQRQDVQMANGSDGGDGGDGGNGGNGGSITIYTRNLDSLNQIFVGAAGGKGGAPGMGGGGGQACQCSQPYWTVESCSGRPGDSGYRCSTEEFRCFNGLNGRDGRSGIAGQDGLTGRLTVLNLDRPLEPDRPGTTVSLDVLKNQGFNLSKNIWETRPGAAQLLAPGSVIADEYLILLDRIERSFLVVWNAPQPFERFANTNVSLTLTEDNQIAPELPSNLWLEGTTQQRNNVTEFVVYNAMWEGDATSLGRLTLSGSGNNLKLSLVDEANQSNLMATKFRLRYRVTNEDPRFRPPSTYTLRYEGEIEDSLVTVNGNQFTIDIGQLPIPPKDLESGTGVEIELVAERTFSGNTAEQKLIIRDLIRGRN2 2 0 0 4,8 51261,186 Synechocystisouter membrane-bounded periplasmic space (GO:0030288);Complete proteome; Reference proteome;[1390935826213]
299 Q55426 Q55426_SYNY3Slr0841 protein 24,836 6,87 MRLNFSRTLFFAAIMGGFALAMGKAQPFFPSNSVQAMETSKSQSLQGTTWYISGWPSAPVPGSAPITLQFKGAPHSGSLRDRLTGTAGCNTFNGAYTSGDGNLTINQALATTRKACTAEVMAQEQRFLQLLPQVTSYSIGNDGQLTLTYLKDGEQGSISFIPANQYSALHNSQWELVTMAGVEPIANENSRAIPQLQFLGDRLTGTGGCNRLMGQFTIDGDNLTVDERMASTMMACSEPLMAQEQQFIQALVNAQKYEILTSGELVIDYLMGEKTEQLVFLPLTEEDSAPR3 2 0 0 4,92 31566,706 Synechocystisouter membrane-bounded periplasmic space (GO:0030288);Complete proteome; Reference proteome;[1390935826213]
300 P74142 RS1B_SYNY330S ribosomal protein S1 homolog B24,639 6,89 MPSSSNSAAFSLDEFAKALDKHDYHAEKGQTVHGKICQHANEGVYVDFGGKSPGFVPVQELGLRPHAEIEDSFPLDSAWDFLVTSEQNDEGQVRLSRRQLQIQQSWENLAELEESGKTLEMVVTGTNKGGVVGDVEGLRGFIPRSHLMHKDNMDALVGQVLKAHILEANQDNNKLVLTQRRIQQAESMGKIAAGNIYEGKVAKIQPYGVFVEIEGVTGLLHVSQVSGTRVDSLNTLFAFGQAISVYVQEIDEYKNRISLSTRILETYPGELVEKFDEMMADAPNRLPLVQSKQNLGDKQEQLEKS3 2 0 0 5,19 33794,99 Synechocystisribosome (GO:0005840); RNA binding (GO:0003723); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference proteome; Repeat; Ribonucle p otein; Ribosomal protein; RN -binding;[1390935826213]
301 Q55550 Q55550_SYNY3Slr0169 protein 24,628 9,39 MGIELRSYVYLDSLQSQHAAYIGTVASGFLPLPGDCSLWVEVSPGIEINRITDIALKAAVVRPGVLFVERLYGLLEIHASNQGEVRAAGQAILAYIGAKASDCIKPKVVSSQIIRNIDAYQTQLINRNRRGHMLLAGQTLFVLEVQPAAYASLAANEAEKSASINILQVSSIGSFGRLYLGGEERDIKAGARAAIAAIENAPGKVPTLEGKNE3 2 0 0 7,76 22745,132 Synechocystis Complete proteome; Reference proteome;[1390935826213]
302 P74113 P74113_SYNY3Slr1970 protein 24,529 9,25 MSIQEIFTKALQDGYLTPAMEAEVGRLCESGVDLDQGEYEALDRLMAALLAGDVVAMPHKKFINVMEEMVLTEVVSQVSKYQKTTEKQPDIADIAAYALNRLPPLYATSEEGAEYQRQRASEELEFLIQQQVKDGLGRYFDRPQIADRKPLEPLVKQDLISQMALLLEALAQD2 2 0 0 4,5 19451,225 Synechocystis Complete proteome; Reference proteome;[1390935826213]
303 P73636 RS6_SYNY3 30S ribosomal protein S624,295 11,5 MLVNSYELMVILRPDLNEERVSQEVTKYQEFLTNNAAEEVSVKVWGKRRLAYQIRRFNDGIYVLFNFNGEGQQIALIERDMRLNDNVMRFLSIKLTPEKPEKEKKAKAVAVEA2 2 0 0 8,92 13237,269 Synechocystisribosome (GO:0005840); rRNA binding (GO:0019843); structural constituent of ribosome (GO:0003735); translation (GO:0006412);Complete proteome; Reference proteome; Ribonucleoprot i ; Ribosomal protein; RNA-binding; rRNA-binding;[1390935826213]
304 P74375 P74375_SYNY3Slr0442 protein 24,245 3,6 MNTRFFLNFLTAPKRNAGFAMPMVIMGGLVITVAAAAIAMKGMNDQNQVTAKAAKSSSDAAAETGLARVQGLLASSKYAALFDDSDWATLIQSDGTPNSETTLGAVLEEHLNSVSSNSGSICSEGSSSGVDSAKLASQKQVLGKLRELATEASAGQVEPINSNSSFRIVSYKVGVEEENKGKIPQGQVIGRLVVEGVSSKGATDAVTRLMVDIPISGKPGTSTFGGSDTVPALWISEGGVDKGTAGDTVDTTGTPAVPKTGEIRGNIVLAGCGSTDLTDAYIDDLNSIQNAAGGFAAVRASTPMPSIPLSALASARSQNRVYTLNVGNNDSISLPRSGEQPVDGYYYYESSSLDRKFELNFDNTGGKKYRLYVTGDIGRNAEINGTCNTADGCQPTDIQIFGLSSSGSICMNGNSSRTTKAFVLAPNYDIGRTGNGSYEGMLLGKTYAKGNCAVNNGKLAVTQTSQTWGSVPPDLRPLTAPSPTLTSFSSWSQIDSSLADDDAITEPPIYTGSFLTASSSPSPSPSPSPSPSPSPSPSPSPSPSPSPSPSPSPSPSPSPSPSPSPSPSPSPSPSPSPTPVTVNVQNKKACDDLGGTYSQSGNNKTCTYIPR3 2 0 0 5,11 62907,721 Synechocystis Complete proteome; Reference proteome;[1390935826213]
305 P73031 P73031_SYNY3Ssl1918 protein 24,233 14,43 MLFTGTAMENIVNNVEEYLLSREERILQVRNLVETLRAAEEIAKQGYLITSSELADLMDINPSAVTSRGDHWSWRNWVVSRVRREGNQILWQLERVD3 2 0 0 5,1 11331,812 Synechocystis Complete proteome; Reference proteome;[1390935826213]
306 P73053 THYX_SYNY3Thymidylate synthase ThyX24,097 9,77 MDVRFISLTKPEIVIDGEPLSPEGLIAYCARVSSPNQENPNYTKLLQFCIREGHWSIFEMVDMTLEITTTRAIAPQILRHRSFSFQEFSLRYSCATEYECYEARRQDVKNRQNSLDDFDESTKKWFNQAQAAVWEKSHQLYEEALAKGIAKECARSILPLNTVTRLYMKGSVRSWIHYFSVRCDQATQKEHREIALAARKIFMKHFPTVAAALEW2 2 0 0 8,19 25066,625 Synechocystisflavin adenine dinucleotide binding (GO:0050660); thymidylate synthase (FAD) activity (GO:0050797); dTMP biosynthetic process (GO:0006231);Complete proteome; FAD; Flavoprotein; Methyltransferase; NADP; Nucleotide biosynthesis; Reference proteom ; ransferase;[1390935826213]
307 Q55671 Q55671_SYNY3Slr0013 protein 23,937 16 MKLIDSRGRIFGIVSLLDLGAALIILMVAVGIFVLPGSSGKSILAQANAASIELTTIVRGLNVLDPQVVLDEFKAEKTNIIIRNQPAGQVEVVNVQELPRNLAVPQPDGSVKSLPDPRPESNYSRDMLLTLKGRGDFTSTGMVLGGQKVKIGTVLELEGKNYNFNASVVGINQPK2 2 0 0 9,3 18689,774 Synechocystis Complete proteome; Reference proteome;[1390935826213]
308 P73145 SSBT_SYNY3Thylakoid-associated single-stranded DNA-binding protein slr103423,746 10,85 MNSFVLMATVIREPELRFTKENQTPVCEFLVEFPGMRDDSPKESLKVVGWGNLANTIKETYHPGDRLIIEGRLGMNMIERQEGFKEKRAELTASRISLVDSGNGINPGELSSPPEPEAVDLSNTDDIPF3 2 0 0 4,76 14408,305 Synechocystisthylakoid membrane (GO:0042651); single-stranded DNA binding (GO:0003697); DNA replication (GO:0006260);Complete proteome; Direct protein sequencing; DNA-binding; Membrane; Reference proteome; Thylakoid;[1390935826213]
309 P72952 P72952_SYNY3Sll0645 protein 23,609 7,84 MSNRPGKLLFAGLMGLALAFPFGISPSYGSTVKSSSQLIALKFPQANTDRGQTATSGGGGVRQTSGGSCLTKANLPFQLLIPGDYNQGSGFHNTANKETFIYAYVPPQSEVTAKVQLADPITKAQNQTTFAVSKEGGIVRFPVTLPDNAIKDDFYNVTLTLICDANNAADNLTVELTVNYTPLAPSPTKPDSSLAKAAFYAEQGLWLDALNALAAIAKEEPEEWQEFLESGGFKTWAEAPVVECCQMVKTSASAN2 2 0 0 5,11 27096,567 ynechocystis Complete proteome; Reference proteome;[1390935826213]
310 P73730 P73730_SYNY3Sll1620 protein 23,585 9,49 MGALLAVLLSGMVWFAALPGFEQIFAGSPPENLGITSGQLAPCPDMPNCVNSQISADSIHAIEPLHYQGDLANARNLLTEILGVVPGTTIVQSQDNYIRAEVRSRLMGFVDDLEFYFPGDRPVIEVRSASRLGESDLGVNRRRLEQIRLALADLEQGN4 2 0 0 4,71 17177,557 Synechocystis Complete proteome; Reference proteome;[1390935826213]
311 P74438 PYRC_SYNY3Dihydroorotase 23,176 5,26 MEKLTITRPDDWHLHLRDGAALKAVLPHTVRQFARAIVMPNLKPPVRSVADAAAYRERILAAIPAGGQFEPLMTLYLTDNTNPEEIIAAKASQFVKAVKYYPAGATTNSDFGVTDIHRCDAVLAAMEQVDLPLLLHGEVTDSNIDIFDREKVFIEKYLIPLREKFPRLRVVLEHITTSDAVQFVLSANNIAATITPQHLLFSRNALFKGGICPHFYCLPILKREEHRLSLLHAATSGNPKFFLGTDSAPHARNSKESLCGCAGCYSALHAMELYAEAFESVNSLDKLEAFASFYGPDFYQLPRNTAQITLMKNPWRIPAELPFPESGLVPLRAGEEITWQMV3 2 0 0 6,46 38126,957 Synechocystisdihydroorotase activity (GO:0004151); zinc ion binding (GO:0008270); 'de novo' UM  biosynthetic process (GO:0044205); pyrimidine nucleobase biosynthetic process (GO:0019856);Complete proteome; Hydrolase; Metal-binding; Pyrimidine biosynthesis; eference proteome; Zinc;[1390935826213]
312 P73595 Y1410_SYNY3Uncharacterized WD repeat-containing protein slr141022,989 6,59 MKHKFLVSFLLGLTISFAGAQVIAKTPSVNNAPVARSVNQSPIQLEVIKSYQGHTLKGEAIIQIHYSQDGNYLLSTATDGLAKLWTADGELVREFAGKPVAMIFNGAFSRDGKAIITAGYNGVARIWDVQGNVLGEILGHTSAVTDVVFLSDDMGVVTSSDDGTIEGWSNIKEPLFTVTRPGVSRNMDFNAQTNLIAVTQDIGEITLLNPAGKVVRIIETDQGRLNDVDFSQDGKLLVTAGFDGTARVFNLDGQEILKIDVLDDGWVTGVAINQDNLIATVSDDGILRVWNLQGQLLGQYNPNLERLGSVSFHPNGKNLAIAAYHGTIILLELQ3 2 0 0 4,95 35989,824 Synechocystisouter membrane-bounded periplasmic space (GO:0030288);Complete proteome; Reference proteome; Repeat; WD repeat;[1390935826213]
313 Q55167 Y461_SYNY3Uncharacterized protein sll046122,954 5,71 MTSDDAAAGLVRVLDAAQGAFLALDSYGGNDRSRAVLAMAEALERSFAQILEANTLDLVVSREMSVADCLCEWLKLTPERLQNTVTILKRLASLPDPLQRVMASPYQFNLAQTYCQLMPLGVVALVYESFPELAAIAAGFCLKTGNSLVLRSCGASSHSTAAICEILREGLLDADLPVDSVSHIPSETSPNVQDLVGNASQLNLVIPYGRPSFVEQISQQCTPPVLKAAMGNCYLYWSSKGDLEMVRQMIIDSHVGHPDPVNAIEKVLVSPGQNPAPLVRLLNNLQAKGFKLRGDAELCEQFPDHLTLAKENEWGKAYLDRTVAFRTTQNLKTAIAWINSHSSGHGDCIATDSYQESRQFSMGVDSALVYVNIPPYFCRNPRHGESLFLGVSSQKGQRRGLIGLEAFMTPKQIVQGESRS2 2 0 0 5,68 45772,305 Synechocystiscytoplasm (GO:0005737); glutamate-5-semialdehyde dehydrogenase activity (GO:0004350); NADP binding (GO:0050661); proline biosynthetic process (GO:0006561);Complete proteo e; Reference proteom ;[139093 826213]
314 Q55852 Q55852_SYNY3Sll0596 protein 22,178 6,15 MQLHLSTWPEVENYLQSSSGIIFPIGSTEQHGPTGLIGTDAICAEAIAKGVGEATGAMVGPTINVGMALHHLAFPGSISLRPSTLIQVVMDYVSSLANAGFSRFYFINGHGGNIATLKAAFSETYHHLGSHGQDVRCQVGNWFMARGVYQLAKELYSDQEGSHATPSEVAVTQFVYPEAIKTAPLNSEVASGHSIYSAQDFRAHYSDGRMGSNPALATPEHGQRFYEVAVKELSESYQRFLAEN2 2 0 0 5,79 26325,429 Synechocystis Complete proteome; Reference proteome;[1390935826213]
315 P73128 P73128_SYNY3Sulfolipid biosynthesis protein SqdB21,712 5,74 MRALVIGGDGYCGWATALYLSNKGYEVGILDSLVRRYWDAQLGAETLTPIAPIRQRLDRWYELTGKKIDLFIGDINDYPFLTNALRQFQPDAVVHFGEQRSAPFSMIDREHAVLTQANNVLGNLNLLYALKEDFPDCHLVKLGTMGEYGTPNIDIEEGYITIEHKGRKDTLPYPKQPGSFYHLSKVHDSHNIHFACKIWGLRATDLNQGIVYGVLTEETGMDEMLINRLDYDGVFGTALNRFCIQAAIGHPLTVYGKGGQTRGLLDIRDTVRCIELAIANPADKGQFRVFNQYTELFSVGDLAQMVQKAGADLGLKVEIDHLENPRVELEEHYFNAVNTNLLDLGLQPHFLSDSLLDSLLNFATKYKDRVDQKHILPKVTWRG2 2 0 0 5,72 43202,211 Synechocystiscatalytic activity (GO:0003824); coenzyme binding (GO:0050662); cellular metabolic process (GO:0044237);Complete proteome; Refer nce proteome;[1390935826213]
316 P73297 RPOA_SYNY3DNA-directed RNA polymerase subunit alpha21,675 6,69 MAQFQIECVESSTRKNQQQYSKFSLEPLDRGQGTTVGNALRRVLLSNLPGAAVTAIRIAGVNHEFATILGVREDVLEIMLNMKELVLKSYTDQPQIGRLTAIGPGTVTAAQFEVPSEVEVIDPNQYIATLAEGAKLEMEFRVERGVGYRVIERGKDENSSLDFLQIDSVFMPVTKVNYTVEDIRADGMSPKDRLILDIWTNGSIQPREALSEASDIIANLFIPLKDLNELEAAHSDYQDEVNPESQIPIEELQLSVRAYNCLKRAQINSVADLLEYSQEDLLEIKNFGLKSAEEVIEALQKRLGITLPHEKAKA2 2 0 0 4,76 35003,781 SynechocystisDNA binding (GO:0003677); DNA-directed RNA polymerase activity (GO:0003899); DNA repair (GO:0006281); transcription, DNA-dependent (GO:0006351);Complete proteome; DN - irected RNA polymerase; Nucleotidyltransferase; Reference proteome; Transcription; Transf rase;[1390935826213]
317 Q6ZEQ1 Q6ZEQ1_SYNY3Sll5079 protein 21,67 6,99 MILVSLYPFRVDRSNSIHTTLTIVKKLDGKVAVVTGASKGIGAEIAKHLAGEGAAVVVNYASSKEGADRVVDEIVSTGGKAIAVQANVAKKAEIQQLFAETKQAFGKLDILVNNAGIYEFSPLEGITEEHFYKQFDLNVLGLLLTSQQAVKSFGEEGGSIINISSIVSTLTPANSLVYNATKAAVDAITKSLAKELGSRNIRVNSINPGMVETEGARTAGITESEGRRQVEAITPLGRIGQPHDIAPAVVFLASSDSAWITGETLYITGGLY2 2 0 0 6,13 28689,691 Synechocystisoxidoreductase activity (GO:0016491); oxidation-reduction process (GO:0055114);Complete proteome; Plasmid; Reference prote me;[1390 35826213]
318 P72802 P72802_SYNY3Mitochondrial outer membrane 72K protein21,628 5,64 MLILKNSMASPHPFPWPQRFTVMALTFAWGLSLPVLAQTKSAVQWYNDGVDKLAAQNFSGAIADFTESIKLNDQDADAYYNRGYAKHVLGQYQAAITDYNQAISLNPEFAYALGNRCYAYFLLSQYDKAIQDCSNAIEINPNYADFYVYRGNSQSQLGNETTAIADYNDAIRINAQHANAYYNRALTHNRLKQDQQALADYNQSIQLDPDSAEAYFNRGLTQYRLGDEPKAIADLTKAAELFNAQEKKDMAQKAEAILTQIRAIDA2 2 0 0 5,21 29889,279 Synechocystisouter membrane-bounded periplasmic space (GO:0030288);Complete proteome; Reference proteome; Repeat; TPR repeat;[1390935826213]
319 P72805 P72805_SYNY3Sll1665 protein 21,351 3,4 METLSLVLAVIIGLVVGFAGTYFTLVTKLQKKLDSTKSKLGRAKSASEDTETLQFQLEAQKAETQALQARLESLESSHRNQLDELQTAQAAALAQLTAEKTALEDELQSLRESGPAEEQRPLDQSDEVAALQAQLLAMEQEHQARVQALQNQYQAEIESLQQAQPSVEEQEEPLAEEESFDADVAPPAIAEFTEVPGEEFIPAAEPVAEFMEATVTEETPEIAEITPEQEENWVDAPPTAELETEPLDYQGPVGEPMVEEETFSPFDAPPTETTEVEAEADLENWVDAPPEASLPDMDFGGGEENFEPMDLATELPDINDEGITNPGQQLAELSSVETPEAAETEQSSDQFLAELTEEQSAPELPLFSETPAETETLGELEDLGDDLSFTSDSGDDLNLSEDLLASLGTDTPAPELTTEEILPGDGDAEADDLDFLLELQTEETELFPGQNEDEFLPEFSNEEPISAGFVGMETLGEGSGDFPDLLELNPETHGGDPFINILDEDPNSSDNDLLALLQTDEGNANQAELHEDDDLFPGLADMLGEAPSSGSGELDDLDALLSDTSSPGADAVISTSLDDFDFGPDDHDP2 2 0 0 3,44 63607,329 Synechocystis Complete proteome; Reference proteome;[1390935826213]
320 P73222 P73222_SYNY3Slr2005 protein 21,333 6,9 MKRRKFIRTAGAGLLAVAGVQIGDRLRPATAQASSGLQVEWLGHSAFLFSANGFRILANPFRAIGCTKGFRLPKVQADLVLISSQLWDEGAAENLPGNPRILFEPGSYDIGGIQFQGISAPHDRLGGRRFGQNVVWRWSQGGIRIVHMGGAASPITEEQKILLGSPDLALIPVGGGPKNYDAAEAKAAMAILNPRMVVPTQYATPAADRGNCDLQTLQPFLDLVEGMNVQRINGNSLSLRANNLPAEGTLIRIFSEQGLLV2 2 0 0 9,84 27975,188 Synechocystisouter membrane-bounded periplasmic space ( O:0030288); hydrolase activity (GO:0016787);Complete proteome; Reference proteome;[1390935826213]
321 P74656 P74656_SYNY3Sll1549 protein 20,909 5,88 MKWANRLLLFGVMLWVQSMEVSFSPNNPSLISGLNLELAKVAAQEMTPGEQANRDFQDKLNKKDLLEALRQGGYVIYIRHGQTEKDYADQVTAEMGNCATQRTLSEVGWQQAKAIGEAFKKYAIPYDKVFSSQYCRAWQTADLAFGRYEKNGDLNFPKAEDYSPEQIAQMKALLMPFLTEIPAPGTNNVVVGHDDLFEAATGIYPDPQGMAYVVKPLGGDQFTLVANVRAEEWLELGQ5 2 0 0 4,98 26624,223 Synechocystisouter membrane-bounded periplasmic space (GO:0030288);Complete proteome; Reference proteome;[1390935826213]
322 P73679 P73679_SYNY3Isopenicillin N epimerase20,893 4,49 MADPVNLIPDRQQFPGLANKTYFNFGGQGILPTVALEAITAMYGYLQENGPFSIAANQYIQQLIAQLRQALGETFNVDPNTITITDNVTTGCDIVLWGIDWQKGDEILLTDCEHPGIIAIVQAIAARFGVTYRFFPVADTLNQGDAAAVLVNHLGPKTRLVILSHLLWNTGQVLPLGEIMAVCRRHQGDYPVRVLVDGAQSAGSLPLDFSRLEVDYYAFTGHKWFAGPAGVGGLYIHGDAKGTANAARLGEINPTYVGWRSITYGSKGEPTGWAEGGKRFEVATSAYPQYAGLLAALQLHQRQGTAEERYQAICQRSELLWQGLNQLPHVHCLATSPPQAGLVSFTIDSPLGHRAIVQKLEEQRIYLRTIADPDCVRACCHYITNEEEIEHLLSRLAEFTP3 2 0 0 5,63 43999,011 Synechocystiscatalytic activity (GO:0003824); pyridoxal phosphate binding (GO:0030170);Complete proteome; Pyridoxal phosphate; Reference proteome;[1390935826213]
323 Q55564 Q55564_SYNY3Sll0162 protein 20,76 7,73 MGLFDDVGRFLEDRLEEFLQNNPHLELEALLEQLKEQEADARRLLTDLQRKKQDQEAQILNLAQDIQAWHSRIQQAKAAGREDLAQRAQEREATLLRQGNQVWGQRVGTEQRISQAQSLLQEIQQRQKEVQQKAKQMAAEQKASEAQRRAADTMGWNQGSTGETYRRELDPLEAEFKKWELEKELERLKRNATK3 2 0 0 5,9 22688,343 Synechocystis Complete proteome; Reference proteome;[1390935826213]
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324 P74507 GPMI_SYNY3 2,3-bisphosphoglycerate-independent phosphoglycerate mutase20,597 3,01 MAEAPIAPVVLVILDGWGYRPDTRANAIAQANTPIMDSLIAAYPNTLVNTSGKDVGLPKGQMGNSEVGHLNLGAGRVVPQELVRISDAIEDGTFFDNQALIEVCQRVRDRRGKLHLIGLCSDGGVHSHIDHLLGLIDLAKLQGISQLCIHAITDGRDTPTNEGAHFVQQIQAHLEKIGLGRIVSVSGRYYALDRDRRWDRVEKAYRVMTEDGVGDGRSAAQVIKDYYASDITDEFIPPTRIGAGAIASGDGVIFYNFRPDRARQLCYALVNPSFDGFPRERIQPLDFVTFTQYDPALPVVVAFEPQNLNNILGEIISRQGMKQFRTAETEKYPHVTYFFNGGLEQPFAGEDRELIQSPMVSTYDKAPQMSAKAVTDAVCRAMEKGIYSLVVVNYANPDMVGHTGKLKEAIQAIETVDLNLGRLLASAAKVGGTVLITADHGNAEYMSDESGNPWTAHTTNPVPFILVEGEGRKIPGHGGEVKLREGGKLADIAPTILDILQLPVPAEMTGKTLIDQPLVEIKANRTPVNLSR3 2 0 0 5,6 57981,995 Synechocystiscytoplasm (GO:0005737); 2,3-bisphosphoglycerate-independent phosphoglycerate mutase activity (GO:0046537); manganese ion binding (GO:0030145); glycolysis ( O:0006096);Complete proteome; lycolysis; Isomerase; Ma gane e; Metal-binding; Reference proteome;[1390935826213]
325 P80507 IPYR_SYNY3 Inorganic pyrophosphatase20,59 6,51 MDLSRIPAQPKAGLINVLIEIPAGSKNKYEFDKDMNCFALDRVLYSSVQYPYDYGFIPNTLADDGDPLDGMVIMDQPTFPGCVITARPIGMLEMIDGGDRDEKILCVPAKDPRYTYVKSINDLAGHRLDEIAEFFRSYKNLEKKVTEILGWKDVDAVLPLVEECVKNYK4 2 0 0 4,77 19087,978 Synechocystiscytoplasm (GO:0005737); inorganic diphosphatase activity (GO:0004427); magnesium ion binding (GO:0000287); phosphate-containing compound metabolic process (GO:0006796);Complete proteome; Cytoplasm; Direct protein sequencing; Formylation; Hydrolase; Magnesium; Metal-binding; Refere ce proteome;[1390935826213]
326 P27179 ATPA_SYNY3ATP synthase subunit alpha20,291 4,37 MVSIRPDEISSIIRQQIESYDQSVQVSNVGTVLQVGDGTARIYGLEQVMSQELLEFEDGTIGIALNLEEDNVGAVLMGDGFGIQEGSTVKTTGQIAQIPIGDAMVGRVVDSLGRPIDGKGPISSTATRLLESPAPGIIERKSVCEPMQTGITAIDAMIPIGRGQRELIIGDRKTGKTAIAIDTIINQKSEDVICVYVAIGQKASTVAQIIDTLTEKGAMAYTIVVAANANDPATLQYLAPYTGATLAEHFMYQGKSTLVIYDDLSKQAQAYRQMSLLMRRPPGREAYPGDVFYIHSRLLERAAKLSDALGGGSMTALPVIETQAGDVSAYIPTNVISITDGQIFLSTDLFNAGFRPAINAGISVSRVGSAAQTKAMKKVAGKLKLELAQFAELEAFSQFASDLDAATQAQLARGQRLRQLLKQPENSPLSVWEQVAISYAGLNGYIDTIPVDKVTEFAQGLRDYLKANKAKYVEIINSSKALTDEAETLLKEGIKEFTQGFAA2 2 0 0 5,01 53965,584 Synechocystisplasma membrane proton-transporting ATP synthase complex (GO:0045260); proton-transporting ATP synthase complex, catalytic core F(1) (GO:0045261); thylakoid membrane (GO:0042651); AT  binding (GO:0005524); proton-transporting ATP synthase activity, rotational mechanism (GO:0046933); proton-transporting TPase activity, rotational mechanism (GO:0046961); ATP hydrolysis coupled proton transport (GO:0015991); plasma membrane ATP synthesis coupled proton transport (GO:0042777);ATP synthesis; ATP-binding; CF(1); Complete proteome; Hydrogen ion tr s rt; Hydrolase; Ion trans ort; Membrane; Nucleotide-binding; Reference proteome; Thylakoid; Transport;[1390935826213]
327 Q55746 LPXA_SYNY3Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase20,082 5,8 MLTDNRLGEATLSPSIHPTAIIHPQAQLHATVQVGAFSVIGEKVTIGANTVIGPHVVVEGPTEIGTGNRIFPGAVIGCEPQDLKYKGGESWVKIGNDNQIREYVTINRATEEGAVTRIGDRNLLMAYAHVAHNCVIENEVIIANSVALAGHIYIESQARISGVLGVHQFVHIGRLAMVGGMSRIERDVPPFTIVEGNPSRVRSLNLIGLQRSGMSAEDLSALKQAFRLIYRSDTPYQQALEELGRSAAHPYVQHFQCFLQKSSYDQGRRGPIPGKK2 2 0 0 8,44 30002,25 Synechocystiscytoplasm (GO:0005737); acyl-[acyl-carrier-protein]-UDP-N-acetylglucosamine O-acyltransferase activity (GO:0008780); lipid A biosynthetic process (GO:0009245);Acyltransfer se; Complete proteome; Cytoplasm; Lipid A biosynthesis; Lipid biosynthesis; ipid metabolism; Reference pro eome; epeat; Transferase;[1390935826213]
328 Q6ZEI6 Q6ZEI6_SYNY3Slr7012 protein 19,867 5,47 MLDSLKSQFQPSFPRLASGHYVHFLMLRHSQSFPVFQTDGVLNTTRTQAGLLEKTDQLSRLVMFKRKQTTPERLAGRELLRNLGLTSADKSAKNLCEYNGEGSCKQCPDCILYGFAIGDSGSERSKVYSDSAFSLGAYEQSHRSFTFNAPFEGGTMSEAGVMRSAINELDHILPEVTFPTVESLRDATYEGFIYVLGNLLRTKRYGAQESRTGTMKNHLVGIVFADGEIFSNLHLTQALYDQMGGELNKPISELCETAATVAQDLLNKEPVRKSELIFGAHLDTLLQEVNDIYQNDAELTKLLGSLYQQTQDYATEFGALSGGKKKAKS2 2 0 0 6,1 36485,193 Synechocystis omplete proteome; Plasmid; Reference proteome;[1390935826213]
329 Q55146 Q55146_SYNY3Sll0064 protein 19,468 5,45 MLLKSAFTWLALTFTTGLVAIAPVQAETVLERVARTGELRAGTRTDAVPFGFEMANGEMEGYGVDLMALIALKLAEEMGKTITVDLDRVDLQSRFEAIASGELDIVCEATTITQDRLELVDFSAPFFISGAKFLMKQGSVEGFNINGTLEGIPIAYIQNTTTFDIIPKIYPLAQWVPVQDREEGIAKLDGGQVKAVVSDGILLVGELLKQGKNPAEYALGPYQPITTELYACILPQGDGDWKRFVDEVISSTENHDLLQEWFNIDQTNVVRVDPL2 2 0 0 4,4 30177,54 Synechocystisouter membrane-bounded periplasmic space (GO:0030288); transporter activity (GO:0005215);Complete proteome; Reference proteome;[1390935826213]
330 P74598 Y1491_SYNY3Uncharacterized WD repeat-containing protein sll149119,281 4,02 MNNYFPRLKQFSAPATFFLTVACLVYPGENAHANASTPNPYTVAQTTASPSVAVENLSGFQGIITALNITPDGKYLAVATADNQITLIDLANQEVVYSQRSPVNNFADLAISADGQWLAIAADNNVDVRRVRDGMRVETLVGHTDKVSGVAFSPDGETIVSVSGGDRTIRIWERASGNLIQTLADNLGPTTSVVFTPDGSQFITGAIGQDRTIKFWDANTFELLGTSPQQPGFINGLAVTPDGRKLVGAVRNFVKAWNLADAKELFSVRGPSLEINTIAVSPNNRWVATANKEGTIMIFDLANGKQVTTLRGHQGWVLSLAFSPDGNTLYSGAEDKTVKIWDLSALAR3 2 0 0 5,47 37347,023 Synechocystisouter membrane-bounded periplasmic space (GO:0030288);Complete proteome; Reference proteome; Repeat; WD repeat;[1390935826213]
331 P73411 G6PD_SYNY3Glucose-6-phosphate 1-dehydrogenase19,273 3,73 MVTLLENPFRTGLRQERTPEPLILTIFGASGDLTQRKLVPAIYQMKRERRLPPELTVVGFARRDWSHDHFREQMRKGIEEFSTGIGSEDLWNEFAQGLFYCSGNMDDPESYLKLKNFLGELDEKRNTRGNRVFYLAVSPNFFPPGIKQLGAAGMLSDPVKSRIVIEKPFGRDLSSAQSLNRVVQSVCKENQVYRIDHYLGKETVQNLMVFRFANAIFEPLWNRQFVDHVQITVAETVGVEERAGYYESAGALRDMVQNHLMQLFCLTAMDPPNAIDADSIRNEKVKVLQATRLADINNLENAGIRGQYKAGWMGGKPVPGYREEPGVDPSSTTPTFAALKLMVDNWRWQGVPFYLRTGKRMPKKVSEIAIQFRQVPLLIFQSVAHQANPNVLSLRIQPNEGISLRFEAKMPGSELRTRTVDMDFSYGSSFGVAAADAYHRLLLDCMLGDQTLFTRADEVEEAWRVVTPVLSAWDAPSDPLSMPLYEAGTWEPAEAEWLINKDGRRWRRL2 2 0 0 7,07 57886,135 Synechocystisglucose-6-phosphate dehydrogenase activity (GO:0004345); AD  binding (GO:0050661); pentose-phosphate shunt (GO:0006098);Carbohydrate m tabolism; Complete proteome; Glucose metabolism; NADP; Oxidor ductase; Reference proteome;[1390935826213]
332 P73098 DNAK3_SYNY3Chaperone protein dnaK319,055 1,95 MGKVVGIDLGTTNSVVAVMEGGKPIVIANAEGMRTTPSVVGFNKEGELVVGQMGRRQAVLNPQNTFYGVKRFMGRRYTDLTPESKRVAYTIRRDDRDNIKVRCPRLKKDFAPEEISAMILRKLAEEASRYLGEKVTGAVITVPAYFNDSQRQATRDAGKIAGLEVLRIINEPTAASLAYGLDQGRIQKILVFDLGGGTFDVSVLEVGDGIFEVKATSGDTQLGGNDFDRRIVDWLAEKFLEAEKVDLRQDRQALQRLTEAAEKAKIELSGVGTTEINLPFITATEDGPKHLETQLSRSEFEDLCGDLVTRLQRPVKRVLKDAGLSPVQIDEVVLVGGGTRMPMVKGLVRSFIDREPNENVNPDEVVAIGAAIQAGILDGEVKDILLLDVTPLSFGLETIGGVMKKLLPRNTTIPVRKSDIFSTGENNQTVVEVHVLQGEREMASDNISLGRFKLSGIPPAPRGVPQVQVSFDIDANGILQVTARDKTTGREQSITVQGASILSEGEVNRMIQEAETFAAQDRERRERIEKRNSAKALTDQAQRRLKEVTLDFGSAFTVSYRRQVDALCSEILDSLEKDDERRLDRAQADLQDVLYELNREVRLQYDDKEEGFFEAIKKTFTGDFDDDDDYYNRRPAPRDDYRGGNDYGRYDDYNYNAPSRREAPMPRAGAGRGPSLSKDYRSTAYADWDQSRVTRQRPYQGESLGGTYDDRRSSPQDDYSRGDRQKDYDYRENAPSRSGRGGNGRYGERPAQPGRNAPLQNGWDDDDDDWF5 2 0 0 5,16 86030,118 SynechocystisATP binding (GO:0005524); protein folding (GO:0006457); response to stress (GO:0006950);ATP-binding; Chaperone; Complete proteome; Nucleo ide-binding; Phosphoprotein; Reference proteome; Stress response;[1390935826213]
333 Q55544 APCE_SYNY3Phycobiliprotein ApcE18,782 3,35 MSVKASGGSSLARPQLYQTVPVSAISQAEQQDRFLEGSELNELTAYFQSGALRLEIAETLTQNADLIVSRAANRIFTGGSPLSYLEKPVERQPALVGASSDSRNGSVTYAESNGSGGLFGGLRSVFSSTGPIPPGFRPINIARYGPSNMQKSLRDMSWFLRYTTYAIVAGDPNIIVVNTRGLKEVIENACSIDATIVAIQEMRAASADYFRNNAQAKEIVLQYFDILLSEFKAPTPANKVRQGPSNDIQGLELPQSYFNAAAKRQKYAMKPGLSALEKNAVIKAAYRQIFERDITKAYSQSISYLESQVRNGDISMKEFVRRLAKSPLYRKQFFEPFINSRALELAFRHILGRGPSSREEVQKYFSIVSSGGLPALVDALVDSQEYADYFGEETVPYLRGLGVEAQECRNWGMQQDLFSYSAPFRKVPQFITTFAQYDRPLPDQHVYGSGNDPLEIQFGAIFPKETRNPSKRPAPFNKDTKRILIHRGPAVNNQVGNPSAVGEFPGSLGAKVFRLNGGLPGAKVGKNTGTSVKFGESSTQALIRAAYRQVFGRDLYEGQRLSVAEIQLENGDISVREFIKRLAKSELFLKLYWAPHYVCKAIEYMHRRLLGRPTYGRQEMNQYFDIASKQGFYAVVEAMIDSKEYSDAFGEDTVPYERYLTPGGLQMRSARVGSLREDIGQRVDKEVTPRFVELGQVSAIRTEPEIAYRSNQGVTRQRQQTKVFKLVSTYDKVAVKNAIRAAYRQVFERDLEPYIINSEFTALESKLSNNEINVKEFIEGLGTSELYMKEFYAPYPNTKVIEMGTKHFLGRAPLNQKEIQQYNQILASQGLKAFIGAMVNGMEYLQTFGEDTVPYRRFPTLPAANFPNTERLYNKLTKQDKELVVPSFTPVVKVGG2 2 0 0 9,29 100295,902 Synechocystisphycobilisome (GO:0030089); lyase activity (GO:0016829); oxidation-reduction process (GO:0055114); photosynthesis ( O:0015979); protein-chromophore linkage (GO:0018298);3D-structure; Bile pigment; Chromophore; Complete proteome; Electron transport; Lyase; Membrane; Photosynthesis; Phycobilisome; Refe nce proteome; Repeat; Thylakoid; Transport;[1390935826213]
334 P77962 GLYA_SYNY3Serine hydroxymethyltransferase17,48 3,28 MNQTNLDFLATSDPALAAIIDRELQRQRTHIELIASENFTSAAVMAAQGSVLTNKYAEGLPGKRYYGGCEFVDQAETLAISRVKELFGAAHANVQPHSGAQANFAVFLTLLQPGDTIMGMDLSHGGHLTHGSPVNVSGKWFEVAHYGVEKETGRLDYDKIRQQALEVKPKLLICGYSAYPRQIEFDKFRAIADEVGAYLMADIAHIAGLVASGHHPSPLPYCDVVTTTTHKTLRGPRGGLIMTNNEELGKKFDKSVFPGTQGGPLEHVITAKAVAFGEALKPEFKVYSGQVIANAQAMADQLQKRGFDLVSGGTDNHLMLVDLRSIAMTGKVGDQLLGEINITANKNTVPFDPESPFVTSGLRLGSPAMTTRGMQEDEFRTIANIIADRLLSPEDEGVKADCLRRVSELCAGFPLYDHLRIPVAVIA2 2 0 0 5,97 46259,743 Synechocystiscytoplasm (GO:0005737); glycine hydroxymethyltransferase activity (GO:0004372); pyridoxal phosphate binding (GO:0030170); glycine biosynthetic process from serine (GO:0019264); tetrahydrofolate interconversion (GO:0035999);Amino-acid biosynthesis; Complete prot om ; Cytoplasm; One-carbon metabolism; Pyridoxal phosphate; Reference proteome; Transfe as ;[1390935826213]
335 Q55469 MURE_SYNY3UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase17,287 3,56 MVKLGQLLASVPEVVAAAPWLAQESDRCPALGKIVTGLSTNSHACPPGTLFIGMPGTRVDGGEFWSGALEAGAIAAVVSEKALQKFPPQNGECVIAVPDLVPVCAGLAAAFYQHPAQTLQLVGVTGTNGKTTTSHLIEYFLNQQQRSSALLGTLYTRWPGYQKTATHTTPFATDLQKQLAEALQAGNQYAVMEVSSHALAQGRVLQCGFACAVFTNLTQDHLDFHGTMENYFAAKALLFKESYLQGRAVINQDDPYGQRLIDRLPLDQVYTYSVNDSTADFYTKDLDYQPTGVKGTFVTPQGEFPFLSPLVGQFNLANVLAAIASGLHLGLDPAAMVKDLLDFPGVPGRMEQVQIRPDQDISVMVDYAHTPDSLENALKAARPFIPGRLICIFGCGGDRDRTKRPLMGNIAAQLADLAVVTSDNPRTEDPEQILADVVQGISLDIEPWIIGDRATAIHKAIREAKPGDGVLIAGKGHEDYQILGTEKIHFDDREQAREALILRYS3 2 0 0 5,25 54601,124 Synechocystiscytoplasm ( O:0005737); TP binding (GO:0005524); UDP-N-acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase activity (GO:0008765); cell cycle (GO:0007049); cell division (GO:0051301); peptidoglycan biosynthetic process ( O:0009252); regulation of cell shape (GO:0008360);TP-binding; Cell cycle; Cell division; Cell shape; Cell wall biogenesis/de radation; Complete proteome; Cytopl sm; Ligase; Nucleotide-binding; Peptidoglycan synthes ; Reference proteom ;[1390935826213]
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Partner 6 – The University of Sheffield 
Deliverable D7.2 
Intermediate stage identification of bottlenecks based on comprehensive –omics and flux analysis of: 
-omics and metabolite data together with assembled metabolic network for the best identified 




1.  Introduction 
In the USFD 18 month summary report, a number of developments that had taken place between 
the completion of D7.1 and the report were highlighted.  To maintain and reflect continuity of 
progress through the project, this report begins by discussing how these achievements were built 
on, resulting in dynamic restructuring of our approach to achieving the longer-term objectives, tasks 
and deliverables.  The main body of the report starts with detailed description of the in-house 
developments we have made to our proteomic pipeline (contributing to O7.1, Task 7.2, Task 7.3 and 
M7.1), and then discusses each of our partner interactions that have gone towards completing this 
deliverable. Finally, the report concludes by highlighting the recommendations from our 
observations and improvements to the system for both improved bioengineering and hydrogen 
production.   
In the 18 month summary report, it was highlighted that the exogenous hydrogenase mutant in the 
hox background developed by UU would first be analysed in non-hydrogen producing conditions, to 
assess background effects that the transformation process might have on cell functional capacity.  
Investigation by UU on the mutant demonstrated that it was unable to produce hydrogen in a stable 
environment, eventually leading to their pioneering work on bicistronic design (BCDs) and the 
synthetic active site in Synechocystis.  The generation of the non-native hydrogenase mutant was 
originally intended to provide the basis for the D7.2 on suggestions for increased H2 production, so 
while this was ongoing, our focus was redirected on insights gained into engineered system 
modifications to and analyses. This altered focus was designed to address concerns that the design 
may not be realised in time to carry out all the required omics investigations required for the USFD 
to complete the ‘best engineered system’ deliverables required from WP7. A number of other 
avenues were investigated, culminating in additional collaborations with both IBMC and RUB (D7.2 - 
see below).  
The 18 month summary report suggested that a metabolic finger-print analysis under the Burrows 
media conditions would be carried out, however, feedback from the mid-term review meeting 
encouraged focus on CyanoFactory partner samples for the future deliverables, rather than samples 
generated at USFD.  In addition, a detailed review of the approach indicated that, at this time, it 
would not directly contribute towards our deliverable requirement for measuring the metabolic flux. 
Through discussions with UPVLC, it became apparent that the original plan to run flux analysis on 
media variants under hydrogen-producing conditions was practically infeasible.  The major limitation 
to this was that Synechocystis does not fix carbon when it is producing hydrogen, due to increased 
oxygen levels within the cells, and so monitoring an idealised state of carbon uptake would best be 
performed on either the best-engineered system available or the best bioreactor design.  The high 
cost of labelled bicarbonate needed for each experiment made running the experiment in the large-
scale photobioreactor impossible, and so a pragmatic decision was taken to instead limit analysis to 
the most optimal and readily available strain, the olive mutant from RUB, using the best practical 
bioreactor produced by KSD (more details of this experiment in D7.3). This provides a more 
scientifically useful outcome as a consequence.   
In addition to the omic-level bottlenecks for features like carbon flow, an operational ‘bottleneck’ 
that was identified during the project was the need to understand how partners can transfer 
knowledge more effectively.  Celso Gomes (a social sciences doctoral candidate from USFD) has 
 3 
been interviewing CyanoFactory partners throughout the project and collecting data on how 
knowledge transfer takes place within EU consortia.  UPVLC took steps to address this issue during 
the 24 month meeting by preparing a separate room for the early career members of the 
consortium to discuss the project collectively, whilst the PIs dealt with management matters.  
Celso’s findings will be published in his doctoral thesis, which is expected to be completed in 2016.    
 4 
2 Proteomics pipeline improvements   
The findings in this section contribute collectively towards O7.1, the delivery of quantitative 
proteomics data together with recommendations for forward engineering. They achieve this by 
facilitating the work carried out in Task 7.2 where new chassis-circuits have been designed by UU 
and IBMC and are analysed with proteomic methods; and Task 7.3 where systems-level effects are 
analysed using quantitative proteomics.  Clearly improved protein identification and quantification 
on both a localised and systems level analysis is key to generating the high quality data required for 
computational modelling work. 
2.1 Upgrades to the standard lab protocol 
As mentioned previously at consortium meetings, in periods where there was down-time between 
omic analyses of consortium partner biomass, USFD focused on improving our in-house proteomic 
pipeline.  This has resulted in a significant improvement for Synechocystis related investigations, 
with the original capacity (D7.1) to confidently quantify 200 - 345 proteins with 2 or more unique 
peptides in Synechocystis (using the techniques described in the project BIOMODULARH2 – NEST - 
043340) being improved by 6 to 8 fold to over 1850 confident quantifications from a single run. This 
number of quantifications is close to the practical maximum number of observable proteins 
(discussed in D 7.3).  This was achieved by assessing the latest developments in the literature and 
highlighting the limitations that were often observed in production strain proteomics.  Of particular 
note from this analysis were:  
 A catalogue of techniques for cell disruption linked to the number of downstream 
identifications. 
o The processing method used for cell samples received by USFD has been updated to 
a combination of glass bead beating and sonication. 
 An assessment of peptide liquid chromatography fractionation techniques 
o The USFD standard HILIC separation was found to be less effective compared to a 
porous graphitic carbon hypercarb column. Whilst requiring more cleaning cycles 
per use, it demonstrates a higher resolution of peptides, which translates to higher 
numbers of protein identified and quantified. 
 Improved gel-free protein quantification methods 
o The highly chromophoric nature of many proteins associated with cyanobacteria 
causes disparities between measured protein concentrations from standard 
colourimetric protein assays, such as Bradford quantification. This is particularly 
notable when a change to the system produces a visible change in the cells, which 
occurs during nitrogen starvation conditions crucial to hydrogen production in 




 = 183[230nm] – 75.8[260nm] (Kalb et al, 1977) 
This formula provides much more accurate assessment of protein that was less 
sensitive to these changes is now performed as standard practice. This improvement 
is important for quantification and identification purposes; as whilst global uneven 
loading on quantification can be corrected mathematically using techniques like 
 5 
median correction, doing so makes assumptions about the data and can skew 
observations – particularly for very low and high abundance proteins.  
 Standardised cell pellet requirements for proteomic samples 
o Following a case where insufficient cell pellet material was available for analysis 
from a CyanoFactory sample, USFD issued a standardised request for biological 
material for proteomic analysis.  Based on improved protein quantification, it was 
found that the cells should have biomass at least equal to the equivalent of 50 ml 
volume with an OD730 value of 0.7.  
Some of these findings were disseminated in an article in ‘Trends in Biotechnology’, featuring a focus 
on Synechocystis and its pioneering role in the field as a cyanobacterial cell factory candidate 
(Landels et al, 2015). The remainder will be published this year in the doctoral thesis of Andrew 
Landels (a chemical and biological engineering student from USFD), which is expected to be 
completed during 2016. 
2.2 Upgrades to the standard data analytical techniques 
Part of the improvements we made to the pipeline came from collaboration with partners UPVLC.  
As mentioned previously, we were in close communication with UPVLC about both our metabolic 
flux work (discussed in D7.3) and improving the ease of UPVLC to utilise our proteomic data for their 
modelling work.  It became apparent that the data USFD were producing was limited in terms of 
application to computational modelling.  Part of this was due to a limitation in the amount of 
information available from the USFD proteomic data processing pipeline; which whilst robust in 
generating proteomic quantifications and highlighting significant changes, was unable to provide 
comprehensive information on other details in a compact and efficient manner for ease of data 
integration.  A number of different proteomic standard software packages were trialled against our 
USFD Phenyx server, including Mascot, Peaks, X!Tandem and MaxQuant.  
MaxQuant was selected as the best candidate, due to the combination of it being open-source 
software, the level of information it generated from the proteomic sample, the active development 
community it has and the efficient files it produces (with the data being stored in a number of 
compressible flat text files).  Once this decision was made, key details concerning the level of the 
information that would now be available to other partners were disseminated to UPVLC and UM 
(appendix).  Following this change, a number of parsing scripts were also written, to maintain 
compatibility between the previous data pipeline and our new data pipeline; as a result, all analyses 
performed by USFD on proteomic data throughout the CyanoFactory project have utilised consistent 
statistical techniques and generated SOPs. 
2.3 Investigation into optimum isobaric tagging quantification protocols for proteome profiling 
Finally on the proteomic pipeline development front, an analysis comparing the use of iTRAQ 
(isobaric tags for relative and absolute quantification) tagging reagents to TMT (tandem mass tags) 
tagging reagents for use in Synechocystis has been carried out.  This analysis also presented the 
opportunity to benchmark the Q-Exactive (QE) mass spectrometer (a new addition to the USFD mass 
spectrometry facility) against the maXis (the best performing instrument prior to purchase of the 
QE) on the Synechocystis proteome analysis simultaneously.  
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Previous experimental work in UFSD on quantification analysis has used a mix of proteins at the 
same concentration, either protein standards or whole cell lysate, which is then diluted to a known 
concentration range and measured for fold change (Ow et al., 2009).  One issue with this design is 
that it is not representative of the typical proteomic sample for purposes of CyanoFactory. It also 
means that typical methods used for correcting the data cannot be applied. We addressed these 
constraints by using pseudo-complex mixture of known standards, both in isolation and spiked into a 
Synechocystis proteome background at biologically relevant concentrations.  The balanced design 
means that the data can be treated just like a normal proteomic sample, with a controlled set of 
proteins acting as a proteomic compression ruler within the sample.  The spike concentration was 
chosen based on a modelled output of cumulative Synechocystis data collected by USFD looking at 
emPAI values (reflecting individual protein abundance) using an in-house script (Appendix). 
Work on this has highlighted that more consistent results can be obtained with iTRAQ labels, rather 
than TMT labels, in Synechocystis.  In addition, the QExactive spectrometer has shown more 
accurate quantification of the labels, whilst the maXis demonstrated systematic bias in label 




3 Partner interactions 
3.1 CNR-ISE 
As described in the 18 month summary report, a lyophilised sample of Synechocystis grown in a 
large outdoor photo bioreactor was received from CNR-ISE. It was hoped that this sample would 
build towards further suggestions, however extensive analysis of the data produced very limited 
practical results. Of particular note was the way the high-level biological contamination of proteomic 
samples affected the ability to assess the proteome. During processing, the samples looked to be of 
high quality, with gels showing a large number of proteins under coomassie staining, however 
biological contamination skewed the results on 2 levels. Firstly, it reduced the overall concentration 
of Synechocystis protein, reducing the dynamic range and therefore the capacity to visualise low 
abundance proteins. The more significant issue was having proteins from an unrelated organism in 
the sample. Having identified the protein contaminant to be Crysophyceae, the possible benefit of 
meta-proteomic analysis of the mixed culture, however since it was a destructive relationship (the 
Crysophyceae preyed upon the Synechocystis) H2 production was not positively impacted. This 
contamination issue could be effectively cleaned with a chemical approach (altering the pH), thus 
there was no benefit to a metaproteomic approach at this time.  However, investigation into the 
possibility of meta-proteomic analysis resulted in inclusion of a section in our trends article (Landels 
et al, 2015).  Following this, CNR-ISE sent replacement samples from their 1000 L outdoor 
photobioreactor, the results of this experiment are discussed in D7.3. 
3.2 UU 
Work with UU detailed in this section of the report contributes to Task 7.2, where new chassis 
circuits have been analysed and tested by USFD with the results being fed back to UU to encourage 
further development of the system. UU provided both full-proteome scale samples and individual 
gel-slice fractions to USFD, during progression of their engineering the advanced hydrogenase, which 
turned out to be pivotal for USFD troubleshooting recommendations for both UU hydrogenase 
transformations and our proteomic pipeline improvements.  There were two main studies carried 
out between USFD and UU for this deliverable, namely the protein gel slice analysis and the 
transformed hydrogenase iTRAQ. Through mass spectrometry investigation of targeted gel bands 
from the proteome of Synechocystis mutants, USFD identified the presence of the exogenous 
hydrogenase-related proteins confirming that they had been successfully transformed into 
Synechocystis.  
The iTRAQ analysis was carried out before month 18 of the project, which was prior to the pipeline 
improvements and thus resulted in limited dynamic range, with just 200 proteins identified and 
quantified. The statistically significant changes in the proteome reflected fluctuations in 
phycocyanins and ribosomal proteins – high abundance proteins with stable expression levels. We 
believe this reflects both protein over-estimation issues described in section 2.1, and the reduction 
in protein identification rate resulting from analysis of the membrane and soluble proteome 
represented in the sample.  Literature searching confirmed that studies with the highest number of 
protein hits analysed the soluble and membrane fractions independently; however to gain the full 
benefit of this, the fractions would need to be kept separate throughout processing, which doubles 
the time and cost of the analysis.  A practical “half-way” solution was to merge the extraction 
methods, by including a low concentration of detergent (such as SDS) in the lysis buffer and using a 
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more vigorous cell disruption method combining of both bead-beating and sonication for higher 
protein recovery and thus representation of the membrane and soluble fractions.   
3.3 IBMC 
Work with IBMC detailed in this section of the report contributes to Task 7.2. Chassis developments 
by IBMC have been analysed by USFD, with the results being fed back to IBMC and UU to encourage 
further development of the chassis and provide a neutral genetic background for chassis-circuits to 
be developed in.  USFD collaborated with the IBMC in their work on isolating genetically neutral sites 
for genetic modifications to the Synechocystis genome.  These sites are crucial for the stable 
transformation of Synechocystis, as they limit unwanted background genetic side-effects.  A combi-
iTRAQ experiment was performed, merging the results of two separate iTRAQs with over-lapping 
samples into a single investigation of 5 potential neutral site candidates, including 2 controls, each 
with 2 experimental replicates.  Our USFD methodology was to merge of data from individual iTRAQ 
data sets, extending the number of practically available labels from 8 up to 14.  This was done by 
providing a 2 sample overlap between both experiments, cutting down the list of quantified proteins 
to only those isolated in both iTRAQs, and then normalising each of the protein ratios in the second 
iTRAQ to the mean of shared samples from the first iTRAQ. This represents a technical advance in 
iTRAQ data analysis. During the analysis, 639 proteins were quantified in total, with 444 proteins 
being common to both iTRAQs and carried forwards for further analysis. 
 
Each of the sites was investigated for systematic proteomic changes, and the work was integrated 
with transcription analysis performed by IBMC and modelling work carried out by UPVLC.  Three of 
the target sites showed tight clustering between paired replicates, however two sites had samples 
where the protein concentration varied significantly and resulted in a non-clustered effects. In 
addition, expression levels of GFP were quantified to analyse site production capabilities as well, 
these were found to be concordant with the expression levels identified by visual means.  No 
systems-level proteomic changes were identified in any of the candidate neutral sites, suggesting 
that there would be no significant impediment to growth (and therefore hydrogen productivity) 
between each of the sites (figure).  As a result, we recommend picking a site best tuned to the 
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expression level required for the genetic construct – which is dependent on future genetic 
engineering requirements.  The work has been published (Pinto et al, 2015) with all experimental 
details available in the paper.  USFD recommendations based on the iTRAQ work were compiled in a 




4 Summary of recommendations 
As detailed in this report, the following recommendations have been made to the CyanoFactory 
project: 
1. A standardised form for sample delivery for proteomic analysis has been issued, improving 
data quality and uniformity of downstream analysis of samples. 
2. A number of hydrogenase subunits were identified in UU samples, enabling trouble-shooting 
and further engineering of the hydrogen production machinery. This investigation identified 
that the inserted hydrogenase was being produced in the cells, although it was found 
through other investigation to be non-functioning. 
3. An iTRAQ investigating background proteomic effects of the transforming the external 
hydrogenase into a delta-hox background, produced by UU, showed that there was no 
significant systematic changes to the proteome under standard growth conditions. 
4. A technically advanced iTRAQ investigated 5 candidate neutral sites produced by IBMC.  The 
sites didn’t show any systematic changes to the proteomic network under normal growth 
conditions, but did have differing effects on the strength of expression of the inserted 
genetic construct. As a result, USFD recommends that the neutral sites chosen by partners in 
CyanoFactory for maximising hydrogen production should be tuned to the expression level 
required by the particular genetic construct – with details of the sites and their respective 
strengths available in Pinto et al., 2015. 
 
254 CHAPTER 8. APPENDICES
8.3 Deliverable 7.3
Partner 6 – The University of Sheffield 
Deliverable D7.3 
Final design analysis combining optimised cells in optimised photobioreactor configuration: -omics 
data and assembled metabolic network for best identified engineered system in suitable 
photobioreactor to date. Suggestions for improvements to the system (bioreactor and cell) to 
potentially increase H2 production.  
1. Introduction 
For our final deliverable report, USFD present the most recent work carried out in conjunction with 
CyanoFactory partners. In addition, a list of the experimental work to take place over the next 2 
months for omics level analysis is included, along with a roadmap for the publications that will be 
built from this work in the coming months. It is important to highlight that all samples presented in 
this report were made available to USFD in the final months of the project and so the research being 
presented here is bleeding edge. The recommendations presented here are valid and fulfil the 
requirements agreed to prior to beginning the project; and a more comprehensive analysis of this 
data will be carried out as this work gets converted into publications – in collaboration with UPVLC, 
CNR-ISE, RUB, UU, IMBC and UL.  All initial data and findings presented in this report have been 
forwarded to the respective partners who sent samples, and will be passed to UM to be uploaded to 
the data warehouse once the full analysis is completed. 
There are 4 major partnerships within CyanoFactory that have yielded the information presented in 
this report – investigation into the effects of the final design of the 1000 L outdoor photo-bioreactor 
(1000 L PBR) produced by CNR-ISE on Synechocytis over the course of a typical operational day, 
assessment of the reduced antenna Olive strain, isolated and characterised by RUB against the 
consortium WT strain using metabolic flux techniques, assessment of the hydrogenase active site 
complex investigation being carried out by UU, and investigation into the effects of key halo-
tolerance genetic modifications produced by IBMC using RNAseq and proteomic techniques. Each 
case has a dedicated section of this report, which summarise the work carried out to date, highlight 
the conclusions drawn from assessment of the gathered data; and then identify the next stages of 
work to be carried out, indicating how publications from the work will be approached. The final 
section of this report ties together key findings into an idealised combination of all aspects, with 
suggestions for future experiments or practices that should maximise hydrogen production and 
growth efficiency in an industrial setting. 
Publication Roadmap: Each of the sections mentioned in this report is building towards a 
CyanoFactory publication.  The CNR-ISE proteomic time-course assessments on how the cells change 
either during an operational day or over the course of hydrogen production will either be bundled 
into a publication combining the comprehensive operational analyses carried out by CNR-ISE and 
published with an operational biotechnology focus, or else the proteomic dataset assessments will 
be re-focused for proteomics journals, and will include details of best practices for the advancement 
of proteomic analyses in biotech targeted investigations.  The metabolic flux analysis of the Olive 
strain, which will feature collaboration between RUB, UPVLC and USFD, will be bundled with the 
proteomic assessment of the different olive strains (RUB, UU & USFD), forming an over-arching 
comparison between the consortium WT and the olive mutant.  The proteomic assessment of the 
UU synthetic complex upon the external hydrogenase will be completed as a self-contained report to 
UU, who will decide what the next course of action to build towards their publication on the 
synthetic hydrogenase will be, either through further experiments or else analysing the data with a 
focus to complete a biological story.  The RNAseq data and proteomic data collected for the halo-
tolerance experiment conducted by IBMC will be assessed with the assistance of UPVLC, who will 
contribute the statistical expertise needed to generate concordant findings between the two 
datasets.  The data should also provide additional information to improve the UPVLC Synechocystis 
model. 
In addition to the work presented here, USFD is also in collaboration with UL to characterise 
proteomic changes in samples from an experiment of samples grown in controlled media versus 
standard environmental conditions (brook water).  Through earlier discussions, USFD recommended 
UL make an analysis of the metals present in the water using inductively coupled plasma mass 
spectrometry, which they have completed.  USFD have the samples in-hand from UL, which are 
currently queued to run in the mass spectrometer and should be completed by the end of this week.  
Findings of this investigation will be processed and circulated to the consortium via the data 
warehouse (UM) upon completion of analysis.  The proteomic data for these samples will form part 
of a publication investigating the effects of Synechocystis released into the environment and the 
formation of biofilms.  
2. 1000 L outdoor photo-bioreactor 
The work in this section contributes towards O7.1, Task 7.3 and M7.3, by providing key proteomic 
datasets that feed into the best-case PBR design scenario. The findings in this section form the basis 
for this entire report, with output from the subsequent sections feeding back into it to keep the 
large-scale industrial applicability context of the CyanoFactory work in prime importance. The data 
here has not yet been circulated to the rest of the consortium, as further experimental processing on 
the samples will yield a more statistically significant and concordant dataset to upload to the data 
warehouse (UM). 
CNR-ISE and USFD had a series of discussions and Skype calls following the consortium meeting at 
UPVLC with regard to the best way to assess, using -omic techniques, the interesting findings CNR-
ISE presented during the meeting. It was decided that 2 experiments were of key interest to the 
consortium, the first was a time-course assessment of samples taken over a typical day of running 
the PBR and the second was an analysis of the changes that took place during large-scale hydrogen 
production. An analysis of the changes that took place in Synechocystis during a sharp spike in pH, 
such as the one used to remove external contamination from the bioreactor (please see D7.2), was 
also discussed – however it was felt that since there were multiple publications that already 
presented data on pH changes that this was a lower priority experiment to carry out. 
The daily time-course experiment was conducted first, as having a basic understanding of the 
systematic changes that took place over the course of a typical day was deemed to be the most 
important set of information to feed back to the consortium. This was decided because it presented 
information that could not be gathered or accurately simulated in any other way in the lab, and was 
vitally important to understanding changes that took place when simulating other experimental 
conditions in the 1000L PBR. Three replicate samples were collected from a continuous cultivation 
on separate days, which were chosen based on having similar temperature and cloud cover to a 
typical summer day in the north of Italy. The samples were taken at 4 time points throughout the 
day: 0900, 1100, 1400 and 1700.  The samples were collected from the reactor, spun down into a 
pellet of cells, and stored at -20 (-80 for long term storage). They were then mailed to USFD on dry 
ice – as per the standard delivery instructions devised during improvement of the proteomic 
pipeline. This is discussed in more detail in D7.2. 
The 3 replicates were designed into a 2-iTRAQ experiment, similar to the one conducted with IMBC 
during the neutral site investigation (D7.2), in such a way that the iTRAQs could be assessed 
independently or combined together. The first 8-plex had one label per time-point sample for the 
first and second samples days, whilst the second included the second and third sample days. Each of 
these iTRAQs was considered to be robust and suitable for publication in their own right; but as 
discussed previously (D7.2; Landels et al., 2015), it is important to raise the quality of proteomics in 
industrial biotech publications to improve systems-level engineering approaches. For our work here, 
data from the first of these iTRAQs is presented. In this analysis, 1870 proteins were identified and 
quantified, with at least 2 confident unique peptide identifications.  This represents ~85% of the 
entire observable proteome.  The samples were initially assessed for significance in systematic 
progression (ie. 0900 vs 1100, 1100 vs 1400, etc.), however this did not produce significant findings.  
This was investigated by generating a heatmap and applying Ward clustering techniques to see how 
the different labels related to each other (figure 1).  
 Figure 1: A heatmap of the time-course data collected from the 1000 L PBR by CNR-ISE. The Ward-
linkage clustering method shows high relatedness within sample B, leading increasingly similar 
expression profiles over the course of the day. Large variations are present in sample A, in time-
points 1400 and 1700 in particular. To clarify groupings, white separators have been included in the 
diagram. The protein clustering profile has also been included in this diagram as a dendrogram on 
the left; this is also calculated using Ward linkage. 
Figure 1 clearly shows a disparity between the first and second replicate set. Whilst heatmaps are 
useful for looking at data trends, they are of limited use in quantifying that similarity – for this 
purpose USFD typically engages principal component analysis (PCA) techniques to identify 
relatedness. PCA is a useful technique as it collapses the data from a multi-dimensional problem, 
where finding similarities can be challenging, into a lower-dimensional problem, where most of the 
sample variation is collected in the first and second principal components (figure 2). 
 
 Figure 2: A PCA plot showing all the samples plotted as reduced dimensional data-points. The first 2 
components (presented as the x and y axes in this figure, respectively) are responsible for ~75% of all 
variance within the iTRAQ experiment. Each faded black circle represents where each protein falls in 
the plot and the vectors within the circle indicate the Eigenvectors for each of the conditions.  In 
simple terms, the length of the arrow indicates the magnitude of change, and the angle of the arrow 
indicates the ‘direction’ of change, such that 2 arrows in a similar direction consist of a similar 
protein expression pattern, ie. B: 11:00 and B: 14:00 have almost equal orientation and magnitude, 
and so are ~75% – the variance explained by this figure – identical in protein expression patterns. 
Negative magnitude (B: 09:00 vs A: 11:00) indicates variance in the same set of proteins but in the 
opposite direction. It’s important to mention at this point that the angle in PCA has no bearing on 
whether proteins in the set are in higher or lower concentrations, they either change in the same 
direction or opposite directions. For this reason, PCA alone cannot determine features about 
proteomic sets. Perpendicular arrows suggest that the vectors are changing independently of each 
other – in practical terms, the variance of protein expression in each of these samples is explained by 
different (independent) sets of proteins (ie. A: 09:00 and A: 17:00). A simplified variant of this figure 
is presented below, where the key findings are discussed further. 
  
  
Figure 3: This is the same PCA plot as presented above, although most of the features have been 
removed from it to make the explanation of effects within the sample simpler. As can be seen here, 
almost parallel vectors can be plotted running from 0900 for each sample through to 1700 (blue 
arrows). In replicate B, all the time-points fall near to this line, in the order of progression through 
sampling time. This is to be expected as systematic changes in proteome response to increased light 
and heat build-up in the system. In replicate A, sample 1400 (red circle) lies in the opposite direction 
to this vector. This suggests that there is a problem with this sample, enabling it to be excluded from 
the analysis at this time. This data also shows that there is a lot of independence between the two 
samples at the beginning of sampling, even though the direction of change across both samples is 
the same (in this case, upwards on PC2). 
Figure 3 highlights a potential ‘change vector’ running through the samples in the PCA plot. The 
14:00 sample taken from replicate A falls in the opposite direction to this vector, discordant with all 
other samples in the experiment, and so is considered to be an outlier to be removed from further 
analysis.  A comparison between the samples taken at 0900 and the samples taken at 1700 was 
made, to generate a list of proteins significantly affected over the time-course.  The large disparity 
between the initial states of these two samples (separation on PC1 in PCA, large dendrogram 
separation between identical time-points in heatmap), supports the limited number of significant 
identifications made between the two time-points (Figure 4).  Further analysis will increase the 
number of targets by applying more advanced statistical techniques to the dataset. 
The proteins identified as significantly upregulated are involved with reductive stress response, 
metal ion imbalances and nitrogen deficiency (list in appendix).  These are well documented effects 
triggered by high-light intensity or reductive stress, where the light-harvesting structures are 
damaged by high intensity light and must be regenerated by the cells.  Interestingly for 
CyanoFactory, the state the cells are in at the end of a day of high solar productivity is similar to the 
idealised state attained by creating artificial nutrient deficiencies or subjecting the cells to high 
intensity light.  This in turn means that having a system where the cells are producing biomass 
during the day before being subjected to anaerobic hydrogen producing condition in the 
evening/overnight may be highly advantageous to efficient hydrogen production.  Prior to 
publication, the remaining half of this iTRAQ experiment with the 2nd and 3rd replicates will be run on 
the mass spectrometer, to increase the statistical significance of these findings as well as providing a 
workaround for the outlying sample. 
 
Figure 4: Heatmap layout of the proteins found to be significantly up-regulated, outliers are excluded 
The next experimental samples to be analysed, which are now held in-hand by USFD, are the 
experiments from the large-scale hydrogen production experiment.  In this experiment, CNR-ISE 
subjected the cells to nitrogen starvation conditions over 3 consecutive days, before running a 4 day 
anaerobic hydrogen production experiment.  The observations from this experiment were very 
interesting; however the experimental design for analysing this data in iTRAQ 8-plex format is 
complex and involves 3 iTRAQ kits and a TMT 6-plex kit as a fail-safe. As in the 1st experiment, these 
data were collected in triplicate, with a morning (0900) and an afternoon (1700) measurement taken 
each day. The 2 days prior to hydrogen production tagged with 4 of the labels in each iTRAQ, and the 
first 2 days of hydrogen production tagged with the remaining 4 labels of each iTRAQ. The first time-
point (2 days prior to anaerobic conditions) and the first time point after hydrogen production has 
begun (first anaerobic measurement) for each of the 3 replicates will be labelled with TMT tags and 
compared to provide a linking dataset between the 3 iTRAQ experiments. Although USFD have 
identified previously (D7.2) that there is a compression effect on TMT tags in Synechocystis, any bias 
introduced through the use of TMT tags can be accounted for with a conversion factor as a result of 
the iTRAQ vs TMT modelled analysis work described in D7.2.  
3. Metabolic characterisation of the Olive strain vs WT 
The work presented in this section covers the requirements for M7.2, Task 7.2 and O7.3 by 
characterising a key chassis modification with metabolic flux analysis and proteomic investigation.  
The experimentation was carried out in the 5 L photo-bioreactor produced by KSD, as it was 
determined to be a suitable bioreactor system produced from the consortium.  These samples were 
collected close to the end of the project, and so the integrated analysis of the fluxes to be carried 
out with in collaboration with UPVLC is still underway.  The experimental data gathered and the 
time-course values already calculated will be presented in this section.  All data presented in this 
section has already been circulated to both RUB and UPVLC, and will circulated to the rest of the 
consortium (via the data warehouse produced by UM) once the findings have been analysed more 
comprehensively. 
Following on from the work in the previous section, it is apparent that one of the major contributing 
factors to any large-scale hydrogen production system in Synechocystis is how to utilise the effects 
of high-intensity solar radiation on the culture.  The olive strain, isolated by RUB, has a reduced set 
of antenna proteins that allow increased transmission of light through the culture. These effects 
have been characterised by RUB and modelled by UPVLC, with details described elsewhere in the 
CyanoFactory project.  A key future experiment would be to replicate the time-course experiment 
carried out in the 1000 L PBR with the olive strain, to see if the effects of solar radiation were 
equivalent, or if they had more rapid/slower onset.  Due to the high daily variability between the 
initial states of the samples measured within the 1000 L PBR, it is important to further characterise 
metabolic features of the olive strain – particularly when making comparisons against the wild type – 
to understand how far the conditions of the reactor (ie. the solar radiation) and how far the 
metabolic response of the organism is responsible. Without understanding where the division of 
responsibility for these effects lies, it is difficult to make recommendations for further improvements 
to either the chassis or the bioreactor. 
For this reason, the C13 labelling experiment was carried out on the olive strain and the consortium 
WT stain of Synechocystis, to determine if there were significant variations in the fluxes in the olive 
strain that might be important for future modelling work.  This work is completely novel – no one 
else has attempted to characterise the metabolic fluxes of the olive strain to date.  The 
experimentation was carried out in the 5 L KSD photo-bioreactor in RUB.  This is the largest feasible 
bioreactor the experiment could be performed in without making the cost of the experiment 
impractically large.  The cost for this work is almost completely absorbed by the large amounts of 
stably labelled carbonate needed for the experiment, with a single time-series replicate costing 
more than an 8-plex iTRAQ experiment.   
As this is the first time an experimental analysis of stably labelled metabolite samples from photo-
autotrophic conditions had been conducted in USFD, a number of preliminary experiments were 
required before the samples could be analysed.  The first of these was a test with key metabolite 
standards, to identify how the metabolites would act individually, in a simple mixture, and in a 
complex background.  A series of experiments with 5 standards chosen from the central carbon 
metabolism pathway were carried out, using the experimental technique described by Shastri and 
Young in their pioneering work on characterising the photo-autotrophic metabolic network in 
Synechocystis (Young et al., 2011).  From this, elution times for the measured metabolites were 
measured, along with the characteristic masses associated with the different metabolites to 
facilitate identification in a more complex mixture.  These times were compared to a series of 
elution times using the same liquid chromatography method (identical column, gradient, buffers) 
utilised by Dr Shastri in her doctoral thesis work.  This comparison enabled the inference of 
metabolite elution times, for compounds where standards were regrettably unavailable. 
The next series of experiments carried out by USFD were with physical dry-runs of the sampling 
experiment using shake-flasks.  By carrying out these runs on unlabelled samples, spiking in 
unlabelled carbonate to the mixture and running through the experiment, USFD were able to 
determine potential bottlenecks in the procedure. One of these was the grouping of samples 
together during extraction, to avoid losses caused by excessive resting time in methanol used for 
quenching.  This quenching step is vital for the experiment, however if the entire experiment is 
completed without removing the quenching agent quickly, then the metabolites will be leeched 
from the sample and the experiment will fail.  These samples were assessed with low resolution 
mass spectrometry in the same method used for the standards; however individual metabolites 
could not be confidently determined from the system due to high sample complexity. This 
necessitated the use of high resolution mass spectrometry, which was available but would require 
re-organisation of the system and was to be conducted at a time when the demand for the machine 
was lower. .  Due to booking constraints, all high-resolution analysis was run at the same time, which 
took place in December 2015 after the final samples had been collected in RUB. 
Once the experimental procedure had been characterised for completion in USFD, test runs using 
labelled carbonate were carried out on batch shake-flask cultures.  These samples were assessed for 
the presence of 13C labelling using low resolution mass spectrometry, to confirm increasing levels of 
labelling could be detected, although as stated above individual metabolites could not be 
confidently determined from the system, due to high sample complexity.  Following confirmation 
that each part of the analysis could be completed at USFD, a PhD student from USFD travelled to 
RUB to translate the experiment to the KSD 5 L PBR in September 2015.  During this visit, there was a 
key transfer of information both from RUB to USFD and vice versa. RUB shared extensive knowledge 
concerning both the running and maintenance of continuous culture bioreactor systems, as well as 
the growth features of the olive strain.  USFD explained the experimental process and highlighted 
the key findings that the preliminary experimental work showed.  Together, USFD and RUB devised a 
method for running the experiment, however due to an unforeseen culture crash with the cultures 
in the bioreactors the sampling could not be completed before the end of the visit. RUB further 
characterised the 13C spike method and successfully produced the samples for analysis in November 
2015, which were analysed using high resolution mass spectrometry by USFD – (data shown in 
Figure 5). 
The next step for this analysis is to work with UPVLC to determine the fluxes of the identified 
metabolites, which will be done using the INCA framework devised by Jamey Young.  Once these 
fluxes have been determined, a more kinetically accurate model of the olive strain can be computed.  
This will provide better understanding of the differences and similarities of these strains.  
  
Figure 5: Top: Isolated data for Fructose-6-Phosphate at 4 time-points in WT Synechosytis, shown as 
an example of raw data from the mass spectrometer. Bottom: the distribution of metabolites shown 
over the time series for 2 identified key metabolites in the central carbon metabolism, 3-
phosphoglyceric acid (3PG) and fructose-6-phosphate (F6P). Due to a problem during sampling, the 
30 minute time-point and 30 second time-point were unavailable for the Wild Type; however these 
are not needed to calculate the system fluxes. 
In addition to the work on metabolic flux analysis, protein samples have also been gathered by RUB 
and UU for both the UU WT strain and 2 genetically distinct olive strains.  These samples have been 
processed in such a way that the membrane proteins and soluble proteins were collected separately.  
This will enable a final comparison between the cost-efficient merging of these fractions against the 
potential signal stability offered by processing the samples separately (D7.2). These protein samples 






4. Characterising the external hydrogenase system 
The work presented in this section contributes to O7.1, Task 7.2, and M7.4.  This section highlights 
work that demonstrates a clear progression from the samples described in D7.2, where USFD gave 
feedback on the engineering work performed by UU.  It is a key example of the iterative 
improvements to the system described in M7.4.  
UU have done extensive work generating a mutant Synechocystis containing an exogenous 
hydrogenase enzyme.  Having successfully transformed the HydA1 hydrogenase (apo enzyme) from 
C. reinhardtii into the delta hox background, it was found that the active site the hydrogenase 
required to function would not form.  When a synthetic variant of this site was generated using 
synthetic chemistry methods combined with the enzyme it was shown to have the ability to produce 
hydrogen. USFD ran an 8-plex iTRAQ analysis to investigate the changes found to occur within the 
cells under hydrogen production conditions utilising this compound.  The key comparison in the 
iTRAQ investigated the effect of the presence and absence of the synthetic complex (+ vs -) to the 
cells containing HydA1 in the delta hox background.  A control comparison was also carried out to 
investigate systematic effects of the synthetic complex in a delta hox background where no HydA1 
was expressed.  1980 proteins were quantified with 2 or more confidently identified unique peptides 
in the experiment, representing ~90% of the observable proteome. This is the largest number of 
unique protein quantifications of Synechocystis identified by USFD to date.  The HydA1 protein was 
successfully identified to a high degree of confidence. 
Initially, the data were plotted on a with a PCA unit circle to identify sample grouping and make sure 
that there were no unexpected effects that could cause problems for statistical analysis of the data 
(figure 6).  For further details on this type of figure, please see section 2 of this report.  The PCA plot 
confirmed that most of the systematic variance in the data occurred between the HydA1 mutants in 
the presence and absence of the synthetic compound.  This comparison was run though our 
statistical pipeline, generating a list of 584 significantly up- and down-regulated proteins between 
the conditions.  In addition to this, a protein ‘trend effects’ analysis was conducted (figure 7, figure 
8), identifying 710 potential candidates for investigation into systematic effects. This highlights 
proteins that show systematic changes concordant with the statistically significant proteins, but lack 
the peptide-level evidence to generate statistically statistical leads.  Both of these datasets have 
been included with this report as appendices. 
Due to an issue with the KEGGmapper bioinformatics software, pathway maps are currently 
unavailable for this data.  In lieu of that, the data here are presented with functions as general 
descriptors.  These findings have been sent to UU to discuss potential proteomic leads, since 
pathway level information is not currently available and the list contains multiple protein systems.  
The data will also be further analysed in collaboration with UPVLC, to attempt to map them onto the 
best case metabolic pathway available to date.  Discussions are underway to determine the next 
proteomic experiment necessary to further characterise the system and aid a publication of these 
findings. 
 Figure 6: A unit circle PCA diagram, showing the general grouping of the different conditions 
investigated in the 8-plex iTRAQ experiment.  The principal components account for ~70% (PC1 - 
45.8%, PC2 - 25.8%) of the cumulative variance in the sample.  The HydA1 mutants are all separated 
from the delta hox background across the 2nd principal component, suggesting an underlying 
systematic change resulting from the presence or absence of the inserted hydrogenase.  There is a 
clear separation across the 1st principal component for the presence or absence of the synthetic 
complex in the HydA1 mutants indicating a systematic difference in the cells that are able to produce 
hydrogen.  This is not as clear in the delta hox background mutants, where the samples are more 
closely clustered by parallel experimental repeat. Due to the clustering effects, this plot suggests that 
the 2 comparisons of most interest from this data are HydA1(+) against Hyd1A (-), and all the Hyd1A 
mutants against all the delta hox mutants. 
 Figure 7: A heatmap of the HydA1 proteomics 8-plex iTRAQ, the dendrograms on this heatmap use 
Ward linkage and the coloured bars on the left of the figure group proteins by cutting the 
dendrogram off at the point where there are 4 branches.  This data is in agreement with the features 
seen in Figure 6, with close clustering of the hyd1A mutants in the absence of the synthetic complex.  
The coloured clusters on the left of the diagram were added as an attempt to categorise protein 
expression patterns by systematic expression trends, in the absence of a functional KEGG map tool. 
 Figure 8: A PCA plot showing the condition vectors describing the effects seen in the experiment 
within a unit circle (pink).  The proteins are overlaid as faded circles, coloured according to which 
cluster they were localised in from Figure 7, with the area best representing each cluster highlighted 
with a coloured oval.  This figure shows that the clusters separate the different clusters out across the 
first principal component.  Proteins in the red and green clusters appear to be associated with the 
presence or absence of the synthetic complex.  The PCA alone cannot determine direction changes, 
however when considering both Figure 7 and 8 simultaneously it emerges that the red cluster 
contains proteins generally up-regulated in the presence of the complex, whilst the green cluster 
contains proteins generally down-regulated in the presence of the complex.  This gives us a key 
insight into the proteins responsible for the variation observed on the 1st principal component. 
  
5. Investigation of halo-tolerance genetic modifications 
The work presented in this section covers the requirements for O7.2, Task 7.2 and M7.3 by 
characterising a genetic modification with RNAseq analysis and proteomic investigation.  The 
transcriptomic analysis was initially planned to be carried out annually using microarrays, however 
an oversight in the budget assignment of ‘consumables’ caused a delay with this, as some of the 
funds needed to be categorised as ‘services’ to have the arrays read.  This was correction was agreed 
at the mid-term meeting and confirmed at the 24 month point.  During this delay, developments in 
RNAseq technology meant that for an equivalent cost, a more sensitive RNA analysis could be 
performed.  This work was combined with a proteomic analysis, to generate the integrated –omic 
analysis mentioned in O7.2.  All of the RNAseq samples were combined into a single, multi-condition 
comparative experiment covering both an investigation into genetic modifications to the chassis, as 
well as environmental changes to the bioreactor by adding NaCl, satisfying the requirements for 
M7.3. 
Beyond modifications to the hydrogen production systems, it’s important to consider the media 
conditions within the 1000 L PBR and whether it can be made more economical, by removing the 
requirements for 1000 L of fresh water for every run.  Discussions with IBMC in Ljubljana during the 
24 month consortium meeting lead to plans for an experiment investigating the effects of halo-
tolerance gene knock-outs/over-expression in low and high salt conditions. The experiment 
investigates the effect the genes glucosyl-glycerol-phosphate synthase (ggpS) and glucosyl-glycerol-
phosphate phosphatase (ggpP). Three genetic conditions are investigated: WT, ΔggpS, and OE ggpS 
+ ggpP.  For each of these, 3 environmental conditions were investigated: 0% NaCl, 3% NaCl and 3% 
NaCl (9 day culture).  Two experimental replicates were taken of each condition in the experiment, 
resulting in 18 samples.  As there was only funding available for 16 samples, the 9 day culture NaCl 
was removed from ΔggpS.  A post-doc from USFD travelled to IBMC for a period of 1 week, to assist 
with the extraction of RNA and to provide continuity with the sample analysis.  As with the 13C 
metabolic flux analysis experiment, this is the first time USFD has performed an RNAseq analysis on 
Synechocystis and so a more detailed 
analysis of the data will follow as 
familiarity with the data structure 
improves.  The initial investigation on 
these data was targeted to a list of genes 
provided by IBMC as potential targets of 
interest, one of these, the sucrose 
biosynthetic enzyme spp (slr0953), was 
found to have increased expression in 
the ΔggpS conditions (Figure 9). 
 Figure 9: Absolute transcript levels in 
fragments per kilobase pair for the gene 
slr0953. The levels were found to be 




Figure 10: Summary analyses performed on the RNAseq data. Top Row: A density plot and heatmap 
of all genes identified during the experiment.  The density plot shows that there is an even 
distribution of transcript intensities between all samples after normalisation.  The heatmap shows 
the general clustering between the samples exposed to 3% salt stress versus the ones not exposed to 
salt stress.  Samples that have been genetically perturbed, either as a KO or OE, appear to cluster 
apart from the WT samples. Bottom Row: A volcano plot and scatter plot comparing WT 
Synechocystis in 0% NaCl against3% NaCl conditions.  Genes which show statistically significant 
differential expression are highlighted in red in the volcano plot.  This is 1 of 28 comparisons made 
between the different experimental conditions, the full list of which are available as appendices to 
this report. The graphics in this figure were generated with R, using the cummeRbund RNAseq data 
analysis package. 
The RNA analysis identified 2214 genes, with 4264 isoforms, 4188 transcription start sites, 3562 
coding sequences and 61992 promoters within the genome over the 2 replicates of 8 conditions.  
There is a large amount of analysis still to take place on this extremely comprehensive dataset, 
which will take place over the coming months as our bioinformatics experts become more familiar 
with the data structure and utilise more of the features in the data.  This RNA expression dataset 
details important information about the consortium strain, and is a useful complementary addition 
to the genome data of the consortium strain analysed by UM.  This data will be passed to UM to be 
uploaded to the data warehouse. 
In addition to the RNA analysis performed on the experimental set up, additional samples were 
collected to perform proteome analysis.  As there are 8 samples with 2 replicates, the clearest 
sample combination approach was to run 2 separate iTRAQ experiments, with replicates being run 
on separate iTRAQs.  The reason for this design is that previous experimental experience at USFD has 
shown that as long as there is data from similar conditions present in both iTRAQS to normalise the 
absolute values against; the scale of variation and direction of change of protein expression can be 
accounted for.  The first iTRAQ experiment has been run, however as there is currently no 
replication data and therefore no variance, no statistical analysis has been performed on this data to 
date.  In this first iTRAQ, 907 proteins were confidently identified and quantified, with 2 or more 
unique proteins (appendix).  Integration of the proteomic and transcriptomic data is recognised in 
the literature as a challenging endeavour (Haider and Pal, 2013).  When preparing the experimental 
design with IBMC, certain features such as concurrent sampling for RNA and protein from the same 
flasks, was agreed upon to make the data more suited to this task.  The final output of this work will 
be presented as a publication in collaboration with IBMC.  
6. Summary of final recommendations to the consortium: 
A number of areas of interesting future research are highlighted in this report.  Whilst there are still 
several datasets waiting to be run and analysed, due to a high volume of samples from the 
consortium arriving the last quarter of 2015, there are clear patterns for future investigation 
emerging from the data that we have analysed so far: 
 Exposure to the sun over the course of the day builds up reductive stress and activates the 
proteomic profile for hydrogenase expression.   
 Collected data suggests that timing the O2 removal for after 5 pm following an aerobic 
growth phase during a sunny day should trigger significantly increased H2 production.  
 Additionally, the cells have naturally lower levels of nitrogen as they are repairing the 
photosystems which coincides with a wealth of established literature on H2 production. 
 It would also be interesting to measure what levels of intracellular oxygen might be present 
with biological modelling of light vs dark phase growth. 
 USFD recommend running the 1000 L PBR time course experiment with the olive strain by 
RUB to compare against WT and to provide important data on the scaled up growth of olive 
in outdoor conditions. 
 The UU synthetic site doesn’t appear to generate a systematic effect on delta hox 
Synechocystis without a hydrogenase apo-enzyme. 
 The UU synthetic site produces a large number of systematic changes in delta hox 
Synechocystis with a hydrogenase apo-enzyme, suggesting the possibility of a phenotypic 
rescue.  This suggests that the synthetic site may act as a suitable positive control for 
structurally accurate genetically engineered expression of the active site. 
274 CHAPTER 8. APPENDICES
8.4 Neutral sites analysis report
Neutral site proteomics report
Mathematica data analysis by Andrew Landels
Experimental description
2 iTRAQ experiments were run as part of a single investigation into 5 neutral sites in the Syne-
chocystis PCC6803 genome, denoted 5, 8, 10, 15 and 16. Controls in these experiments were the 
wild-type unmodified Synechocystis and a blank insert (at site 15). In all other cases GFP was 
inserted into the genome at the site of interest.
To link the two iTRAQ experiments together, the same WT Synechocystis samples were used in 
both cases. These experimental repeats are individually labelled in the experiment to differentiate 
them, this same differentiation is not done with any other samples.
The labels were assigned as follows:









Where a or b indicates the iTRAQ, the number indicates the site and the value following the hyphen 
indicates the treatment (GFP is shortened to G in the diagram labels).
Standard proteome pipeline investigation
Initially, we analysed both iTRAQs individually with our proteome pipeline (Khoa et al. Proteomics. 
2010 Sep;10(17):3130-41. doi: 10.1002/pmic.200900448) to generate a list of proteins that 
appeared to be significantly up or down regulated based on a P-value cut-off. Unfortunately, due to 
a loss of some experimental material from 1 of the iTRAQs (iTRAQ a) a direct comparison using the 
standard pipeline was difficult to acheive.
We produced a series of initial figures assessing the iTRAQs individually for relatedness and sent a 
list of proteins from signifiQuant which passed the statistical stringency test for being up or down 
regulated.
To generate a more informative analysis, we decided to investigate the effects of the combination of 
both iTRAQs in more detail, particularly from a clustering point of view. The first step was to work 
forward from the data that we had gathered from our proteomics pipeline. 
(1) iTRAQ a 464 proteins (with 2 or more peptides)
(2) iTRAQ b 631 proteins (with 2 or more peptides)
12 18185 444
We found an intersection of 444 proteins that had been successfully quantified by the standard 




















The values in this investigation were all generated relative to tag 113 (WT), which forms a joining 
point between the two datasets, however with the exception of the linking tag the two iTRAQs 
cluster separately. This is particularly notable for WT2 and is likely due to either the additional 
information present in iTRAQ b, or the manner in which the standard pipeline handles 0-intensity 
values.
As a result, it is difficult to draw clear conclusions about the features of the sites in general by meta-
analysis of the terminal data alone.
Manually normalising the data
The first step was to look at the raw peptide information. The number of peptide spectral matches 
(PSMs) was compared.
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iTRAQ PSMs Unique Sequences Proteins
a 7999 1923 540
b 14814 3306 722
In total, 749 unique proteins had been identified with at least 1 PSM
We assessed both Channel sum - equalising the sum total intensity for each label - and median 
correction as normalisation methods for this data. Median correction was used as it produced a 
better ranking effect.
As certain proteins (notably GFP) were either below the level of detection or not present in all 
samples, a value α was added to all the label intensities. This has two benefits, firstly as we’re 
interested in ratio data it removes 0s from the analysis which removes the infinite value (divide by 0) 
issue from the analysis. Secondly, as α is a fixed value it masks low-intensity labels which can 
contribute to abnormally large ratio readings. This is shown below for iTRAQ a, but the graph for 
iTRAQ b is almost identical (with the exception of the x-axis being almost double the range).








Prior to α addition, x-axis = ranked PSMs by reporter intensity, y-axis = intensity.






Following α addition. α is set as 0.5, which removes the inaccurate low-intensity readings whilst not 
affecting the high-intensity readings.
The next step was to select only high-quality proteins for comparative analysis. As a result, the 
datasets were filtered by peptides twice - only proteins that had both 3 or more peptides for quantifi-
cation AND at least 2 unique sequence matches were retained. A total of 552 conidently identified 
and quantified unique proteins were found in the entire investigation, of which 365 overlapped 
between the two experiments.
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iTRAQ PSMs Unique Sequences Proteins Intersecting Proteins
a 7656 1719 371 365
b 13327 3090 546 365
The intensity values were converted to natural log form and the geometric mean was calculated for 
each of the common proteins. The final step in normalisation was to generate ratios. To avoid 
having a single label generating all the ratios and therefore having all values on that label collapsed 
down to 1, all labels were divided by the mean of both the WT samples in each iTRAQ.
Cluster Analysis 
The first step in assessing the normalised data is to quickly look at all the values to check consis-
tency with a heatmap.
At a glance (not shown), the WT labels show very similar patterning which is a good sign. On close 
examination there is a checker - board type effect, indicating that the experimental samples are 
varying in similar directions rather than clustering by experimental replicate.
The test conditions also look like they have the correct patterning. The telltale sign of this is the GFP 
intensities (right - most column) which are visible for all samples that have GFP, but not for the WT 
(top 4 rows) or the blank (middle rows) controls. A second, larger version of this heatmap is pro-
vided as an appendix at the end of this report.
Over-interpretation of a heatmap can be misleading, however there do seem to be certain proteins 
in b5-GFP and b10-GFP that show similar patterning. This is clearer when using cluster tools such 
as a dendrogram or heatmap.
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aWT bWT bWT2 aWT2 a15_blank b8G b8G b10G b5G a15G a15G a16G a16G a15_blank b5G b10G
This dendrogram shows a clear relatedness between matching wild-type Synechocystis samples 
from the different iTRAQ experiments. It nicely demonstrates the amount of experimental variation 
(a vs b) as well as the experimental variation (WT vs WT2).
The GFP mutants all cluster clearly together away from the WT controls, although the blanks don’t 
appear to be clearly separated in this graphic. The amount of experimental variation between paried 
samples for sites 8, 15 and 16 match the expected experimental variation (based on the WT con-
trols). The variation beyond experimental variation for these samples appears to be minimal. 
Notably, b5-GFP and b10-GFP have suppressed the diagram by being significantly different to all 
the other samples, reflecting the observation made earlier on the heatmap.
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The pca plot clearly shows 3 clusters. For a simple interpretation of the axes, the y-axis relates to 
the amount of GFP detected, where lower values on the axis indicates an increased amount of 
GFP. The x-axis (responsible for the majority of the data variation) appears to be related to other 
background effects within the cell.
The top-right quadrant contains the control samples including the blank insertion control, the experi-
mental-replicate clustering is clearer on the dendrogram as the samples are too crowded on the 
PCA, however it is interesting to note that the blank clusters closely to the WT, albeit with slightly 
more variation between the two experimental repeats than the unmodified cells. 
The lower-right quadrant contains most of the GFP insertion mutants. The 15-blank cells show the 
same amount of x-axis spread-separation between the biological replicates as amongst all the 
clustered GFP-insertion mutants, suggesting that there are no major side-effects proteomically as a 
result of gene insertion into 3 of the neutral sites - 8, 15 and 16..
The left-half of the plot contains the final two samples, b10-GFP and b5-GFP. These show notable 
changes in the background variation axis, although as only an individual repeat has shown this 
effect in both cases it is difficult to assess statistically significant site-specific effects from the data 
we have available.
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PCA plot of proteins. A version with annotation is in the appendix, however the labels are cluttered 
and difficult to read.
The protein PCA shows a relatively small number of proteins that stand out from the rest of the 
proteins identified in the experiment, however these don’t shed much light on pathway-level 
changes withing the cell. 
Here we’ve highlighted a couple of directions of change on the PCA, the trend towards the bottom 
left corner is purely centered around photosystems, energy and carbon fixation. The 3 proteins 
pushing away from the bulk of the proteins at a perpendicular angle towards the middle top are 
mostly uncharacterised and don’t show any specific trend in function.
(top center)
P42212 = GFP 
Direction 1 (Origin towards bot left, starting on the left)
P29254 = PS1
P29256 = PS1
m1m7g3 = phycobili prot 
m1m7t6 = ribulose bisphosphate carboxylase
m1ml90 = fructose bisphosphate aldolase
m1lgt6 = atp synthase
m1mdr0 = uncharacterised aldehyde lyase
m1lzc3 = phycobili prot
Direction 2 (middle right, starting from the top)
m1mf82 = uncharacterised (hydrolase GO)
m1lhp6 = quinone oxireductase
F7URK1 = uncharacterised
Relative GFP levels
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The table below shows the relative amounts of GFP that have been detected. It is important to note 
that these values have been calculated relative to a given α value and so values from non-GFP 
producing strains can be considered as the noise level. As a result, the variation between iTRAQ a 
and iTRAQ b make cross-iTRAQ investigation of these values impractical.
Each table contains two rows, the first is the Log of protein intensity, the second is the predicted 
ratio-linear values.
aWT aWT2 a15G a15G a16G a16G a15_blank a15
1.00393 0.996067 7.28006 6.80283 6.77149 8.11185 0.556368 0.866531
2.72899 2.70761 1451.07 900.393 872.612 3333.73 1.74433 2.37864
bWT bWT2 b5G b5G b8G b8G b10G b10G
0.98286 1.01714 5.01068 3.9141 5.99852 4.63505 5.25372 2.30489
2.67209 2.76528 150.007 50.104 402.832 103.033 191.276 10.0231
Sample a15-GFP seems to have the most consistent GFP production levels. Generally speaking, 
the protein production in neutral sites tends to vary by up to about a 4-fold amount between repli-
cates. It is important to note that the outlying b10-GFP has much lower GFP intensity than its experi-
mental counterpart, a 20-fold reduction with measured levels approaching the noise level. 
b5-GFP production seems to be about half that of b8-GFP. This might be an indicator of genetic 
interference with protein production in these sites. 
To generate more accurate data on these values, it might be worthwhile running a targeted pro-
teomics experiment to get directly relatable spectral counts on all these proteins, coupled with some 
other form of measurement such as transcript analysis or fluorescence intensity.
Further work
These are things that I intended to do with this report, but had so much trouble re-working the data 
into a compatible form that I decided to send on what I had now just so you could see that we’re 
making progress. Apologies again for the delay with this - I’m still learning a lot on the way! :-)
* Run signifiQuant with b10G and b5G vs WT to look for specific proteins that seem to be coming 
up in the heatmap.
* Re-work the α value to be relatively peptide specific to make the GFP values more stable. (I’ve 
done this on a previous analysis and I’m still undecided what the best way to go forward with it is)
* Generate a protein-labelled dendrogram-heatmap in the R, to look more closely at the protein-
specific clusters in the data rather than just the label clustering effects. This might highlight protein 
families of interest that whilst not appearing on the signifiQuant analysis might make sense in GO 
terms or on a KEGG map.
Appendix - heatmap
The columns are (from left to right)
4x WT, 2x 15-GFP, 2x 16-GFP, 2x 15-blank, 2x 5-GFP, 2x 8-GFP, 2x 10-GFP
The outliers are the far-right column and 5th from the right.
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1.9 The ideal cleavage patterns of a peptide following collision. Rn are the func-
tional groups on the amino acids and dotted lines indicate fragmentation -
for example fragmentation between R4 and R5 would produce fragments b4
(amino fragment) and y4 (acid fragment). Observation of these fragments
within a spectrum enables identification of the sequence of the amino acids
within a peptide. Taken from (Steen and Mann, 2004) . . . . . . . . . . 55
1.10 A summary of isobaric tags. A: The isobaric tag is made up of an amine
specific peptide reactive group enables the tag to bind to the peptide, and
a reporter and balancer group that weigh equal amounts cumulatively. B:
This image shows the tag covalently bound to a peptide. In this example,
the isobaric tag is an iTRAQ 4-plex. There are 4 tags with m/z values
differing by 1, and each phenotype is labelled with a different tag. At this
point the weight of all phenotypes has been increased by an equal amount,
due to the balancer group. C: When the peptides move into the spectro-
meter, they remain isobaric within the survey scan, but during the collision
phase they fragment. The reporters from the tags are then measured by
spectrum intensity, which can be used to determine quantifications. Taken
from (Ross et al., 2004b) . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
1.11 Two plots populated with data generated from the same formula, y =
0.1×x+sin(x). In the first case the linear model appears to fit well (left),
but further observations may reveal this to be an incomplete picture of the
underlying trend (right). . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
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2.1 The number of proteins identified in each proteomic study of Synechocystis
per year. All studies that confidently identified more that 1000 proteins
are highlighted in yellow, all the green points were conducted by the same
lab over the last 4 years, and the point in red was the first study that
focused primarily on increasing the number of protein identifications. . . 72
2.2 A slice of a gel image, showing a size ladder in the top row and Synecho-
cystis proteins in the bottom row. The four strongest bands on the gel
are the phycobiliproteins, which dominate the protein sample. The blue
colour on the proteins here is as a result of dyeing with the Bradford re-
agent, however the phycobiliproteins also showed as a blue shift on the
band whilst the gel was running. . . . . . . . . . . . . . . . . . . . . . . . 72
2.3 The topics being published in Synechocystis over time. Each publication
was given a tag based on the topic, which are as follows: mut – Mutant
study; rev – Review; starv – Stress, Starvation; tol – Stress, Tolerence; tech
– Technical improvement study; exp – Exploritory Studies. In cases where
a publication addresses multiple topics, it was assigned multiple tags, to
reflect current knowledge and direction of interest in the field. No single
publication was given multiple counts of the same tag, regardless of the
size of the study. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
2.4 The overall number of publications per month since January 2012. The
levels remained largely steady until a large spike in publications at the
beginning of 2015 – the dip at the end of the graph results from an in-
complete set of data, as this was collected over the first 16 days of March,
2015; suggesting a continuation in the publication trend. This figure is
taken from the supplementary materials of (Landels et al., 2015). . . . . 73
2.5 A selection from a rank-plot of the 200 most frequently used words in ab-
stracts of production-strain proteomics publications, ranked by frequency.
Words in blue are higher-ranked in production-strain proteomics than in
proteomics in general; words in red are lower ranked, words in black have
not changed relative position. Faded words have changed rank by 5 places
or fewer and words in bold-face are only present in the production-strain
list. The solid line indicates the change in rank. This figure presents a
snapshot of the full list, which is available in the supplementary material. 87
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3.1 Synechocystis cells being visualised under a microscope. When counting
with a haemocytometer, cells that appeared as type A were considered to
be a single count, whilst cells of type B, where a septum had begun to form
for cell division, were counted twice. This was done to provide some degree
of consistency between cells counted near the start of the measurement,
and those counted towards the end or on a recount. These images were
taken with a light microscope under a 100-fold magnification, where the
bars are approximately 2 microns across. . . . . . . . . . . . . . . . . . . 104
3.2 Samples prior to H2 sampling. Each serum bottle has been capped with a
rubber septum and sealed over with parafilm. . . . . . . . . . . . . . . . 106
3.3 A flow-chart outlining the experimental design used in the BG11 vs Bur-
rows proteomic experiment. The entire experiment starts from 4 separ-
ate flasks which produced paired replicates through the experiment; which
are subsequently exposed to differing media and environmental conditions.
This was done to keep the proteomic background as similar as possible
between the replicates. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
3.4 Cell culture was grown in BG11, transferred to either BG11 (left) or auto-
claved Burrows media (right) and 100 µl was left overnight within a cu-
vette, which was topped with parafilm to prevent evaporation. Some set-
tling was observed in BG11 media, but a much more substantial separation
event was observed in the Burrows media. As a result, for all further ex-
perimentation the constituents of the Burrows media were prepared sterile
and combined under sterile conditions to autoclaved dd-H2O, which did
not show the same settling effects (data not shown). . . . . . . . . . . . . 110
3.5 Cells were transferred at OD 1 into serum bottles under different growth
conditions overnight, to determine if any clear physiological changes would
take place, such as the settling observed in the autoclaved media. Trans-
ferring the cells to serum bottles did not appear to make a clear difference
over a 24 hour period under either media condition when bubbled with
either air or nitrogen. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
3.6 Within the KEGG structure, metabolites are nodes and proteins are edges.
Proteins that are found to be statistically ‘up-regulated’ or ‘down-regulated’
in a condition will result in the colouring of any node that they point to.
Conflicts aren’t resolved in this with kinetics, and so the last colour over-
laid onto the figure will dictate the apparent fold change; as a result these
figures are guidelines rather than definitive informative graphics. . . . . . 112
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3.7 A coloured KEGG metabolic pathway map, the nodes are metabolites and
the edges are proteins. The proteins that were identified in the study are
highlighted in black – it is important to note that only the proteins were
identified, and so the nodes are inferred by the identification of an edge.
The different pathways have been approximately grouped and highlighted
in a colour, to aid understanding of the major effects in the different com-
parisons in this chapter. . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
3.8 KEGG pathway maps highlighting the changes between aerobic and an-
aerobic states in BG11 (top) and Burrows media (bottom). In both cases
there is a relative reduction in carbon fixation, however BG11 shows a
large reduction in the pentose phosphate pathway, whilst Burrows shows
a systematic switch off in the GTP synthesis pathway. . . . . . . . . . . . 115
3.9 KEGG pathway maps highlighting the changes between BG11 and Burrows
media under anaerobic (top) and aerobic (bottom) conditions. Across
both states, the effects of the media change are uniform and highlight the
dominant effects the media produce on the cells, suggesting a completely
independent effect to oxygen availability. In both cases, proteins that
heavily consum nitrogen – in this case the photosynthetic machinery – are
less abundant in Burrows, whilst machinery that recycles nitrogen, such as
amino acid biosynthesis, is much more active. In Burrows ATP and GTP
production are both up, along with lipid metabolism, indicating a higher
turnover of cellular energy and membrane breakdown. . . . . . . . . . . . 116
4.1 A protein gel showing a full set of samples extracted with the improved
method, demonstrating a broad extraction range across the proteome. This
extraction technique does not produce a bias against proteins based on size.129
4.2 Whilst these metabolite samples were not analysed, this clearly shows that
the same extraction technique is suitable for lysing cells for metabolomic
analysis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
4.3 A comparison was run between Synechocystis peptides separated on both
a HILIC column (top) and a Hypercarb column (bottom), using the same
buffers and buffer ramp profile. The Hypercarb column showed a much
more even distribution of peaks across the chromatography profile, sug-
gesting a more even separation of peptides within the sample. . . . . . . 131
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4.4 A wave-scan of whole-cell Synechocystis under increasing light intensity
(solid, to dashed, to dotted lines respectively), adapted from (Kopečná
et al., 2012). Three verticle lines have been added to the plot, highlighting
the different absorbances for the bicinchonic acid assay, Bradford assay,
and Folin’s phenol assay (running from left to right). The peaks for phy-
cocyanin and chlorophyll are indicated with the maximal absorbance values
(620 and 682 respectively). . . . . . . . . . . . . . . . . . . . . . . . . . . 133
4.5 A SDS-PAGE gel stained with Coomassie blue and a densitometry analysis
of the image. This shows the relative quantifications of protein between
the samples. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
4.6 A comparison between serial dilutions of a known BSA standard and Syne-
chocystis proteins from a proteomics experiment on H2 production. Whilst
the two curves are not supposed to match, the ratio of the coefficients in
the general linear model should be consistant between the two. The Syn-
echocystis proteins show a realtively higher contribution from high-order
polynomial terms, suggesting non-linear interferrence. . . . . . . . . . . . 137
4.7 A comparison between serial dilutions of BG11 and Burrows media. The
ratio of the coefficients in the general linear model should be consistant
between the two; but as in figure 4.6, this is not the case. The dilution
series are coloured by replicate. Cells grown in Burrows media appear
to show the heteroscedastisity expected in a hierarchically-linked dilution
series, whilst this is not as evident in BG11. . . . . . . . . . . . . . . . . 138
4.8 A Poisson distribution (left) and the histogram of the label intensities
measured in the empty iTRAQ channels (right). Due to the discrete nature
of the mass spectrometer measurements at low intensities, the data ob-
served approximates a Poisson distribution, which was therefore used for
the background noise model. . . . . . . . . . . . . . . . . . . . . . . . . . 145
4.9 Cluster plot taken from supplementary material in (Pinto et al., 2015).
This cluster plot was built through 2 replicates of a shared wild type (WT)
samples across the two separate iTRAQ experiments. These are labelled
as WT1 and WT2, with a and b denoting the iTRAQ experiment across
all of the samples. After normalisation, the samples clustered very closely
together across the two iTRAQ experiments. Two of the samples stood out
during the analysis as containing a substantially different set of proteins,
mainly related to the cell membrane. . . . . . . . . . . . . . . . . . . . . 155
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4.10 A box-whisker plot showing the range of peptide intensities (measured in
direct counts) before (top) and after (bottom) median correction. Post-
median correction values are in log space. Two iTRAQ 8-plex experiments
were plotted side by side, the first 8 from one experiment and the second 8
from the second. All values in the bottom graph were normalised so that
the median values were all equal, and so that the spread of the centre 10%
of the data fell within the same range. This transformation improves the
quality of the data in each experiment independently, but by itself doesn’t
improve the overall quality of comparison – please see fig 4.12 (p. 158). . 156
4.11 The same dataset from figure 4.10 (p. 156), scaled as described in the text.
The scalar transformation doesn’t affect the overall distribution of the data.157
4.12 A graphs made up of 2 separate iTRAQ experiments. The first row and
second row are each of the 4 different test conditions plotted against each
other, within experiment 1 and 2, respectively. Row 3 is biological replic-
ates plotted against each other between experiment 1 and 2 before scal-
ing; and row 4 is biological replicates plotted against each other between
experiment 1 and 2 after scaling. . . . . . . . . . . . . . . . . . . . . . . 158
4.13 A principal component analysis (PCA) on the dataset, where the letters
refer to experimental conditions and the numbers refer to replicates. 1
and 2 are replicates from the first experiment, and 3 and 4 are replicates
from the second experiment. In this PCA analysis, sample D4 has been
highlighted as an outlier. . . . . . . . . . . . . . . . . . . . . . . . . . . . 158
4.14 This PCA uses the same data as above, but with the proposed outlier
D4 removed. As PCA is vulnerable to outliers, since they compress other
effects in the data, this re-analysis was important to ensure the close clus-
tering observed was not an artefact of the outlier. . . . . . . . . . . . . . 159
4.15 The error outputs from each of the K-means top-down cluster simulations
(left), and the hierarchical graph of the bottom-up paired clusters, resulting
from the selected K-pairs cut-off in the bottom-up clustering (right). The
error within the dataset shows a diminishing reduction in error as the
number of clusters is increased. The selected clusters in the hierarchical
graph show this diminishing error is present in both bottom-up and top-
down calculations, as can be seen from the length of the edges in the graph.167
4.16 An example of how the output of the GO cluster tool would look when
applied to a dataset. The heatmap shows the different grouped clusters,
each assigned to a different colour (top). The GO analysis linked to the
different clusters is displayed in a bar chart, where the colours indicate the
cluster the analysis is linked to (bottom). . . . . . . . . . . . . . . . . . . 168
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5.1 These stacked bar charts show how the internal protein concentrations
within the experiment are initially balanced in the iTRAQ experiment,
but are then expanded to a much larger range through the use of a simple
dilution step. In this case, the different colours represent the amounts of
different protein labelled with each iTRAQ tag. The top bar chart shows
the master mix, whilst the chart below shows the mix after it has had a
dilution step applied to it. This dilution step is the same as the one used
in the 3rd experiment described here, and the chart indicates the relative
amounts of iTRAQ tag, and the corresponding protein levels, spiked into
the complex background. . . . . . . . . . . . . . . . . . . . . . . . . . . . 184
5.2 A scatter-graph showing the linear relationship between protein mass and
length in Synechocystis, and the corresponding histogram of protein masses.
96.5% of proteins are present in the 5 – 100 kDa range. (Image created in
Wolfram Mathematica, data obtained from uniprot) . . . . . . . . . . . . 189
5.3 A scatter-graph showing the relationship between protein mass and the
number of observable peptides within Synechocystis, and the corresponding
histogram of the number of observable unique peptides. The scatter-graph
shows far more variation between these values, compared with the length-
mass relationship, despite this the relationship between the two values is
largely linear with more stochasticity present. The majority of proteins are
present in the 5 – 100 observable unique peptide range, and so in figure
5.5 (p. 193), the higher value proteins have been excluded due to sparsity.
(Image created in Wolfram Mathematica, data obtained from uniprot) . . 191
5.4 Protein concentration distribution, measured in natural log, generated by
the emPAI formula. The distribution is almost Gaussian, however left tail
is cut down and falls off abruptly. This is likely due to the fact that the
proteins in this region are approaching the lower detectable limits of the
machine. (Image created in Wolfram Mathematica.) . . . . . . . . . . . . 192
5.5 At the top, the histogram shows observed proteins from the dataset against
all observable proteins in Synechocystis proteome, binned in groups of 5 by
the number of unique peptides per protein. The blue bars show an approx-
imation to the protein size distribution within the genome (see figure 5.2
(p. 189)), and the orange bars show the number of identified proteins from
each bin that were observed, demonstrating the sampling distribution for
the Synechocystis background. The observation rates are given in the bar
chart below. This figure shows that there is a bias against the identification
of very small proteins, with a general upward trend in the rate of identi-
fications, until the statistics become unstable in the sparser ‘higher-mass’
region of the proteome. (Image created in Wolfram Mathematica.) . . . . 193
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5.6 A 2x2 grid showing the simple mixtures and their diluted expansions. In-
dividual proteins from the spike-in mix are highlighted in the correspond-
ing colours in the legend, these are bovine serum albumin (P02769, red),
bovine β casein (P02666, green), equine cytochrome C (P00004, blue),
and equine myoglobin (P68082, magenta). The solid black line shows the
expected relationship between the observed and expected ratios. The dot-
ted line shows the best linear fit for the data when considering the entire
dataset. iTRAQ data are shown on the top row and TMT data are shown
on the bottom row. The shaded grey area around the lines indicates the
variance in the linear models applied to the data, the broader the shaded
area, the lower the precision. The hollow circles are individual data meas-
urements and show the abundance and spread of the data measured at
each point for each protein. (Images created with the ggplot2 package in R.)197
5.7 A 2x2 grid showing the simple mixtures and their diluted expansions from
figure 5.6 p. 197 under log-transformed axes. Proteins are bovine serum al-
bumin (P02769, red), bovine β casein (P02666, green), equine cytochrome
C (P00004, blue), and equine myoglobin (P68082, magenta). The solid
black line shows the expected relationship between the observed and ex-
pected ratios. The dotted line shows the best linear fit for the data when
considering the entire dataset. iTRAQ data are shown on the top row and
TMT data are shown on the bottom row. The shaded grey area around
the lines indicates the variance in the linear models applied to the data,
the broader the shaded area, the lower the precision. The hollow circles
are individual data measurements and show the abundance and spread of
the data measured at each point for each protein. (Images created with
the ggplot2 package in R.) . . . . . . . . . . . . . . . . . . . . . . . . . . 198
5.8 A 2x2 grid showing the complex bg mixtures. Individual proteins from
the spike-in mix are highlighted in the corresponding colours in the le-
gend, these are bovine serum albumin (P02769, red), bovine β casein
(P02666, green), equine cytochrome C (P00004, blue), and equine myo-
globin (P68082, magenta). The solid black line shows the expected rela-
tionship between the observed and expected ratios. The dotted line shows
the best linear fit for the data when considering the entire dataset. iTRAQ
data are shown on the top row and TMT data are shown on the bottom
row. The shaded grey area around the lines indicates the variance in the
linear models applied to the data, the broader the shaded area, the lower
the precision. The hollow circles are individual data measurements and
show the abundance and spread of the data measured at each point for
each protein. (Image created with the ggplot2 package in R.) . . . . . . . 200
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5.9 A 2x2 grid showing the complex bg mixtures from figure 5.8 p. 200 un-
der log-transformed axes. Individual proteins from the spike-in mix are
highlighted in the corresponding colours in the legend, these are bovine
serum albumin (P02769, red), bovine β casein (P02666, green), equine
cytochrome C (P00004, blue), and equine myoglobin (P68082, magenta).
The solid black line shows the expected relationship between the observed
and expected ratios. The dotted line shows the best linear fit for the
data when considering the entire dataset. iTRAQ data are shown on the
top row and TMT data are shown on the bottom row. The shaded grey
area around the lines indicates the variance in the linear models applied
to the data, the broader the shaded area, the lower the precision. The
hollow circles are individual data measurements and show the abundance
and spread of the data measured at each point for each protein. (Image
created with the ggplot2 package in R.) . . . . . . . . . . . . . . . . . . . 201
5.10 A comparison between the extended-range mix without the addition of a
complex background, with TMT on the top row and iTRAQ on the bottom.
The left column are the data collected from the QExactive HF, whilst the
right is data collected from the maXis. In this figure, each clear circle is
a protein quantification for a single label. All labels have been normalised
to the mean and put into a log scale, so the points at the top and bottom
of the image are from proteins with the furthest spread in ratio (1 : 37.5)
and the central points the smallest. (Image created in R.) . . . . . . . . . 203
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